
<html lang="en"     class="pb-page"  data-request-id="283e96ca-e805-43e5-8618-8ce4b3843090"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-23;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b01497"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity" /></meta><meta name="dc.Creator" content="Antonella  Messore" /></meta><meta name="dc.Creator" content="Valentina Noemi  Madia" /></meta><meta name="dc.Creator" content="Luca  Pescatori" /></meta><meta name="dc.Creator" content="Francesco  Saccoliti" /></meta><meta name="dc.Creator" content="Valeria  Tudino" /></meta><meta name="dc.Creator" content="Alessandro  De Leo" /></meta><meta name="dc.Creator" content="Martina  Bortolami" /></meta><meta name="dc.Creator" content="Daniela  De Vita" /></meta><meta name="dc.Creator" content="Luigi  Scipione" /></meta><meta name="dc.Creator" content="Federico  Pepi" /></meta><meta name="dc.Creator" content="Roberta  Costi" /></meta><meta name="dc.Creator" content="Silvia  Rivara" /></meta><meta name="dc.Creator" content="Laura  Scalvini" /></meta><meta name="dc.Creator" content="Marco  Mor" /></meta><meta name="dc.Creator" content="Fabiana Fosca  Ferrara" /></meta><meta name="dc.Creator" content="Emiliano  Pavoni" /></meta><meta name="dc.Creator" content="Giuseppe  Roscilli" /></meta><meta name="dc.Creator" content="Giuliana  Cassinelli" /></meta><meta name="dc.Creator" content="Ferdinando M.  Milazzo" /></meta><meta name="dc.Creator" content="Gianfranco  Battistuzzi" /></meta><meta name="dc.Creator" content="Roberto  Di Santo" /></meta><meta name="dc.Creator" content="Giuseppe  Giannini" /></meta><meta name="dc.Description" content="Heparanase is the only mammalian endo-β-d-glucuronidase involved in a variety of major diseases. The up-regulation of heparanase expression increases tumor size, angiogenesis, and metastasis, repre..." /></meta><meta name="Description" content="Heparanase is the only mammalian endo-β-d-glucuronidase involved in a variety of major diseases. The up-regulation of heparanase expression increases tumor size, angiogenesis, and metastasis, repre..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 9, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01497" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01497" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01497" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01497" /></link>
        
    
    

<title>Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01497" /></meta><meta property="og:title" content="Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0016.jpeg" /></meta><meta property="og:description" content="Heparanase is the only mammalian endo-β-d-glucuronidase involved in a variety of major diseases. The up-regulation of heparanase expression increases tumor size, angiogenesis, and metastasis, representing a validated target in the anti-cancer field. To date, only a few small-molecule inhibitors have been described, but none have gotten through pre-clinical development. Previously, we explored 2-(4-(4-(bromo-methoxybenzamido)benzylamino)phenyl) benzazole derivatives as anti-heparanase agents, proposing this scaffold for development of broadly effective heparanase inhibitors. Herein, we report an extended investigation of new symmetrical 2-aminophenyl-benzazolyl-5-acetate derivatives, proving that symmetrical compounds are more effective than asymmetrical analogues, with the most-potent compound, 7g, being active at nanomolar concentration against heparanase. Molecular docking studies were performed on the best-acting compounds 5c and 7g to rationalize their interaction with the enzyme. Moreover, invasion assay confirmed the anti-metastatic potential of compounds 5c, 7a, and 7g, proving the inhibition of the expression of proangiogenic factors in tumor cells." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01497"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01497">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01497&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01497&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01497&amp;href=/doi/10.1021/acs.jmedchem.8b01497" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10834-10859</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01445" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01504" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Antonella Messore</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonella Messore</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonella++Messore">Antonella Messore</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0158-5816" title="Orcid link">http://orcid.org/0000-0003-0158-5816</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Valentina Noemi Madia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Valentina Noemi Madia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Valentina+Noemi++Madia">Valentina Noemi Madia</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5724-612X" title="Orcid link">http://orcid.org/0000-0002-5724-612X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luca Pescatori</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luca Pescatori</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luca++Pescatori">Luca Pescatori</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4734-7856" title="Orcid link">http://orcid.org/0000-0003-4734-7856</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francesco Saccoliti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francesco Saccoliti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Saccoliti">Francesco Saccoliti</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2907-5503" title="Orcid link">http://orcid.org/0000-0002-2907-5503</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Valeria Tudino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Valeria Tudino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Valeria++Tudino">Valeria Tudino</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9024-9835" title="Orcid link">http://orcid.org/0000-0001-9024-9835</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alessandro De Leo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alessandro De Leo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++De+Leo">Alessandro De Leo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martina Bortolami</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martina Bortolami</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martina++Bortolami">Martina Bortolami</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5740-6499" title="Orcid link">http://orcid.org/0000-0001-5740-6499</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniela De Vita</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniela De Vita</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++De+Vita">Daniela De Vita</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0370-4244" title="Orcid link">http://orcid.org/0000-0002-0370-4244</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luigi Scipione</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luigi Scipione</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luigi++Scipione">Luigi Scipione</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Federico Pepi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Federico Pepi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Federico++Pepi">Federico Pepi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roberta Costi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roberta Costi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roberta++Costi">Roberta Costi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Silvia Rivara</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Silvia Rivara</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Rivara">Silvia Rivara</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8058-4250" title="Orcid link">http://orcid.org/0000-0001-8058-4250</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura Scalvini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Scalvini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Scalvini">Laura Scalvini</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3610-527X" title="Orcid link">http://orcid.org/0000-0003-3610-527X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marco Mor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marco Mor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Mor">Marco Mor</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0199-1849" title="Orcid link">http://orcid.org/0000-0003-0199-1849</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fabiana Fosca Ferrara</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabiana Fosca Ferrara</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takis S.R.L., Via Castel Romano 100, I-00128 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabiana+Fosca++Ferrara">Fabiana Fosca Ferrara</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emiliano Pavoni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emiliano Pavoni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takis S.R.L., Via Castel Romano 100, I-00128 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emiliano++Pavoni">Emiliano Pavoni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giuseppe Roscilli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giuseppe Roscilli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takis S.R.L., Via Castel Romano 100, I-00128 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Roscilli">Giuseppe Roscilli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giuliana Cassinelli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giuliana Cassinelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Ricerca Applicata e Sviluppo Tecnologico, Unità di Farmacologia Molecolare, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, I-20133 Milano, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giuliana++Cassinelli">Giuliana Cassinelli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ferdinando M. Milazzo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ferdinando M. Milazzo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">R&D Alfasigma S.p.A., Via Pontina Km 30,400, Pomezia, I-00071 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ferdinando+M.++Milazzo">Ferdinando M. Milazzo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gianfranco Battistuzzi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gianfranco Battistuzzi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">R&D Alfasigma S.p.A., Via Pontina Km 30,400, Pomezia, I-00071 Roma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gianfranco++Battistuzzi">Gianfranco Battistuzzi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roberto Di Santo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roberto Di Santo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci Bolognetti, “Sapienza” Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#f0829f929582849fde949983919e849fb0859e99829f9d91c1de9984"><span class="__cf_email__" data-cfemail="4a3825282f383e25642e23392b243e250a3f24233825272b7b64233e">[email protected]</span></a>; phone: +39-06-49913150.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Di+Santo">Roberto Di Santo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4279-7666" title="Orcid link">http://orcid.org/0000-0002-4279-7666</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Giuseppe Giannini</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giuseppe Giannini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">R&D Alfasigma S.p.A., Via Pontina Km 30,400, Pomezia, I-00071 Roma, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#bfd8d6caccdacfcfda91d8d6ded1d1d6d1d6ffded3d9deccd6d8d2de91dcd0d2"><span class="__cf_email__" data-cfemail="43242a3630263333266d242a222d2d2a2d2a03222f2522302a242e226d202c2e">[email protected]</span></a>; phone: +39-06-91393640.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Giannini">Giuseppe Giannini</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01497&amp;href=/doi/10.1021%2Facs.jmedchem.8b01497" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10834–10859</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 9, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 September 2018</li><li><span class="item_label"><b>Published</b> online</span>9 November 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 December 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01497" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01497</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01497"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1577</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01497" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Antonella&quot;,&quot;last_name&quot;:&quot;Messore&quot;},{&quot;first_name&quot;:&quot;Valentina&quot;,&quot;last_name&quot;:&quot;Noemi Madia&quot;},{&quot;first_name&quot;:&quot;Luca&quot;,&quot;last_name&quot;:&quot;Pescatori&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Saccoliti&quot;},{&quot;first_name&quot;:&quot;Valeria&quot;,&quot;last_name&quot;:&quot;Tudino&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;De Leo&quot;},{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Bortolami&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;De Vita&quot;},{&quot;first_name&quot;:&quot;Luigi&quot;,&quot;last_name&quot;:&quot;Scipione&quot;},{&quot;first_name&quot;:&quot;Federico&quot;,&quot;last_name&quot;:&quot;Pepi&quot;},{&quot;first_name&quot;:&quot;Roberta&quot;,&quot;last_name&quot;:&quot;Costi&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Rivara&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Scalvini&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Mor&quot;},{&quot;first_name&quot;:&quot;Fabiana&quot;,&quot;last_name&quot;:&quot;Fosca Ferrara&quot;},{&quot;first_name&quot;:&quot;Emiliano&quot;,&quot;last_name&quot;:&quot;Pavoni&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Roscilli&quot;},{&quot;first_name&quot;:&quot;Giuliana&quot;,&quot;last_name&quot;:&quot;Cassinelli&quot;},{&quot;first_name&quot;:&quot;Ferdinando&quot;,&quot;last_name&quot;:&quot;M. Milazzo&quot;},{&quot;first_name&quot;:&quot;Gianfranco&quot;,&quot;last_name&quot;:&quot;Battistuzzi&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Di Santo&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Giannini&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;10834-10859&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01497&quot;},&quot;abstract&quot;:&quot;Heparanase is the only mammalian endo-β-d-glucuronidase involved in a variety of major diseases. The up-regulation of heparanase expression increases tumor size, angiogenesis, and metastasis, representing a validated target in the anti-cancer field. To date, only a few small-molecule inhibitors have been described, but none have gotten through pre-clinical development. Previously, we explored 2-(4-(4-(bromo-methoxybenzamido)benzylamino)phenyl) benzazole derivatives as anti-heparanase agents, proposing this scaffold for development of broadly effective heparanase inhibitors. Herein, we report an extended investigation of new symmetrical 2-aminophenyl-benzazolyl-5-acetate derivatives, proving that symmetrical compounds are more effective than asymmetrical analogues, with the most-potent compound, 7g, being active at nanomolar concentration against heparanase. Molecular docking studies were performed on the best-acting compounds 5c and 7g to rationalize their interaction with the enzyme. Moreover, invasion assay&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01497&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01497" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01497&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01497" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01497&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01497" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01497&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01497&amp;href=/doi/10.1021/acs.jmedchem.8b01497" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01497" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01497" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01497%26sid%3Dliteratum%253Aachs%26pmid%3D30412404%26genre%3Darticle%26aulast%3DMessore%26date%3D2018%26atitle%3DNovel%2BSymmetrical%2BBenzazolyl%2BDerivatives%2BEndowed%2Bwith%2BPotent%2BAnti-Heparanase%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D23%26spage%3D10834%26epage%3D10859%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/jmcmar.2018.61.issue-23/20181213/jmcmar.2018.61.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Heparanase is the only mammalian <i>endo</i>-β-<span class="smallcaps smallerCapital">d</span>-glucuronidase involved in a variety of major diseases. The up-regulation of heparanase expression increases tumor size, angiogenesis, and metastasis, representing a validated target in the anti-cancer field. To date, only a few small-molecule inhibitors have been described, but none have gotten through pre-clinical development. Previously, we explored 2-(4-(4-(bromo-methoxybenzamido)benzylamino)phenyl) benzazole derivatives as anti-heparanase agents, proposing this scaffold for development of broadly effective heparanase inhibitors. Herein, we report an extended investigation of new symmetrical 2-aminophenyl-benzazolyl-5-acetate derivatives, proving that symmetrical compounds are more effective than asymmetrical analogues, with the most-potent compound, <b>7g</b>, being active at nanomolar concentration against heparanase. Molecular docking studies were performed on the best-acting compounds <b>5c</b> and <b>7g</b> to rationalize their interaction with the enzyme. Moreover, invasion assay confirmed the anti-metastatic potential of compounds <b>5c</b>, <b>7a</b>, and <b>7g</b>, proving the inhibition of the expression of proangiogenic factors in tumor cells.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67142" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67142" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Heparan sulfate proteoglycans (HSPGs) are ubiquitous macromolecules associated with the cell surface and extracellular matrix (ECM) of a wide range of cells and have been found to play regulatory roles in many biological functions, including both physiological and pathological processes.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> This class of carbohydrate-modified proteins exerts its multiple functions via several mechanisms combining structural, biochemical, and regulatory aspects. By interacting with other macromolecules such as laminin, fibronectin, and collagens I and IV, HSPGs contribute to the structural integrity, self-assembly, and insolubility of the ECM and basement membrane, thus intimately modulating cell–ECM interactions.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Additionally, HSPGs regulate the transfer of information from extracellular space to intracellular kinases and cytoskeletal elements, thus affecting cell signaling, adhesion, and motility.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">The key structural component of cell-surface- and matrix-associated HSPGs is heparan sulfate (HS), whose function is to bind and interact with signaling proteins, growth factors, plasma proteins, immune modulators, and other factors, thereby regulating protein distribution, bioavailability, and action on target cells. Moreover, the HS chains ensure that a wide variety of bioactive molecules bind to the cell surface and ECM, thus regulating morphogenesis, tissue repair, inflammation, vascularization, and cancer metastasis.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">The sole enzyme responsible for the degradation of mammalian HS is heparanase (Hpse), an <i>endo</i>-β-<span class="smallcaps smallerCapital">d</span>-glucuronidase that cleaves the HS side chains of HSPGs into segments of 10–20 sugar units<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> by hydrolyzing the β-glycosidic bond at specific intrachain sites with retention of the anomeric configuration, thus producing physiologically active saccharide fragments of 10–20 sugar units and allowing, at the same time, the release of HS-bound macromolecules.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> By virtue of its activity on HSPGs, Hpse influences a multitude of both normal and disease-related processes.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Indeed, under physiological conditions, Hpse is expressed at high levels in placenta and some blood-borne cells such as platelets, neutrophils, mast cells, and lymphocytes, while it is undetectable in other human tissues. On the contrary, the de-regulated expression and function of Hpse has been involved not only in several inflammatory-based diseases (such as chronic inflammation, atherosclerosis, thrombosis, fibrosis, neurite outgrowth, diabetic nephropathy, and bone osteolysis) but also in a variety of human hematological and solid malignancies of both epithelial and mesenchymal origin.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a></div><div class="NLM_p">Clinically, Hpse up-regulation has been associated with the growth and aggressiveness of several cancer types, being correlated with an increased tumor size, angiogenesis, metastasis, and poor prognosis.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Pioneering and breakthrough studies have highlighted the link between Hpse and cancer. In particular, the significant impairment of tumor growth and progression observed in tumor-bearing mice by Hpse gene expression knock-down or by treatment with Hpse inhibitors has provided the pre-clinical evidence of the potential of Hpse as target in anticancer therapy.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Recently, Hpse up-regulation has also been associated with the induction of resistance in response to anticancer therapeutics, an effect attributed, at least in part, to the Hpse-mediated promotion of autophagy.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> However, chemotherapy itself induces the expression and the release of Hpse by surviving tumor cells, thus contributing to promote an aggressive phenotype.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Overall, these studies provide a strong rationale to include Hpse inhibitors in combination regimens with chemotherapeutic drugs to overcome chemoresistance. Indeed, compounds able to specifically target Hpse are highly desired to widen therapeutic options in the oncologic context as well as in those clinical indications in which Hpse is pathologically involved. The relevant role of Hpse in sustaining specific pathological conditions has led to the search for molecules able to interfere with its biological activity. However, although, in the last two decades, intensive efforts have been made in developing Hpse inhibitors, and huge progresses have been made in the knowledge of Hpse functions, no drug able to inhibit or modulate Hpse activity and functions has been registered so far.<a onclick="showRef(event, 'ref8 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref8 ref15 ref16">(8,15,16)</a></div><div class="NLM_p">Several Hpse inhibitors have been described, spanning from nucleic acids, proteins, and monoclonal antibodies to polysulfated saccharides. Among them, only four drugs have hitherto reached different phases of clinical trials. They are polysaccharide derivatives of natural origin, such as roneparstat (SST0001), muparfostat (PI-88), and necuparanib (M-402), or obtained by synthesis as pixatimod (PG545). These HS mimics show various limitations, mainly related to their high molecular weight and heterogeneous nature, which could affect product characterization, standardization, and interpretation of biological data and are also related to their parenteral delivery route that might limit the patient compliance.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Moreover, despite expectancy from pre-clinical and early clinical trials, after interim analysis muparfostat was discontinued because it failed to meet the trial primary end point<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and, similarly, the necuparanib trial was interrupted as a consequence of interim futility analysis.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, the pixatimod trial was initially suspended due to local injection site reactions seen in patients, and the route of administration is currently being changed from subcutaneous to intravenous.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> Recent clinical reports showed that pixatimod and roneparstat displayed good safety profile in advanced solid tumors and multiple myeloma in early clinical trials.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a></div><div class="NLM_p">The development of small molecule inhibitors of Hpse has the potential to overcome some of the limitations of polysaccharides. Small molecules are, in fact, particularly desirable because they offer the opportunity to be properly designed to get favorable pharmacokinetic properties and oral availability. Among synthetic small molecules, some benzimidazole and benzoxazole derivatives have been described as Hpse inhibitors, such as 1-[4-(1H-benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea <b>1</b>,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> or benzoxazol-5-yl acetic acid <b>2</b>,<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> that displayed good Hpse inhibitory potency (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of benzazole-Hpse inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Very recently, our efforts to develop small molecule Hpse inhibitors led to the identification of 2-(4-(4-(bromo-methoxybenzamido)benzylamino)phenyl)benzimidazoles <b>3</b> (SST0867AA1) and <b>4</b> (SST0871AA1) as effective Hpse inhibitors, with IC<sub>50</sub> values of 2.86 and 0.64 μM, respectively (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> These compounds did not affect cell proliferation but were able to decrease the in vitro invasive ability of human cancer cell lines and to affect transcription of genes encoding for proangiogenic factors, effects that can be referred to their good ability to inhibit the Hpse enzymatic activity. Notably, the potency of these inhibitors against Hpse was enhanced by the presence of (i) fluorine atoms on the inner phenyl ring and (ii) amino acid residue on the lateral chain.</div><div class="NLM_p">Taking into account the good Hpse inhibitory activity of symmetrical inhibitors like compound <b>1</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and suggestions provided by our previous molecular docking studies performed with compounds <b>3</b> and <b>4</b>, we decided to design new symmetrical derivatives, introducing a more-rigid central portion in the structure to allow a better fit in the enzyme pocket, thus giving the opportunity for the lateral chains to have further positive interactions with the target.</div><div class="NLM_p">Thus, we designed and synthesized the derivatives reported in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>. In detail, the new compounds are characterized by a rigid central core, typically a ureidic group, and by a symmetrical shape. The new derivatives show one or more of the following structural characteristics: (i) a benzoxazol-5-yl or benzimidazol-5-yl acetic acid scaffold; (ii) functionalization of the acetic acid moiety with amino acidic groups or aminoalkyl boronic acids; (iii) replacement of the benzoxazol-5-yl acetic acid scaffold with a 5,6-dimethylbenzoxazolyl one; (iv) replacement of the urea with a thiourea, a guanidine, an isopropanol, or acetone; (v) introduction of a 1,3-di(piperidin-4-yl)urea replacing the 1,3-diphenylurea; (vi) benzazole ring opening and introduction of an <i>ortho</i>-hydroxyamide, amide or sulfonamide function; (vii) replacement of the 2-(3-benzamidophenyl)acetic acid with a 3-benzamidobenzoic acid or (3-benzamidophenyl)boronic acid; (viii) shift of the urea moiety from para to meta position of the inner rings; and (ix) introduction of a fluorine atom in ortho to urea or thiourea moiety.</div><figure id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0001.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of the Newly Designed Benzazole Derivatives <b>5a–f</b>, <b>6a,b</b>, <b>7a–g</b>, <b>8a–c</b>, <b>9a,b</b>, <b>10a,b</b> and <b>11a–i</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The newly synthesized compounds have been evaluated in vitro for their capacity to inhibit Hpse enzymatic activity and to affect the proliferation and invasive potential of malignant cells. In addition, the effect of selected compounds on the expression of genes encoding for proangiogenic factors has been assessed in a tumor cell line. Moreover, based on docking studies in the crystal structure of human Hpse, a rationalization of the interaction between the best-acting compounds and the biological target has been proposed.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The benzazole derivatives <b>5a–e</b>, <b>6a,b</b>, <b>7a–c,g</b>, and <b>8a,b</b> were synthesized as reported in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Urea and thiourea derivatives <b>16a</b>–<b>d</b> and <b>17a</b> were obtained from the corresponding amines <b>12a</b>–<b>c</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <b>13</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> after reaction with triphosgene or thiocarbonyldiimidazole (thio-CDI) as a condensing agent. Differently, thioureas <b>16e</b> and <b>17b</b> have been obtained by microwave-assisted reaction of the amines <b>12c</b> and <b>13</b> with isothiocyanates <b>14</b> and <b>15</b>, which have been generated by reaction of the same amines, <b>12c</b> and <b>13</b>, with thiophosgene.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to <b>5a-e</b>, <b>6a,b</b>, <b>7a-c,g</b>, and <b>8a,b</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry or THF dry, N<sub>2</sub>, 0 °C to room temp, 24–44 h, 40–100% yield; (ii) thio-CDI, CH<sub>2</sub>Cl<sub>2</sub>, 40 °C, 12 h, 60% yield; (iii) thiophosgene, chlorobenzene, DMF cat., reflux, 2–4 h, 100% yield; (iv) <b>12c</b> or <b>13</b>, DMSO dry, 200 W, N<sub>2</sub>, 80 °C, 3 min, 30–70% yield; (v) LiOH, 5:1 THF/H<sub>2</sub>O, room temp, 3.5–48 h, 49–99% yield; (vi) NaOH, 5:1 THF/H<sub>2</sub>O, room temp, overnight, 44–100% yield; (vii) appropriate amino ester detailed in the <a class="ref internalNav" href="#sec6" aria-label="Experimental section">Experimental section</a>, EDCI, DMAP, DIPEA, THF dry, or DMF dry, N<sub>2</sub>, room temp, overnight, 64–85% yield.</p></p></figure><div class="NLM_p">Next, the esters <b>16a</b>–<b>e</b> and <b>17a,b</b> were hydrolyzed in alkaline medium (LiOH or NaOH) to give the corresponding acid derivatives <b>5a</b>–<b>e</b> and <b>6a,b</b>. The latter underwent coupling reactions with the proper amino ester in the presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI) and 4-dimethylaminopyridine (DMAP) using <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) as base to give esters <b>18a–c,g</b> and <b>19a,b</b> that were, in turn, hydrolyzed in alkaline medium to give the corresponding amino acid derivatives <b>7a–c,g</b> and <b>8a,b</b>.</div><div class="NLM_p">Guanidine derivative <b>5f</b> was synthesized according to <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Compound <b>16d</b> was reacted with hexamethyldisilazane in the presence of EDCI to furnish guanidine <b>20</b> that subsequently underwent to alkaline hydrolysis with LiOH to give the corresponding acid derivative <b>5f</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to the <b>5f</b> Derivative<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) hexamethyldisilazane, EDCI, MeCN, 0 °C to room temp, 5 days, 70% yield; (ii) LiOH, 5:1 DMSO/H<sub>2</sub>O, room temp, 3 days, 70% yield.</p></p></figure><div class="NLM_p">Boronic acids <b>7e,f</b> and <b>8c</b> and isopentyl derivative <b>7d</b> were synthesized as described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The appropriate alkyl boronic ester as ammonium salts were coupled with benzazol-5-yl acetic acid derivatives <b>5c</b> and <b>6a</b> in the presence of 2-(1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium tetrafluoroborate (TBTU) and DIPEA at −80 °C for 3.5 h, giving the pinanediol boronic ester derivative <b>21</b> as previously described in the literature<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> or boronic acids <b>7f</b> and <b>8c</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route to <b>7d</b>–<b>f</b> and <b>8c</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (<i>R</i>)-boroLeu-(+)-pinanediol HCl, EDCI, DMAP, DIPEA, THF dry, N<sub>2</sub>, room temp, overnight, 87% yield; (ii) (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methanaminium chloride, TBTU, DIPEA, DMF dry, N<sub>2</sub>, −80 °C to room temp, 5 h, 30–35 yield; (iii) (<i>R</i>)-boroLeu-(+)-pinanediol HCl, TBTU, DIPEA, DMF dry, N<sub>2</sub>, −80 °C to room temp, 5 h, 96.2% yield; (iv) NH<sub>4</sub>OAc<sub>aq</sub> 0.1 N, NaIO<sub>4</sub>, THF, room temp, 47 h, 60% yield.</p></p></figure><div class="NLM_p">We speculated that pinanediol esters are more resistant to hydrolysis<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and, therefore, an oxidative cleavage of the pinanediol was carried out by using sodium metaperiodate in the presence of NH<sub>4</sub>OAc<sub>aq</sub> 0.1 N, according to a known procedure reported for boronic esters.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The use of such electrophilic oxidant was due to the awareness of the susceptibility of boronic acids to nucleophilic oxidative agents.</div><div class="NLM_p">Interestingly, by modifying both coupling-reaction conditions and coupling agent, the isopentylacetamide derivative <b>7d</b> was obtained. In fact, this compound was obtained from the benzoxazol-5-yl acetic acid <b>5c</b> that was reacted with (<i>R</i>)-boroLeu-(+)-pinanediol HCl in the presence of EDCI and DMAP, using DIPEA as a base, at room temperature for 24 h.</div><div class="NLM_p">5,6-Dimethylbenzoxazolyl derivatives <b>9a</b> and <b>9b</b> were synthesized as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. 2-Amino-4,5-dimethylphenol<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> was acylated with the proper acyl chloride in the presence of triethylamine to furnish amides <b>22a</b> and <b>22b</b> that subsequently underwent to ring closure using <i>p</i>-toluenesulfonic acid (PTSA) as a catalyst, obtaining 5,6-dimethylbenzoxazolyl nitro derivatives <b>23a</b> and <b>23b</b>. After catalytic reduction, the amines <b>24a</b> and <b>24b</b> were reacted with triphosgene to give the corresponding urea derivatives <b>9a</b> and <b>9b</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to <b>9a,b</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) proper acyl chloride, Et<sub>3</sub>N, THF dry, N<sub>2</sub>, 0 °C to room temp, 3 h, 100% yield; (ii) PTSA, toluene, reflux, overnight, 40–68% yield; (iii) H<sub>2</sub>, Pd/C, AcOEt, 40 psi, room temp, 3–6 h, 75–95% yield; (iv) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry, N<sub>2</sub>, 0 °C to room temp, overnight, 32% yield.</p></p></figure><div class="NLM_p">Alicyclic urea derivatives <b>10a</b> and <b>10b</b> were achieved as depicted in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. 2-Amino-4,5-dimethylphenol<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> or methyl 2-(3-amino-4-hydroxyphenyl)acetate<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> were reacted with potassium <i>O</i>-ethyl xanthogenate that can act as a double electrophilic reagent, thus providing a convenient synthetic equivalent of thiophosgene.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The resulting unstable 2-mercaptobenzoxazole intermediates immediately underwent to nucleophilic substitution by treating the sulfur moiety with 4-(<i>N</i>-Boc-amino)piperidine,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> resulting in derivatives <b>25a</b> and <b>25b</b>. Following deprotection of the Boc-protected amine by means of trifluoroacetic acid, amine derivatives <b>26a</b> and <b>26b</b> were obtained and then condensed with triphosgene furnishing ureas <b>27a</b> and <b>10b</b>. Finally, the acetic acid derivative <b>10a</b> was obtained through alkaline hydrolysis with LiOH of the corresponding ester <b>27a</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to <b>10a,b</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 1) potassium ethyl xanthogenate, pyridine, N<sub>2</sub>, reflux, 2 h, 2) 4-(<i>N</i>-Boc-amino)piperidine, <i>m</i>-xylene, N<sub>2</sub>, 150 °C, 1.5 h, 62–67% yield; (ii) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub> dry, room temp, 45 min, 100% yield; (iii) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry, 0 °C to room temp, overnight, 11–68% yield; (iv) LiOH, 5:1 THF/H<sub>2</sub>O, room temp, overnight, 100% yield.</p></p></figure><div class="NLM_p">Syntheses of amide derivatives <b>11a</b>–<b>h</b> were performed as reported in Schemes <a class="ref internalNav" href="#sch6" aria-label="6">6</a> and <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. More in detail, compounds <b>11b,d–h</b> were synthesized by applying a divergent synthetic approach, first building the central diphenyl urea, thiourea, isopropanol or acetone moiety, while derivatives <b>11a</b> and <b>11c</b> were obtained by synthesizing the amide function first.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route to <b>11b,d–g</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry, N<sub>2</sub>, 0 °C to room temp, overnight, 23% yield; (ii) thiophosgene, chlorobenzene, DMF cat., room temp to reflux, 1 h, 61% yield; (iii) methyl 4-amino-3-fluorobenzoate, DMSO dry, 200 W, N<sub>2</sub>, 80 °C, 1 min, 30% yield; (iv) (1) TosMIC, NaOH 40%, TBAI, CH<sub>2</sub>Cl<sub>2</sub>, N<sub>2</sub>, room temp, 3 h; (2) HCl 37%, 64% yield; (v) ethylene glycol, PTSA monohydrate, toluene, reflux, overnight, 80% yield; (vi) NaBH<sub>4</sub>, 1:1 MeOH/THF, 0 °C to room temp, overnight, 70% yield; (vii) LiOH, 5:1 THF/H<sub>2</sub>O, room temp, 24–96 h, 45–82% yield; (viii) NaOH 20%, 5:1 THF/H<sub>2</sub>O, reflux or room temp, 24–72 h, 63–71% yield; (ix) methyl 2-(3-aminophenyl)acetate or ethyl 3-aminobenzoate, EDCI, HOBt, NMM, DMF dry, N<sub>2</sub>, room temp, 4–48 h, 51–85% yield; (x) (1) oxalyl chloride, THF dry, DMF dry cat., N<sub>2</sub>, room temp, 4–24 h; (2) methyl 2-(3-aminophenyl)acetate or methyl 2-(3-amino-4-hydroxyphenyl)acetate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry or THF dry, N<sub>2</sub>, 0 °C to room temp, 0.5–24 h, 20–100% yield; (xi) LiOH, 10:1 DMSO/H<sub>2</sub>O, room temp, 0.5–72 h, 70–90% yield; (xii) CF<sub>3</sub>COOH, N<sub>2</sub>, room temp, overnight, 80% yield.</p></p></figure><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthetic Route to <b>11a,c</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>p</i>-nitrobenzoyl chloride, Et<sub>3</sub>N, THF dry, N<sub>2</sub>, 0 °C to room temp, 3 h 100% yield; (ii) <i>p</i>-nitrobenzenesulfonyl chloride, pyridine, dichloroethane dry, N<sub>2</sub>, 0 °C to room temp, overnight, 88.5% yield; (iii) acetic anhydride, Et<sub>3</sub>N, room temp, 48 h, 52% yield; (iv) H<sub>2</sub>, Pd/C, AcOEt, 40 psi, room temp, 1 h, 100% yield; (v) ammonium formate, Et<sub>3</sub>N, Pd/C, dioxane, N<sub>2</sub>, 30 °C, 2 h, 67% yield; (vi) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry or 1:1 CH<sub>2</sub>Cl<sub>2</sub>/THF dry, N<sub>2</sub>, 0 °C to room temp, 24–48 h, 20–22% yield; (vii) LiOH, 5:1 THF/H<sub>2</sub>O, room temp, overnight, 13–49% yield.</p></p></figure><div class="NLM_p">In particular, derivatives <b>11b,d-h</b> have been synthesized as shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. The key intermediates for these syntheses are the acids <b>33b,d,e,g</b>.</div><div class="NLM_p">The (thio)ureas <b>33b,d</b>, were obtained by alkaline hydrolysis of the corresponding esters <b>29b,d</b>. The urea <b>29b</b> was synthesized by the reaction of methyl 4-aminobenzoate with triphosgene using triethylamine as a base, while the thiourea <b>29d</b> was obtained via the microwave-assisted reaction of methyl 4-amino-3-fluorobenzoate with <b>28</b>. This isothiocyanate has been achieved by reaction of the same methyl 4-amino-3-fluorobenzoate with thiophosgene.</div><div class="NLM_p">The isopropanol and ketal derivatives <b>33e,g</b> were synthesized by reaction with aqueous base of the corresponding esters <b>32</b> and <b>31</b>, respectively. Both compounds have been obtained starting from the joint intermediate <b>30</b>, which reacted with ethylene glycol to furnish ketal <b>31</b>, or underwent reduction by NaBH<sub>4</sub> to give the corresponding alcohol <b>32</b>. The key 1,3-diphenylacetone derivative <b>30</b> was obtained via a TosMIC (<i>p</i>-toluenesulfonylmethyl isocyanide)-modified reaction following a procedure previously reported in the literature.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">Thus, acids <b>33b,d,e,g</b> were then transformed into the corresponding amides <b>34b,d–h</b> by reaction with the proper amine (methyl 2-(3-aminophenyl)acetate for <b>34b,d,f,g</b>; methyl 2-(3-amino-4-hydroxyphenyl)acetate for <b>34e</b>, ethyl 3-aminobenzoate for <b>34h</b>) using EDCI and 1-hydroxybenzotriazole (HOBt) and <i>N</i>-methylmorpholine (NMM) as a base, or via acyl chloride.</div><div class="NLM_p">Finally, the ester function of <b>34b,d–h</b> was hydrolyzed in alkaline medium to give the corresponding acid derivatives <b>11b,d–f,h</b> and <b>35</b>. Notably, ketal <b>35</b> was subsequently deprotected by reaction with trifluoroacetic acid to give the corresponding ketone <b>11g</b>.</div><div class="NLM_p"><a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a> describes the synthetic route to obtain derivatives <b>11a,c</b>. Commercially available methyl 2-(3-aminophenyl)acetate or methyl 2-(3-amino-4-hydroxyphenyl)acetate were acylated with <i>p</i>-nitrobenzoyl chloride or <i>p</i>-nitrobenzenesulfonyl chloride, respectively, to give amides <b>36a</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <b>36c</b>. Nitro derivatives <b>36c</b> and <b>37</b>, obtained after protection via acetylation with acetic anhydride of <b>36a</b>, underwent to Leuckart or catalytic reduction of nitro group, giving the corresponding amines <b>38a,c</b> that were reacted with triphosgene to obtain urea compounds <b>34a,c</b>. Finally, acid derivatives <b>11a,c</b> were obtained after an alkaline hydrolysis with LiOH.</div><div class="NLM_p">The aryl-boronic acid derivative <b>11i</b> was synthesized from the corresponding bromo derivative <b>39</b> via boronic ester, as depicted in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>. 3-Bromoaniline was acylated with <i>p</i>-nitrobenzoyl chloride to give amide <b>39</b> that underwent to a cross-coupling reaction with bis(pinacolate)diboron in the presence of a catalytic amount of PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, obtaining boronic ester derivative <b>40</b>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Followed a catalytic reduction of nitro group, giving the corresponding amine <b>41</b> that was reacted with triphosgene to obtain urea derivative <b>34i</b>. Finally, the oxidative cleavage of the pinacol ester group furnished the corresponding boronic acid compound <b>11i</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthetic Route to <b>11i</b> Derivative<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>p</i>-nitrobenzoyl chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry, N<sub>2</sub>, 0 °C to room temp, 3 h, 92% yield; (ii) KOAc, pinacol diborane, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, dioxane dry, N<sub>2</sub>, 100 °C, 2 h, 75% yield; (iii) H<sub>2</sub>, Pd/C, AcOEt, 40 psi, room temp, 1.5 h, 95% yield; (iv) triphosgene, Et<sub>3</sub>N, THF dry, N<sub>2</sub>, 0 °C to room temp, overnight, 43% yield; (v) 0.1 N NH<sub>4</sub>OAc<sub>aq</sub>, NaIO<sub>4</sub>, acetone, room temp, 27 h, 95% yield.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Evaluation of Biochemical Activities</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vitro Screening for Hpse Inhibitory Activity</h3><div class="NLM_p">All compounds were tested for their ability to inhibit Hpse catalytic activity by using an in vitro assay, originally developed by Hammond and co-workers based on the Hpse-mediated cleavage of the synthetic heparin fragment, the pentasaccharide Fondaparinux (AGA*IA), which corresponds to the methyl glycoside of the antithrombin III (ATIII)-activating pentasaccharide sequence of heparin.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> shows the IC<sub>50</sub> values generated from the dose–response curve for compounds <b>5a–f, 6a,b, 7a–g, 8a–c, 9a,b, 10a,b</b> and <b>11a</b>–<b>i</b> and for reference compounds <b>1</b>–<b>4</b> and Roneparstat (SST0001).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Hpse Inhibitory Activities (Fondaparinux Hpse assay) of the Newly Synthesized Compounds <b>5a–f, 6a,b, 7a–g, 8a–c, 9a,b, 10a,b</b>, and <b>11a</b>–<b>i</b> vs Reference Compounds (<b>1–4</b> and <b>SST0001</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0015.gif" alt="" id="GRAPHIC-d7e1581-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cpd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">μM</th><th class="colsep0 rowsep0" align="center">μg/mL</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-NHCONH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">3.20</td><td class="colsep0 rowsep0" align="left">1.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-NHCONH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-F, 4-NHCONH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-NHCSNH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">1.81</td><td class="colsep0 rowsep0" align="left">1.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-F,4-NHCSNH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">1.40</td><td class="colsep0 rowsep0" align="left">0.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-C(NH)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">6.02</td><td class="colsep0 rowsep0" align="left">3.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-F,4-NHCONH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.98</td><td class="colsep0 rowsep0" align="left">0.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-F,4-NHCSNH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.99</td><td class="colsep0 rowsep0" align="left">0.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.45</td><td class="colsep0 rowsep0" align="left">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.37</td><td class="colsep0 rowsep0" align="left">0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.72</td><td class="colsep0 rowsep0" align="left">0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">B(OH)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">4.87</td><td class="colsep0 rowsep0" align="left">4.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7f</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">B(OH)<sub>2</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7g</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">0.82</td><td class="colsep0 rowsep0" align="left">0.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">B(OH)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">2.73</td><td class="colsep0 rowsep0" align="left">1.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">1.76</td><td class="colsep0 rowsep0" align="left">1.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11d</b></td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">CS</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">2.61</td><td class="colsep0 rowsep0" align="left">1.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11e</b></td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CHOH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11f</b></td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CHOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11g</b></td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11h</b></td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">9.17</td><td class="colsep0 rowsep0" align="left">4.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11i</b></td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">CO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">B(OH)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.56</td><td class="colsep0 rowsep0" align="left">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">0.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.86</td><td class="colsep0 rowsep0" align="left">1.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.64</td><td class="colsep0 rowsep0" align="left">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>SST0001</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">0.10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Dose causing 50% inhibition of Hpse enzymatic activity as determined from dose response curves (mean of duplicates; SD always <10%) repeated at least twice in separate experiments, stated in both micromole concentration and micrograms per milliliter.</p></div></div></div><div class="NLM_p">In general, derivatives of the series <b>5</b>–<b>8</b> proved to be the best inhibitors of Hpse among the newly synthesized derivatives, showing 13 compounds (out of 18 tested) active in the low-micromolar range and sometimes also in the nanomolar range. Conversely, compounds belonging to series <b>9</b>–<b>11</b> gave less-interesting results, with 4 compounds (out of 13 tested) active in the micromolar range.</div><div class="NLM_p">Compounds <b>5</b> and <b>6</b> are characterized by a symmetric urea or thiourea, a benzazole heterocyclic core, and an unfunctionalized acetic chain. These compounds were very active, showing IC<sub>50</sub>s ranging from 0.18 and 6.02 μM, and only one derivative was inactive (<b>5b</b>, IC<sub>50</sub> > 10 μM). A comparison between <b>5a</b> (IC<sub>50</sub> = 3.20 μM) and its <i>meta</i> isomer <b>5b</b> leads to conclude that the orientation given by the <i>meta</i> derivative is fully detrimental for the enzyme inhibition.</div><div class="NLM_p">Replacement of the urea moiety of <b>5a</b> by a guanidine group gave compound <b>5f</b> that showed a 2-fold decrease of the inhibitory potency (<b>5a</b>, IC<sub>50</sub> = 3.20 μM; <b>5f</b>, IC<sub>50</sub> = 6.02 μM). Conversely, the substitution of the urea portion of <b>5a</b> with a thiourea one led to compound <b>5d</b> that resulted nearly two times more active than the parent compound (<b>5a</b>, IC<sub>50</sub> = 3.20 μM; <b>5d</b>, IC<sub>50</sub> = 1.81 μM). Thus, it is possible to state that for non fluorinated benzoxazoles <b>5a,d,f</b> the inhibitory activity decreases in the following order: thiourea > urea > guanidine.</div><div class="NLM_p">The same approach was applied to fluorinated benzoxazoles <b>5c</b> and <b>5e</b>. However, in this case, the urea derivative was found about 10 times more active than the thiourea counterpart (<b>5c</b>, IC<sub>50</sub> = 0.18 μM; <b>5e</b>, IC<sub>50</sub> = 1.40 μM). Finally, within the small series of benzimidazole compounds, a comparable potency was observed between urea derivative <b>6a</b> and its thiourea counterpart <b>6b</b> (<b>6a</b>, IC<sub>50</sub> = 0.98 μM; <b>6b</b>, IC<sub>50</sub> = 0.99 μM).</div><div class="NLM_p">Interestingly, the thiourea benzimidazole derivative <b>6b</b> (IC<sub>50</sub> = 0.99 μM) and its benzoxazole analogue <b>5e</b> (IC<sub>50</sub> = 1.40 μM) showed comparable inhibitory potencies, suggesting that both scaffolds are effective in inhibiting the targeted enzyme, in a similar fashion to our previous findings.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> However, the urea <b>5c</b> showed a 5-fold increase of potency if compared to its benzimidazole counterpart <b>6a</b> (<b>5c</b>, IC<sub>50</sub> = 0.18 μM; <b>6a</b>, IC<sub>50</sub> = 0.98 μM), suggesting that the presence of the fluorinated benzoxazole scaffold along with urea moiety may cause a favorable cooperative effect on the enzymatic inhibition.</div><div class="NLM_p">As we previously observed,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> the introduction of a fluorine atom on the inner ring, in the <i>ortho</i> position to the urea group, gave a strong increase of anti-Hpse activity. This observation was confirmed in this work, in which we found that for example the fluorine derivative <b>5c</b> was almost 20 times more active than its non fluorinated analogue <b>5a</b> (<b>5a</b>, IC<sub>50</sub> = 3.20 μM; <b>5c</b>, IC<sub>50</sub> = 0.18 μM). The same trend, although less relevant, was retained for the thiourea compounds. In fact, the fluorinated compound <b>5e</b> showed IC<sub>50</sub> = 1.40 μM, while its unfluorinated counterpart <b>5d</b> showed IC<sub>50</sub> = 1.81 μM.</div><div class="NLM_p">In another series of derivatives, the benzoxazol-5-yl acetic acid scaffold of compounds <b>5a</b> and <b>5c</b> was replaced with a 5,6-dimethylbenzoxazolyl one, resulting in derivatives <b>9a</b> and <b>9b</b>. In both cases, this structural modification did not improve the inhibitory potency, leading to inactive compounds and highlighting that the introduction of a fluorine atom in <i>ortho</i> position of the urea moiety of <b>9a</b> did not positively affect the activity. Notably, 5,6-dimethylbenzoxazolyl derivative <b>9a</b> proved to be also less effective than its parent compound <b>1</b> characterized by a 5,6-dimethylbenzimidazolyl scaffold, allowing us to hypothesize that the 5,6-dimethylbenzoxazolyl core does not represent a useful strategy for Hpse inhibition.</div><div class="NLM_p">To better understand the role of the 1,3-diphenylurea moiety in inhibiting Hpse, we designed 1,3-di(piperidin-4-yl)ureas, obtaining acetic and dimethyl derivatives <b>10a</b> and <b>10b,</b> respectively. This replacement led to compound completely inactive, proving the very important role played by the 1,3-diphenyl urea core to design an effective Hpse inhibitor.</div><div class="NLM_p">A further aspect that we decided to examine in depth was the effect on the anti-Hpse activity of compounds endowed with more extended shape if compared with the acetic derivatives <b>5</b> and <b>6</b>. In fact, we recently proved that molecules characterized by the elongated shape and side-chain endowed with increased degrees of freedom could have a good fit with the long substrate binding pocket of Hpse.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Thus, we designed and synthesized derivatives <b>7</b> and <b>8</b> as amino acid derivatives of <b>5</b> and <b>6</b>, respectively.</div><div class="NLM_p">In particular, the functionalization of the acetic acid portion of <b>5c</b> with various amino acids led to derivatives <b>7a</b>–<b>c</b>, which proved to be active, although less potent than the parent compound. Indeed, glycine (<b>7a</b>, IC<sub>50</sub> = 0.45 μM), alanine (<b>7b</b>, IC<sub>50</sub> = 0.37 μM) and phenylalanine (<b>7c</b>, IC<sub>50</sub> = 0.72 μM) derivatives, even though reported submicromolar inhibitory potency, were 2–4 times less active than the corresponding acetic acid counterpart <b>5c</b>. Thus, in this subseries the activity decreases with the following order: Ala > Gly > Phe.</div><div class="NLM_p">Very interestingly, the introduction of the glycine lateral chain on the thiourea <b>5e</b>, gave the corresponding amide <b>7g</b> that showed a 18-fold increase in potency in respect to its parent compound <b>5e</b> (<b>7g</b>, IC<sub>50</sub> = 0.08 μM; <b>5e</b>, IC<sub>50</sub> = 1.40 μM). Moreover, the thiourea <b>7g</b> was also 6 times more active than its urea counterpart <b>7a</b> (IC<sub>50</sub> = 0.45 μM).</div><div class="NLM_p">Derivative <b>7g</b> was the most-potent inhibitor among the newly synthesized anti-Hpse compounds, showing nanomolar potency. It could be interesting to compare the activity of the small molecule <b>7g</b> to that of polysaccharide derivative SST0001, one of the most potent Hpse inhibitor reported (that is, in clinical trials). In fact, although <b>7g</b> is 16 times less potent that SST0001 if the activity is expressed in molar concentration (<b>7g</b>, IC<sub>50</sub> = 0.08 μM; SST0001, IC<sub>50</sub> = 0.005 μM), the amount potentially necessary for its clinical use could be about the half of that of SST0001 due to their huge difference in molecular weight (<b>7g</b>, IC<sub>50</sub> = 0.06 μg/mL; SST0001, IC<sub>50</sub> = 0.10 μg/mL).</div><div class="NLM_p">The effect of amino acid introduction was also investigated within the benzimidazole series by functionalizing the acetic acid portion of <b>6a</b> with glycine or phenylalanine residues to obtain <b>8a</b> and <b>8b</b>, respectively. Surprisingly, the glycine derivative <b>8a</b> proved to be inactive, while the phenylalanine <b>8b</b> showed IC<sub>50</sub> = 0.82 μM, comparable to that of the parent compound <b>6a</b> (IC<sub>50</sub> = 0.98 μM).</div><div class="NLM_p">We also investigated the effect of the acetic acid functionalization of benzoxazole compound <b>5c</b> by introducing an isopentylamine group to obtain the amide <b>7d</b>, resulting in a complete loss of activity, thus confirming our previous findings demonstrating the relevance of hydrophilic groups in establishing polar interactions with the enzyme.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">Notably, the activity of groups that could mimic the glycine moiety was evaluated by its substitution with an (aminomethyl)boronic acid group. Indeed, derivatives <b>7f</b> and <b>8c</b> represent the boronic acid counterparts of benzoxazole <b>7a</b> and of benzimidazole <b>8a</b>, respectively. Both boronic acid derivatives showed inactivity at the tested concentrations, suggesting that such substitution is detrimental for the inhibition. The combination between an alkyl group (an isopentyl substituent) and boronic acid gave compound <b>7e</b> endowed with marginal activity (IC<sub>50</sub> = 4.87 μM) if compared with the activities of the remaining amino acid derivatives. However, <b>7e</b> proved to be better if compared with its parent compounds <b>7d</b> and <b>7f</b> both resulting inactive (IC<sub>50</sub> > 10 μM). Finally, we decided to open the benzoxazole ring and/or to modify the central urea moiety obtaining derivatives of series <b>11</b> with the aim of modifying the planar shape of benzazole derivatives.</div><div class="NLM_p">The compound characterized by the presence of an <i>ortho</i>-hydroxyphenyl amide group (<b>11a</b>) showed comparable activity to the corresponding benzoxazole derivative <b>5a</b> (<b>11a</b>, IC<sub>50</sub> = 2.73 μM; <b>5a</b>, IC<sub>50</sub> = 3.20 μM), suggesting that the ring opening does not affect the inhibitory potency. As a matter of fact, by opening the benzoxazole ring and replacing the hydroxy group with a hydrogen (<b>11b</b>), a slight gain of activity was reached (IC<sub>50</sub> = 1.76 μM). Indeed, compound <b>11b</b> proved to be 1.5 times more potent than its hydroxylated analogue <b>11a</b> and nearly 2 times more active than its benzoxazole counterpart <b>5a</b>. On the contrary, the replacement of the amide group of <b>11b</b> with a sulfonamide one (<b>11c</b>) led to an activity loss. The same approach of ring opening was applied for thiourea benzoxazole derivative <b>5e</b>, thus obtaining thiourea amide compound <b>11d</b>. Differently from the trend observed with urea amide derivative <b>11b</b>; in this case, the opening of benzoxazole ring led to a 2-fold activity decrease (<b>11d</b>, IC<sub>50</sub> = 2.61 μM; <b>5e</b>, IC<sub>50</sub> = 1.40 μM), suggesting that for thiourea derivatives this approach is not useful, in contrast to what previously noticed for both acetic acid and glycine benzoxazole compounds. In the same way, the replacement of the central core of the structure (the urea group) with an acetonyl or 2-hydroxypropyl moiety led to activity loss. More in detail, the replacement of the urea portion of <b>11a</b> and <b>11b</b> with a 2-hydroxypropyl group gave <b>11e</b> and <b>11f</b>, respectively, which were inactive at the tested concentration, suggesting that the urea moiety is important for anti-Hpse activity. Accordingly, the same trend was observed by substituting the urea of <b>11b</b> with a 2-propanonyl moiety (<b>11g</b>). Indeed, the inactivity of compound <b>11g</b> confirmed the aforementioned hypothesis according to which the urea moiety is relevant for Hpse inhibition.</div><div class="NLM_p last">Also for amide derivatives <b>11</b>, structural modifications of the acetic acid group were carried out. Indeed, the acetic acid moiety of derivative <b>11b</b> was replaced with a carboxylic acid group and boronic acid function (<b>11h</b> and <b>11i</b>, respectively). Both compounds <b>11h</b> and <b>11i</b> resulted inactive as Hpse inhibitors in biochemical assay, thus denoting that acetic acid group can positively contribute to the enzymatic inhibitory activity.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Molecular Modeling</h3><div class="NLM_p">To investigate the putative binding mode of symmetrical Hpse inhibitors and rationalize the role of the terminal acidic groups of the most-potent inhibitors, molecular docking studies were performed for the reference compound <b>1</b> and the benzoxazole derivatives <b>5c</b> and <b>7g</b> into the crystal structure of human Hpse. Mature human Hpse is a heterodimer composed of the N-terminal 8 kDa and C-terminal 50 kDa chains noncovalently assembled into a (β/α)<sub>8</sub>-TIM barrel fold. As revealed by the X-ray structures of the enzyme in complex with saccharide derivatives,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> the active site of Hpse is characterized by a narrow, extended channel with the catalytic residues E225 and E343 placed in the middle of the substrate binding site. At the two extremities of the channel, the binding site is flanked by the heparin binding domain 1 (HBD-1, residues 158–171) and heparin binding domain 2 (HBD-2, residues 270–280), identified as protein motifs involved in the interaction with the heparan sulfate substrate.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Docking studies were performed into a model of GS3 Hpse (that is, a catalytically active form of the enzyme in which the 8 and 50 kDa chains are linked together by a short peptide)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> because this enzyme construct was used for the evaluation of the inhibitory activity of the newly synthesized compounds. GS3 model building starting from the X-ray structure 5E9C has already been described.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Analysis of docking poses reveals that compounds <b>1</b>, <b>5c</b>, and <b>7g</b> assume similar binding modes. They were accommodated within the substrate binding site of the enzyme and placed the urea or thiourea group close to the catalytic residue E225 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), overlapping the position occupied by the cocrystallized tetrasaccharide inhibitor dp4 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Although the three compounds are accommodated within the substrate binding site with similar geometries, inhibitors <b>5c</b> and <b>7g</b> interact with HBD-1 and HBD-2 regions, thus undertaking a higher number of polar contacts with the protein counterpart. The urea group of compound <b>1</b> occupies the catalytic site with its nitrogen atoms interacting with the side chain of E225. 5,6-Dimethylbenzimidazoles form hydrogen bonds with G350 and N227 (Figure 3A). G350 is a relevant amino acid for the recognition of Hpse substrates as its backbone NH interacts with the carboxylic group of the glucuronic acid portion accommodated into the catalytic site. The binding mode of <b>5c</b> reveals that, similarly to compound <b>1</b>, the urea group occupies the catalytic site, with the nitrogen atoms interacting with E225 and the carbonyl oxygen forming an additional hydrogen bond with K231, which lies on a short helix positioned between HBD-1 and HBD-2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). The terminal carboxylic groups undertake polar intractions with residues N64, A388 and G389 on one side, and with R273 and the backbone of K274 belonging to HBD-2 on the opposite side. A cation-π interaction might be envisaged between R272 (HBD-2) and one of the phenylbenzoxazole portions. Amino acids interacting with the inhibitors are also involved in substrate recognition. In fact, in crystal structures the backbone NH of G389 is hydrogen-bonded to a sulfate group of a glucosamine, while that of A388 interacts with the same sulfate by the interposition of a water molecule. A similar binding pose was obtained also for the thiourea derivative <b>7g</b>, with the conjugated amino acids interacting with HBD-2 (residues N227, R272, and R273), and with N64, K98, and G350 on the opposite site (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). Being both the HBD-1 and HBD-2 regions highly polar and rich in basic amino acids, the terminal acidic portions of compounds <b>5c</b> and <b>7g</b> can efficiently interact with the surrounding protein residues, which might explain the higher inhibitory potency observed for these compounds compared to reference <b>1</b>.</div><figure id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding poses obtained for compounds <b>1</b> (green carbons, panel A), <b>5c</b> (orange carbons, panel B), and <b>7g</b> (violet carbons, panel C). In panel A, the co-crystallized tetrasaccharide inhibitor dp4 is represented with purple carbons (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E9C">5E9C</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, docking studies were not able to catch all finer structure–activity relationships (SAR), probably because compounds were docked into the crystal structure of heparanase in complex with a sulfated glycoside inhibitor, and large conformational arrangements may play a role in the mutual adaptation of inhibitor and binding site. Thus, the differential role of fluorination of the benzene ring in the benzoxazole and benzimidazole series could not be accounted for by docking scores calculated for compounds <b>5c</b>, <b>5e</b>, <b>6a</b>, and <b>6b</b>. However, the interaction energy estimated by the docking procedure (Emodel; see <a class="ref internalNav" href="#notes1" aria-label="Table S1">Table S1</a>), correctly predicted the rank order of potencies for nonfluorinated derivatives with various central linkers, i.e., thiourea (<b>5d</b>), urea (<b>5a</b>), and guanidine (<b>5f</b>). Indeed the three compounds interact with the catalytic residue E225 through their thiourea, urea, and guanidine NH groups, assuming arrangements similar to that depicted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> for compound <b>5c</b>. Values of the Emodel for the best docking solution of the three compounds (in order of decreasing potency) were −108.7 kcal/mol for <b>5d</b>, −106.1 kcal/mol for <b>5a</b>, and −93.4 kcal/mol for <b>5f</b>.</div><div class="NLM_p last">Molecular dynamics (MD) was applied to evaluate the stability of the binding poses identified by docking studies. The Hpse-inhibitor complexes were stable during short MD simulations (10 ns, corresponding to the 100 frames analyzed in <a class="ref internalNav" href="#notes1" aria-label="Figure S1">Figure S1</a> for a representative simulation). In <a class="ref internalNav" href="#notes1" aria-label="Figure S1">Figure S1</a>, the root-mean-square deviation (RMSD) of compound <b>5c</b> heavy atoms and the total number of hydrogen bonds undertaken by its carboxylate groups are reported. During the simulation the inhibitor remains within the substrate binding cleft, with the urea fragment anchored to E225. The increase of RMSD is due to the flexible terminal acetic groups, which interact with different amino acid counterparts during the simulation, yet the average number of hydrogen bonds is conserved throughout the simulation.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Evaluation of Biological Activities</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30458" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30458" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Proliferation Assay</h3><div class="NLM_p">A few compounds (<b>5a</b>, <b>5c</b>, <b>7a–c</b>, and <b>7g</b> as well as reference compound <b>3</b>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> found active in the enzyme assay were further characterized in vitro by a cell proliferation assay to assess their effect on the growth of three human tumor cell lines, namely HT1080 (fibrosarcoma), U2OS (osteosarcoma), and U87MG (glioma) expressing different levels of Hpse.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40−42)</a> Cells were treated for 72 h with serial dilutions (in the range 10–0.2 μM, covering the active concentrations in the Hpse enzyme assay) of each test compound as well as of the internal reference compound <b>3.</b> As determined by cell proliferation curves (not shown), none of the newly synthesized derivatives showed antiproliferative activity up to the maximum concentration assessed (10 μM), whereas the internal reference compound <b>3</b> moderately inhibited proliferation of the three cell lines (IC<sub>50</sub> values between 1.7 and 8.7 μM) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Overall, these data show that the newly synthesized compounds are able to inhibit Hpse at concentrations not interfering with tumor cell proliferation, making their use particularly advantageous for therapeutic applications in non-oncology fields.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiproliferative Activity of Newly Synthesized Benzazoles <b>5a</b>, <b>5c</b>, and <b>7a</b>–<b>c,g</b> and Reference Compound <b>3<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">cell line IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">HT1080</th><th class="colsep0 rowsep0" align="center">U87MG</th><th class="colsep0 rowsep0" align="center">U2OS</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7g</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">8.7</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">1.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Anti-proliferative activity of compounds tested on HT1080, U87MG, and U2OS tumor cells upon 3 days of treatment.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values (micromoles; SD always <10%) determined from dose response curves (each concentration tested in duplicate) repeated at least twice in separate experiments. NA: not active.</p></div></div></div><div class="NLM_p">Starting from these data achieved on tumor cell lines expressing moderate amount of Hpse protein, we wondered if the result would have been the same against tumor cells expressing highest levels of Hpse. To this end, we have chosen to test the putative antiproliferative activity of compound <b>5c</b>, against the human CME-1 synovial sarcoma cell line, known to express high levels of Hpse.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a></a>A, compound <b>5c</b> inhibited CME-1 cell proliferation in a dose-dependent way, with IC<sub>50</sub> = 9.5 ± 1.0 μM.</div><figure id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>5c</b> and inhibition of the proliferation of human CME-1 synovial sarcoma cells. Cells were treated with drug concentrations in the range of 10–0.7 μM. After 72 h, cells were counted and the results expressed as proliferation percent with respect to control cells. Curve is from one representative experiment out of two, performed in duplicate. Data represent mean percentage values ± SD; IC<sub>50</sub> is from two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Invasion Assay</h3><div class="NLM_p">According to the well-known pivotal role of Hpse in promoting cancer cell invasion and metastasis, we examined the effects of selected representative compounds (<b>5c, 7a</b>, <b>7b</b>, and <b>7g</b>) on the invasive activity of human cancer cell lines HT1080, U87MG, and U2OS, by Matrigel invasion assay. All of the compounds were assayed at the fixed concentration of 10 μM that allowed the inhibition of Hpse enzymatic activity without affecting cell proliferation.</div><div class="NLM_p">Instead, the internal reference compound <b>3</b> was tested at concentration below the IC<sub>10</sub> values measured in the proliferation assay against each cell line. Interestingly, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, all the newly synthesized compounds were able to inhibit, although at a different extent, the invasion of the three tumor cell lines and, in most cases, with potency similar to that of the internal reference compound <b>3</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of Invasive Potential of HT1080, U87MG, and U2OS Human Cell Lines by Derivatives <b>3</b>, <b>5c</b>, <b>7a</b>, <b>7b</b>, and <b>7g</b> and Reference Compound <b>3</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">concentration tested (μM)</th><th class="colsep0 rowsep0" align="center">HT1080</th><th class="colsep0 rowsep0" align="center">U87MG</th><th class="colsep0 rowsep0" align="center">U2OS</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">+</td><td class="colsep0 rowsep0" align="left">++</td><td class="colsep0 rowsep0" align="left">++</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">++</td><td class="colsep0 rowsep0" align="left">++</td><td class="colsep0 rowsep0" align="left">+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">+</td><td class="colsep0 rowsep0" align="left">++</td><td class="colsep0 rowsep0" align="left">+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7g</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">++</td><td class="colsep0 rowsep0" align="left">++</td><td class="colsep0 rowsep0" align="left">+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">++</td><td class="colsep0 rowsep0" align="left">++</td><td class="colsep0 rowsep0" align="left">++</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Matrigel cell invasion assay on HT1080, U87MG, and U2OS tumor cells upon 24 h of treatment. Score symbols: plus sign indicates a <50% inhibition and double plus sign indicates a 50–90% of inhibition of cell invasion with respect to cell invasion in the absence of drugs.</p></div></div></div><div class="NLM_p">Because treatment with Hpse inhibitors heparin derivatives has been previously reported to heavily affect the invasive capacities of soft tissue sarcoma cell lines, including the CME-1 cell line,<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> we further investigated the anti-invasive activity of compound <b>5c</b> in this cellular model. To this end, compound <b>5c</b> was tested at three concentrations below the IC<sub>50</sub> value measured by the proliferation assay on the same cell line.</div><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">4</a></a>, compound <b>5c</b> inhibited Matrigel invasion by CME-1 cells in a dose-dependent way being active also at nontoxic concentrations (i.e., 1.55 and 3.12 μM), as resulted by the antiproliferative assay, thus resembling data seen on the other tumor cells reported in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> (similar results were obtained with <b>7a</b> and <b>7g</b> on HT1080 cells; see <a class="ref internalNav" href="#notes1" aria-label="Figure S2">Figure S2</a>).</div><figure id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>5c</b> inhibition of the invasive ability of human CME-1 synovial sarcoma cells. Cells pretreated with compound <b>5c</b> at the indicated concentrations were transferred to Matrigel-coated Transwell chambers and incubated for an additional 24 h. Results are expressed as invasion percent (mean plus or minus the SE of two experiments performed in duplicate) with respect to the control cells. Representative images of filters are shown. Original magnification: 100×. Asterisks indicate <i>P</i> < 0.05</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The maximum effect was achieved at the highest dose, 6.25 μM, that is nearby the IC<sub>50</sub> value measured after 72 h of drug treatment. It is noteworthy that in the Matrigel invasion assay, CME-1 cells were treated only for 24 h, and compound <b>5c</b> was not able to affect cell proliferation after this time (data not shown). Altogether, these data would suggest that suppression of tumor invasion by these compounds might be mediated by inhibition of Hpse activity.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Effects on Gene Expression</h3><div class="NLM_p">We next wondered if our selected Hpse inhibitors are also able to affect transcription of genes, an effect associated with the nuclear-located active form of Hpse that contribute to drive an aggressive tumor phenotype expression.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> To this end, HT1080 cells were treated for 24 h with derivatives <b>5c</b>, <b>7a</b>, and <b>7g</b> as compared to the internal reference compound <b>3</b> at concentrations allowing the inhibition of Hpse enzymatic activity but not of tumor cell proliferation. Then, the mRNA levels of genes encoding for proangiogenic factors, such as FGF1/2, VEGF, and MMP-9, and for Hpse (HPSE-1) were measured by a quantitative real-time polymerase chain reaction (q-PCR) assay.</div><div class="NLM_p">Overall, results highlighted a weak or moderate inhibitory effect of all the compounds on transcription of these genes (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">5</a></a>), although none derivative appeared more efficacious than the others. Interestingly, only derivatives <b>7a</b> and <b>7g</b> were shown to decrease (about 40% with respect to control cells) transcription of the gene encoding for the same Hpse. Furthermore, compound <b>7g</b> was more effective also in inhibiting the other proangiogenic factors evaluated.</div><figure id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compounds <b>5c</b>, <b>7a</b>, and <b>7g</b> as compared to the internal reference <b>3</b> with regard to the expression of selected angiogenesis-related genes. The expression levels of FGF-1, FGF-2, VEGF, MMP-9, and HSPE-1 mRNA in HT1080 cells, upon 24 h of treatment, were measured through real-time quantitative polymerase chain reaction analysis. Results are expressed as percent with respect to untreated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, we reported the design, synthesis and biological evaluation of symmetrical 2-aminophenyl-benzazolyl-5-acetate derivatives as new Hpse inhibitors. Interestingly, we found that these symmetrical compounds were more effective in inhibiting the targeted enzyme with respect to our previously reported asymmetrical benzazole derivatives (i.e., <b>3</b> and <b>4</b>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Indeed, the thiourea glycine benzoxazole compound <b>7g</b> (SST0872AA1), with an IC<sub>50</sub> of 0.08 μM, represents the best acting Hpse inhibitor among the newly synthesized compounds reported in this study. The relevance of compound <b>7g</b> was also confirmed by invasion and real-time PCR test.</div><div class="NLM_p">As we previously reported, the introduction of a fluorine atom in the <i>ortho</i> position of the urea group remarkably improved the inhibitory profile, as suggested by the increase in inhibitory potency of urea <b>5c</b> or thiourea <b>5d</b> in respect to their non fluorinated analogues urea <b>5a</b> and thiourea <b>5e</b>. Moreover, the introduction of thiourea as central core seems to be a useful strategy, as confirmed by the non fluorinated acetic acid derivative <b>5d</b> (in comparison to its urea analogue, <b>5a</b>) and the fluorinated glycine derivative <b>7g</b> (in comparison to its urea counterpart, <b>7a</b>). Accordingly to our previously results, also for symmetrical inhibitors, it is possible to denote the relevant role of flexible lateral chain such as the acetic acid group and/or acetic group functionalized with amino acids, suggesting that side chains endowed with increased degrees of freedom could better fit within the binding pocket of Hpse.</div><div class="NLM_p">The best active derivatives <b>5c</b> and <b>7g</b> were evaluated through molecular docking studies, in comparison to reference compound <b>1</b>. The in silico studies confirmed that the acidic portions of the flexible side chain of compounds <b>5c</b> and <b>7g</b> can efficiently interact with relevant Hpse protein residues of the catalytic site, which might explain the higher inhibitory potency observed for these compounds compared to 5,6-dimethylbenzimidazole <b>1</b>.</div><div class="NLM_p last">Interestingly, our findings highlighted the ability of Hpse inhibitors to affect biological processes related to Hpse enzymatic activity, confirming both the anti-metastatic and the anti-angiogenic potential of small molecule Hpse inhibitors. Indeed, representative compounds <b>5a</b>, <b>5c</b>, <b>7a</b>–<b>c</b>, and <b>7g</b> were proven to inhibit Hpse without interfering with tumor cell proliferation, differently from our previously reported asymmetrical benzimidazole derivative <b>3</b>, suggesting useful applications in nononcology fields. Moreover, invasion assay confirmed the anti-metastatic potential of compounds <b>5c</b>, <b>7a</b>, and <b>7b</b>, with potency comparable to that of our previously reported compound <b>3</b>. Notably, <b>5c</b> inhibited invasion in CME-1 cells at nontoxic concentrations, in a similar fashion to heparin-like Hpse inhibitors. Consistent with their ability to inhibit Hpse, likely resulting also in degradation of the nuclear heparin sulfate that is known to affect the control of gene transcription, compounds <b>5c</b>, <b>7a</b>, and <b>7g</b> are also able to inhibit the transcription of genes encoding for proangiogenic factors in tumor cells, although a mechanism of inhibition not depending on the enzymatic activity of HPSE cannot be excluded. Overall, these findings identify in the compound <b>7g</b> one of the most-potent inhibitors of Hpse and provide useful insights for the future optimization and development of highly potent selective anti-Hpse agents.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry: General</h3><div class="NLM_p last">Melting points were determined on a Bobby Stuart Scientific SMP1 melting point apparatus and are uncorrected. Compounds purity were always >95% determined by high-performance liquid chromatography (HPLC). HPLC analyses were carried out with a Shimadzu LC-10AD VP CTO-10AC VP. Column used was generally Discovery Bio Wide Pore C18 and C8 (10 cm × 4.6 mm, 3 μm). IR spectra were recorded on a PerkinElmer Spectrum-One spectrophotometer. <sup>1</sup>H nuclear magnetic resonance (NMR) spectra were recorded at 400 MHz on a Bruker AC 400 Ultrashield 10 spectrophotometer (400 MHz). Dimethyl sulfoxide-<i>d</i><sub>6</sub> 99.9% (CAS 2206-27-1), deuterochloroform 98.8% (CAS 865-49-6), and <i>N</i>,<i>N</i>-dimethylformamide-<i>d</i><sub>7</sub> (CAS 4472-41-7) of isotopic purity (Aldrich) were used. Mass spectra were recorded on a ThermoFinnigan LCQ Classic liquid chromatography–tandem mass spectrometry (LC–MS/MS) ion trap equipped with an electrospray ionization (ESI) source and a syringe pump. Samples (10<sup>–4</sup>–10<sup>–5</sup> M in MeOH/H<sub>2</sub>O 90:10) were infused in the electrospray system at a flow rate of 5–10 μL min<sup>–1</sup>. When necessary, 50 μL of 10<sup>–2</sup> M HCOOH or 10<sup>–2</sup> M NH<sub>3</sub> were added to the sample solution to promote the analyte ionization. Column chromatographies were performed on silica gel (Merck; 70–230 mesh). All compounds were routinely checked with thin-layer chromatography by using aluminum-baked silica gel plates (Fluka DC-Alufolien Kieselgel 60 F<sub>254</sub>). Developed plates were visualized by UV light. Solvents were reagent grade and, when necessary, were purified and dried by standard methods. Concentration of solutions after reactions and extractions involved the use of rotary evaporator (Büchi) operating at a reduced pressure (ca. 20 Torr). Organic solutions were dried over anhydrous sodium sulfate (Merck). All solvents were freshly distilled under nitrogen and stored over molecular sieves for at least 3 h prior to use. Analytical results agreed to within ±0.40% of the theoretical values.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Microwave Irradiation Experiments</h3><div class="NLM_p">Microwave reactions were conducted using a CEM Discover system unit (CEM. Corp., Matthews, NC). The machine consists of a continuous focused microwave-power delivery system with operator selectable power output from 0 to 300 W. The temperature of the contents of the vessel was monitored using a calibrated infrared temperature control mounted under the reaction vessel. All experiments were performed using a stirring option whereby the contents of the vessel are stirred by means of a rotating magnetic plate located below the floor of the microwave cavity and a Teflon-coated magnetic stir bar in the vessel.</div><div id="sec6_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Procedure A (GP-A) to Obtain Acid Derivatives (<b>5a-c,f</b>, <b>6a</b>, <b>7a-c</b>, <b>8a,b</b>, <b>10a</b>, <b>11a-f,h</b>, <b>33b,g</b>, and <b>35</b>)</h4><div class="NLM_p last">A solution of LiOH (5 mmol) in distilled water (1 volume) was added to a suspension of the appropriate ester (1 mmol) in 5 volumes of THF or DMSO (for derivatives <b>5f</b>, <b>11b</b>, <b>11d</b>, and <b>11h</b>) and the reaction was stirred vigorously for the proper time. The organic phase was removed under vacuum and the resulting suspension was acidified with 1 N HCl (pH 4–5). The solid that formed was filtered and then washed with water and dried under IR lamp to afford pure acids. For each compound are reported the amount of ester, THF or DMSO, time of reaction, retention factor (<i>R</i><sub>f</sub>), yield (%), melting point (°C), recrystallization solvent, IR, <sup>1</sup>H NMR, and MS (ESI) results.</div></div><div id="sec6_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> General Procedure B (GP-B) to Obtain Thiourea and Alcohol Acid Derivatives (<b>5d,e</b>, <b>6b</b>, <b>7g</b>, and <b>33d,e</b>)</h4><div class="NLM_p last">A mixture of NaOH 20% (5 mmol) and the appropriate ester (1.38 mmol) in THF (50 mL) and H<sub>2</sub>O (20 mL) was stirred at room temperature (or reflux for derivative <b>33e</b>) for the proper time. The solvent was removed under vacuum, and the crude product was treated with 1 N HCl until pH 3–4. The solid that formed was filtered, washed with water, and dried under an IR lamp to give pure acids. For each compound, the amount of ester, THF, time of reaction, <i>R</i><sub>f</sub>, yield (%), melting point (°C), recrystallization solvent, IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> General Procedure C (GP-C) to Obtain Amino Ester and Isopentyl Derivatives (<b>7d</b>, <b>18a–c,g</b>, and <b>19a,b</b>)</h4><div class="NLM_p last">Amino ester hydrochloride (2.4 mmol), EDCI (2.4 mmol), DMAP (2.4 mmol), and DIPEA (4.8 mmol) were added into a well-stirred mixture of acid derivative (1 mmol) in anhydrous THF or DMF. The reaction was stirred to room temperature overnight under argon atmosphere. The organic phase was removed under vacuum and the crude product was treated with water. The solid that formed was filtered, washed with water, and dried under an IR lamp to afford the pure amide derivative. For each compound, amount of amino ester hydrochloride, THF or DMF, <i>R</i><sub>f</sub>; yield (%), melting point (°C), recrystallization solvent, IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure D (GP-D) to Obtain Boronic Acid Derivatives (<b>7e</b> and <b>11i</b>)</h4><div class="NLM_p last">NH<sub>4</sub>OAc<sub>aq</sub> (43.5 mL, 0.1 N) and NaIO<sub>4</sub> (0.97 g, 4.52 mmol) were added into a stirred solution of the pinacol boronate ester (1 mmol) in THF (15 mL) (acetone for <b>41</b>, 8 mL). The mixture was stirred vigorously at room temperature for 48 h (24 h for <b>11i</b>), then the solvent was removed under vacuum, and the resulting solid was collected by filtration, washed with water and dried under IR lamp. For derivative <b>7e</b>, the dried precipitate was washed with dichloromethane and reacted again in the same conditions described above for 24 h. The THF was removed under vacuum and the resulting solid was filtered, washed with water, dried under IR lamp, then washed again with dichloromethane, affording pure boronic acid derivative. For each compound, the amount of boronate ester derivative, <i>R</i><sub>f</sub>, yield (%), recrystallization solvent, and IR and MS (ESI) results are reported.</div></div><div id="sec6_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Procedure E (GP-E) to Obtain Boronic Derivatives (<b>7f</b>, <b>8c</b>, and <b>21</b>)</h4><div class="NLM_p last">The appropriate ammonium salt (2.5 mmol), carboxylic acid derivative (1 mmol), and TBTU (2.75 mmol) were solubilized in dry DMF or THF and DMF, and the mixture was cooled to −80 °C while stirring. Then a solution of i-Pr<sub>2</sub>NEt (7.25 mmol) in dry DMF (4 mL) was added dropwise in 2 h, maintaining the temperature at −80 °C. The mixture was further stirred for 1.5 h and then slowly heated to room temperature. The solvent was removed under vacuum and the crude product was treated with distilled water; the solid that formed was filtered, washed with water, and dried under an IR lamp to afford the final product. For each compound, the amount of acid and ammonium salt, volume of solvent, <i>R</i>f, yield (%), melting point (°C), IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> General Procedure F (GP-F) to Obtain Urea Derivatives (<b>9a,b</b>, <b>10b</b>, <b>16a–d</b>, <b>17a</b>, <b>27a</b>, <b>29b</b>, and <b>34a,c,i</b>)</h4><div class="NLM_p last">Triphosgene (0.18 mmol) (or thiocarbonyldiimidazole, 1.03 mmol, for <b>16d</b>) was added to a stirred solution of the appropriate amine (1 mmol) and Et<sub>3</sub>N (1.05 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (dry CH<sub>2</sub>Cl<sub>2</sub>/THF 1:1 for derivative <b>34c,</b> dry THF for derivative <b>34i</b>) in an ice-cooled flask. After 10 min, the ice bath was removed, and the mixture was stirred under nitrogen atmosphere at room temperature (40 °C for derivative <b>16d</b>) for the appropriate time. The solvent was removed under vacuum, and the crude product was treated with distilled water; the resulting solid was filtered, washed with water, and dried under an IR lamp to afford the products. For each compound, the time of reaction, amount of amine, volume of solvent, chromatography eluent (if applicable), <i>R</i><sub>f</sub>, yield (%), melting point (°C), recrystallization solvent, IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> General Procedure G (GP-G) to Obtain Isothiocyanates (<b>14</b>, <b>15</b>, and <b>28</b>)</h4><div class="NLM_p last">A mixture of the proper aryl amine (1.66 mmol), thiophosgene (2.2 mmol) in chlorobenzene (3.5 mL), and DMF (0.013 mL) was prepared at room temperature and slowly heated to reflux. Heating at reflux and stirring were continued for the proper time. Then, the mixture was cooled and concentrated under reduced pressure to give the pure isothiocyanates. For each compound time of reaction, the amount of amine, <i>R</i><sub>f</sub>, yield (%), melting point (°C), recrystallization solvent, IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> General Procedure H (GP-H) to Obtain Thiourea Derivatives (<b>16e</b>, <b>17b</b>, and <b>29d</b>)</h4><div class="NLM_p last">A mixture of the proper amine (3.33 mmol) and the corresponding isothiocyanate derivative (3.5 mmol) in dry DMSO (1 mL) was irradiated with microwave at 80 °C for 3 min (or 1 min for derivative <b>29d</b>) under argon atmosphere. After cooling, water was added (5 mL), and the precipitate that formed was filtered. The solid was washed with water, dissolved in THF and precipitated with <i>n</i>-hexane (for <b>16e</b>), washed with THF (for <b>17b</b>) or washed with 1 N HCl, and used for the next step without purification. For each compound, the amount of amine, amount of isothiocyanate, <i>R</i><sub>f</sub>, yield (%), melting point (°C), recrystallization solvent, IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> General Procedure I (GP-I) to Obtain Amide Derivatives (<b>22a,b</b>, <b>34b,d,e</b>, <b>36a</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <b>39</b>)</h4><div class="NLM_p last">To a suspension of the proper amine (1 mmol) in THF dry or CH<sub>2</sub>Cl<sub>2</sub> dry under argon was added triethylamine (2 mmol) followed by a solution of appropriate chloride (1 mmol) in dry THF or CH<sub>2</sub>Cl<sub>2</sub> (20 mL) in ice-bath and stirred for 3 h (30 min for derivative <b>34d</b> and overnight for derivative <b>34b</b>) at room temperature. Upon reaction completion, checked by means of MS, the solution was reduced under pressure, and water and ethyl acetate were added (200 mL). The aqueous layer was further extracted with ethyl acetate (2 × 50 mL). The organic fractions were combined, dried (with Na<sub>2</sub>SO<sub>4</sub>), and concentrated to give the subtitle compound that was used directly in the next reaction without purification. For each compound, the amount of amine, THF or CH<sub>2</sub>Cl<sub>2</sub>, <i>R</i><sub>f</sub>, yield (%), melting point (°C), IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> General Procedure J (GP-J) to Obtain Nitrobenzoxazole Derivatives (<b>23a,b</b>)</h4><div class="NLM_p last"><i>p</i>-Toluenesulfonic acid monohydrate (2.1 mmol) was added into a stirred suspension of dimethyl amide derivative (1 mmol) in toluene. A Dean–Stark trap was fitted, and the reaction was refluxed overnight. The reaction was cooled to room temperature, and the volume of solvent was reduced. The mixture was diluted with ethyl acetate (200 mL) and washed with saturated aqueous sodium hydrogen carbonate solution (200 mL). The organic layer was separated and the aqueous layer was further extracted with ethyl acetate (2 × 100 mL). The organic fractions were combined and washed with water (200 mL) and saturated sodium chloride solution (200 mL), dried (with Na<sub>2</sub>SO<sub>4</sub>), and concentrated to give the subtitle compounds. For each compound, the amount of amide, toluene, <i>R</i><sub>f</sub>, yield (%), melting point (°C), IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> General Procedure K (GP-K) to Obtain Arylamines (<b>24a,b</b>, <b>38a</b>, and <b>41</b>)</h4><div class="NLM_p last">A total of 10% palladium on activated carbon was added into a stirred solution of the appropriate nitro compound (1 mmol) in ethyl acetate under argon atmosphere. The reaction vessel was purged with hydrogen (40 psi) and stirred for the appropriate time. The mixture was filtered through celite and washed with ethyl acetate (100 mL) and dried (with Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed under reduced pressure to give the subtitle compounds. For each compound, the amounts of nitro compound, ethyl acetate, reaction time, <i>R</i><sub>f</sub>, yield (%), melting point (°C), IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> General Procedure L (GP-L) to Obtain Piperinidyl Benzoxazole Derivatives (<b>25a,b</b>)</h4><div class="NLM_p last">To a stirred solution of commercially available 2-amino-4,5-dimethylphenol<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> or methyl 2-(3-amino-4-hydroxyphenyl)acetate<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (1 mmol) in pyridine (1.8 mL) was added potassium <i>O</i>-ethyl xanthogenate (1.4 mmol).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The mixture was refluxed for 2 h under inert atmosphere. The reaction was then cooled to room temperature, diluted with ethyl acetate (400 mL), and washed with 2 N HCl (180 mL) and with saturated aqueous sodium chloride solution (400 mL) 5 times. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to give the corresponding unstable 2-mercaptobenzoxazole intermediates that immediately underwent to reaction with 4-(<i>N</i>-Boc-amino)piperidine (2 mmol) in <i>m</i>-xylene (8.5 mL). The mixture was refluxed for 1.5 h under inert atmosphere and then was diluted with ethyl acetate (400 mL) and washed with water and saturated sodium chloride solution (200 mL), dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The raw was purified by column chromatography (SiO<sub>2</sub>) to give the subtitled compounds. For each compound, the amount of amino phenol, chromatography eluent, recrystallization solvent, <i>R</i><sub>f</sub>, yield (%), melting point (°C), IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> General Procedure M (GP-M) to Obtain 4-Aminopiperinidyl Benzoxazole Derivatives (<b>26a,b</b>)</h4><div class="NLM_p last">To a stirred solution of 4-(<i>N</i>-Boc-amino)piperidinyl benzazoles (1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> anhydrous (10 mL) trifluoroacetic acid was added dropwise (2 mmol), and the reaction was stirred at room temperature for 45 min. The solvent was evaporated under vacuum and the crude was used for the next step without further purification. For each compound, the amount of 4-(<i>N</i>-Boc-amino)piperidinyl derivative, <i>R</i><sub>f</sub>, yield (%), IR, and MS (ESI) results are reported.</div></div><div id="sec6_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> General Procedure N (GP-N) to Obtain Acyl Chlorides of Acids <b>33a,b,d,e</b></h4><div class="NLM_p last">To a well-stirred solution of the proper carboxylic acid (1 mmol) in THF dry (15 mL) oxalyl chloride (15 mmol) and 4 drops of DMF dry were added, and the reaction was stirred at room temperature under argon atmosphere overnight (or for 4 h for derivative <b>33b</b>). The solvent was evaporated under vacuum, and the crude was immediately used for the next step without characterization and further purification.</div></div><div id="sec6_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> General Procedure O (GP-O) for Coupling Reaction Derivatives (<b>34f,g,h</b>)</h4><div class="NLM_p last">EDCI (2.2 mmol), HOBt (4.4 mmol), NMM (4.4 mmol), and a solution of methyl 2-(3-aminophenyl)acetate (2.2 mmol) in DMF dry (6 mL) were added to a well-stirred solution of acid derivative (1 mmol) in DMF dry (6 mL). The mixture was stirred at room temperature for 4 h under argon atmosphere. The crude was quenched with water and extracted with ethyl acetate (100 mL). The organic layer was washed with saturated sodium chloride solution (400 mL), dried (with Na<sub>2</sub>SO<sub>4</sub>), and concentrated to afford the pure amide derivatives. For each compound, the amount of amine, <i>R</i><sub>f</sub>, yield (%), melting point (°C), recrystallization solvent, IR, <sup>1</sup>H NMR, and MS (ESI) results are reported.</div></div><div id="sec6_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2,2′-(((Carbonylbis(azanediyl))bis(4,1-phenylene))bis(benzo[<i>d</i>]oxazole-2,5-diyl))diacetic Acid (<b>5a</b>)</h4><div class="NLM_p last">Compound <b>5a</b> was prepared from <b>16a</b> by means of GP-A. <b>16a</b> (0.8 g, 1.35 mmol); 17.7 mL; overnight; <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.7; 62% as a white solid; 305 °C dec.; THF; IR ν 3329 (OH acid), 2489 (NH), 1691 (C=O acid), 1596 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF d<sub>7</sub>, δ): 3.64 (s, 4H, CH<sub>2</sub>), 7.24 (d, 2H, benzoxazole C6–H, <i>J</i> = 9 Hz), 7.54 (d, 2H, benzoxazole C7–H, <i>J</i> = 8 Hz), 7.85–8.07 (m, 10 H, benzene H and benzoxazole C4–H), 12.12 (br s, 2H, OH acid); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>22</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>, 562.15; found, 562.80.</div></div><div id="sec6_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2,2′-(((Carbonylbis(azanediyl))bis(3,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))diacetic Acid (<b>5b</b>)</h4><div class="NLM_p last">Compound <b>5b</b> was prepared from <b>16b</b> by means of GP-A. <b>16b</b> (0.15g, 0.26 mmol); 75 mL; overnight; <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.5; 70% as a white solid; 300 °C dec.; DMF; IR ν 3279 (OH acid), 2953 (NH), 1697 (C=O acid), 1694 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF d<sub>7</sub>, δ): 3.72 (s, 4H, CH<sub>2</sub>), 7.44 (d, 2H, benzoxazole C6–H, <i>J</i> = 8 Hz), 7.60 (d, 2 H, benzene H, <i>J</i> = 8 Hz), 7.82–7.92 (m, 6H, benzoxazole C4–H an dC7-H and 2H,benzene H), 8.74 (s, 2 H, benzene H), 9.80 (s, 2H, NH); 12.48 (br s, 2H, OH acid); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>22</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>, 562.15; found, 563.13.</div></div><div id="sec6_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[<i>d</i>]oxazole-2,5-diyl))diacetic Acid (<b>5c</b>)</h4><div class="NLM_p last">Compound <b>5c</b> was prepared from <b>16c</b> by means of GP-A. <b>16c</b> (0.27 g, 0.43 mmol); 20 mL; overnight; <i>R</i><sub>f</sub> (chloroform/methanol 10:1): 0.07; 80% as a white solid; 290 °C dec ; THF<b>;</b> IR ν 3266 (OH acid), 2921 (NH), 1721 (C=O urea), 1694 (C=O acid) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF d<sub>7</sub>, δ): 3.62 (s, 4H, CH<sub>2</sub>), 7.19 (d, 2H, benzoxazole C6–H, <i>J</i> = 4 Hz), 7.50–7.55 (m, 4H, benzoxazole C4–H and C7–H), 7.88 (m, 4 H, benzene H, <i>J</i> = 8 Hz), 8.43 (d, 2 H, benzene H, <i>J</i> = 8 Hz), 9.48 (s, 2H, NH); 12.48 (br s, 2H, OH acid); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>20</sub>F<sub>2</sub>N<sub>4</sub>O<sub>7</sub>]<sup>−</sup>, 598.13; found, 596.47.</div></div><div id="sec6_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2,2′-(((Thiocarbonylbis(azanediyl))bis(4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))diacetic Acid (<b>5d)</b></h4><div class="NLM_p last">Compound <b>5d</b> was prepared from <b>16d</b> by means of GP-B. <b>16d</b> (0.84 g, 1.38 mmol); 50 mL; overnight; <i>R</i><sub>f</sub> (chloroform/methanol 10:1): 0.10; 44% as a brow solid; carbonizes 300 °C; washed with diethyl ether; IR ν 2953 (OH acid), 2608 (NH), 1690 (C=O acid) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF d<sub>7</sub>, δ): 3.76(s, 4H, CH<sub>2</sub>), 7.32–7.34 (d, 2H, benzoxazole C6–H), 7.65–7.69 (m, 4H, benzoxazole C7–H and benzoxazole C4–H), 8.01–8.03 (d, 4 H, benzene H), 8.16–8.18 (d, 4H, benzene H),11.21 (br s, 2H, NH), 12.55 (br s, 2H, OH acid); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>22</sub>N<sub>4</sub>O<sub>6</sub>S]<sup>−</sup>, 578.13; found, 576.53.</div></div><div id="sec6_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2,2′-(((Thiocarbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))diacetic Acid (<b>5e</b>)</h4><div class="NLM_p last">Compound <b>5e</b> was prepared from <b>16e</b> by means of GP-B. <b>16e</b> (0.13 g, 0.20 mmol); 50 mL; overnight; <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.4; 100% as a yellow solid; 330 °C dec.; washed with diethyl ether; IR ν 3113 (OH acid), 2620 (NH), 1716 (C=O acid), 1327 (C=S) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF d<sub>7</sub>, δ): 3.77(s, 4H, CH<sub>2</sub>), 7.36–7.38 (d, 2H, benzoxazole C6–H), 7.68–7.72 (m, 4H, benzoxazole C7–H and benzoxazole C4–H), 7.99–8.05 (m, 4 H, benzene H), 8.23–8.27 (t, 2H, benzene H),9.68 (br s, 2H, NH), 12.60 (br s, 2H, OH acid); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>20</sub>F<sub>2</sub>N<sub>4</sub>O<sub>6</sub>S]<sup>−</sup>, 614.11; found, 612.60.</div></div><div id="sec6_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2,2′-((((Iminomethylene)bis(azanediyl))bis(4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))diacetic Acid (<b>5f</b>)</h4><div class="NLM_p last">Compound <b>5f</b> was prepared from <b>20</b> by means of GP-A. <b>20</b> (0.3 g, 0.51 mmol); 1.25 mL; 3 d; <i>R</i><sub>f</sub> (chloroform/methanol 10:1): 0.71; 70% as a yellow solid; 270 °C dec.; washed with diethyl ether; IR ν 3065 (OH acid), 1667 (C=O acid) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 3.61 (s, 4H, CH<sub>2</sub>), 5.73 (br d, 2H, NH guanidine), 7.18–7.55 (m, 10H, benzene H and benzoxazole C4–H, C6–H and C7–H), 8.00 (br d, 4H, benzene H), 9.54 (br s, 2H, NH), 11.84 (br s, 2H, OH acid); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>23</sub>N<sub>5</sub>O<sub>6</sub>]<sup>+</sup>, 561.16; found, 563.37.</div></div><div id="sec6_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(1<i>H</i>-benzo[<i>d</i>]imidazole-2,5-diyl))diacetic Acid (<b>6a</b>)</h4><div class="NLM_p last">Compound <b>6a</b> was prepared from <b>17a</b> by means of GP-A. <b>17a</b> (180 mg, 0.288 mmol); 2.2 mL; overnight; <i>R</i><sub>f</sub> (chloroform/ethyl acetate 1:1): 0.12; 49% as a yellow solid; 185 °C dec.; THF/DMF; IR ν 2952 (NH and OH), 1726 (C=O), 1600 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 3.68 (s, 4H, CH<sub>2</sub>), 7.11–8.45 (m, 12H, Ar), 9.43 (s, 2H, NH urea), 12.46 (br s, 2H, acid), 12.86 (s, 2H, benzimidazole); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>22</sub>F<sub>2</sub>N<sub>6</sub>O<sub>5</sub>]<sup>−</sup>, 595.16; found, 594.80.</div></div><div id="sec6_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2,2′-(((Thiocarbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(1<i>H</i>-benzo[<i>d</i>]imidazole-2,5-diyl))diacetic Acid (<b>6b</b>)</h4><div class="NLM_p last">Compound <b>6b</b> was prepared from <b>17b</b> by means of GP-B. <b>17b</b> (100 mg, 0.156 mmol); 25 mL; overnight; <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.27; 90% as a gray solid; 260 °C dec.; IR ν 2854 (OH and NH), 1710 (C=O), 1600 (C=O), 1326 (C=S) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 3.77 (s, 4H, CH<sub>2</sub>–Ar), 7.31 (br t, 2H, benzene H), 7.63–7.68 (m, 4H, benzimidazole C6–H and C7–H), 8.08–8.21 (m, 4H, benzene H and benzimidazole C4–H), 8.53 (br t, 2H, benzimidazole C7–H), 9.71 (s, 2H, thiourea); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>22</sub>N<sub>4</sub>O<sub>7</sub>]<sup>−</sup>, 612.13; found, 594.93 (M – H<sub>2</sub>S + H<sub>2</sub>O); [C<sub>31</sub>H<sub>22</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>, 612.13; found, 596.80 (M – H<sub>2</sub>S + H<sub>2</sub>O).</div></div><div id="sec6_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2,2′-((2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[<i>d</i>]oxazole-2,5-diyl))bis(acetyl))bis(azanediyl))diacetic Acid (<b>7a</b>)</h4><div class="NLM_p last">Compound <b>7a</b> was prepared from <b>18a</b> by means of GP-A. <b>18b</b> (0.10 g, 0.130 mmol); 50 mL; overnight; <i>R</i><sub>f</sub> (chloroform/methanol 3:7): 0.54; 65% as a yellow solid; 269 °C dec ; IR ν 3282 (NH), 3077 (OH), 1726 (C=O), 1727 (C=O), 1650 (C=O), 1600 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 3.62 (s, 4H, CH<sub>2</sub>), 3.77 (d, 4H, <i>J</i> = 4 Hz, <i>CH</i><sub>2</sub>-NH), 7.32 (d, 2H, <i>J</i> = 8 Hz, benzoxazole C6–H), 7.68–7.70 (m, 4H, benzoxazole C4–H and C7–H), 8.00–8.04 (m, 4H, benzene H), 8.44 (br t, 2H, <i>NH</i>–CH<sub>2</sub>), 8.52 (t, 2H, <i>J</i> = 8 Hz, benzene H), 9.6 (br s, 2H, NH–C=O). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>35</sub>H<sub>26</sub>F<sub>2</sub>N<sub>6</sub>O<sub>9</sub>]<sup>−</sup>, 712.17; found, 711.03.</div></div><div id="sec6_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2,2′-((2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[<i>d</i>]oxazole-2,5-diyl))bis(acetyl))bis(azanediyl))dipropionic Acid (<b>7b</b>)</h4><div class="NLM_p last">Compound <b>7b</b> was prepared from <b>18b</b> by means of GP-A. <b>18b</b> (0.33 g, 0.42 mmol); 167.5 mL; 3.5 h; <i>R</i><sub>f</sub> (chloroform/methanol 3:7): 0.51; 89% as a white-yellow solid; 232 °C dec.; IR ν 3267 (OH and NH), 2956 (NH), 1712 (C=O), 1608 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 1.28 (br d, 6H, CH<sub>3</sub>), 3.60 (s, 4H, CH<sub>2</sub>–Ar), 4.18 (br m, 2H, CH), 7.31 (br d, 2H, benzoxazole C6–H), 7.60–7.70 (m, 4H, benzoxazole C7–H and C4–H), 7.90–8.05 (m, 4H, benzene H), 8.52 (t, 2H, benzene H, <i>J</i> = 8 Hz) 8.60 (d, 2H, NH–CO, <i>J</i> = 8 Hz), 9.61 (s, 2H, NH urea), 12.7 (br s, 2H, acid); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>37</sub>H<sub>30</sub>F<sub>2</sub>N<sub>6</sub>O<sub>9</sub>]<sup>−</sup>, 740.68; found, 368.80 (M/2), 738.80 (M<sup>–</sup>).</div></div><div id="sec6_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2,2′-((2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))bis(acetyl))bis(azanediyl))bis(3-phenylpropanoic acid) (<b>7c</b>)</h4><div class="NLM_p last">Compound <b>7c</b> was prepared from <b>18c</b> by means of GP-A. <b>18c</b> (0.17 g, 0.184 mmol); 87.5 mL; 3.5 h; <i>R</i><sub>f</sub> (chloroform/methanol 3:7): 0.55; 95% as a yellow solid; 210 °C dec.; IR ν 3268 (OH and NH), 2973 (NH), 1716 (C=O), 1649 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 2.86–3.10 (m, 4H, CH<sub>2</sub>–Bz), 3.56 (s, 4H, CH<sub>2</sub>–Ar), 4.42–4.47 (m, 2H, CH), 7.17–7.24 (m, 12H, benzene H and benzoxazole C6–H), 7.59 (s, 2H, benzoxazole C4–H), 7.64 (d, 2H, benzoxazole C7–H, <i>J</i> = 8 Hz), 8–8.05 (m, 4H, benzene H), 8,47 (d, 2H, NH–CO, <i>J</i> = 8 Hz), 8.53(t, 2H, benzene H, <i>J</i> = 8 Hz), 9.63 (s, 2H, NH urea), 13.5 (br s, 2H, acid); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>49</sub>H<sub>38</sub>F<sub>2</sub>N<sub>6</sub>O<sub>9</sub>]<sup>−</sup>, 892.87; found, 890.87.</div></div><div id="sec6_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[<i>d</i>]oxazole-2,5-diyl))bis(<i>N</i>-isopentylacetamide) (<b>7d</b>)</h4><div class="NLM_p last">Compound <b>7d</b> was prepared from <b>5c</b> by means of GP-C. (<i>R</i>)-BoroLeu-(+)-Pinanediol HCl (390 mg, 1.28 mmol); 75 mL THF; <i>R</i><sub>f</sub> (chloroform/methanol 4:1): 0.63; 87%; 248 °C dec.; washed with diethyl ether; IR ν 3284 (NH), 2955 (NH), 1674 (C=O), 1608 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 0.86 (d, 12H, <i>J</i> = 8 Hz, CH<sub>3</sub>–<sup>i</sup>Pr), 1.30 (q, 4H, <i>J</i> = 8 Hz, CH<sub>2</sub>–<sup>i</sup>Pr), 1.54–1.59 (m, 2H, CH–<sup>i</sup>Pr), 3.06 (q, 4H, <i>J</i> = 8 Hz, αCH<sub>2</sub>N), 3.52 (s, 4H, CH<sub>2</sub>–Ar), 7.28–8.53 (m, 14H, Ar and NH amide), 9.60 (s, 2H, NH urea); 99.02%; MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>41</sub>H<sub>42</sub>F<sub>2</sub>N<sub>6</sub>O<sub>5</sub>]<sup>−</sup>, 736.82; found, 357.69 (M – H<sub>2</sub>O/2).</div></div><div id="sec6_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (((2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[<i>d</i>]oxazole-2,5-diyl))bis(acetyl))bis(azanediyl))bis(3-methylbutane-1,1-diyl))diboronic Acid (<b>7e</b>)</h4><div class="NLM_p last">Compound <b>7e</b> was prepared from <b>21</b> by means of GP-D. <b>21</b> (0.20 g, 0.183 mmol); <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.67; 60% as a gray solid; 226 °C; THF/DMF; IR ν 3271 (OH and NH), 2956 (NH), 1603 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 0.84 (s, 12H, CH<sub>3</sub>), 1.31–1.61 (m, 6H, 2CH<sub>2</sub>–<sup>i</sup>Pr and 2CH(CH<sub>3</sub>)<sub>2</sub>), 3.52 (s, 4H, CH<sub>2</sub>Ar), 5.22 (s, 2H, αCH-B), 5.56 (s, 4H, OH), 7.30 (d, 2H, <i>J</i> = 8 Hz, benzoxazole C6–H), 7.66–87.98 (m, 4H, benzoxazole C4–H and C7–H), 7.97–8.02 (m, 4H, benzene H), 8.40 (d, 2H, <i>J</i> = 8 Hz, NH amide), 8.51 (t, 2H, <i>J</i> = 8 Hz, benzene H), 9.58 (s, 2H, NH urea); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>41</sub>H<sub>44</sub>B<sub>2</sub>F<sub>2</sub>N<sub>6</sub>O<sub>9</sub>]<sup>−</sup>, 824.45; found, 862.73.</div></div><div id="sec6_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (((2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[<i>d</i>]oxazole-2,5-diyl))bis(acetyl))bis(azanediyl))bis(methylene))diboronic Acid (<b>7f</b>)</h4><div class="NLM_p last">Compound <b>7f</b> was prepared from <b>5c</b> by means of GP-E. (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methanaminium chloride (0.24 g, 1.2 mmol); 2 mL DMF; <i>R</i><sub>f</sub> (methanol +0.05% TFA): 0.12; 30% as a white solid; 237 °C dec.; DMF; IR ν 3356 (OH and NH), 2962 (NH), 1718 (C=O), 1604 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 2.27 (d, 4H, <i>J</i> = 4 Hz, αCH<sub>2</sub>–B), 3.56 (s, 4H, CH<sub>2</sub>Ar), 6.90 (bt, 2H, NH amide), 7.32–8.54 (m, 12H, Ar), 9.60 (s, 2H, NH urea); 99.64%; MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>28</sub>B<sub>2</sub>F<sub>2</sub>N<sub>6</sub>O<sub>9</sub>]<sup>−</sup>, 712.24; found, 710.77.</div></div><div id="sec6_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2,2′-((2,2′-(((Thiocarbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))bis(acetyl))bis(azanediyl))diacetic Acid (<b>7g</b>)</h4><div class="NLM_p last">Compound <b>7g</b> was prepared from <b>18g</b> by means of GP-B. <b>18g</b> (0.150g, 0.19 mmol); 20 mL; overnight; <i>R</i><sub>f</sub> (CHCl<sub>3</sub>: MeOH 1:1) 0.23; 70% as a yellow solid; 200 °C dec.; IR ν 3277 (OH and NH), 1719 (C=O acid), 1644 (C=O amide), 1329 (C=S) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 3.60–3.63 (m, 4H, CH<sub>2</sub>NH), 3.76–3.79 (m, 4H, CH<sub>2</sub> Gly), 7.28–8.54 (m, 14H, Ar and NH Gly), 9.61 (br s, 2H, tiourea) 98.21%; MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>35</sub>H<sub>26</sub>F<sub>2</sub>N<sub>6</sub>O<sub>8</sub>S]<sup>−</sup>, 728.15; found, 694.07 (M – H<sub>2</sub>S).</div></div><div id="sec6_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2,2′-((2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(1<i>H</i>-benzo[<i>d</i>]imidazole-2,5-diyl))bis(acetyl))bis(azanediyl))bis(3-phenylpropanoic acid) (<b>8a</b>)</h4><div class="NLM_p last">Compound <b>8a</b> was prepared from <b>19a</b> by means of GP-A. <b>19a</b> (0.2 g, 0.261 mmol); 5 mL; overnight; <i>R</i><sub>f</sub> (ethyl acetate/methanol 1:1): 0.13; 99% as a gray solid; 190 °C dec.; THF/DMF; IR ν 3348 (OH and NH), 1727 (C=O), 1601 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 3.56 (s, 4H, CH<sub>2</sub>–Ar), 3.78 (br d, 4H, CH), 7.25–8.49 (m, 14H, Ar and NH amide), 9.66 (s, 2H, NH urea), 12.6 (br s, 2H, acid); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>35</sub>H<sub>28</sub>F<sub>2</sub>N<sub>8</sub>O<sub>7</sub>]<sup>−</sup>, 710.20; found, 708.93.</div></div><div id="sec6_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2,2′-((2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(1<i>H</i>-benzo[<i>d</i>]imidazole-2,5-diyl))bis(acetyl))bis(azanediyl))bis(3-phenylpropanoic acid) (<b>8b</b>)</h4><div class="NLM_p last">Compound <b>8b</b> was prepared from <b>19b</b> by means of GP-A. <b>19b</b> (0.3 g, 0.326 mmol); 5 mL; overnight; <i>R</i><sub>f</sub> (ethyl acetate/methanol 1:1): 0.17; 52% as a gray solid; 198–199 °C; THF/DMF; IR ν 3270 (OH and NH), 1721 (C=O), 1637 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 2.89–3.09 (m, 4H, CH<sub>2</sub>–Bz), 3.60 (s, 4H, CH<sub>2</sub>–Ar), 4.44 (br m, 2H, CH), 7.20–8.53 (m, 24H, Ar and NH amide), 9.72 (s, 2H, NH urea), 12.6 (br s, 2H, acid); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>49</sub>H<sub>40</sub>F<sub>2</sub>N<sub>8</sub>O<sub>7</sub>]<sup>−</sup>, 890.90; found, 888.93.</div></div><div id="sec6_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (((2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(1H-benzo[d]imidazole-2,5-diyl))bis(acetyl))bis(azanediyl))bis(methylene))diboronic Acid (<b>8c</b>)</h4><div class="NLM_p last">Compound <b>8c</b> was prepared from <b>6a</b> by means of GP-E. (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methanaminium chloride (240 mg, 1.2 mmol); 6.5 mL of THF and 4.4 mL of DMF; <i>R</i><sub>f</sub> (ethyl acetate/methanol 2:1+ 0.1% CH<sub>3</sub>COOH): 0.44; 35% as a light brown solid; 251 °C; DMF; IR ν 3193 (OH and NH), 1652 (C=O), 1602 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 3.51 (s, 4H, CH<sub>2</sub>–Ar), 4.50 (br d, 4H, <i>CH</i><sub>2</sub>-NH), 5.57 (s, 1H, OH), 7.10 (br t, 2H, benzene H), 7.43–7.55 (m, 4H, benzimidazole C6–H and C7–H), 7.79 (s, 1H, OH), 7.95–7.99 (m, 4H, benzene H and benzimidazole C4–H), 8.41 (br d, 2H, benzene H), 8.63 (br t, 2H, NH amide), 9.41 (s, 2H, NH urea), 12.82 (br s, 2H, benzimidazole NH). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>30</sub>B<sub>2</sub>F<sub>2</sub>N<sub>8</sub>O<sub>7</sub>]<sup>+</sup>, 710.24; found, 675.20 (M<sup>+</sup> – 2H<sub>2</sub>O).</div></div><div id="sec6_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1,3-Bis(4-(5,6-dimethylbenzo[d]oxazol-2-yl)phenyl)urea (<b>9a</b>)</h4><div class="NLM_p last">Compound <b>9a</b> was prepared from <b>24a</b> by means of GP-F. Overnight; <b>24a</b> (1g, 4.2 mmol); 70 mL; <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.1; 32% as a yellow solid; 320 °C dec.; DMF; IR ν 3324 (NH), 1650 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF d<sub>7</sub>, δ): 2.31 (s, 6H, CH<sub>3</sub>), 2.33 (s, 6H, CH<sub>3</sub>), 7.49 (s, 4H benzoxazole C4–H and C7–H), 7.77–7.79 (d, 2H,benzene H), 8.09–8.11 (d, 4H, benzene H), 9.47 (bs, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>26</sub>N<sub>4</sub>O<sub>3</sub>]<sup>+</sup>, 502.20; found, 503.20.</div></div><div id="sec6_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1,3-Bis(4-(5,6-dimethylbenzo[d]oxazol-2-yl)-2-fluorophenyl)urea (<b>9b</b>)</h4><div class="NLM_p last">Compound <b>9b</b> was prepared from <b>24b</b> by means of GP-F. Overnight; <b>24b</b> (0.7 g, 3.4 mmol); 150 mL; <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.1; 32% as a yellow solid; 240 °C dec.; DMF; IR ν 3270 (NH), 1702 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF d<sub>7</sub>, δ): 2.29 (s, 6H, CH<sub>3</sub>), 2.33 (s, 6H, CH<sub>3</sub>), 7.50 (s, 4H benzoxazole C4–H and C7–H), 7.69 (s, 2H,benzene H), 8.17 (s, 2H,benzene H), 8.53–8.57 (t, 2H, benzene H), 9.58 (bs, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>24</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub>]<sup>+</sup>, 538.18; found, 539.20.</div></div><div id="sec6_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2,2′-(((Carbonylbis(azanediyl))bis(piperidine-4,1-diyl))bis(benzo[<i>d</i>]oxazole-2,5-diyl))diacetic Acid (<b>10a</b>)</h4><div class="NLM_p last">Compound <b>10a</b> was prepared from <b>27a</b> by means of GP-A. <b>27a</b> (0.58 g, 0.96 mmol); 12.6 mL; overnight; <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.6; 100% as a white solid; 274–275 °C; DMF; IR ν 3313 (NH), 2931 (OH), 1720 (C=O acid), 1643 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF-d<sub>7</sub>, δ): 1.43–1.46 (m, 4H, CH<sub>2</sub>N), 1.89–1.92 (m, 4H, CH<sub>2</sub>N), 3.21–3.27 (m, 4H, CH<sub>2</sub>), 3.60 (s, 4H, CH<sub>2</sub>CO), 3.74–3.78 (m, 2H, CH), 4.03–4.06 (m, 4H, CH<sub>2</sub>), 6.92 (d, 2H, <i>J</i> = 8 Hz, benzoxazole C6–H), 7.25 (s, 2H, benzoxazole C4–H), 7.27 (d, 2H, <i>J</i> = 8 Hz, benzoxazole C5–H), 12.44 (br s, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>29</sub>H<sub>32</sub>N<sub>6</sub>O<sub>7</sub>]<sup>+</sup>, 576.23; found, 577.04.</div></div><div id="sec6_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1,3-Bis(1-(5,6-dimethylbenzo[<i>d</i>]oxazol-2-yl)piperidin-4-yl)urea (<b>10b</b>)</h4><div class="NLM_p last">Compound <b>10b</b> was prepared from <b>26b</b> by means of GP-F. Overnight; <b>26b</b> (0.56 g, 2.3 mmol); 20 mL; <i>R</i><sub>f</sub> (chloroform/methanol 10:1): 0.77; 11% as a white-gray solid; 300 °C dec.; DMF; IR ν 3310 (NH), 1689 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 2.37 (s, 12H, CH<sub>3</sub>), 3.12–3.17 (m, 4H, CH<sub>2</sub>N), 3.22–3.29 (m, 4H, CH<sub>2</sub>), 4.09–4.12 (m, 2H, CH), 4.47–4.51 (m, 4H, CH<sub>2</sub>), 3.99–4.03 (m, 4H, CH<sub>2</sub>N), 7.32 (d, 2H, <i>J</i> = 8 Hz, benzoxazole C5–H), 7.45 (s, 2H, benzoxazole C4–H), 9.25 (s, 2H, NH urea). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>29</sub>H<sub>36</sub>N<sub>6</sub>O<sub>3</sub>]<sup>+</sup>, 516.28; found, 517.13.</div></div><div id="sec6_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2,2′-(((4,4′-(Carbonylbis(azanediyl))bis(benzoyl))bis(azanediyl))bis(4-hydroxy-3,1-phenylene))diacetic Acid (<b>11a</b>)</h4><div class="NLM_p last">Compound <b>11a</b> was prepared from <b>34a</b> by means of GP-A. <b>34a</b> (0.5 g, 0.63 mmol); 15 mL; overnight; <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.3; 13% as a white solid; 263–264 °C; methanol; IR ν 3289 (OH and NH), 1685 (C=O acid), 1657 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 3.63 (s, 4H, CH<sub>2</sub>), 6.76–6.85 (m, 4H, benzene H), 7.49–7.55 (m, 6H, benzene H), 7.85 (d, 4H, <i>J</i> = 8 Hz, benzene H), 9.22 (s, 2H, NH urea), 9.38 (br s, 2H, NH amide), 9.64 (s, 2H, OH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>26</sub>N<sub>4</sub>O<sub>9</sub>]<sup>−</sup>, 598.17; found, 596.73.</div></div><div id="sec6_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2,2′-(((4,4′-(Carbonylbis(azanediyl))bis(benzoyl))bis(azanediyl))bis(3,1-phenylene))diacetic Acid (<b>11b</b>)</h4><div class="NLM_p last">Compound <b>11b</b> was prepared from <b>34b</b> by means of GP-A. <b>34b</b> (0.2 g, 0.33 mmol); 10 mL; 3 h; <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.14; 70% as a white solid; 261–262 °C; DMF; IR ν 3250 (OH and NH), 1696 (C=O acid), 1659 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 3.48 (s, 4H, CH<sub>2</sub>), 6.90 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.20 (t, 2H, <i>J</i> = 8 Hz, benzene H), 7.53–7.62 (m, 8H, benzene H), 7.87 (d, 4H, <i>J</i> = 8 Hz, benzene H), 9.10 (s, 2H, NH urea), 10.02 (s, 2H, NH amide), 12.25 (s, 2H, OH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>26</sub>N<sub>4</sub>O<sub>7</sub>]<sup>−</sup>, 566.18; found, 565.33.</div></div><div id="sec6_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2,2′-((((Carbonylbis(azanediyl))bis(4,1-phenylenesulfonyl))bis(azanediyl))bis(3,1-phenylene))diacetic Acid (<b>11c</b>)</h4><div class="NLM_p last">Compound <b>11c</b> was prepared from <b>34c</b> by means of GP-A. <b>34c</b> (0.15 g, 2.25 mmol); 3.3 mL; overnight; <i>R</i><sub>f</sub> (ethyl acetate/methanol 4:1): 0.46; 49% as a white solid; 213 °C dec.; benzene; IR ν 3234 (OH and NH), 1698 (C=O acid), 1657 (C=O urea), 1332 (SO<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 3.63 (s, 4H, CH<sub>2</sub>), 6.79 (d, 2H, <i>J</i> = 8 Hz, benzene H), 6.84 (d, 2H, <i>J</i> = 8 Hz, benzene H), 6.95 (s, 2H, benzene H), 7.04 (t, 2H, <i>J</i> = 8 Hz, benzene H), 7.45 (d, 4H, <i>J</i> = 8 Hz, benzene H), 7.58 (d, 4H, <i>J</i> = 8 Hz, benzene H), 9.17 (s, 2H, NH urea), 10.05 (s, 2H, NH amide), 12.22 (br s, 2H, OH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>29</sub>H<sub>26</sub>N<sub>4</sub>O<sub>9</sub>S<sub>2</sub>]<sup>−</sup>, 638.11; found, 637.02.</div></div><div id="sec6_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2,2′-(((4,4′-(Thiocarbonylbis(azanediyl))bis(3-fluorobenzoyl))bis(azanediyl))bis(3,1-phenylene))diacetic Acid (<b>11d</b>)</h4><div class="NLM_p last">Compound <b>11d</b> was prepared from <b>11d</b> by means of GP-A. <b>11d</b> (0.13 g, 0.2 mmol); 20 mL; overnight; <i>R</i><sub>f</sub> (chloroform/methanol 1:1): 0.41; 90% as a yellow solid; 245–246 °C; washed with THF; IR ν 3283 (OH and NH), 1692 (C=O acid), 1646 (C=S thiourea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 3.48 (s, 4H, CH<sub>2</sub>), 6.93 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.22 (t, 2H, <i>J</i> = 8 Hz, benzene H), 7.59–7.92 (m, 8H, benzene H), 10.08 (s, 2H, NH thiourea), 10.22 (s, 2H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>24</sub>F<sub>2</sub>N<sub>4</sub>O<sub>6</sub>S]<sup>−</sup>, 618.14; found, 616.40.</div></div><div id="sec6_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-(3-(4-(3-(4-((5-(Carboxymethyl)-2-hydroxyphenyl)carbamoyl)phenyl)-2-hydroxypropyl)-3-hydroxybenzamido)phenyl)acetic Acid (<b>11e</b>)</h4><div class="NLM_p last">Compound <b>11e</b> was prepared from <b>34e</b> by means of GP-A. <b>34e</b> (0.10 g, 0.16 mmol); 2.2 mL; overnight; <i>R</i><sub>f</sub> (ethyl acetate/methanol 7:3): 0.16; 80% as a gray solid; 198 °C dec.; washed with diethyl ether; IR ν 3099 (OH and NH), 1702 (C=O acid), 1639 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 2.61–2.65 (m, 4H, CH<sub>2</sub>), 3.54 (s, 4H, CH<sub>2</sub>CO), 3.90–3.94 (m, 1H, CH), 4.71–4.74 (m, 1H, OH), 6.76–6.84 (m, 4H, benzene CH), 7.14–7.29 (m, 4H, benzene H), 7.50 (s, 2H, benzene H), 7.77–7.81 (m, 4H, benzene H), 9.38 (s, 2H, NH amide), 12.26 (br s, 2H, OH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>30</sub>N<sub>2</sub>O<sub>9</sub>]<sup>−</sup>, 598.20; found, 597.01.</div></div><div id="sec6_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2,2′-(((4,4′-(2-Hydroxypropane-1,3-diyl)bis(benzoyl))bis(azanediyl))bis(3,1-phenylene))diacetic Acid (<b>11f</b>)</h4><div class="NLM_p last">Compound <b>11f</b> was prepared from <b>34f</b> by means of GP-A. <b>34f</b> (0.10 g, 0.17 mmol); 2.2 mL; overnight; <i>R</i><sub>f</sub> (<i>n</i>-hexane/THF 1:1): 0.11; 82% as a white solid; 219–220 °C; washed with diethyl ether; IR ν 3259 (OH and NH), 1696 (C=O acid), 1650 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 2.66–2.72 (m, 4H, CH<sub>2</sub>), 3.47 (s, 4H, CH<sub>2</sub>CO), 3.88–3.91 (m, 1H, CH), 3.90–3.94 (m, 1H, OH), 6.90 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.19 (t, 2H, <i>J</i> = 8 Hz, benzene H), 7.28 (d, 4H, <i>J</i> = 8 Hz, benzene H), 7.59 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.62 (s, 2H, benzene H), 7.80 (d, 4H, <i>J</i> = 8 Hz, benzene H), 10.09 (s, 2H, NH amide), 12.28 (br s, 2H, OH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>30</sub>N<sub>2</sub>O<sub>7</sub>]<sup>−</sup>, 566.21; found, 565.04.</div></div><div id="sec6_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Synthesis of 2,2′-(((4,4′-(2-Oxopropane-1,3-diyl)bis(benzoyl))bis(azanediyl))bis(3,1-phenylene))diacetic Acid (<b>11g</b>)</h4><div class="NLM_p last">The ketal compound <b>35</b> (0.02 g, 0.033 mmol) was dissolved in trifluoroacetic acid (3 mL), and the mixture was stirred vigorously at room temperature under inert atmosphere overnight. The reaction was quenched with water, and the resulting solid was collected by filtration, washed with water, and dried under an IR lamp, affording pure derivative <b>11g</b> as a white solid (0.015 g, 80%). <i>R</i><sub>f</sub> (ethyl acetate): 0.48; 252–253 °C; washed with diethyl ether; IR ν 3273 (OH and NH), 1699 (C=O acid), 1651 (C=O amide), 1541 (C=O ketone) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 3.49 (s, 4H, CH<sub>2</sub>CO), 3.89–3.92 (m, 4H, CH<sub>2</sub>), 6.89 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.16–7.26 (m, 6H, benzene H), 7.56–7.60 (m, 4H, benzene H), 7.81 (d, 4H, <i>J</i> = 8 Hz, benzene H), 10.01 (s, 2H, NH), 12.24 (br s, 2H, OH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>28</sub>N<sub>2</sub>O<sub>7</sub>]<sup>−</sup>, 564.19; found, 563.10.</div></div><div id="sec6_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 3,3′-((4,4′-(Carbonylbis(azanediyl))bis(benzoyl))bis(azanediyl))dibenzoic Acid (<b>11h</b>)</h4><div class="NLM_p last">Compound <b>11h</b> was prepared from <b>34h</b> by means of GP-A. <b>34h</b> (0.50 g, 0.84 mmol); 10 mL; 3 days; <i>R</i><sub>f</sub> (chloroform/methanol 4:1): 0.11; 75% as a gray solid; 190 °C dec.; washed with THF; IR ν 3268 (OH and NH), 1685 (C=O acid), 1662 (C=O amide), 1643 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 7.48 (t, 2H, <i>J</i> = 8 Hz, benzene H), 7.59–7.68 (m, 6H, benzene H), 7.98 (d, 4H, <i>J</i> = 8 Hz, benzene H), 8.05 (d, 2H, <i>J</i> = 8 Hz, benzene H), 8.43 (s, 2H, benzene H), 9.56 (s, 2H, NH urea), 10.31 (s, 2H, NH amide);MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>29</sub>H<sub>22</sub>N<sub>4</sub>O<sub>7</sub>]<sup>−</sup>, 538.52; found, 537.17.</div></div><div id="sec6_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (((2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[<i>d</i>]oxazole-2,5-diyl))bis(acetyl))bis(azanediyl))bis(3-methylbutane-1,1-diyl))diboronic Acid (<b>11i</b>)</h4><div class="NLM_p last">Compound <b>11i</b> was prepared from <b>34i</b> by means of GP-D. 34i (0.40 g, 0.57 mmol); <i>R</i><sub>f</sub> (chloroform/methanol 4:1): 0.21; 95% as a gray solid; 229–230 °C; washed with THF; IR ν 3287 (NH), 2746 (OH),1665 (C=O amide), 1644 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 6.50 (br s, 2H, OH), 7.32 (t, 2H, <i>J</i> = 8 Hz, benzene H), 7.53 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.62 (d, 4H, <i>J</i> = 8 Hz, benzene H), 7.85 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.96 (d, 4H, <i>J</i> = 8 Hz, benzene H), 8.08 (s, 2H, benzene H), 9.32 (s, 2H, NH urea), 10.08 (s, 2H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>27</sub>H<sub>24</sub>Br<sub>2</sub>N<sub>4</sub>O<sub>7</sub>]<sup>−</sup>, 538.18; found, 537.00.</div></div><div id="sec6_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Methyl 2-(2-(4-Aminophenyl)benzo[d]oxazol-5-yl)acetate (<b>12a</b>)</h4><div class="NLM_p last">Synthesis, analytical, and spectroscopic data are reported in the literature.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec6_2_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Methyl 2-(2-(3-Mminophenyl)benzo[d]oxazol-5-yl)acetate (<b>12b</b>)</h4><div class="NLM_p last">Synthesis, analytical, and spectroscopic data are reported in the literature.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec6_2_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Methyl 2-(2-(4-Amino-3-fluorophenyl)benzo[d]oxazol-5-yl)acetate (<b>12c</b>)</h4><div class="NLM_p last">Synthesis, analytical, and spectroscopic data are reported in the literature.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec6_2_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Methyl 2-(2-(4-Amino-3-fluorophenyl)-1H-benzo[d]imidazol-5-yl)acetate (<b>13</b>)</h4><div class="NLM_p last">Synthesis, analytical, and spectroscopic data are reported in the literature.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec6_2_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Methyl 2-(2-(3-Fluoro-4-isothiocyanatophenyl)benzo[d]oxazol-5-yl)acetate (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was prepared from <b>12c</b> by means of GP-G. 2 h; methyl 2-(2-(4-amino-3-fluorophenyl)benzo[d]oxazol-5-yl)acetate (0.5 g, 1.66 mmol); <i>R</i><sub>f</sub> (<i>n</i>-hexane/ethyl acetate 1:1): 0.92; 100% as an orange solid; 175–176 °C; IR ν 2021 (Isothiocyanate), 1732 (C=O ester) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 3.55 (s, 3H, CH<sub>3</sub>), 3.76 (s, 2H, CH<sub>2</sub>), 7.27–7.29 (d, 1H, benzoxazole C6–H), 7.59–7.66 (m, 3H, benzoxazole C4–H, C7–H, and benzene H), 7.94–7.96 (d, 1 H, benzene H), 8.03–8.05 (d, 1H, benzene H), 9.30 (br s, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>17</sub>H<sub>11</sub>FN<sub>2</sub>O<sub>3</sub>S]<sup>+</sup>, 342.34; found, 340.07.</div></div><div id="sec6_2_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Methyl 2-(2-(3-Fluoro-4-isothiocyanatophenyl)-1H-benzo[d]imidazol-5-yl)acetate (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was prepared from <b>13</b> by means of GP-G. 4 h; methyl 2-(2-(4-amino-3-fluorophenyl)-1H-benzo[d]imidazol-5-yl)acetate (0.5 g, 1.67 mmol); <i>R</i><sub>f</sub> (<i>n</i>-hexane/ethyl acetate 1:1): 0.51; 100% as a yellow solid; 180–181 °C; IR ν 2927 (NH benzimidazole), 2020 (isothiocyanate), 1739 (C=O ester) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 3.64 (s, 3H, CH<sub>3</sub>), 3.92 (s, 2H, CH<sub>2</sub>), 7.34–7.43 (m, 2H, benzimidazole C4–H and benzene H), 7.66–7.82 (m, 2H, benzimidazole C6–H and C7–H), 8.20 (d, 1H, <i>J</i> = 8 Hz, benzene H), 8.40 (d, 1H, <i>J</i> = 8 Hz, benzene H); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>17</sub>H<sub>12</sub>FN<sub>3</sub>O<sub>2</sub>S]<sup>+</sup>, 341.36; found, 342.40.</div></div><div id="sec6_2_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Dimethyl 2,2′-(((Carbonylbis(azanediyl))bis(4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))diacetate (<b>16a</b>)</h4><div class="NLM_p last">Compound <b>16a</b> was prepared from <b>12a</b> by means of GP-F. Overnight; methyl 2-(2-(4-aminophenyl)benzo[d]oxazol-5-yl)acetate <b>12a</b> (0.90g, 3.18 mmol); 130 mL; SiO<sub>2</sub>, 30:1 chloroform/methanol; <i>R</i><sub>f</sub> (chloroform/methanol 10:1): 0.4; 40% as a yellow solid; 275 °C; THF; IR ν 3285 (NH), 1731 (C=O ester), 1638 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF d<sub>7</sub>, δ): 3.63 (s, 6H, CH<sub>3</sub>), 3.82 (s, 4H, CH<sub>2</sub>), 7.31 (d, 2H, benzoxazole C6–H, <i>J</i> = 8 Hz), 7.65–7.67 (m, 4H, benzoxazole C4–H and C7–H), 7.80 (d, 4H, benzene H, <i>J</i> = 8 Hz), 8.14 (d, 4H, benzene H, <i>J</i> = 8 Hz), 9.30 (br s, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>26</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>, 590.18; found, 590.93.</div></div><div id="sec6_2_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Dimethyl 2,2′-(((Carbonylbis(azanediyl))bis(3,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))diacetate (<b>16b</b>)</h4><div class="NLM_p last">Compound <b>16b</b> was prepared from <b>12b</b> by means of GP-F. Overnight; methyl 2-(2-(3-aminophenyl)benzo[d]oxazol-5-yl)acetate <b>12b</b> (4.04g, 14.31 mmol); 100 mL; <i>R</i><sub>f</sub> (chloroform,/methanol 30:1): 0.2; 100% as a white solid; 298–299 °C; DMF; IR ν 3280 (NH), 1732 (C=O ester), 1637 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 3.63 (s, 6H, CH<sub>3</sub>), 3.84 (s, 4H, CH<sub>2</sub>), 7.26 (d, 2H, benzoxazole C6–H, <i>J</i> = 8 Hz), 7.46–7.49 (m, 4H, benzoxazole C4–H and C7–H), 7.65–7.77 (m, 6H, benzene H), 8.54 (s, 2H, benzene H), 9.05 (s, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>26</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>, 590.18; found, 590.80.</div></div><div id="sec6_2_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Dimethyl 2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))diacetate (<b>16c</b>)</h4><div class="NLM_p last">Compound <b>16c</b> was prepared from <b>12c</b> by means of GP-F. Overnight; methyl 2-(2-(4-amino-3-fluorophenyl)benzo[d]oxazol-5-yl)acetate <b>12c</b> (2.7 g, 9 mmol); 200 mL; SiO<sub>2</sub>, 30:1 chloroform/methanol; <i>R</i><sub>f</sub> (chloroform/methanol 30:1): 0.18; 58% as a yellow solid; 295 °C; methanol; IR ν 3381 (NH), 1733 (C=O urea), 1706 (C=O ester) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF d<sub>7</sub>, δ): 3.63 (s, 6H, CH<sub>3</sub>), 3.83 (s, 4H, CH<sub>2</sub>), 7.33 (d, 2H, benzoxazole C6–H, <i>J</i> = 8 Hz), 7.66–7.69 (m, 4H, benzoxazole C4–H and C7–H), 8.02–8.04 (m, 4H, benzene H), 8.57 (d, 2H, benzene H, <i>J</i> = 8 Hz), 9.60 (br s, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>24</sub>F<sub>2</sub>N4O<sub>7</sub>]<sup>+</sup>, 626.16; found, 627.13.</div></div><div id="sec6_2_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Dimethyl 2,2′-(((Thiocarbonylbis(azanediyl))bis(4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))diacetate (<b>16d</b>)</h4><div class="NLM_p last">Compound <b>16d</b> was prepared from <b>12a</b> by means of GP-F. 12 h. methyl 2-(2-(4-aminophenyl)benzo[d]oxazol-5-yl)acetate <b>12a</b> (0.61g, 2.2 mmol); 100 mL; SiO<sub>2</sub>, 30:1 chloroform/methanol; <i>R</i><sub>f</sub> (chloroform/methanol 10:1): 0.55; 60% as a yellow solid; 195–196 °C; washed with diethyl ether ; IR ν 3284 (NH), 1731 (C=O ester) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF d<sub>7</sub>, δ): 3.80 (s, 6H, CH<sub>3</sub>), 3.99 (s, 4H, CH<sub>2</sub>), 7.48–7.51 (d, 2H, benzoxazole C6–H), 7.82–7.86 (m, 4H, benzoxazole C4–H and C7–H), 8.06–8.08(d, 4H, benzene H), 8.33–8.35 (d, 4H, benzene H), 10.60 (s, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>26</sub>N<sub>4</sub>O<sub>6</sub>S]<sup>+</sup>, 606.16; found, 606.80</div></div><div id="sec6_2_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Dimethyl 2,2′-(((Thiocarbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))diacetate (<b>16e</b>)</h4><div class="NLM_p last">Compound <b>16e</b> was prepared from <b>12c</b> and <b>14</b> by means of GP-H. <b>12c</b> (1g, 3.33 mmol); <b>14</b> (1.20 g, 3.5 mmol); <i>R</i><sub>f</sub> (chloroform/methanol 30:1): 0.23; 70% as a yellow solid; 169–170 °C; washed with <i>n</i>-hexane; IR ν 3117 (NH), 1743 (C=O ester) 1329 (C=S) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 3.55 (s, 6H, CH<sub>3</sub>), 3.77 (s, 4H, CH<sub>2</sub>), 7.26–7.28 (d, 2H, benzoxazole C6–H), 7.65–7.68 (m, 4H, benzoxazole C4–H and C7–H), 7.94–7.97(d, 4H, benzene H), 8.02–8.06 (t, 2H, benzene H), 10.15 (br s, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>24</sub>F<sub>2</sub>N<sub>4</sub>O<sub>6</sub>S]<sup>+</sup>, 642.14; found, 643.13.</div></div><div id="sec6_2_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Dimethyl 2,2′-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(1<i>H</i>-benzo[<i>d</i>]imidazole-2,5-diyl))diacetate (<b>17a</b>)</h4><div class="NLM_p last">Compound <b>17a</b> was prepared from <b>13</b> by means of GP-F. 44 h; methyl 2-(2-(4-amino-3-fluorophenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)acetate <b>13</b> (1.05 g, 4.58 mmol); 49,5 mL; <i>R</i><sub>f</sub> (AcOEt: MeOH 20:0.1): 0.16; 100% as a white-beige solid; 220–223 °C; washed with THF; IR ν 3067 (NH), 1736 (C=O ester), 1707 (C=O urea) cm<sup><i>-1</i></sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 3.62 (s, 3H, OCH<sub>3</sub>), 3.77–3.79 (m, 2H, CH<sub>2</sub> acetic), 7.10–8.45 (m, 12H, Ar), 9.43 (s, 2H, NH urea), 12.87 (bs, 2H, benzimidazole); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>26</sub>F<sub>2</sub>N<sub>6</sub>O<sub>5</sub>]<sup>−</sup>, 624.19; found, 623.07.</div></div><div id="sec6_2_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Dimethyl 2,2′-(((Thiocarbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(1<i>H</i>-benzo[<i>d</i>]imidazole-2,5-diyl))diacetate (<b>17b</b>)</h4><div class="NLM_p last">Compound <b>17b</b> was prepared from <b>13</b> and <b>15</b> by means of GP-H. <b>13</b> (200 mg, 0.59 mmol); <b>15</b> (166 mg, 0.56 mmol); <i>R</i><sub>f</sub> (ethyl acetate): 0.37; 30% as a dark yellow solid; 205 °C; IR ν 3270 (NH), 2927 (NH), 1726 (C=O), 1327 (C=S) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d6, δ): 3.64 (s, 6H, CH<sub>3</sub>), 3.90 (s, 4H, CH<sub>2</sub>–Ar), 7.30–7.36 (m, 2H, benzene H), 7.65–7.72 (m, 4H, benzimidazole C6–H and C7–H), 8.06–8.23 (m, 5H, benzene H and benzimidazole C4–H), 8.54 (br t, 1H, benzimidazole C7–H), 9.75 (s, 1H, NH-thiourea), 10.36 (s, 1H, SH-thiourea); 95.62%; MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>22</sub>N<sub>4</sub>O<sub>7</sub>]<sup>−</sup>, 640.67; found, 638.80.</div></div><div id="sec6_2_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Diethyl 2,2′-((2,2′-(2,2′-((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[<i>d</i>]oxazole-5,2-diyl))bis(acetyl))bis(azanediyl))diacetate (<b>18a</b>)</h4><div class="NLM_p last">Compound <b>18a</b> was prepared from <b>5c</b> by means of GP-C. Glycine ethyl ester hydrochloride (0.11 g, 0.79 mmol); 50 mL THF; <i>R</i><sub>f</sub> (CHCl<sub>3</sub>/ MeOH 40:1): 0.66; 72% as an orange solid; 174–176 °C; washed with THF; IR: ν 3289 (NH), 1728 (C=O ester), 1649, 1600 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF <i>d</i><sub>7</sub>, δ): 1.39 (t, 6H, CH<sub>3</sub>CH<sub>2</sub>O, <i>J</i> = 8 Hz), 3.95 (s, 4H, CH<sub>2</sub> acetic), 4.17 (d, 4H, CH<sub>2</sub> Gly, <i>J</i> = 8 Hz), 4.31 (q, 4H, CH<sub>3</sub>CH<sub>2</sub>O, <i>J</i> = 8 Hz), 7.60–8.86 (m, 14H, Ar and NH Gly), 9.88 (s, 2H, urea); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>39</sub>H<sub>34</sub>F<sub>2</sub>N<sub>6</sub>O<sub>9</sub>]<sup>−</sup>, 768.24; found, 766.67.</div></div><div id="sec6_2_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Diethyl 2,2′-((2,2′-(2,2′-((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[<i>d</i>]oxazole-5,2-diyl))bis(acetyl))bis(azanediyl))dipropanoate (<b>18b</b>)</h4><div class="NLM_p last">Compound <b>18b</b> was prepared from <b>5c</b> by means of GP-C. Alanine ethyl ester hydrochloride (0.2 g, 1.28 mmol); 75 mL THF; <i>R</i><sub>f</sub> (CHCl<sub>3</sub>/ MeOH 4:1): 0.77; 85% as a white solid; 235–238 °C; washed with THF; IR ν 3280 (NH), 1732 (C=O ester), 1646, 1601 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 1.15 (t, 6H, CH<sub>3</sub>CH<sub>2</sub>O, <i>J</i> = 8 Hz), 1.30 (d, 6H, CH<sub>3</sub>PhAla, <i>J</i> = 4 Hz), 3.61 (s, 4H, CH<sub>2</sub> acetic), 4.04–4.09 (m, 4 H, CH<sub>3</sub>CH<sub>2</sub>O), 4.22–4.26 (m, 2 H, CH Ala), 7.31 (d, 2H, benzoxazole C6–H, <i>J</i> = 8 Hz), 7.60–7.70 (m, 4H, benzoxazole C7–H and C4–H), 7.90–8.05 (m, 4H, benzene H), 8.52 (t, 2H, benzene H, <i>J</i> = 8 Hz) 8.60 (d, 2H, N<u class="uu">H</u>CO, <i>J</i> = 8 Hz), 9.61 (s, 2H, NH urea); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>41</sub>H<sub>38</sub>F<sub>2</sub>N<sub>6</sub>O<sub>9</sub>]<sup>−</sup>, 796.27; found, 794.53.</div></div><div id="sec6_2_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Dimethyl 2,2′-((2,2′-(2,2′-((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[<i>d</i>]oxazole-5,2-diyl))bis(acetyl))bis(azanediyl))bis(3-phenylpropanoate) (<b>18c</b>)</h4><div class="NLM_p last">Compound <b>18c</b> was prepared from <b>5c</b> by means of GP-C. Phenylalanine methyl ester hydrochloride (0.17 g, 0.79 mmol); 50 mL; <i>R</i><sub>f</sub> (CHCl<sub>3</sub>/MeOH 40:1): 0.87; 64% as an orange solid; 182–185 °C; washed with THF; IR ν 3267 (NH), 1733 (C=O ester), 1648, 1599 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 2.89–2.93 (m, 2H, CH<sub>2</sub>PhAla), 3.00–3.08 (m, 2H, CH<sub>2</sub>PhAla), 3.57 (s, 4H, CH<sub>2</sub> acetic), 3.61(s, 6H, OCH<sub>3</sub>), 4.46–4.52 (m, 2H, CH PhAla), 7.17–7.24 (m, 12H, benzene and benzoxazole C6–H), 7.59 (s, 2H, benzoxazole C4–H), 7.65 (d, 2H, benzoxazole C7–H, <i>J</i> = 8 Hz), 8–8.05 (m, 4H, benzene H), 8.53(t, 2H, benzene H, <i>J</i> = 8 Hz), 8.63 (d, 2H, N<u class="uu">H–</u>CO, <i>J</i> = 8 Hz), 9.62 (s, 2H, NH urea); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>51</sub>H<sub>42</sub>F<sub>2</sub>N<sub>6</sub>O<sub>9</sub>]<sup>−</sup>, 920.30; found, 918.86.</div></div><div id="sec6_2_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Diethyl 2,2′-((2,2′-(((Thiocarbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))bis(acetyl))bis(azanediyl))diacetate (<b>18g</b>)</h4><div class="NLM_p last">Compound <b>18g</b> was prepared from <b>5e</b> by means of GP-C. Glycine ethyl ester hydrochloride (0.11 g, 0.78 mmol); 50 mL THF; <i>R</i><sub>f</sub> (CHCl<sub>3</sub>: MeOH 40:1) 0.8; 80% as a yellow solid; 186–187 °C; IR ν 2625 (NH), 1766 (C=O ester), 1723 (C=O amide), 1330 (C=S) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMF <i>d</i><sub>7</sub>, δ):1.21 (t, 6H, CH<sub>3</sub>CH<sub>2</sub>O, <i>J</i> = 8 Hz), 3.75–3.79 (m, 4H, CH<sub>2</sub>NH), 3.97–4.01 (m, 4H, CH<sub>2</sub> Gly), 4.12 (q, 4H, CH<sub>3</sub>CH<sub>2</sub>O, <i>J</i> = 8 Hz), 6.83–8.69 (m, 14H, Ar and NH Gly), 9.85 (br s, 2H, tiourea) MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>39</sub>H<sub>34</sub>F<sub>2</sub>N<sub>6</sub>O<sub>8</sub>S]<sup>−</sup>, 784.21; found, 783.10.</div></div><div id="sec6_2_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Diethyl 2,2′-((2,2′-(2,2′-((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(1<i>H</i>-benzo[<i>d</i>]imidazole-5,2-diyl))bis(acetyl))bis(azanediyl))diacetate (<b>19a</b>)</h4><div class="NLM_p last">Compound <b>19a</b> was prepared from <b>6a</b> by means of GP-C. Glycine ethyl ester hydrochloride (0.12 g, 0.89 mmol); 7 mL DMF; <i>R</i><sub>f</sub> (AcOEt: MeOH 1:1): 0.92; 71% as a white-gray solid; 217–219 °C; THF/DMF; IR ν 3277 (NH), 1734 (C=O ester), 1648, 1601 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 1.18 (br t, 6H, CH<sub>3</sub>CH<sub>2</sub>O), 3.58–3.60 (m, 4H, CH<sub>2</sub> acetic), 3.84 (bd, 4H, CH<sub>2</sub>Gly), 4.10 (br q, 4H, CH<sub>3</sub>CH<sub>2</sub>O), 7.12–8.45 (m, 14H, Ar and NH Gly), 9.41 (s, 2H, urea), 12.82 (br s, 2H, benzimidazole); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>39</sub>H<sub>36</sub>F<sub>2</sub>N<sub>8</sub>O<sub>7</sub>]<sup>−</sup>, 766.27; found, 765.20.</div></div><div id="sec6_2_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Dimethyl 2,2′-((2,2′-(2,2′-((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(1<i>H</i>-benzo[<i>d</i>]imidazole-5,2-diyl))bis(acetyl))bis(azanediyl))bis(3-phenylpropanoate) (<b>19b</b>)</h4><div class="NLM_p last">Compound <b>19b</b> was prepared from <b>6a</b> by means of GP-C. Phenylalanine methyl ester hydrochloride (0.26 g, 1.21 mmol); 9.5 mL DMF; <i>R</i><sub>f</sub> (AcOEt: MeOH 1:1): 0.75; 87% as a white-yellow solid; 210–212 °C; THF/DMF; IR ν 3273 (NH), 1733 (C=O ester), 1647, 1603 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 2.90–2.96 (m, 2H, CH<sub>2</sub>PhAla), 3.00–3.07 (m, 2H, CH<sub>2</sub>PhAla), 3.54 (s, 4H, CH<sub>2</sub> acetic), 3.61 (s, 6H, CH<sub>3</sub>O), 4.49 (m, 2H, CH PhAla), 6.98–8.45 (m, 22H, Ar), 8.55 (bd, 2H, NH amide), 9.45 (s, 2H, urea), 12.80 (br s, 1H, benzimidazole) MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>51</sub>H<sub>44</sub>F<sub>2</sub>N<sub>8</sub>O<sub>7</sub>]<sup>+</sup>, 918.33; found, 918.96.</div></div><div id="sec6_2_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Synthesis of Dimethyl 2,2′-((((Iminomethylene)bis(azanediyl))bis(4,1-phenylene))bis(benzo[d]oxazole-2,5-diyl))diacetate (<b>20</b>)</h4><div class="NLM_p last">To a stirred suspension of <b>16d</b> (0.10 g, 0.165 mmol) in MeCN (2 mL) was added hexamethyldisilazane (0.027g, 0.165 mmol, 0.034 mL) and EDCI (0.063 g, 0.33 mmol) in an ice bath, and the mixture was stirred at room temperature for 5 days. The solvent was removed under vacuum, and the crude was purified by column chromatography (Al<sub>2</sub>O<sub>3</sub>, 30:1 chloroform/methanol as eluent) to give the subtitle compound as a yellow solid (0.07 g, 70%). <i>R</i><sub>f</sub> (chloroform/methanol 30:1): 0.4; 145–146 °C; washed with diethyl ether; IR ν 3286 (NH), 2954 (NH), 1731 (C=O ester) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 3.47 (s, 6H, CH<sub>3</sub>), 3.49 (s, 4H, CH<sub>2</sub>), 5.66 (br d, 2H, NH guanidine), 7.19 (d, 2H, <i>J</i> = 8 Hz, C7–H benzoxazole), 7.57 (s, 2H, C4–H benzoxazole), 7.60 (d, 2H, <i>J</i> = 8 Hz, C6–H benzoxazole), 7.63 (d, 4H, <i>J</i> = 8 Hz, benzene H), 8.04 (d, 4H, benzene H), 9.21 (s, 2H, NH). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>29</sub>N<sub>5</sub>O<sub>6</sub>]<sup>+</sup>, 591.21; found, 592.10.</div></div><div id="sec6_2_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 2-(2-(3-Fluoro-4-(3-(2-fluoro-4-(5-(2-((3-methyl-1-((3a<i>R</i>,4<i>R</i>,6<i>R</i>,7a<i>S</i>)-5,5,7a-trimethylhexahydro-4,6-methanobenzo[<i>d</i>][1,3,2]dioxaborol-2-yl)butyl)amino)-2-oxoethyl)benzo[<i>d</i>]oxazol-2-yl)phenyl)ureido)phenyl)benzo[<i>d</i>]oxazol-5-yl)-<i>N</i>-(3-methyl-1-((3a<i>S</i>,4<i>S</i>,6<i>S</i>,7a<i>R</i>)-5,5,7a-trimethylhexahydro-4,6-methanobenzo[<i>d</i>][1,3,2]dioxaborol-2-yl)butyl)acetamide (<b>21</b>)</h4><div class="NLM_p last">Compound <b>21</b> was prepared from <b>5c</b> by means of GP-E. (<i>R</i>)-boroLeu-(+)-pinanediol HCl (0.38 g, 1.2 mmol); 2 mL DMF; <i>R</i><sub>f</sub> (chloroform/methanol 4:1): 0.42; 96.2% as a yellow solid; 189 °C; washed with diethyl ether; IR ν 3274 (OH and NH), 2922 (NH), 1726 (C=O), 1601 (C=O) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 0.80–2.33 (m, 50H, αCH–B, 10CH<sub>3</sub>, 6CH<sub>2</sub>, 6CH), 3.75 (s, 4H, CH<sub>2</sub>Ar), 4.00 (d, 2H, <i>J</i> = 8 Hz, CH pinane-O), 7.30 (d, 2H, <i>J</i> = 8 Hz, benzoxazole C6–H), 7.68 (s, 2H, C4–H), 7.74 (d, 2H, <i>J</i> = 8 Hz, benzoxazole C7–H), 7.99–8.05 (m, 4H, benzene H), 8.52 (t, 2H, <i>J</i> = 8 Hz, benzene H), 9.40 (s, 2H, NH amide), 9.60 (s, 2H, NH urea); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>61</sub>H<sub>72</sub>B<sub>2</sub>F<sub>2</sub>N<sub>6</sub>O<sub>9</sub>]<sup>−</sup>, 1092.55; found, 1090.67.</div></div><div id="sec6_2_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> <i>N</i>-(2-Hydroxy-4,5-dimethylphenyl)-4-nitrobenzamide (<b>22a</b>)</h4><div class="NLM_p last">Compound <b>22a</b> was prepared from 4-nitrobenzoyl chloride by means of GP-I. 2-amino-4,5-dimethylphenol (4.18 g, 30 mmol); 90 mL THF; <i>R</i><sub>f</sub> (<i>n</i>-hexane/ethyl acetate 1:1): 0.87; 100% as a yellow solid; 202–203 °C; benzene; IR ν 2987 (OH and NH), 1654 (C=O amide), 1559 (NO<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 2.30 (s, 3H, CH<sub>3</sub>), 2.33 (s, 3H, CH<sub>3</sub>), 6.86 (s, 1H, benzene H), 7.08 (s, 1H, benzene H), 8.18 (d, 2H, <i>J</i> = 8 Hz, benzene H), 8.37 (d, 2H, <i>J</i> = 8 Hz, benzene H), 9.90 (s, 1H, NH). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>14</sub>N<sub>2</sub>O<sub>4</sub>]<sup>+</sup>, 286.10; found, 286.99.</div></div><div id="sec6_2_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 3-Fluoro-<i>N</i>-(2-hydroxy-4,5-dimethylphenyl)-4-nitrobenzamide (<b>22b</b>)</h4><div class="NLM_p last">Compound <b>22b</b> was prepared from 3-fluoro-4-nitrobenzoyl chloride by means of GP-I. 2-amino-4,5-dimethylphenol (3.70 g, 27 mmol); 100 mL THF; <i>R</i><sub>f</sub> (<i>n</i>-hexane/ethyl acetate 1:1): 0.83; 100% as an orange solid; 218–219 °C; benzene; IR ν 2993 (OH and NH), 1660 (C=O amide), 1549 (NO<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 2.34 (s, 3H, CH<sub>3</sub>), 2.37 (s, 3H, CH<sub>3</sub>), 6.88 (s, 1H, benzene H), 7.11 (s, 1H, benzene H), 7.82–8.19 (m 3H, benzene H), 9.97 (s, 1H, NH). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>13</sub>FN<sub>2</sub>O<sub>4</sub>]<sup>+</sup>, 304.09; found, 305.01.</div></div><div id="sec6_2_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 5,6-Dimethyl-2-(4-nitrophenyl)benzo[d]oxazole (<b>23a</b>)</h4><div class="NLM_p last">Compound <b>23a</b> was prepared from <i>N</i>-(2-hydroxy-4,5-dimethylphenyl)-4-nitrobenzamide <b>22a</b> (5 g, 17 mmol) by means of GP-J; 160 mL; <i>R</i><sub>f</sub> (chloroform/ethyl acetate 9:1): 0.61; 68% as a yellow solid; 270–271 °C; IR ν 1556 (NO<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>-<i>d</i>, δ): 2.33 (s, 3H, CH<sub>3</sub>), 2.35 (s, 3H, CH<sub>3</sub>), 7.34 (s, 1H, benzoxazole C4–H), 7.51 (s, 1H, benzoxazole C7–H), 8.31–8.33 (m, 4H, benzene H). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub>]<sup>+</sup>, 268.08; found, 269.20.</div></div><div id="sec6_2_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 2-(3-Fluoro-4-nitrophenyl)-5,6-dimethylbenzo[d]oxazole (<b>23b</b>)</h4><div class="NLM_p last">Compound <b>24a</b> was prepared from 3-fluoro-<i>N</i>-(2-hydroxy-4,5-dimethylphenyl)-4-nitrobenzamide <b>22b</b> (8.21 g, 27 mmol) by means of GP-J; 100 mL; <i>R</i><sub>f</sub> (chloroform/ethyl acetate 9:1): 0.84; 40% as an orange solid; 229–230 °C; IR ν, 1556 (NO<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>-<i>d</i>, δ): 2.33 (s, 3H, CH<sub>3</sub>), 2.36 (s, 3H, CH<sub>3</sub>), 7.33 (s, 1H, benzoxazole C4–H), 7.50 (s, 1H, benzoxazole C7–H), 8.06–8.08 (m, 2H, benzene H), 8.12–8.14 (t, 1H, benzene H). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>11</sub>FN<sub>2</sub>O<sub>3</sub>]<sup>+</sup>, 268.08; found, 269.20.</div></div><div id="sec6_2_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 4-(5,6-Dimethylbenzo[d]oxazol-2-yl)aniline (<b>24a</b>)</h4><div class="NLM_p last">Compound <b>24a</b> was prepared from <b>23a</b> by means of GP-K. <b>23a</b> (3 g, 11 mmol); 150 mL; 3 h; <i>R</i><sub>f</sub> (chloroform: ethyl acetate 9:1): 0.18; 95% as a yellow solid; 150–151 °C; IR ν, 3313 (NH<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>-<i>d</i>, δ): 2.29 (s, 3H, CH<sub>3</sub>), 2.35, 4.00 (bs, 2H, NH<sub>2</sub>), 6.58–6.60 (d, 2H, benzene H) 7.29 (s, 1H, benzoxazole C4–H), 7.59 (s, 1H, benzoxazole C7–H), 7.77–7.80 (m, 2H, benzene H); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>14</sub>N<sub>2</sub>O]<sup>+</sup>, 238.11; found, 239.21.</div></div><div id="sec6_2_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 4-(5,6-Dimethylbenzo[d]oxazol-2-yl)-2-fluoroaniline (<b>24b</b>)</h4><div class="NLM_p last">Compound <b>24b</b> was prepared from <b>23b</b> by means of GP-K. <b>23b</b> (1g, 3.5 mmol); 100 mL; 6 h; <i>R</i><sub>f</sub> (chloroform: ethyl acetate 9:1): 0.45; 75% as an orange solid; 162–163 °C; IR ν, 3315 (NH<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>-<i>d</i>, δ): 2.30 (s, 3H, CH<sub>3</sub>), 2.31 (s, 3H, CH<sub>3</sub>), 6.76–6.81 (t, 1H,benzene H), 7.24 (s, 1H benzoxazole C4–H), 7.40 (s, 1H, benzoxazole C7–H), 7.78–7.81 (m, 2H, benzene H); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>13</sub>FN<sub>2</sub>O]<sup>+</sup>, 256.10; found, 256.28.</div></div><div id="sec6_2_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> Methyl 2-(2-(4-((Tert-butoxycarbonyl)amino)piperidin-1-yl)benzo[d]oxazol-5-yl)acetate (<b>25a</b>)</h4><div class="NLM_p last">Compound <b>25a</b> was prepared from methyl 2-(3-amino-4-hydroxyphenyl)acetate by means of GP-L. Methyl 2-(3-amino-4-hydroxyphenyl)acetate (2.00 g, 11 mmol); <i>n</i>-hexane/ethyl acetate 1:1; toluene; <i>R</i><sub>f</sub> (<i>n</i>-hexane/ethyl acetate 1:1): 0.41; 62% as a pink solid; 268–269 °C; IR ν 3348 (NH), 1729 (C=O ester), 1675 (C=O Boc) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 1.29–1.33 (m, 9H, CH<sub>3</sub> Boc), 1.81–1.88 (m, 4H, CH<sub>2</sub>NBoc), 3.09–3.14 (m, 2H, CH<sub>2</sub>N), 3.42–3.45 (m, 1H, CH), 3.52 (s, 3H, CH<sub>3</sub>), 3.60 (s, 2H, CH<sub>2</sub>), 3.93–3.98 (m, 2H, CH<sub>2</sub>N), 6.80 (d, 1H, <i>J</i> = 6.4 Hz, NH), 6.95 (d, 1H, <i>J</i> = 8 Hz, benzoxazole C6–H), 7.11 (d, 1H, <i>J</i> = 8 Hz, benzoxazole C5–H), 7.22 (s, 1H, benzoxazole C4–H). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>20</sub>H<sub>27</sub>N<sub>3</sub>O<sub>5</sub>]<sup>+</sup>, 389.20; found, 390.17.</div></div><div id="sec6_2_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> <i>Tert</i>-butyl (1-(5,6-Dimethylbenzo[<i>d</i>]oxazol-2-yl)piperidin-4-yl)carbamate (<b>25b</b>)</h4><div class="NLM_p last">Compound <b>25b</b> was prepared from 2-amino-4,5-dimethylphenol by means of GP-L. 2-Amino-4,5-dimethylphenol (2.2 g, 16 mmol); <i>n</i>-hexane/ethyl acetate 2:1; toluene; <i>R</i><sub>f</sub> (<i>n</i>-hexane/ethyl acetate 2:1): 0.48; 67% as a yellow solid; 253–254 °C; IR ν 3350 (NH), 1681 (C=O Boc) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 1.28–1.32 (m, 9H, CH<sub>3</sub> Boc), 1.88–1.92 (m, 4H, CH<sub>2</sub>NBoc), 2.31 (s, 3H, CH<sub>3</sub>), 2.42 (s, 3H, CH<sub>3</sub>), 3.12–3.17 (m, 2H, CH<sub>2</sub>N), 4.47–4.51 (m, 1H, CH), 3.99–4.03 (m, 2H, CH<sub>2</sub>N), 6.94 (d, 1H, <i>J</i> = 6.4 Hz, NH), 7.11 (d, 1H, <i>J</i> = 8 Hz, benzoxazole C6–H), 7.32 (d, 1H, <i>J</i> = 8 Hz, benzoxazole C5–H), 7.45 (s, 1H, benzoxazole C4–H). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>19</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub>]<sup>+</sup>, 345.21; found, 346.14.</div></div><div id="sec6_2_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Methyl 2-(2-(4-Aminopiperidin-1-yl)benzo[d]oxazol-5-yl)acetate (<b>26a</b>)</h4><div class="NLM_p last">Compound <b>26a</b> was prepared from <b>25a</b> by means of GP-M. <b>25a</b> (0.5 g, 1.3 mmol); <i>R</i><sub>f</sub> (ethyl acetate): 0.22; 100% as a white solid; IR ν 3233 (NH<sub>2</sub>) cm<sup>–1</sup>; MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>]<sup>+</sup>, 289.14; found, 290.02.</div></div><div id="sec6_2_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 1-(5,6-Dimethylbenzo[<i>d</i>]oxazol-2-yl)piperidin-4-amine (<b>26b</b>)</h4><div class="NLM_p last">Compound <b>26b</b> was prepared from <b>25b</b> by means of GP-M. <b>25b</b> (0.5 g, 1.45 mmol); <i>R</i><sub>f</sub> (ethyl acetate): 0.18; 100% as a white solid; IR ν 3218 (NH<sub>2</sub>) cm<sup>–1</sup>; MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>14</sub>H<sub>19</sub>N<sub>3</sub>O]<sup>+</sup>, 245.15; found, 246.10.</div></div><div id="sec6_2_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Dimethyl 2,2′-(((Carbonylbis(azanediyl))bis(piperidine-4,1-diyl))bis(benzo[<i>d</i>]oxazole-2,5-diyl))diacetate (<b>27a</b>)</h4><div class="NLM_p last">Compound <b>27a</b> was prepared from <b>26a</b> by means of GP-F. Overnight; <b>26a</b> (2.99 g, 10.0 mmol); 70 mL; <i>R</i><sub>f</sub> (ethyl acetate): 0.56; 68% as a gray solid; 227–228 °C; dioxane; IR ν 2938 (NH), 1733 (C=O ester), 1644 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>-<i>d</i>) 1.40–1.44 (m, 4H, CH<sub>2</sub>N), 2.01–2.09 (m, 4H, CH<sub>2</sub>N), 3.21–3.26 (m, 1H, CH), 3.58 (s, 6H, CH<sub>3</sub>), 3.63 (s, 4H, CH<sub>2</sub>CO), 3.79–3.83 (m, 1H, CH), 5.21–5.24 (m, 8H, CH<sub>2</sub>), 6.88 (d, 2H, <i>J</i> = 8 Hz, benzoxazole C6–H), 7.11 (d, 2H, <i>J</i> = 8 Hz, benzoxazole C5–H), 7.18 (s, 2H, benzoxazole C4–H). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>31</sub>H<sub>36</sub>N<sub>6</sub>O<sub>7</sub>]<sup>+</sup>, 604.26; found, 605.11.</div></div><div id="sec6_2_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Methyl 3-Fluoro-4-isothiocyanatobenzoate (<b>28</b>)</h4><div class="NLM_p last">Compound <b>28</b> was prepared from methyl 4-amino-3-fluorobenzoate by means of GP-G. 1 h; methyl 4-amino-3-fluorobenzoate (3.85 g, 23 mmol); <i>R</i><sub>f</sub> (dichloromethane): 0.26; 61% as a white solid; 169–170 °C; IR ν 2042 (Isothiocyanate), 1711 (C=O ester) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 3.43 (s, 3H, CH<sub>3</sub>), 7.51 (t, 1H, <i>Jo</i><sub>HH</sub> = 8 Hz, <i>Jm</i><sub>HF</sub> = 8 Hz, benzene H), 7.72 (d, 1H, <i>Jo</i> = 8.4 Hz, benzene H), 7.78 (d, 1H, <i>Jo</i> = 10 Hz, benzene H); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>9</sub>H<sub>6</sub>FNO<sub>2</sub>S]<sup>+</sup>, 211.01; found, 212.11.</div></div><div id="sec6_2_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Dimethyl 4,4′-(Carbonylbis(azanediyl))dibenzoate (<b>29b</b>)</h4><div class="NLM_p last">Compound <b>29b</b> was prepared from methyl 4-amino-benzoate by means of GP-F. Overnight; methyl 4-amino-benzoate (5 g, 5.5 mmol); 60 mL; SiO<sub>2</sub>, chloroform/ethyl acetate 1:1; <i>R</i><sub>f</sub> (chloroform/ethyl acetate 1:1): 0.21; 23% as a gray solid; 201–201 °C; benzene; IR ν 3357 (NH), 1712 (C=O ester), 1687 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 3.75 (s, 6H, CH<sub>3</sub>), 7.65 (d, 4H, <i>J</i> = 8 Hz, benzene H), 8.01 (d, 4H, <i>J</i> = 8 Hz, benzene H), 9.46 (br s, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>17</sub>H<sub>16</sub>N<sub>2</sub>O<sub>5</sub>]<sup>+</sup>, 328.11; found, 329.01</div></div><div id="sec6_2_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Dimethyl 4,4′-(Thiocarbonylbis(azanediyl))bis(3-fluorobenzoate) (<b>29d</b>)</h4><div class="NLM_p last">Compound <b>29d</b> was prepared from <b>28</b> and methyl 4-amino-3-fluorobenzoate by means of GP-H. <b>28</b> (0.5 g, 2.6 mmol); methyl 4-amino-3-fluorobenzoate (0.43 g, 2.6 mmol); <i>R</i><sub>f</sub> (dichloromethane): 0.31; 30% as a yellow solid; 192–193 °C; toluene; IR ν 3303 (NH), 1743 (C=O ester) 1280 (C=S) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 3.78 (s, 6H, CH<sub>3</sub>), 7.60 (t, 2H, <i>Jo</i><sub>HH</sub> = 8 Hz, <i>Jm</i><sub>HF</sub> = 8 Hz, benzene H), 7.79 (d, 2H, <i>Jo</i> = 8.4 Hz, benzene H), 7.82 (d, 2H, <i>Jo</i> = 10 Hz, benzene H), 10.09 (br s, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>17</sub>H<sub>14</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S]<sup>+</sup>, 380.06; found, 381.01.</div></div><div id="sec6_2_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> Synthesis of Dimethyl 4,4′-(2-oxopropane-1,3-diyl)dibenzoate (<b>30</b>)</h4><div class="NLM_p last">To a stirred solution of the commercially available methyl 4-(bromomethyl)benzoate (0.50 g, 2.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was added TosMIC (0.21 g, 1.1 mmol) and TBAI (0.097 g, 0.26 mmol), followed by the addition of a solution of NaOH 40% (8.55 mL), and the mixture was stirred at room temperature for 2 h and 30 min under argon atmosphere. A solution of 2 N HCl was then added (0.6 mL), and the crude was extracted with CH<sub>2</sub>Cl<sub>2</sub> (200 mL). The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under vacuum to furnish a yellow oil that subsequently underwent to hydrolysis in HCl 37% (0.6 mL) in CH<sub>2</sub>Cl<sub>2</sub> (3.42 mL) at room temperature for 30 min. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (200 mL), washed with saturated sodium bicarbonate solution (200 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under vacuum. The raw was purified by column chromatography (SiO<sub>2</sub>, 7:3 hexane/ethyl acetate as eluent) to give the subtitle compound as a white solid (0.23 g, 64%). <i>R</i><sub>f</sub> (hexane/ethyl acetate 7:3): 0.3; 156–157 °C; toluene; IR ν 1708 (C=O ester), 1692 (C=O ketone) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 3.76 (s, 6H, CH<sub>3</sub>), 3.93 (s, 4H, CH<sub>2</sub>), 7.24 (d, 4H, <i>J</i> = 8 Hz, Ar), 7.81 (d, 4H, <i>J</i> = 8 Hz, Ar). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>19</sub>H<sub>18</sub>O<sub>5</sub>]<sup>+</sup>, 326.12; found, 327.18.</div></div><div id="sec6_2_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> Synthesis of Dimethyl 4,4′-((1,3-Dioxolane-2,2-diyl)bis(methylene))dibenzoate (<b>31</b>)</h4><div class="NLM_p last">To a solution of <b>30</b> (0.5 g, 1.53 mmol) in toluene (5 mL) were added PTSA monohydrate (0.003 g, 0.016 mmol) and ethylene glycol (0.1 mL, 1.79 mmol), and the mixture was refluxed overnight. The solvent was removed under vacuum and then diluted with ethyl acetate (150 mL), washed with saturated sodium bicarbonate solution (100 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The crude was purified by column chromatography (SiO<sub>2</sub>, 7:3 hexane/ethyl acetate as eluent) to give the subtitle compound as a gray solid (0.71 g, 80%). <i>R</i><sub>f</sub> (hexane/ethyl acetate 7:3): 0.57; 142–143 °C; toluene; IR ν 1713 (C=O ester) cm<sup>–1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>-d, δ): 3.01 (s, 4H, CH<sub>2</sub> benzyl), 3.43 (s, 4H, CH<sub>2</sub> ketal), 3.93 (s, 6H, CH<sub>3</sub>), 7.36 (d, 4H, <i>J</i> = 8 Hz, Ar), 7.97 (d, 4H, <i>J</i> = 8 Hz, Ar). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>21</sub>H<sub>22</sub>O<sub>6</sub>]<sup>+</sup>, 370.14; found, 371.01.</div></div><div id="sec6_2_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> Synthesis of Dimethyl 4,4′-(2-Hydroxypropane-1,3-diyl)dibenzoate (<b>32</b>)</h4><div class="NLM_p last">To a solution of <b>30</b> (0.1 g, 0.31 mmol) in 1:1 MeOH/THF (10 mL) was added NaBH<sub>4</sub> (0.056 g, 1.5 mmol) in an ice bath, and the mixture was stirred at room temperature overnight. The solvent was removed under vacuum and then water was added (70 mL), and the precipitate that formed was filtered to give the subtitle compound as a white solid (0.70 g, 70%). <i>R</i><sub>f</sub> (hexane/ethyl acetate 7:3): 0.47; 161–162 °C; toluene; IR ν 2949 (OH), 1717 (C=O ester) cm<sup>–1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>-d, δ): 2.73–2.87 (m, 4H, CH<sub>2</sub>), 3.84 (s, 6H, CH<sub>3</sub>), 4.02–4.05 (m, 1H, CH), 7.23 (d, 4H, <i>J</i> = 8 Hz, Ar), 7.92 (d, 4H, <i>J</i> = 8 Hz, Ar). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>19</sub>H<sub>20</sub>O<sub>5</sub>]<sup>−</sup>, 328.13; found, 327.09.</div></div><div id="sec6_2_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 4,4′-(Carbonylbis(azanediyl))dibenzoic Acid (<b>33b</b>)</h4><div class="NLM_p last">Compound <b>33b</b> was prepared from <b>29b</b> by means of GP-A. <b>29b</b> (2.0 g, 6.0 mmol); 170 mL; 2 days; <i>R</i><sub>f</sub> (ethyl acetate): 0.22; 71% as a white solid; 171–172 °C; toluene; IR ν 3277 (NH), 3063 (OH), 1709 (C=O acid), 1686 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 7.58 (d, 4H, <i>J</i> = 8 Hz, benzene H), 8.04 (d, 4H, <i>J</i> = 8 Hz, benzene H), 9.32 (br s, 2H, NH); 13.22 (br s, 1H, OH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>12</sub>N<sub>2</sub>O<sub>5</sub>]<sup>+</sup>, 300.07; found, 301.00.</div></div><div id="sec6_2_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 4,4′-(Thiocarbonylbis(azanediyl))bis(3-fluorobenzoic acid) (<b>33d</b>)</h4><div class="NLM_p last">Compound <b>33d</b> was prepared from <b>29d</b> by means of GP-B. <b>29d</b> (2.48 g, 6.1 mmol); 300 mL; 3 days; <i>R</i><sub>f</sub> (dichloromethane/ethyl acetate 9:1): 0.13; 63% as a white solid; 211–212 °C; IR ν 3321 (NH), 3124 (OH), 1697 (C=O acid) 1281 (C=S) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 7.61–7.69 (m, 4H, benzene H), 7.93 (t, 2H, <i>Jo</i><sub>HH</sub> = 8 Hz, <i>Jm</i><sub>HF</sub> = 8 Hz, benzene H), 10.23 (br s, 2H, NH), 13.02 (br s, 1H, OH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>10</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S]<sup>−</sup>, 352.03; found, 351.10.</div></div><div id="sec6_2_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> 4,4′-(2-Hydroxypropane-1,3-diyl)dibenzoic Acid (<b>33e</b>)</h4><div class="NLM_p last">Compound <b>33e</b> was prepared from <b>32</b> by means of GP-B. <b>32</b> (0.26g, 0.79 mmol); 14.2 mL; 2 days; <i>R</i><sub>f</sub> (hexane/ethyl acetate 3:7): 0.15; 71% as a white solid; 180–181 °C; IR ν 3019 (OH) cm<sup>–1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>-d, δ): 2.81–2.92 (m, 4H, CH<sub>2</sub>), 4.28–4.32 (m, 1H, CH), 7.45 (d, 4H, <i>J</i> = 8 Hz, Ar), 8.01 (d, 4H, <i>J</i> = 8 Hz, Ar). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>17</sub>H<sub>16</sub>O<sub>5</sub>]<sup>−</sup>, 300.10; found, 299.18.</div></div><div id="sec6_2_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> 4,4′-(2-(1,3-Dioxolan-2-yl)propane-1,3-diyl)dibenzoic Acid (<b>33g</b>)</h4><div class="NLM_p last">Compound <b>33g</b> was prepared from <b>31</b> by means of GP-A. <b>31</b> (0.26g, 0.79 mmol); 35 mL; overnight; <i>R</i><sub>f</sub> (ethyl acetate): 0.18; 80% as a white solid; 176–177 °C; toluene; IR ν 2889 (OH), 1674 (C=O acid) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 2.87 (s, 4H, CH<sub>2</sub> benzyl), 3.52 (s, 4H, CH<sub>2</sub> ketal), 7.25 (d, 4H, <i>J</i> = 8 Hz, Ar), 7.76 (d, 4H, <i>J</i> = 8 Hz, Ar), 12.75 (br s, 2H, OH). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>19</sub>H<sub>18</sub>O<sub>6</sub>]<sup>−</sup>, 342.11; found, 341.13.</div></div><div id="sec6_2_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> Dimethyl 2,2′-(((4,4′-(Carbonylbis(azanediyl))bis(benzoyl))bis(acetylazanediyl))bis(4-acetoxy-3,1-phenylene))diacetate (<b>34a</b>)</h4><div class="NLM_p last">Compound <b>34a</b> was prepared from <b>38a</b> by means of GP-F. 2 days; <b>38a</b> (0.82 g, 2.4 mmol); 20 mL; <i>R</i><sub>f</sub> (ethyl acetate/chloroform 1:1): 0.24; 20% as a white solid; 218 °C; toluene; IR ν, 3243 (NH<sub>2</sub>), 1725 (C=O ester), 1703 (C=O acetyl), 1693 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 2.43 (s, 12H, CH<sub>3</sub>), 3.68 (s, 6H, CH<sub>3</sub>), 3.81 (s, 4H, CH<sub>2</sub>), 6.98 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.38 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.91 (d, 4H, <i>J</i> = 8 Hz, benzene H), 8.01 (d, 4H, <i>J</i> = 8 Hz, benzene H), 8.10 (s, 2H, benzene H), 9.13 (s, 2H, NH urea). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>41</sub>H<sub>38</sub>N<sub>4</sub>O<sub>13</sub>]<sup>+</sup>, 794.24; found, 795.12.</div></div><div id="sec6_2_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> Dimethyl 2,2′-(((4,4′-(Carbonylbis(azanediyl))bis(benzoyl))bis(azanediyl))bis(3,1-phenylene))diacetate (<b>34b</b>)</h4><div class="NLM_p last">Compound <b>34b</b> was prepared from the acyl chloride of derivative <b>33b</b> (obtained by means of GP-N) by means of GP-I. Methyl 2-(3-aminophenyl)acetate (0.22 g, 1.24 mmol); 15 mL CH<sub>2</sub>Cl<sub>2</sub>; <i>R</i><sub>f</sub> (chloroform/methanol 10:1): 0.33; 30%; 197–198 °C; IR ν 3289 (NH), 1712 (C=O ester), 1669 (C=O amide), 1655 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 3.39 (s, 6H, CH<sub>3</sub>), 3.49 (s, 4H, CH<sub>2</sub>), 6.99 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.31 (t, 2H, <i>J</i> = 8 Hz, benzene H), 7.65–7.69 (m, 8H, benzene H), 7.92 (d, 4H, <i>J</i> = 8 Hz, benzene H), 9.21 (s, 2H, NH urea), 10.32 (s, 2H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>30</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>, 594.21; found, 595.11.</div></div><div id="sec6_2_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> Dimethyl 2,2′-((((Carbonylbis(azanediyl))bis(4,1-phenylenesulfonyl))bis(azanediyl))bis(3,1-phenylene))diacetate (<b>34c</b>)</h4><div class="NLM_p last">Compound <b>34c</b> was prepared from <b>38c</b> by means of GP-F. Overnight; <b>38c</b> (0.32 g, 1.01 mmol); 19 mL; <i>R</i><sub>f</sub> (ethyl acetate/chloroform 4:1): 0.21; 22% as a white-yellow solid; 199 °C; toluene; IR ν 3251 (NH), 1718 (C=O), 1608 (C=O), 1345 (SO<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO <i>d</i><sub>6</sub>, δ): 3.48 (s, 6H, CH<sub>3</sub>), 3.49 (s, 4H, CH<sub>2</sub>), 6.41–6.85 (m, 6H, benzene H), 7.03 (t, 2H, <i>J</i> = 8 Hz, benzene H), 7.46 (d, 4H, <i>J</i> = 8 Hz, benzene H), 7.57 (d, 4H, <i>J</i> = 8 Hz, benzene H), 9.11 (s, 2H, NH urea), 10.06 (s, 2H, NH amide). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>S]<sup>+</sup>, 320.08; found, 321.01.</div></div><div id="sec6_2_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> Dimethyl 2,2′-(((4,4′-(Thiocarbonylbis(azanediyl))bis(3-fluorobenzoyl))bis(azanediyl))bis(3,1-phenylene))diacetate (<b>34d</b>)</h4><div class="NLM_p last">Compound <b>34d</b> was prepared from the acyl chloride of derivative <b>33d</b> (obtained by means of GP-N) by means of GP-I. Methyl 2-(3-aminophenyl)acetate (0.96 g, 5.8 mmol); 25 mL CH<sub>2</sub>Cl<sub>2</sub>; <i>R</i><sub>f</sub> (chloroform/methanol 20:1): 0.21; 100%; 268–269 °C; IR ν 3287 (NH), 1732 (C=O acid), 1648 (C=S thiourea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 3.55 (s, 6H, CH<sub>3</sub>), 3.60 (s, 4H, CH<sub>2</sub>), 6.93 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.21 (t, 2H, <i>J</i> = 8 Hz, benzene H), 7.59–7.62 (m, 4H, benzene H), 7.73–7.81 (m, 4H, benzene H), 7.89 (t, 2H, <i>J</i> = 8 Hz, benzene H), 10.00 (s, 2H, NH thiourea), 10.23 (s, 2H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>28</sub>F<sub>2</sub>N<sub>4</sub>O<sub>6</sub>S]<sup>−</sup>, 646.17; found, 645.09</div></div><div id="sec6_2_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> Dimethyl 2,2′-(((4,4′-(2-Hydroxypropane-1,3-diyl)bis(benzoyl))bis(azanediyl))bis(4-hydroxy-3,1-phenylene))diacetate (<b>34e</b>)</h4><div class="NLM_p last">Compound <b>34e</b> was prepared from the acyl chloride of derivative <b>33e</b> (obtained by means of GP-N) by means of GP-I. Methyl 2-(3-amino-4-hydroxyphenyl)acetate (0.53 g, 2.95 mmol); 56 mL THF; <i>R</i><sub>f</sub> (ethyl acetate/methanol 60:1): 0.29; 20%; 232–233 °C; IR ν 3210 (OH and NH), 1721 (C=O ester), 1666 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 2.62–2.66 (m, 4H, CH<sub>2</sub>), 3.50 (s, 6H, CH<sub>3</sub>), 3.57 (s, 4H, CH<sub>2</sub>CO), 3.91–3.96 (m, 1H, CH), 4.75–4.79 (m, 1H, OH), 6.79–6.85 (m, 4H, benzene CH), 7.18–7.26 (m, 4H, benzene H), 7.54 (s, 2H, benzene H), 7.79–7.85 (m, 4H, benzene H), 9.42 (s, 2H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>35</sub>H<sub>34</sub>N<sub>2</sub>O<sub>9</sub>]<sup>−</sup>, 626.23; found, 625.17.</div></div><div id="sec6_2_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> Dimethyl 2,2′-(((4,4′-(2-Hydroxypropane-1,3-diyl)bis(benzoyl))bis(azanediyl))bis(3,1-phenylene))diacetate (<b>34f</b>)</h4><div class="NLM_p last">Compound <b>34f</b> was prepared from acid derivative <b>33e</b> by means of GP-O. Methyl 2-(3-aminophenyl)acetate (0.6 g, 3.6 mmol); <i>R</i><sub>f</sub> (ethyl acetate/methanol 9:1): 0.51; 85%; 201–202 °C; washed with diethyl ether; IR ν 3291 (OH and NH), 1724 (C=O ester), 1662 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 2.62–2.70 (m, 4H, CH<sub>2</sub>), 3.41 (s, 6H, CH<sub>3</sub>), 3.45 (s, 4H, CH<sub>2</sub>CO), 3.82–3.89 (m, 1H, CH), 3.86–3.90 (m, 1H, OH), 6.88 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.16 (t, 2H, <i>J</i> = 8 Hz, benzene H), 7.22 (d, 4H, <i>J</i> = 8 Hz, benzene H), 7.54 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.59 (s, 2H, benzene H), 7.77 (d, 4H, <i>J</i> = 8 Hz, benzene H), 10.01 (s, 2H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>35</sub>H<sub>34</sub>N<sub>2</sub>O<sub>7</sub>]<sup>+</sup>, 594.24; found, 595.18.</div></div><div id="sec6_2_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> Dimethyl 2,2′-(((4,4′-((1,3-Dioxolane-2,2-diyl)bis(methylene))bis(benzoyl))bis(azanediyl))bis(3,1-phenylene))diacetate (<b>34g</b>)</h4><div class="NLM_p last">Compound <b>34g</b> was prepared from acid derivative <b>33g</b> by means of GP-O. Methyl 2-(3-aminophenyl)acetate (0.11 g, 0.64 mmol); <i>R</i><sub>f</sub> (chloroform/ethyl acetate 4:1): 0.48; 54%; 199–200 °C; washed with diethyl ether; IR ν 2959 (NH), 1729 (C=O ester), 1678 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 2.73 (s, 4H, CH<sub>2</sub>), 3.55 (s, 6H, CH<sub>3</sub>), 3.58 (s, 4H, CH<sub>2</sub>CO), 3.70–3.75 (m, 4H, CH<sub>2</sub> ketal), 7.09–7.13 (m, 6H, benzene H), 7.38–7.41 (m, 4H, benzene H), 7.78–7.83 (m, 6H, benzene H), 9.68 (s, 2H, NH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>37</sub>H<sub>36</sub>N<sub>2</sub>O<sub>8</sub>]<sup>+</sup>, 636.25; found, 635.00.</div></div><div id="sec6_2_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> Diethyl 3,3′-((4,4′-(Carbonylbis(azanediyl))bis(benzoyl))bis(azanediyl))dibenzoate (<b>34h</b>)</h4><div class="NLM_p last">Compound <b>34h</b> was prepared from acid derivative <b>33b</b> by means of GP-O. Ethyl 3-aminobenzoate (0.5 g, 6.05 mmol); <i>R</i><sub>f</sub> (chloroform/methanol 10:1): 0.29; 51%; 229–230 °C; washed with THF; IR ν 3245 (NH), 1718 (C=O ester), 1661 (C=O amide), 1645 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 1.32 (s, 6H, CH<sub>3</sub>), 4.39 (s, 4H, CH<sub>2</sub>), 6.92–7.41 (m, 8H, benzene H), 7.98 (d, 4H, <i>J</i> = 8 Hz, benzene H), 8.10 (d, 2H, <i>J</i> = 8 Hz, benzene H), 8.45 (s, 2H, benzene H), 9.25 (s, 2H, NH urea), 10.33 (s, 2H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>33</sub>H<sub>30</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>, 594.21; found, 595.02.</div></div><div id="sec6_2_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> 4,4′-(Carbonylbis(azanediyl))bis(<i>N</i>-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide) (<b>34i</b>)</h4><div class="NLM_p last">Compound <b>34i</b> was prepared from <b>41</b> by means of GP-F. Overnight; <b>41</b> (0.07 g, 0.21 mmol); 1.5 mL; <i>R</i><sub>f</sub> (ethyl acetate): 0.27; 43% as a white solid; 198–199 °C; washed with diethyl ether; IR ν 3299 (NH), 1669 (C=O amide), 1651 (C=O urea) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 1.13 (s, 24H, CH<sub>3</sub>), 7.01–7.27 (m, 6H, benzene H), 7.72 (s, 2H, benzene H), 8.11 (d, 4H, <i>J</i> = 8 Hz, benzene H), 8.18 (d, 4H, <i>J</i> = 8 Hz, benzene H), 9.87 (s, 2H, NH), 10.10 (s, 2H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>39</sub>H<sub>44</sub>Br<sub>2</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>, 702.34; found, 726.12 (M<sup>–</sup> + Na<sup>+</sup>).</div></div><div id="sec6_2_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> 2,2′-(((4,4′-((1,3-Dioxolane-2,2-diyl)bis(methylene))bis(benzoyl))bis(azanediyl))bis(3,1-phenylene))diacetic Acid (<b>35</b>)</h4><div class="NLM_p last">Compound <b>35</b> was prepared from <b>34g</b> by means of GP-A. <b>34g</b> (0.06 g, 0.094 mmol); 1.32 mL; 2 days; <i>R</i><sub>f</sub> (ethyl acetate): 0.23; 45% as a white solid; 183–184 °C; isopropanol; IR ν 2989 (OH), 1700 (C=O acid), 1672 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 2.71 (s, 4H, CH<sub>2</sub>), 3.60 (s, 4H, CH<sub>2</sub>CO), 3.71–3.74 (m, 4H, CH<sub>2</sub> ketal), 7.12–7.17 (m, 6H, benzene H), 7.41–7.45 (m, 4H, benzene H), 7.82–7.85 (m, 6H, benzene H), 9.71 (br s, 2H, NH), 12.99 (br s, 2H, OH); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>10</sub>F<sub>2</sub>N<sub>2</sub>O<sub>5</sub>]<sup>−</sup>, 336.06; found, 335.11.</div></div><div id="sec6_2_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> Methyl 2-(3-(4-Aminobenzamido)-4-hydroxyphenyl)acetate (<b>36a</b>)</h4><div class="NLM_p last">Synthesis of <b>36a</b> was previously reported. For chemical, physical, analytical, and spectroscopic data, see ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>.</div></div><div id="sec6_2_100" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> Synthesis of Methyl 2-(3-((4-nitrophenyl)sulfonamido)phenyl)acetate (<b>36c</b>)</h4><div class="NLM_p last">A suspension of methyl 2-(3-aminophenyl)acetate (1 g, 5.5 mmol) in dichloroethane dry (91.5 mL) under inert atmosphere was added to pyridine (0.49 mL, 6.1 mmol) followed by a solution of <i>p</i>-nitrobenzenesulfonyl chloride (1.22 g, 6.1 mmol) in dichloroethane dry (46.5 mL) in ice bath and stirred at room temperature overnight. Upon reaction completion, 1 N HCl and chloroform were added (200 mL each one), and the organic fractions were combined, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to give the subtitle compound as a brown oil (1.88 g, 88.5%). <i>R</i><sub>f</sub> (<i>n</i>-hexane/ethyl acetate 7:3): 0.62; oil; IR ν 3207 (NH), 1704 (C=O ester), 1531 (NO<sub>2</sub>), 1349 (SO<sub>2</sub>), 1312 (NO<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 3.48 (s, 3H, CH<sub>3</sub>), 3.50 (s, 2H, CH<sub>2</sub>), 6.86–6.91 (m, 3H, benzene H), 7.09 (t, 1H, <i>J</i> = 8 Hz, benzene H), 7.89 (d, 2H, <i>J</i> = 8 Hz, benzene H), 8.26 (d, 2H, <i>J</i> = 8 Hz, benzene H), 10.50 (br s, 1H, NH). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>14</sub>N<sub>2</sub>O<sub>6</sub>S]<sup>+</sup>, 350.35; found, 351.01.</div></div><div id="sec6_2_101" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> Synthesis of Methyl 2-(4-Acetoxy-3-(<i>N</i>-acetyl-4-nitrobenzamido)phenyl)acetate (<b>37</b>)</h4><div class="NLM_p last">To a solution of <b>36a</b> (2.00 g, 6.00 mmol) in acetic anhydride (1.22 mL, 12.00 mmol) triethylamine (25.29 mL, 18.00 mmol) was added, and the reaction was stirred at room temperature for 2 days. Upon reaction completed, a mixture of crushed ice and water and ethyl acetate were added (300 mL each one), and the organic fractions were combined, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to give the subtitle compound as a red oil (3.50 g, 52%). <i>R</i><sub>f</sub> (chloroform/ethyl acetate 1:1): 0.73; oil; IR ν 1734 (C=O ester), 1702 (C=O acetyl), 1698 (C=O amide), 1533 (NO<sub>2</sub>), 1314 (NO<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 2.38 (s, 6H, CH<sub>3</sub>), 3.60 (s, 3H, CH<sub>3</sub>), 3.73 (s, 2H, CH<sub>2</sub>), 6.93 (d, 1H, <i>J</i> = 8 Hz, benzene H), 7.21 (d, 1H, <i>J</i> = 8 Hz, benzene H), 7.82–7.90 (m, 3H, benzene H), 8.01 (d, 2H, <i>J</i> = 8 Hz, benzene H). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>20</sub>H<sub>18</sub>N<sub>2</sub>O<sub>8</sub>]<sup>+</sup>, 414.11; found, 415.02.</div></div><div id="sec6_2_102" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> Methyl 2-(4-Acetoxy-3-(<i>N</i>-acetyl-4-aminobenzamido)phenyl)acetate (<b>38a</b>)</h4><div class="NLM_p last">Compound <b>38a</b> was prepared from <b>37</b> by means of GP-K. <b>37</b> (1 g, 2.6 mmol); 57 mL; 1 h; <i>R</i><sub>f</sub> (chloroform: ethyl acetate 1:1): 0.47; 100% as a green solid; 181–182 °C; IR ν, 3321 (NH<sub>2</sub>), 1729 (C=O ester), 1701 (C=O acetyl), 1695 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 2.40 (s, 6H, CH<sub>3</sub>), 3.64 (s, 3H, CH<sub>3</sub>), 3.78 (s, 2H, CH<sub>2</sub>), 5.92 (s, 2H, NH<sub>2</sub>), 6.99 (d, 1H, <i>J</i> = 8 Hz, benzene H), 7.34 (d, 1H, <i>J</i> = 8 Hz, benzene H), 7.89 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.99 (d, 2H, <i>J</i> = 8 Hz, benzene H), 8.08 (s, 1H, benzene H). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>20</sub>H<sub>20</sub>N<sub>2</sub>O<sub>6</sub>]<sup>+</sup>, 384.13; found, 384.21.</div></div><div id="sec6_2_103" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> Synthesis of Methyl 2-(3-((4-Aminophenyl)sulfonamido)phenyl)acetate (<b>38c</b>)</h4><div class="NLM_p last">Et<sub>3</sub>N (3.21 mL, 15 mmol), Pd/C 10% (10% w/w) and ammonium formate (0.95 g, 15 mmol) were added to a well-stirred solution of <b>36c</b> (0.53 g, 1.51 mmol) in 1,4-dioxane (22 mL), and it was stirred at 30 °C for 2 h under nitrogen atmosphere. The reaction was quenched with water, cooled to room temperature, filtered on Celite, and washed with AcOEt. The organic layer was evaporated under vacuum, and the raw material was extracted with AcOEt and water. The organic phase was separated, washed with brine, dried over sodium sulfate (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum to afford the pure amine as a yellow oil (0.32 g, 67%). <i>R</i><sub>f</sub> (chloroform/ethyl acetate 4:1): 0.47; oil; IR ν 3251 (NH<sub>2</sub>), 1723 (C=O ester), 1345 (SO<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 3.47 (s, 3H, CH<sub>3</sub>), 3.49 (s, 2H, CH<sub>2</sub>), 5.86 (s, 2H, NH<sub>2</sub>), 6.42 (d, 2H, <i>J</i> = 8 Hz, benzene H), 6.75 (d, 1H, <i>J</i> = 7.2 Hz, benzene H), 6.84 (d, 1H, <i>J</i> = 7.2 Hz, benzene H), 6.90 (s, 1H, benzene H), 7.03 (t, 1H, <i>J</i> = 8 Hz, benzene H), 7.28 (d, 2H, <i>J</i> = 8 Hz, benzene H). MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>S]<sup>+</sup>, 320.08; found, 321.01.</div></div><div id="sec6_2_104" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> <i>N</i>-(3-Bromophenyl)-4-nitrobenzamide (<b>39</b>)</h4><div class="NLM_p last">Compound <b>39</b> was prepared from <i>p</i>-nitrobenzoyl chloride by means of GP-I. 3-Bromoaniline (1.00 g, 5.81 mmol); 18 mL CH<sub>2</sub>Cl<sub>2</sub>; <i>R</i><sub>f</sub> (<i>n</i>-hexane/ethyl acetate 4:1): 0.31; 92%; 165–166 °C; IR ν 3244 (NH), 1687 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO-d<sub>6</sub>, δ): 7.15–7.44 (m, 3H, benzene H), 8.18 (s, 1H, benzene H), 8.22 (d, 2H, <i>J</i> = 8 Hz, benzene H), 8.37 (d, 2H, <i>J</i> = 8 Hz, benzene H), 10.00 (s, 1H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>13</sub>H<sub>9</sub>BrN<sub>2</sub>O<sub>3</sub>]<sup>+</sup>, 319.98; found, 320.72.</div></div><div id="sec6_2_105" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> Synthesis of 4-Nitro-<i>N</i>-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide (<b>40</b>)</h4><div class="NLM_p last">To a solution of <b>39</b> (0.5 g, 1.6 mmol) in dioxane dry (14 mL) was added bis(pinacolate)diboron (0.41 g, 1.6 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.014 g, 0.02 mmol), and KOAc (0.46 g, 4.7 mmol) and the mixture was stirred at 100 °C for 2 h under inert atmosphere. The mixture was diluted with EtOAc (50 mL) and water (30 mL). The organic layer was separated, washed with brine (70 mL), dried over sodium sulfate (Na<sub>2</sub>SO<sub>4</sub>), and evaporated under vacuum to afford the pure boronate as a white solid (0.52 g, 75%). <i>R</i><sub>f</sub> (<i>n</i>-hexane/ethyl acetate 7:3): 0.58; 128–129 °C; IR ν 3203 (NH), 1682 (C=O amide), 1532 (NO<sub>2</sub>), 1314 (NO<sub>2</sub>) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 1.06 (s, 12H, CH<sub>3</sub>), 6.98–7.21 (m, 3H, benzene H), 7.67 (s, 1H, benzene H), 8.01 (d, 2H, <i>J</i> = 8 Hz, benzene H), 8.20 (d, 2H, <i>J</i> = 8 Hz, benzene H), 10.03 (s, 1H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>19</sub>H<sub>21</sub>BrN<sub>2</sub>O<sub>5</sub>]<sup>+</sup>, 368.15; found, 391.03 (M<sup>–</sup> + Na<sup>+</sup>).</div></div><div id="sec6_2_106" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> 4-Amino-<i>N</i>-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide (<b>41</b>)</h4><div class="NLM_p last">Compound <b>41</b> was prepared from <b>40</b> by means of GP-K. <b>40</b> (0.1 g, 0.27 mmol); 2.5 mL; 1.5 h; <i>R</i><sub>f</sub> (ethyl acetate): 0.52; 95% as a yellow oil; oil; IR ν 3310 (NH<sub>2</sub>), 1685 (C=O amide) cm<sup>–1</sup>; <sup>1</sup>H NMR (DMSO d<sub>6</sub>, δ): 1.11 (s, 12H, CH<sub>3</sub>), 6.77–7.02 (m, 3H, benzene H), 7.61 (s, 1H, benzene H), 7.74 (d, 2H, <i>J</i> = 8 Hz, benzene H), 7.89 (d, 2H, <i>J</i> = 8 Hz, benzene H), 10.02 (s, 1H, NH amide); MS: <i>m</i>/<i>z</i> (ESI) calcd for [C<sub>19</sub>H<sub>23</sub>BrN<sub>2</sub>O<sub>3</sub>]<sup>+</sup>, 338.18; found, 361.05 (M<sup>–</sup> + Na<sup>+</sup>).</div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> Molecular Modeling</h3><div class="NLM_p">Molecular modeling studies were performed with the Schrodinger 2015-4 software suite. Ligand molecules were built with Maestro 10.4<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and prepared with LigPrep 3.6.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Docking studies were conducted with Glide 6.9<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> using the SP scoring function.</div><div class="NLM_p">The structure of Hpse GS3 construct was modeled from the crystal coordinates of human Hpse in complex with the tetrasaccharide inhibitor dp4 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E9C">5E9C</a><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>), as described in ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>. The docking grid was built using Glide 6.9<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> and was centered on the position of the tetrasaccharide inhibitor dp4, setting the dimensions of bounding and enclosing boxes to 15 and 50 Å, respectively. The binding poses were ranked according to the Emodel scoring function. The best-ranked docking solution was merged into the Hpse structure, and the complex was minimized with the OPLS2005 force field<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> implemented in MacroModel 11.0 using the Polak–Ribiere conjugate gradient method to a convergence threshold of 0.05 kJ mol<sup>–1</sup> Å<sup>–1</sup>. During the minimization, the ligands and residues within 8 Å from them were free to move, while the backbone of other residues was kept fixed.</div><div class="NLM_p last">Molecular dynamics simulations were performed using Desmond 4.8.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a> The protein was parametrized by applying the ff14SB Amber Force Field,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and the ligands were parametrized by applying the General Amber Force Field (GAFF).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Partial atomic charges of inhibitors were computed by the Antechamber module<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> of AmberTools 14 at the AM1–BCC level. The complexes were solvated with a box of TIP3P water by placing the box boundaries 12 Å far from the complex atoms on each side. The positive charge of the system was neutralized by adding Cl<sup>–</sup> counter-ions. After a relaxation protocol was implemented to progressively release the positional restraints applied to the heavy atoms of the complexes, 10 ns of unrestrained MD simulations were performed using the Langevin<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> coupling scheme in the NPT ensemble and by setting the temperature to 300 K. Bond lengths to hydrogen atoms were constrained using M-SHAKE.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Short-range electrostatic interactions were cut off at 9 Å, whereas long-range electrostatic interactions were computed using the Smooth Particle Mesh Ewald method.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> A RESPA integrator<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> was used with a time-step of 2 fs, and long-range electrostatics were computed every 6 fs. MD simulations were replicated three times for each complex obtaining similar results.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134"> Biological Methods</h3><div id="sec6_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> In Vitro Screening for Hpse Activity</h4><div class="NLM_p last">To determine the activity of the Hpse inhibitors, a homogeneous assay based on the cleavage of the synthetic heparin oligosaccharide Fondaparinux (Arixtra; Aspen) has been used. The assay measures colorimetrically the appearance of the disaccharide product of Hpse-catalyzed fondaparinux cleavage using the tetrazolium salt WST-1. The assay was essentially performed as described<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> with minor modifications. The assay was carried out with 100 microliters per well of assay solution containing 40 mM sodium acetate buffer (pH 5.0), 100 μM Fondaparinux, 2.5 nM recombinant Hpse (GS3), and serial dilutions of test compounds (tested in triplicate). Plates were sealed with adhesive tape and incubated, in the dark, for 3 h at 37 °C, followed by developing with 1.69 mM WST-1 (Santa Cruz biotechnology), for 1 h at 60 °C. Then, the absorbance at 560 nm was measured through a microplate reader (Victor 3, PerkinElmer). The IC<sub>50</sub> value for each compound, versus Hpse, was calculated by GraphPad software. Finally, the measurements were corrected by subtracting both the reagent background and the inner absorbance value of test compound.</div></div><div id="sec6_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> Cell Lines and Maintenance</h4><div class="NLM_p last">HT1080 (fibrosarcoma), U87MG (glioblastoma), and U2OS (osteosarcoma) human cell lines were purchased from the American Type Culture Collection (ATCC; Manassas, VA) and maintained according to the manufacturer’s recommendations. Briefly, HT1080 and U87MG were grown in modified Eagle medium (Thermo Fisher Scientific), while U2OS cells were grown in McCoy’s 5a medium (Thermo Fisher Scientific), all supplemented with 10% FCS (Thermo Fisher Scientific), 100 U/mL penicillin, and 100 μg/mL streptomycin (Thermo Fisher Scientific) and 2 mM <span class="smallcaps smallerCapital">l</span>-Gglutamine (Thermo Fisher Scientific). The human synovial sarcoma cell line CME-1 was provided by M. Pierotti<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and cultured in RPMI medium (Lonza) supplemented with 10% FBS. All cell lines were maintained at 37 °C with a humidified 5% CO<sub>2</sub> atmosphere.</div></div><div id="sec6_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> Proliferation Assay</h4><div class="NLM_p">HT1080, U87MG, and U2OS exponentially growing cells were seeded into 96-well plates and then, 24 h later, treated for 72 h with several dilutions of test compounds (in the range 10–0.2 μM). Inhibition of cell proliferation was measured by means of a classical sulforhodamine B (SRB) assay performed in triplicate. The drug concentrations able to inhibit cell proliferation by 50% (IC<sub>50</sub>) were ultimately calculated from dose–response curves by using the GraphPad Prism 5.02 software.</div><div class="NLM_p last">Alternatively, exponentially growing CME-1 cells were seeded in 12 wells per plate and, 24 h later, treated with the drug dissolved in DMSO or the solvent alone (0.5% final concentration). The anti-proliferative activity was evaluated after 72 h of drug exposure by cell counting. IC<sub>50</sub> values were calculated as above.</div></div><div id="sec6_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> Matrigel Invasion Assay</h4><div class="NLM_p last">Cells were pretreated with the indicated drug concentrations in complete medium for 24 h. Then, cells were harvested, resuspended in serum-free medium, and transferred (2.5 × 10<sup>4</sup> HT1080, U87MG, and U2OS; 1.2 × 10<sup>5</sup> CME-1 cells per filter, respectively) to the upper chamber of 24-well Transwell plates (Costar, Corning Inc., Corning, NY) previously coated with Growth Factor Reduced Matrigel (BD Biosciences, San Jose, CA). The same drug concentration used for cell pretreatment was added to both the upper and lower chambers. After 24 h of incubation, cells that invaded the Matrigel were stained with SRB and then counted through a microscope at 40×–100× magnification depending on cell density. Statistical analyses were performed by the Student’s two-tailed <i>t</i> test. <i>P</i> < 0.05 was considered significant.</div></div><div id="sec6_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> Real-Time qPCR Assay</h4><div class="NLM_p last">Total RNA was extracted from HT1080 cells, upon 24 h of treatment with test compounds and then retrotranscribed using the iScript Advanced cDNA Synthesis Kit for RT-qPCR (Bio-Rad Laboratories Inc., Hercules, CA) according to the manufacturer’s instructions. Real-time quantitative PCR analysis was performed using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad Laboratories Inc., Hercules, CA) and the following PrimePCR SYBR Green Assays: qHsaCID0015228 (HPSE-1), qHsaCED0002206 (FGF-1), qHsaCID0015510 (FGF-2), qHsaCID0011597 (MMP-9), and qHsaCED0043454 (VEGF-A) (Bio-Rad Laboratories Inc., Hercules, CA). The 7900HT Sequence Detection System instrument and software (Applied Biosystems) were used to quantify the relative expression of the target genes.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i140"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01497" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01497" class="ext-link">10.1021/acs.jmedchem.8b01497</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">RMSD values of derivative <b>5c</b>; values of docking scoring function for compounds <b>5a</b>,<b>c</b>−<b>f</b>, <b>6a</b>,<b>b</b>, and <b>9a</b>,<b>b</b>; cell-invasion assays for <b>7a</b> and <b>7g</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Human GS3 Hpse model in complex with docking poses of compounds <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_003.pdb" class="ext-link">PDB</a>), <b>5c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_004.pdb" class="ext-link">PDB</a>), <b>7g</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_005.pdb" class="ext-link">PDB</a>): authors will release the atomic coordinates and experimental data upon article publication</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_001.csv">jm8b01497_si_001.csv (9.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_002.pdf">jm8b01497_si_002.pdf (461.25 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_003.pdb">jm8b01497_si_003.pdb (300.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_004.pdb">jm8b01497_si_004.pdb (300.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_005.pdb">jm8b01497_si_005.pdb (302.18 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01497" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34473" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34473" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Di Santo</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4279-7666" title="Orcid link">http://orcid.org/0000-0002-4279-7666</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#23514c414651574c0d474a50424d574c63564d4a514c4e42120d4a57"><span class="__cf_email__" data-cfemail="33415c515641475c1d575a40525d475c73465d5a415c5e52021d5a47">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Giannini</span> - <span class="hlFld-Affiliation affiliation">R&D
Alfasigma S.p.A., Via Pontina Km 30,400, Pomezia, I-00071 Roma, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7f18160a0c1a0f0f1a5118161e11111611163f1e13191e0c1618121e511c1012"><span class="__cf_email__" data-cfemail="22454b5751475252470c454b434c4c4b4c4b62434e4443514b454f430c414d4f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonella Messore</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0158-5816" title="Orcid link">http://orcid.org/0000-0003-0158-5816</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valentina Noemi Madia</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5724-612X" title="Orcid link">http://orcid.org/0000-0002-5724-612X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luca Pescatori</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4734-7856" title="Orcid link">http://orcid.org/0000-0003-4734-7856</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Saccoliti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2907-5503" title="Orcid link">http://orcid.org/0000-0002-2907-5503</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valeria Tudino</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9024-9835" title="Orcid link">http://orcid.org/0000-0001-9024-9835</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro De Leo</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Bortolami</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5740-6499" title="Orcid link">http://orcid.org/0000-0001-5740-6499</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela De Vita</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0370-4244" title="Orcid link">http://orcid.org/0000-0002-0370-4244</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luigi Scipione</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federico Pepi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberta Costi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, Piazzale Aldo
Moro 5, I-00185 Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Rivara</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8058-4250" title="Orcid link">http://orcid.org/0000-0001-8058-4250</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Scalvini</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3610-527X" title="Orcid link">http://orcid.org/0000-0003-3610-527X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Mor</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0199-1849" title="Orcid link">http://orcid.org/0000-0003-0199-1849</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabiana Fosca Ferrara</span> - <span class="hlFld-Affiliation affiliation">Takis
S.R.L., Via Castel Romano
100, I-00128 Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emiliano Pavoni</span> - <span class="hlFld-Affiliation affiliation">Takis
S.R.L., Via Castel Romano
100, I-00128 Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Roscilli</span> - <span class="hlFld-Affiliation affiliation">Takis
S.R.L., Via Castel Romano
100, I-00128 Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuliana Cassinelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Ricerca Applicata e Sviluppo Tecnologico, Unità di Farmacologia
Molecolare, Fondazione IRCCS Istituto Nazionale
dei Tumori, via Amadeo 42, I-20133 Milano, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ferdinando M. Milazzo</span> - <span class="hlFld-Affiliation affiliation">R&D
Alfasigma S.p.A., Via Pontina Km 30,400, Pomezia, I-00071 Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gianfranco Battistuzzi</span> - <span class="hlFld-Affiliation affiliation">R&D
Alfasigma S.p.A., Via Pontina Km 30,400, Pomezia, I-00071 Roma, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">For G.C., F.M.M., G.B., and G.G., research was carried out within a collaborative research agreement with Leadiant Biosciences S.A. (Formerly Sigma-Tau Research Switzerland, S.A.), Mendrisio, CH.</p></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i142">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Mrs. Enrica Favini for technical support. This work was carried out using the HPC (High Performance Computing) computational facilities of the University of Parma, Italy; <a href="http://www.hpc.unipr.it" class="extLink">http://www.hpc.unipr.it</a>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS USED</td></tr><tr><td class="NLM_term">HSPGs</td><td class="NLM_def"><p class="first last">heparan sulfate proteoglycans;</p></td></tr><tr><td class="NLM_term">ECM</td><td class="NLM_def"><p class="first last">extracellular matrix</p></td></tr><tr><td class="NLM_term">HS</td><td class="NLM_def"><p class="first last">heparan sulfate</p></td></tr><tr><td class="NLM_term">Hpse</td><td class="NLM_def"><p class="first last">heparanase</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">thio-CDI</td><td class="NLM_def"><p class="first last">thiocarbonyldiimidazole</p></td></tr><tr><td class="NLM_term">PTSA</td><td class="NLM_def"><p class="first last"><i>p</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">TosMIC</td><td class="NLM_def"><p class="first last"><i>p</i>-toluenesulfonylmethyl isocyanide</p></td></tr><tr><td class="NLM_term">TBAI</td><td class="NLM_def"><p class="first last">tetrabutylammonium iodide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">NMM</td><td class="NLM_def"><p class="first last"><i>N</i>-methylmorpholine</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">ATIII</td><td class="NLM_def"><p class="first last">antithrombin III</p></td></tr><tr><td class="NLM_term">HT1080</td><td class="NLM_def"><p class="first last">human fibrosarcoma cell line</p></td></tr><tr><td class="NLM_term">U87MG</td><td class="NLM_def"><p class="first last">human glioblastoma astrocytoma cell line</p></td></tr><tr><td class="NLM_term">U2OS</td><td class="NLM_def"><p class="first last">human osteosarcoma cell line</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">MMP9</td><td class="NLM_def"><p class="first last">matrix metallopeptidase 9</p></td></tr><tr><td class="NLM_term">FGF-1</td><td class="NLM_def"><p class="first last">fibroblast growth factor</p></td></tr><tr><td class="NLM_term">GP</td><td class="NLM_def"><p class="first last">general procedure</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">infrared.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i144">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 62 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parish, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulett, M. D.</span></span> <span> </span><span class="NLM_article-title">Heparanase: a key enzyme involved in cell invasion</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1471</i></span>,  <span class="NLM_fpage">M99</span>– <span class="NLM_lpage">M108</span>, <span class="refDoi"> DOI: 10.1016/S0304-419X(01)00017-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2FS0304-419X%2801%2900017-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=11250066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsl2jsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1471&publication_year=2001&pages=M99-M108&author=C.+R.+Parishauthor=C.+Freemanauthor=M.+D.+Hulett&title=Heparanase%3A+a+key+enzyme+involved+in+cell+invasion&doi=10.1016%2FS0304-419X%2801%2900017-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Heparanase: a key enzyme involved in cell invasion</span></div><div class="casAuthors">Parish, C. R.; Freeman, C.; Hulett, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1471</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">M99-M108</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 50 refs.  The role of the heparanase in cell invasion, the current status of its inhibitors, and key aspects of the enzyme that need to be investigated in the future is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-yuTg1bfgILVg90H21EOLACvtfcHk0lgXCpcfqpibKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsl2jsr8%253D&md5=52fb4b90d755e5ecfc6cfec692e52a16</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0304-419X%2801%2900017-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-419X%252801%252900017-8%26sid%3Dliteratum%253Aachs%26aulast%3DParish%26aufirst%3DC.%2BR.%26aulast%3DFreeman%26aufirst%3DC.%26aulast%3DHulett%26aufirst%3DM.%2BD.%26atitle%3DHeparanase%253A%2520a%2520key%2520enzyme%2520involved%2520in%2520cell%2520invasion%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1471%26spage%3DM99%26epage%3DM108%26doi%3D10.1016%2FS0304-419X%2801%2900017-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fairbanks, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mildner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavey, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drong, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slightom, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienkowski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannow, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrikson, R. L.</span></span> <span> </span><span class="NLM_article-title">Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">29587</span>– <span class="NLM_lpage">29590</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.42.29587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1074%2Fjbc.274.42.29587" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=29587-29590&author=M.+B.+Fairbanksauthor=A.+M.+Mildnerauthor=J.+W.+Leoneauthor=G.+S.+Caveyauthor=W.+R.+Mathewsauthor=R.+F.+Drongauthor=J.+L.+Slightomauthor=M.+J.+Bienkowskiauthor=C.+W.+Smithauthor=C.+A.+Bannowauthor=R.+L.+Heinrikson&title=Processing+of+the+human+heparanase+precursor+and+evidence+that+the+active+enzyme+is+a+heterodimer&doi=10.1074%2Fjbc.274.42.29587"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.42.29587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.42.29587%26sid%3Dliteratum%253Aachs%26aulast%3DFairbanks%26aufirst%3DM.%2BB.%26aulast%3DMildner%26aufirst%3DA.%2BM.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DCavey%26aufirst%3DG.%2BS.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DDrong%26aufirst%3DR.%2BF.%26aulast%3DSlightom%26aufirst%3DJ.%2BL.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BW.%26aulast%3DBannow%26aufirst%3DC.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26atitle%3DProcessing%2520of%2520the%2520human%2520heparanase%2520precursor%2520and%2520evidence%2520that%2520the%2520active%2520enzyme%2520is%2520a%2520heterodimer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D29587%26epage%3D29590%26doi%3D10.1074%2Fjbc.274.42.29587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson-Lindahl, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haage, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taube, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egeciouglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Admyre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, S. L.</span></span> <span> </span><span class="NLM_article-title">Correction: heparanase affects food intake and regulates energy balance in mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">10</span>), <span class="NLM_elocation-id">e34313</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0034313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1371%2Fjournal.pone.0034313" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=10&author=L.+Karlsson-Lindahlauthor=L.+Schmidtauthor=D.+Haageauthor=C.+Hanssonauthor=M.+Taubeauthor=E.+Egeciougluauthor=Y.+Tanauthor=T.+Admyreauthor=J.+O.+Janssonauthor=I.+Vlodavskyauthor=J.+P.+Liauthor=U.+Lindahlauthor=S.+L.+Dickson&title=Correction%3A+heparanase+affects+food+intake+and+regulates+energy+balance+in+mice&doi=10.1371%2Fjournal.pone.0034313"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0034313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0034313%26sid%3Dliteratum%253Aachs%26aulast%3DKarlsson-Lindahl%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DL.%26aulast%3DHaage%26aufirst%3DD.%26aulast%3DHansson%26aufirst%3DC.%26aulast%3DTaube%26aufirst%3DM.%26aulast%3DEgeciouglu%26aufirst%3DE.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DAdmyre%26aufirst%3DT.%26aulast%3DJansson%26aufirst%3DJ.%2BO.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DLindahl%26aufirst%3DU.%26aulast%3DDickson%26aufirst%3DS.%2BL.%26atitle%3DCorrection%253A%2520heparanase%2520affects%2520food%2520intake%2520and%2520regulates%2520energy%2520balance%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D10%26doi%3D10.1371%2Fjournal.pone.0034313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nybakken, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrimon, N.</span></span> <span> </span><span class="NLM_article-title">Heparan sulphate proteoglycans: the sweet side of development</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nrm1681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1038%2Fnrm1681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=16072037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A280%3ADC%252BD2MvgtFKjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=530-541&author=U.+Hackerauthor=K.+Nybakkenauthor=N.+Perrimon&title=Heparan+sulphate+proteoglycans%3A+the+sweet+side+of+development&doi=10.1038%2Fnrm1681"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Heparan sulphate proteoglycans: the sweet side of development</span></div><div class="casAuthors">Hacker Udo; Nybakken Kent; Perrimon Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Molecular cell biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">530-41</span>
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    </div><div class="casAbstract">Pattern formation during development is controlled to a great extent by a small number of conserved signal transduction pathways that are activated by extracellular ligands such as Hedgehog, Wingless or Decapentaplegic.  Genetic experiments have identified heparan sulphate proteoglycans (HSPGs) as important regulators of the tissue distribution of these extracellular signalling molecules.  Several recent reports provide important new insights into the mechanisms by which HSPGs function during development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBI4VWCsjP4z0O18WR3iAofW6udTcc2ea924uMMk-azLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MvgtFKjsg%253D%253D&md5=9398fa60cabf65f4692b7b3fc7f2278d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm1681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1681%26sid%3Dliteratum%253Aachs%26aulast%3DHacker%26aufirst%3DU.%26aulast%3DNybakken%26aufirst%3DK.%26aulast%3DPerrimon%26aufirst%3DN.%26atitle%3DHeparan%2520sulphate%2520proteoglycans%253A%2520the%2520sweet%2520side%2520of%2520development%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2005%26volume%3D6%26spage%3D530%26epage%3D541%26doi%3D10.1038%2Fnrm1681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aalkjaer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boedtkjer, D. B.</span></span> <span> </span><span class="NLM_article-title">Getting neointimal: the emergence of heparanase into the vascular matrix</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">279</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.108.192625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1161%2FCIRCRESAHA.108.192625" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=277-279&author=C.+Aalkjaerauthor=D.+B.+Boedtkjer&title=Getting+neointimal%3A+the+emergence+of+heparanase+into+the+vascular+matrix&doi=10.1161%2FCIRCRESAHA.108.192625"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.108.192625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.108.192625%26sid%3Dliteratum%253Aachs%26aulast%3DAalkjaer%26aufirst%3DC.%26aulast%3DBoedtkjer%26aufirst%3DD.%2BB.%26atitle%3DGetting%2520neointimal%253A%2520the%2520emergence%2520of%2520heparanase%2520into%2520the%2520vascular%2520matrix%26jtitle%3DCirc.%2520Res.%26date%3D2009%26volume%3D104%26spage%3D277%26epage%3D279%26doi%3D10.1161%2FCIRCRESAHA.108.192625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Billings, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacifici, M.</span></span> <span> </span><span class="NLM_article-title">Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries</span>. <i>Connect. Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.3109/03008207.2015.1045066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.3109%2F03008207.2015.1045066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=26076122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1SgsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=272-280&issue=4&author=P.+C.+Billingsauthor=M.+Pacifici&title=Interactions+of+signaling+proteins%2C+growth+factors+and+other+proteins+with+heparan+sulfate%3A+mechanisms+and+mysteries&doi=10.3109%2F03008207.2015.1045066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries</span></div><div class="casAuthors">Billings, Paul C.; Pacifici, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Connective Tissue Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">272-280</span>CODEN:
                <span class="NLM_cas:coden">CVTRBC</span>;
        ISSN:<span class="NLM_cas:issn">0300-8207</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Heparan sulfate (HS) is a component of cell surface and matrix-assocd. proteoglycans (HSPGs) that, collectively, play crucial roles in many physiol. processes including cell differentiation, organ morphogenesis and cancer.  A key function of HS is to bind and interact with signaling proteins, growth factors, plasma proteins, immune-modulators and other factors.  In doing so, the HS chains and HSPGs are able to regulate protein distribution, bio-availability and action on target cells and can also serve as cell surface co-receptors, facilitating ligand-receptor interactions.  These proteins contain an HS/heparin-binding domain (HBD) that mediates their assocn. and contacts with HS.  HBDs are highly diverse in sequence and predicted structure, contain clusters of basic amino acids (Lys and Arg) and possess an overall net pos. charge, most often within a consensus Cardin-Weintraub (CW) motif.  Interestingly, other domains and residues are now known to influence protein-HS interactions, as well as interactions with other glycosaminoglycans, such as chondroitin sulfate.  In this review, we provide a description and anal. of HBDs in proteins including amphiregulin, fibroblast growth factor family members, heparanase, sclerostin and hedgehog protein family members.  We discuss HBD structural and functional features and important roles carried out by other protein domains, and also provide novel conformational insights into the diversity of CW motifs present in Sonic, Indian and Desert hedgehogs.  Finally, we review progress in understanding the pathogenesis of a rare pediatric skeletal disorder, Hereditary Multiple Exostoses (HME), characterized by HS deficiency and cartilage tumor formation.  Advances in understanding protein-HS interactions will have broad implications for basic biol. and translational medicine as well as for the development of HS-based therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcJq2JP2IKDLVg90H21EOLACvtfcHk0lhplVgIicKgSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1SgsbrJ&md5=2dddb8993d1699e267be5ed33d9ba407</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3109%2F03008207.2015.1045066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03008207.2015.1045066%26sid%3Dliteratum%253Aachs%26aulast%3DBillings%26aufirst%3DP.%2BC.%26aulast%3DPacifici%26aufirst%3DM.%26atitle%3DInteractions%2520of%2520signaling%2520proteins%252C%2520growth%2520factors%2520and%2520other%2520proteins%2520with%2520heparan%2520sulfate%253A%2520mechanisms%2520and%2520mysteries%26jtitle%3DConnect.%2520Tissue%2520Res.%26date%3D2015%26volume%3D56%26issue%3D4%26spage%3D272%26epage%3D280%26doi%3D10.3109%2F03008207.2015.1045066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedmann, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aingorn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atzmon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishai-Michaeli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peretz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecker, I.</span></span> <span> </span><span class="NLM_article-title">Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">802</span>, <span class="refDoi"> DOI: 10.1038/10518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1038%2F10518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10395325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=793-802&author=I.+Vlodavskyauthor=Y.+Friedmannauthor=M.+Elkinauthor=H.+Aingornauthor=R.+Atzmonauthor=R.+Ishai-Michaeliauthor=M.+Bitanauthor=O.+Pappoauthor=T.+Peretzauthor=I.+Michalauthor=L.+Spectorauthor=I.+Pecker&title=Mammalian+heparanase%3A+gene+cloning%2C+expression+and+function+in+tumor+progression+and+metastasis&doi=10.1038%2F10518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis</span></div><div class="casAuthors">Vlodavsky, Israel; Friedmann, Yael; Elkin, Michael; Aingorn, Helena; Atzmon, Ruth; Ishai-Michaeli, Rivka; Bitan, Menachem; Pappo, Orit; Peretz, Tuvia; Michal, Israel; Spector, Larissa; Pecker, Iris</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">793-802</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Heparan sulfate proteoglycans interact with many extracellular matrix constituents, growth factors and enzymes.  Degrdn. of heparan sulfate by endoglycosidic heparanase cleavage affects a variety of biol. processes.  The authors have purified a 50-kDa heparanase from human hepatoma and placenta, and now report cloning of the cDNA and gene encoding this enzyme.  Expression of the cloned cDNA in insect and mammalian cells yielded 65-kDa and 50-kDa recombinant heparanase proteins.  The 50-kDa enzyme represents an N-terminally processed enzyme, at least 100-fold more active than the 65-kDa form.  The heparanase mRNA and protein are preferentially expressed in metastatic cell lines and specimens of human breast, colon and liver carcinomas.  Low metastatic murine T-lymphoma and melanoma cells transfected with the heparanase cDNA acquired a highly metastatic phenotype in vivo, reflected by a massive liver and lung colonization.  This represents the first cloned mammalian heparanase, to the knowledge, and provides direct evidence for its role in tumor metastasis.  Cloning of the heparanase gene enables the development of specific mol. probes for early detection and treatment of cancer metastasis and autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmCf4QKJxqWLVg90H21EOLACvtfcHk0lheA1JMxvepsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCrs7s%253D&md5=4af36ad4e654e6538f474d8361236ed6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F10518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F10518%26sid%3Dliteratum%253Aachs%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DFriedmann%26aufirst%3DY.%26aulast%3DElkin%26aufirst%3DM.%26aulast%3DAingorn%26aufirst%3DH.%26aulast%3DAtzmon%26aufirst%3DR.%26aulast%3DIshai-Michaeli%26aufirst%3DR.%26aulast%3DBitan%26aufirst%3DM.%26aulast%3DPappo%26aufirst%3DO.%26aulast%3DPeretz%26aufirst%3DT.%26aulast%3DMichal%26aufirst%3DI.%26aulast%3DSpector%26aufirst%3DL.%26aulast%3DPecker%26aufirst%3DI.%26atitle%3DMammalian%2520heparanase%253A%2520gene%2520cloning%252C%2520expression%2520and%2520function%2520in%2520tumor%2520progression%2520and%2520metastasis%26jtitle%3DNat.%2520Med.%26date%3D1999%26volume%3D5%26spage%3D793%26epage%3D802%26doi%3D10.1038%2F10518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milazzo, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, G.</span></span> <span> </span><span class="NLM_article-title">Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.4155%2Ffmc-2016-0012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=27057774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFSqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=647-680&author=S.+Rivaraauthor=F.+M.+Milazzoauthor=G.+Giannini&title=Heparanase%3A+a+rainbow+pharmacological+target+associated+to+multiple+pathologies+including+rare+diseases&doi=10.4155%2Ffmc-2016-0012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases</span></div><div class="casAuthors">Rivara, Silvia; Milazzo, Ferdinando M.; Giannini, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-680</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, heparanase has attracted considerable attention as a promising target for innovative pharmacol. applications.  Heparanase is a multifaceted protein endowed with enzymic activity, as an endo-β-D-glucuronidase, and nonenzymic functions.  It is responsible for the cleavage of heparan sulfate side chains of proteoglycans, resulting in structural alterations of the extracellular matrix.  Heparanase appears to be involved in major human diseases, from the most studied tumors to chronic inflammation, diabetic nephropathy, bone osteolysis, thrombosis and atherosclerosis, in addn. to more recent investigation in various rare diseases.  The present review provides an overview on heparanase, its biol. role, inhibitors and possible clin. applications, covering the latest findings in these areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNHQlhGkAAgLVg90H21EOLACvtfcHk0lheA1JMxvepsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFSqsL4%253D&md5=9227956bc0ce1c4a2eaca7342b60a36a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0012%26sid%3Dliteratum%253Aachs%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMilazzo%26aufirst%3DF.%2BM.%26aulast%3DGiannini%26aufirst%3DG.%26atitle%3DHeparanase%253A%2520a%2520rainbow%2520pharmacological%2520target%2520associated%2520to%2520multiple%2520pathologies%2520including%2520rare%2520diseases%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D647%26epage%3D680%26doi%3D10.4155%2Ffmc-2016-0012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbieri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noseda, A.</span></span> <span> </span><span class="NLM_article-title">Roneparstat and heparanase inhibition: a new tool for cancer treatment</span>. <i>J. Pharmacol. Clin. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1074</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=1071-1074&issue=2&author=P.+Barbieriauthor=D.+Paolettiauthor=G.+Gianniniauthor=R.+D.+Sandersonauthor=A.+Noseda&title=Roneparstat+and+heparanase+inhibition%3A+a+new+tool+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarbieri%26aufirst%3DP.%26aulast%3DPaoletti%26aufirst%3DD.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DSanderson%26aufirst%3DR.%2BD.%26aulast%3DNoseda%26aufirst%3DA.%26atitle%3DRoneparstat%2520and%2520heparanase%2520inhibition%253A%2520a%2520new%2520tool%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Pharmacol.%2520Clin.%2520Toxicol.%26date%3D2017%26volume%3D5%26issue%3D2%26spage%3D1071%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckhove, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meirovitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkin, M.</span></span> <span> </span><span class="NLM_article-title">Significance of heparanase in cancer and inflammation</span>. <i>Cancer Microenviron.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1007/s12307-011-0082-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1007%2Fs12307-011-0082-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=21811836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=115-132&author=I.+Vlodavskyauthor=P.+Beckhoveauthor=I.+Lernerauthor=C.+Pisanoauthor=A.+Meirovitzauthor=N.+Ilanauthor=M.+Elkin&title=Significance+of+heparanase+in+cancer+and+inflammation&doi=10.1007%2Fs12307-011-0082-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of Heparanase in Cancer and Inflammation</span></div><div class="casAuthors">Vlodavsky, Israel; Beckhove, Phillip; Lerner, Immanuel; Pisano, Claudio; Meirovitz, Amichai; Ilan, Neta; Elkin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Microenvironment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-132</span>CODEN:
                <span class="NLM_cas:coden">CMAICW</span>;
        ISSN:<span class="NLM_cas:issn">1875-2284</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Heparan sulfate proteoglycans (HSPGs) are primary components at the interface between virtually every eukaryotic cell and its extracellular matrix.  HSPGs not only provide a storage depot for heparin-binding mols. in the cell microenvironment, but also decisively regulate their accessibility, function and mode of action.  As such, they are intimately involved in modulating cell invasion and signaling loops that are crit. for tumor growth, inflammation and kidney function.  In a series of studies performed since the cloning of the human heparanase gene, we and others have demonstrated that heparanase, the sole heparan sulfate degrading endoglycosidase, is causally involved in cancer progression, inflammation and diabetic nephropathy and hence is a valid target for drug development.  Heparanase is causally involved in inflammation and accelerates colon tumorigenesis assocd. with inflammatory bowel disease.  Notably, heparanase stimulates macrophage activation, while macrophages induce prodn. and activation of latent heparanase contributed by the colon epithelium, together generating a vicious cycle that powers colitis and the assocd. tumorigenesis.  Heparanase also plays a decisive role in the pathogenesis of diabetic nephropathy, degrading heparan sulfate in the glomerular basement membrane and ultimately leading to proteinuria and kidney dysfunction.  Notably, clin. relevant doses of ionizing radiation (IR) upregulate heparanase expression and thereby augment the metastatic potential of pancreatic carcinoma.  Thus, combining radiotherapy with heparanase inhibition is an effective strategy to prevent tumor resistance and dissemination in IR-treated pancreatic cancer patients.  Also, accumulating evidence indicate that peptides derived from human heparanase elicit a potent anti-tumor immune response, suggesting that heparanase represents a promising target antigen for immunotherapeutic approaches against a broad variety of tumors.  Oligosaccharide-based compds. that inhibit heparanase enzymic activity were developed, aiming primarily at halting tumor growth, metastasis and angiogenesis.  Some of these compds. are being evaluated in clin. trials, targeting both the tumor and tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofpxC8zEsqc7Vg90H21EOLACvtfcHk0lheA1JMxvepsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7nO&md5=8a09c46170effe91706bedc387dabe4d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs12307-011-0082-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12307-011-0082-7%26sid%3Dliteratum%253Aachs%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DBeckhove%26aufirst%3DP.%26aulast%3DLerner%26aufirst%3DI.%26aulast%3DPisano%26aufirst%3DC.%26aulast%3DMeirovitz%26aufirst%3DA.%26aulast%3DIlan%26aufirst%3DN.%26aulast%3DElkin%26aufirst%3DM.%26atitle%3DSignificance%2520of%2520heparanase%2520in%2520cancer%2520and%2520inflammation%26jtitle%3DCancer%2520Microenviron.%26date%3D2012%26volume%3D5%26spage%3D115%26epage%3D132%26doi%3D10.1007%2Fs12307-011-0082-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span> <span> </span><span class="NLM_article-title">Heparin, heparan sulfate and heparanase in inflammatory reactions</span>. <i>Thromb. Haemostasis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">828</span>, <span class="refDoi"> DOI: 10.1160/TH09-02-0091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1160%2FTH09-02-0091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=19888515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFajtr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2009&pages=823-828&author=J.+P.+Liauthor=I.+Vlodavsky&title=Heparin%2C+heparan+sulfate+and+heparanase+in+inflammatory+reactions&doi=10.1160%2FTH09-02-0091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin, heparan sulfate and heparanase in inflammatory reactions</span></div><div class="casAuthors">Li, Jin-ping; Vlodavsky, Israel</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-828</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">A review.  Heparan sulfate (HS) proteoglycans at the cell surface and in the extracellular matrix of most animal tissues are essential in development and homeostasis, and are implicated in disease processes.  Emerging evidence demonstrates the important roles of HS in inflammatory reactions, particularly in the regulation of leukocyte extravasation.  Heparin, a classical anticoagulant, exhibits anti-inflammatory effects in animal models and in the clinic, presumably through interference with the functions of HS, as both polysaccharides share a high similarity in mol. structure.  Apart of regulation during biosynthesis, the structures of HS and heparin are significantly modulated by heparanase, an endoglycosidase that is upregulated in a no. of inflammatory conditions.  Exploring the physiol. roles of HS and heparin and the mode of heparanase action in modulating their functions during inflammation responses is of importance for future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZKBPySlsXrbVg90H21EOLACvtfcHk0liLNe7hsp1-Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFajtr%252FI&md5=ae8b73a83472035e8527de458338bf7c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1160%2FTH09-02-0091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH09-02-0091%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DVlodavsky%26aufirst%3DI.%26atitle%3DHeparin%252C%2520heparan%2520sulfate%2520and%2520heparanase%2520in%2520inflammatory%2520reactions%26jtitle%3DThromb.%2520Haemostasis%26date%3D2009%26volume%3D102%26spage%3D823%26epage%3D828%26doi%3D10.1160%2FTH09-02-0091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pisano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, F.</span></span> <span> </span><span class="NLM_article-title">The potential of heparanase as a therapeutic target in cancer</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2014.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.bcp.2014.02.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2014&pages=12-19&author=C.+Pisanoauthor=I.+Vlodavskyauthor=N.+Ilanauthor=F.+Zunino&title=The+potential+of+heparanase+as+a+therapeutic+target+in+cancer&doi=10.1016%2Fj.bcp.2014.02.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2014.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2014.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DPisano%26aufirst%3DC.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DIlan%26aufirst%3DN.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DThe%2520potential%2520of%2520heparanase%2520as%2520a%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2014%26volume%3D89%26spage%3D12%26epage%3D19%26doi%3D10.1016%2Fj.bcp.2014.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shteingauz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyango, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naroditsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doweck, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span> <span> </span><span class="NLM_article-title">Heparanase enhances tumor growth and chemoresistance by promoting autophagy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">3946</span>– <span class="NLM_lpage">3957</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-0037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1158%2F0008-5472.CAN-15-0037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=3946-3957&author=A.+Shteingauzauthor=I.+Boyangoauthor=I.+Naroditskyauthor=E.+Hammondauthor=M.+Gruberauthor=I.+Doweckauthor=N.+Ilanauthor=I.+Vlodavsky&title=Heparanase+enhances+tumor+growth+and+chemoresistance+by+promoting+autophagy&doi=10.1158%2F0008-5472.CAN-15-0037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-0037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-0037%26sid%3Dliteratum%253Aachs%26aulast%3DShteingauz%26aufirst%3DA.%26aulast%3DBoyango%26aufirst%3DI.%26aulast%3DNaroditsky%26aufirst%3DI.%26aulast%3DHammond%26aufirst%3DE.%26aulast%3DGruber%26aufirst%3DM.%26aulast%3DDoweck%26aufirst%3DI.%26aulast%3DIlan%26aufirst%3DN.%26aulast%3DVlodavsky%26aufirst%3DI.%26atitle%3DHeparanase%2520enhances%2520tumor%2520growth%2520and%2520chemoresistance%2520by%2520promoting%2520autophagy%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D3946%26epage%3D3957%26doi%3D10.1158%2F0008-5472.CAN-15-0037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramani, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbieri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noseda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, R. D.</span></span> <span> </span><span class="NLM_article-title">Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype</span>. <i>Matrix Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.matbio.2016.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.matbio.2016.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=27016342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVWksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=22-34&author=V.+C.+Ramaniauthor=I.+Vlodavskyauthor=M.+Ngauthor=Y.+Zhangauthor=P.+Barbieriauthor=A.+Nosedaauthor=R.+D.+Sanderson&title=Chemotherapy+induces+expression+and+release+of+heparanase+leading+to+changes+associated+with+an+aggressive+tumor+phenotype&doi=10.1016%2Fj.matbio.2016.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype</span></div><div class="casAuthors">Ramani, Vishnu C.; Vlodavsky, Israel; Ng, Mary; Zhang, Yi; Barbieri, Paola; Noseda, Alessandro; Sanderson, Ralph D.</div><div class="citationInfo"><span class="NLM_cas:title">Matrix Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-34</span>CODEN:
                <span class="NLM_cas:coden">MTBOEC</span>;
        ISSN:<span class="NLM_cas:issn">0945-053X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High heparanase expression is assocd. with enhanced tumor growth, angiogenesis, and metastasis in many types of cancer.  However, the mechanisms driving high heparanase expression are not fully understood.  In the present study, we discovered that drugs used in the treatment of myeloma upregulate heparanase expression.  Frontline anti-myeloma drugs, bortezomib and carfilzomib activate the nuclear factor-kappa B (NF-κB) pathway to trigger heparanase expression in tumor cells.  Blocking the NF-κB pathway diminished this chemotherapy-induced upregulation of heparanase expression.  Activated NF-κB signaling was also found to drive high heparanase expression in drug resistant myeloma cell lines.  In addn. to enhancing heparanase expression, chemotherapy also caused release of heparanase by tumor cells into the conditioned medium.  This sol. heparanase was taken up by macrophages and triggered an increase in TNF-α prodn.  Heparanase is also taken up by tumor cells where it induced expression of HGF, VEGF and MMP-9 and activated ERK and Akt signaling pathways.  These changes induced by heparanase are known to be assocd. with the promotion of an aggressive tumor phenotype.  Importantly, the heparanase inhibitor Roneparstat diminished the uptake and the downstream effects of sol. heparanase.  Together, these discoveries reveal a novel mechanism whereby chemotherapy upregulates heparanase, a known promoter of myeloma growth, and suggest that therapeutic targeting of heparanase during anti-cancer therapy may improve patient outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHVXAsywkd3rVg90H21EOLACvtfcHk0liLNe7hsp1-Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVWksrw%253D&md5=2903884c8750865574d1e4609432a9dc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.matbio.2016.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.matbio.2016.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DRamani%26aufirst%3DV.%2BC.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DNg%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBarbieri%26aufirst%3DP.%26aulast%3DNoseda%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DR.%2BD.%26atitle%3DChemotherapy%2520induces%2520expression%2520and%2520release%2520of%2520heparanase%2520leading%2520to%2520changes%2520associated%2520with%2520an%2520aggressive%2520tumor%2520phenotype%26jtitle%3DMatrix%2520Biol.%26date%3D2016%26volume%3D55%26spage%3D22%26epage%3D34%26doi%3D10.1016%2Fj.matbio.2016.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the discovery of heparanase inhibitors as anti-cancer agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.ejmech.2016.05.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=209-220&author=L.+Jiaauthor=S.+Ma&title=Recent+advances+in+the+discovery+of+heparanase+inhibitors+as+anti-cancer+agents&doi=10.1016%2Fj.ejmech.2016.05.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.052%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520heparanase%2520inhibitors%2520as%2520anti-cancer%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D209%26epage%3D220%26doi%3D10.1016%2Fj.ejmech.2016.05.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassinelli, G.</span></span> <span> </span><span class="NLM_article-title">Targeting heparan sulfate proteoglycans and their modifying enzymes to enhance anticancer chemotherapy efficacy and overcome drug resistance</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2860</span>– <span class="NLM_lpage">2886</span>, <span class="refDoi"> DOI: 10.2174/0929867324666170216114248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.2174%2F0929867324666170216114248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=28215163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sru7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=2860-2886&author=C.+Lanziauthor=N.+Zaffaroniauthor=G.+Cassinelli&title=Targeting+heparan+sulfate+proteoglycans+and+their+modifying+enzymes+to+enhance+anticancer+chemotherapy+efficacy+and+overcome+drug+resistance&doi=10.2174%2F0929867324666170216114248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance</span></div><div class="casAuthors">Lanzi, Cinzia; Zaffaroni, Nadia; Cassinelli, Giuliana</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2860-2886</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Targeting heparan sulfate proteoglycans (HSPGs) and enzymes involved in heparan sulfate (HS) chain editing is emerging as a new anticancer strategy.  The involvement of HSPGs in tumor cell signaling, inflammation, angiogenesis and metastasis indicates that agents able to inhibit aberrant HSPG functions can potentially act as multitarget drugs affecting both tumor cell growth and the supportive boost provided by the microenvironment.  Moreover, accumulating evidence supports that an altered expression or function of HSPGs, or of the complex enzyme system regulating their activities, can also depress the tumor response to anticancer treatments in several tumor types.  Thereby, targeting HSPGs or HSPG modifying enzymes appears an appealing approach to enhance chemotherapy efficacy.  A great deal of effort from academia and industry has led to the development of agents mimicking HS, and/or inhibiting HSPG modifying enzymes.  Inhibitors of Sulf-2, an endosulfatase that edits the HS sulfation pattern, and inhibitors of heparanase, the endoglycosidase that produces functional HS fragments, appear particularly promising.  In fact, a Sulf-2 inhibitor (OKN-007), and two heparanase inhibitors/HS mimics (roneparstat, PG545) are currently under early clin. investigation.  In this review, we summarized preclin. studies in exptl. tumor models of the main chem. classes of Sulf-2 and heparanase inhibitors.  We described examples of different mechanisms through which heparanase and HSPGs, often in cooperation, may impact tumor sensitivity to various antitumor agents.  Finally, we reported a few preclin. studies showing increased antitumor efficacy obtained with the use of candidate clin. HS mimics in combination regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvdqVvYpaCJbVg90H21EOLACvtfcHk0liCgvm_3uerrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sru7rF&md5=395b84e9f52c311599d928949376f59c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F0929867324666170216114248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867324666170216114248%26sid%3Dliteratum%253Aachs%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DCassinelli%26aufirst%3DG.%26atitle%3DTargeting%2520heparan%2520sulfate%2520proteoglycans%2520and%2520their%2520modifying%2520enzymes%2520to%2520enhance%2520anticancer%2520chemotherapy%2520efficacy%2520and%2520overcome%2520drug%2520resistance%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2017%26volume%3D24%26spage%3D2860%26epage%3D2886%26doi%3D10.2174%2F0929867324666170216114248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, G.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, L.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, K.-L.</span></span> <span> </span><span class="NLM_article-title">624PD - A phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">v209</span>– <span class="NLM_lpage">v268</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdx369.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1093%2Fannonc%2Fmdx369.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=v209-v268&issue=5&author=P.-J.+Chenauthor=P.-H.+Leeauthor=K.-H.+Hanauthor=J.+Fanauthor=T.+T.+Cheungauthor=R.-H.+Huauthor=S.+W.+Paikauthor=W.-C.+Leeauthor=G.-Y.+Chauauthor=L.-B.+Jengauthor=H.+J.+Wangauthor=J.+Y.+Choiauthor=C.-L.+Chenauthor=M.+Choauthor=M.-C.+Hoauthor=C.-C.+Wuauthor=K.+S.+Leeauthor=Y.+Maoauthor=F.-C.+Huauthor=K.-L.+Lai&title=624PD+-+A+phase+III+trial+of+muparfostat+%28PI-88%29+as+adjuvant+therapy+in+patients+with+hepatitis+virus+related+hepatocellular+carcinoma+%28HV-HCC%29+after+resection&doi=10.1093%2Fannonc%2Fmdx369.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdx369.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdx369.008%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.-J.%26aulast%3DLee%26aufirst%3DP.-H.%26aulast%3DHan%26aufirst%3DK.-H.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DT.%2BT.%26aulast%3DHu%26aufirst%3DR.-H.%26aulast%3DPaik%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DW.-C.%26aulast%3DChau%26aufirst%3DG.-Y.%26aulast%3DJeng%26aufirst%3DL.-B.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DChen%26aufirst%3DC.-L.%26aulast%3DCho%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DM.-C.%26aulast%3DWu%26aufirst%3DC.-C.%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DF.-C.%26aulast%3DLai%26aufirst%3DK.-L.%26atitle%3D624PD%2520-%2520A%2520phase%2520III%2520trial%2520of%2520muparfostat%2520%2528PI-88%2529%2520as%2520adjuvant%2520therapy%2520in%2520patients%2520with%2520hepatitis%2520virus%2520related%2520hepatocellular%2520carcinoma%2520%2528HV-HCC%2529%2520after%2520resection%26jtitle%3DAnn.%2520Oncol.%26date%3D2017%26volume%3D28%26issue%3D5%26spage%3Dv209%26epage%3Dv268%26doi%3D10.1093%2Fannonc%2Fmdx369.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nix, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. P.</span></span> <span> </span><span class="NLM_article-title">Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: phase I results</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1429</span>– <span class="NLM_lpage">1439</span>, <span class="refDoi"> DOI: 10.1634/theoncologist.2017-0472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1634%2Ftheoncologist.2017-0472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=29158367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovFCnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1429-1439&issue=12&author=E.+M.+O%E2%80%99Reillyauthor=J.+Roachauthor=P.+Millerauthor=K.+H.+Yuauthor=C.+Tjanauthor=M.+Rosanoauthor=S.+Krauseauthor=W.+Averyauthor=J.+Wolfauthor=K.+Flahertyauthor=D.+Nixauthor=D.+P.+Ryan&title=Safety%2C+pharmacokinetics%2C+pharmacodynamics%2C+and+antitumor+activity+of+necuparanib+combined+with+nab-paclitaxel+and+gemcitabine+in+patients+with+metastatic+pancreatic+cancer%3A+phase+I+results&doi=10.1634%2Ftheoncologist.2017-0472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results</span></div><div class="casAuthors">O'Reilly, Eileen M.; Roach, James; Miller, Paul; Yu, Kenneth H.; Tjan, Catherine; Rosano, Molly; Krause, Silva; Avery, William; Wolf, Julie; Flaherty, Keith; Nix, Darrell; Ryan, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1429-e139</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1549-490X</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">Lessons Learned : Despite the compelling preclin. rationale of evaluating the genetically engineered heparin deriv., necuparanib, combined with std. therapy in metastatic pancreas adenocarcinoma, the results were ultimately disappointing.  Safety was documented, although dose escalation was limited by the no. of s.c. injections, the potential for skin toxicity (cellulitis), and low-level anticoagulant effect.  Nonetheless, the hypothesis of targeting prothrombotic pathways in pancreas adenocarcinoma remains compelling.  Background : Necuparanib is derived from unfractionated heparin and engineered for reduced anticoagulant activity while preserving known heparin-assocd. antitumor properties.  This trial assessed the safety, pharmacokinetics (PK), pharmacodynamics, and initial efficacy of necuparanib combined with gemcitabine ± nab-paclitaxel in patients with metastatic pancreatic cancer.  Methods : Patients received escalating daily s.c. doses of necuparanib plus 1,000 mg/m2 gemcitabine (days 1, 8, 15, and every 28 days).  The protocol was amended to include 125 mg/m2 nab-paclitaxel after two cohorts (following release of the phase III MPACT data).  The necuparanib starting dose was 0.5 mg/kg, with escalation via a modified 3 + 3 design until the max. tolerated dose (MTD) was detd.  Results : Thirty-nine patients were enrolled into seven cohorts (necuparanib 0.5, 1 mg/kg + gemcitabine; necuparanib 1, 2, 4, 6, and 5 mg/kg + nab-paclitaxel + gemcitabine).  The most common adverse events were anemia (56%), fatigue (51%), neutropenia (51%), leukopenia (41%), and thrombocytopenia (41%).  No deaths and two serious adverse events were potentially related to necuparanib.  Measurable levels of necuparanib were seen starting at the 2 mg/kg dose.  Of 24 patients who received at least one dose of necuparanib + nab-paclitaxel + gemcitabine, 9 (38%) achieved a partial response and 6 (25%) achieved stable disease (63% disease control rate).  Given a cellulitis event and mild activated partial thromboplastin time increases at 6 mg/kg, the 5 mg/kg dose was considered the MTD and selected for further assessment in phase II.  Conclusion : Acceptable safety and encouraging signals of activity in patients with metastatic pancreatic cancer receiving necuparanib, nab-paclitaxel, and gemcitabine were demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkOVw6q0wV0rVg90H21EOLACvtfcHk0liCgvm_3uerrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovFCnt70%253D&md5=e731677d7506bc7f1fdb368acaa77e52</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2017-0472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2017-0472%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DE.%2BM.%26aulast%3DRoach%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DK.%2BH.%26aulast%3DTjan%26aufirst%3DC.%26aulast%3DRosano%26aufirst%3DM.%26aulast%3DKrause%26aufirst%3DS.%26aulast%3DAvery%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DJ.%26aulast%3DFlaherty%26aufirst%3DK.%26aulast%3DNix%26aufirst%3DD.%26aulast%3DRyan%26aufirst%3DD.%2BP.%26atitle%3DSafety%252C%2520pharmacokinetics%252C%2520pharmacodynamics%252C%2520and%2520antitumor%2520activity%2520of%2520necuparanib%2520combined%2520with%2520nab-paclitaxel%2520and%2520gemcitabine%2520in%2520patients%2520with%2520metastatic%2520pancreatic%2520cancer%253A%2520phase%2520I%2520results%26jtitle%3DOncologist%26date%3D2017%26volume%3D22%26issue%3D12%26spage%3D1429%26epage%3D1439%26doi%3D10.1634%2Ftheoncologist.2017-0472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parish, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowden, W. B.</span></span> <span> </span><span class="NLM_article-title">Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3433</span>– <span class="NLM_lpage">3441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=3433-3441&issue=14&author=C.+R.+Parishauthor=C.+Freemanauthor=K.+J.+Brownauthor=D.+J.+Francisauthor=W.+B.+Cowden&title=Identification+of+sulfated+oligosaccharide-based+inhibitors+of+tumor+growth+and+metastasis+using+novel+in+vitro+assays+for+angiogenesis+and+heparanase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParish%26aufirst%3DC.%2BR.%26aulast%3DFreeman%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DK.%2BJ.%26aulast%3DFrancis%26aufirst%3DD.%2BJ.%26aulast%3DCowden%26aufirst%3DW.%2BB.%26atitle%3DIdentification%2520of%2520sulfated%2520oligosaccharide-based%2520inhibitors%2520of%2520tumor%2520growth%2520and%2520metastasis%2520using%2520novel%2520in%2520vitro%2520assays%2520for%2520angiogenesis%2520and%2520heparanase%2520activity%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D14%26spage%3D3433%26epage%3D3441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dredge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bytheway, I.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues</span>. <i>FEBS Open Bio</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1016/j.fob.2013.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.fob.2013.07.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=346-351&author=E.+Hammondauthor=P.+Handleyauthor=K.+Dredgeauthor=I.+Bytheway&title=Mechanisms+of+heparanase+inhibition+by+the+heparan+sulfate+mimetic+PG545+and+three+structural+analogues&doi=10.1016%2Fj.fob.2013.07.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.fob.2013.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fob.2013.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DE.%26aulast%3DHandley%26aufirst%3DP.%26aulast%3DDredge%26aufirst%3DK.%26aulast%3DBytheway%26aufirst%3DI.%26atitle%3DMechanisms%2520of%2520heparanase%2520inhibition%2520by%2520the%2520heparan%2520sulfate%2520mimetic%2520PG545%2520and%2520three%2520structural%2520analogues%26jtitle%3DFEBS%2520Open%2520Bio%26date%3D2013%26volume%3D3%26spage%3D346%26epage%3D351%26doi%3D10.1016%2Fj.fob.2013.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dredge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lickliter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bampton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lankesheer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrish, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millward, M.</span></span> <span> </span><span class="NLM_article-title">A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1041</span>, <span class="refDoi"> DOI: 10.1038/s41416-018-0006-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1038%2Fs41416-018-0006-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=29531325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos12qtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2018&pages=1035-1041&issue=8&author=K.+Dredgeauthor=T.+V.+Brennanauthor=E.+Hammondauthor=J.+D.+Lickliterauthor=L.+Linauthor=D.+Bamptonauthor=P.+Handleyauthor=F.+Lankesheerauthor=G.+Morrishauthor=Y.+Yangauthor=M.+P.+Brownauthor=M.+Millward&title=A+Phase+I+study+of+the+novel+immunomodulatory+agent+PG545+%28pixatimod%29+in+subjects+with+advanced+solid+tumours&doi=10.1038%2Fs41416-018-0006-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours</span></div><div class="casAuthors">Dredge, Keith; Brennan, Todd V.; Hammond, Edward; Lickliter, Jason D.; Lin, Liwen; Bampton, Darryn; Handley, Paul; Lankesheer, Fleur; Morrish, Glynn; Yang, Yiping; Brown, Michael P.; Millward, Michael</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1035-1041</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: PG545 (pixatimod) is a novel immunomodulatory agent, which has been demonstrated to stimulate innate immune responses against tumors in preclin. cancer models.  Methods: This Phase I study investigated the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of PG545 monotherapy.  Escalating doses of PG545 were administered to patients with advanced solid malignancies as a weekly 1-h i.v. infusion.  Results: Twenty-three subjects were enroled across four cohorts (25, 50, 100 and 150 mg).  Three dose-limiting toxicities (DLTs)-hypertension (2), epistaxis (1)-occurred in the 150 mg cohort.  No DLTs were noted in the 100 mg cohort, which was identified as the max.-tolerated dose.  No objective responses were reported.  Best response was stable disease up to 24 wk, with the disease control rate in evaluable subjects of 38%.  Exposure was proportional up to 100 mg and mean half-life was 141 h.  The pharmacodynamic data revealed increases in innate immune cell activation, plasma IFNγ, TNFα, IP-10 and MCP-1.  Conclusion: PG545 demonstrated a tolerable safety profile, proportional PK, evidence of immune cell stimulation and disease control in some subjects.  Taken together, these data support the proposed mechanism of action, which represents a promising approach for use in combination with existing therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJrZFH2H5d6rVg90H21EOLACvtfcHk0ljeGSTk88GdiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos12qtb4%253D&md5=77372f48c3126f68968aad2ff1d255df</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fs41416-018-0006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41416-018-0006-0%26sid%3Dliteratum%253Aachs%26aulast%3DDredge%26aufirst%3DK.%26aulast%3DBrennan%26aufirst%3DT.%2BV.%26aulast%3DHammond%26aufirst%3DE.%26aulast%3DLickliter%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DBampton%26aufirst%3DD.%26aulast%3DHandley%26aufirst%3DP.%26aulast%3DLankesheer%26aufirst%3DF.%26aulast%3DMorrish%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BP.%26aulast%3DMillward%26aufirst%3DM.%26atitle%3DA%2520Phase%2520I%2520study%2520of%2520the%2520novel%2520immunomodulatory%2520agent%2520PG545%2520%2528pixatimod%2529%2520in%2520subjects%2520with%2520advanced%2520solid%2520tumours%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2018%26volume%3D118%26issue%3D8%26spage%3D1035%26epage%3D1041%26doi%3D10.1038%2Fs41416-018-0006-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specchia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einsele, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celeghini, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbieri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambaldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagler, A.</span></span> <span> </span><span class="NLM_article-title">Phase I study of the heparanase inhibitor roneparstat: an innovative approach for multiple myeloma therapy</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">e469</span>, <span class="refDoi"> DOI: 10.3324/haematol.2017.182865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.3324%2Fhaematol.2017.182865" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2018&pages=e469&author=M.+Galliauthor=M.+Chatterjeeauthor=M.+Grassoauthor=G.+Specchiaauthor=H.+Magenauthor=H.+Einseleauthor=I.+Celeghiniauthor=P.+Barbieriauthor=D.+Paolettiauthor=S.+Paceauthor=R.+D.+Sandersonauthor=A.+Rambaldiauthor=A.+Nagler&title=Phase+I+study+of+the+heparanase+inhibitor+roneparstat%3A+an+innovative+approach+for+multiple+myeloma+therapy&doi=10.3324%2Fhaematol.2017.182865"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2017.182865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2017.182865%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DM.%26aulast%3DChatterjee%26aufirst%3DM.%26aulast%3DGrasso%26aufirst%3DM.%26aulast%3DSpecchia%26aufirst%3DG.%26aulast%3DMagen%26aufirst%3DH.%26aulast%3DEinsele%26aufirst%3DH.%26aulast%3DCeleghini%26aufirst%3DI.%26aulast%3DBarbieri%26aufirst%3DP.%26aulast%3DPaoletti%26aufirst%3DD.%26aulast%3DPace%26aufirst%3DS.%26aulast%3DSanderson%26aufirst%3DR.%2BD.%26aulast%3DRambaldi%26aufirst%3DA.%26aulast%3DNagler%26aufirst%3DA.%26atitle%3DPhase%2520I%2520study%2520of%2520the%2520heparanase%2520inhibitor%2520roneparstat%253A%2520an%2520innovative%2520approach%2520for%2520multiple%2520myeloma%2520therapy%26jtitle%3DHaematologica%26date%3D2018%26volume%3D103%26spage%3De469%26doi%3D10.3324%2Fhaematol.2017.182865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonra, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahiji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kussie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselyov, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">1-[4-(1<i>H</i>-benzoimidazol-2-yl)-phenyl]-3-[4-(1<i>H</i>-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.09.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.bmcl.2005.09.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=409-412&issue=2&author=W.+Panauthor=H.+Q.+Miaoauthor=Y.+J.+Xuauthor=E.+C.+Navarroauthor=J.+R.+Tonraauthor=E.+Corcoranauthor=A.+Lahijiauthor=P.+Kussieauthor=A.+S.+Kiselyovauthor=W.+C.+Wongauthor=H.+Liu&title=1-%5B4-%281H-benzoimidazol-2-yl%29-phenyl%5D-3-%5B4-%281H-benzoimidazol-2-yl%29-phenyl%5D-urea+derivatives+as+small+molecule+heparanase+inhibitors&doi=10.1016%2Fj.bmcl.2005.09.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.09.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.09.069%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DW.%26aulast%3DMiao%26aufirst%3DH.%2BQ.%26aulast%3DXu%26aufirst%3DY.%2BJ.%26aulast%3DNavarro%26aufirst%3DE.%2BC.%26aulast%3DTonra%26aufirst%3DJ.%2BR.%26aulast%3DCorcoran%26aufirst%3DE.%26aulast%3DLahiji%26aufirst%3DA.%26aulast%3DKussie%26aufirst%3DP.%26aulast%3DKiselyov%26aufirst%3DA.%2BS.%26aulast%3DWong%26aufirst%3DW.%2BC.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3D1-%255B4-%25281H-benzoimidazol-2-yl%2529-phenyl%255D-3-%255B4-%25281H-benzoimidazol-2-yl%2529-phenyl%255D-urea%2520derivatives%2520as%2520small%2520molecule%2520heparanase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D2%26spage%3D409%26epage%3D412%26doi%3D10.1016%2Fj.bmcl.2005.09.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bathini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manga, V.</span></span> <span> </span><span class="NLM_article-title">3D QSAR based design of novel substituted urea molecules as heparanase inhibitors</span>. <i>J. Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">754</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1016/j.jopr.2013.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.jopr.2013.08.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyls7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=754-761&issue=8&author=R.+Bathiniauthor=S.+Fatimaauthor=S.+K.+Sivanauthor=V.+Manga&title=3D+QSAR+based+design+of+novel+substituted+urea+molecules+as+heparanase+inhibitors&doi=10.1016%2Fj.jopr.2013.08.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">3D QSAR based design of novel substituted urea molecules as heparanase inhibitors</span></div><div class="casAuthors">Bathini, Raju; Fatima, Sabiha; Sivan, Sree Kanth; Manga, Vijjulatha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy Research (Gurgaon, India)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">754-761</span>CODEN:
                <span class="NLM_cas:coden">JPROFW</span>;
        ISSN:<span class="NLM_cas:issn">0974-6943</span>.
    
            (<span class="NLM_cas:orgname">Reed Elsevier India Pvt. Ltd.</span>)
        </div><div class="casAbstract">To study the key pharmacophore requirements for heparanase inhibition and design of new mols.Three dimensional quant. structure activity relationship (3D QSAR) methodologies namely Comparative Mol. Field Anal. (CoMFA) and Comparative Mol. Similarity Indexes Anal. (CoMSIA) were applied, PLS anal. was performed and QSAR models were generated for a set of 43 bezoxazol-5-yl acetic acid derivs. and 1,3-bis 4-(1H-bezimidazol-2-yl)-Ph urea reported as potent inhibitors of heparanase.QSAR model showed good internal and external statistical reliability that is evident from the q2loo, r2ncv and r2pred.  CoMFA model provides a correlation of steric and electrostatic field with biol. activities.  CoMSIA model provides a correlation of steric, electrostatic, acceptor, donor and hydrophobic fields with biol. activities.The identified key features enabled us to design novel sym. 1,3-bis 4-(1H-bezimidazol-2-yl)-Ph urea derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0HTM_dyPhbVg90H21EOLACvtfcHk0ljeGSTk88GdiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyls7rJ&md5=f60b361092754dbbbcbcb9c67674ce10</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jopr.2013.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jopr.2013.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DBathini%26aufirst%3DR.%26aulast%3DFatima%26aufirst%3DS.%26aulast%3DSivan%26aufirst%3DS.%2BK.%26aulast%3DManga%26aufirst%3DV.%26atitle%3D3D%2520QSAR%2520based%2520design%2520of%2520novel%2520substituted%2520urea%2520molecules%2520as%2520heparanase%2520inhibitors%26jtitle%3DJ.%2520Pharm.%2520Res.%26date%3D2013%26volume%3D7%26issue%3D8%26spage%3D754%26epage%3D761%26doi%3D10.1016%2Fj.jopr.2013.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colville, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scopes, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hircock, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhaman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felix, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubberfield, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, P. R.</span></span> <span> </span><span class="NLM_article-title">Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2295</span>– <span class="NLM_lpage">2299</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.bmcl.2005.03.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2295-2299&author=S.+M.+Courtneyauthor=P.+A.+Hayauthor=R.+T.+Buckauthor=C.+S.+Colvilleauthor=D.+J.+Phillipsauthor=D.+I.+Scopesauthor=F.+C.+Pollardauthor=M.+J.+Pageauthor=J.+M.+Bennettauthor=M.+L.+Hircockauthor=E.+A.+McKenzieauthor=M.+Bhamanauthor=R.+Felixauthor=C.+R.+Stubberfieldauthor=P.+R.+Turner&title=Furanyl-1%2C3-thiazol-2-yl+and+benzoxazol-5-yl+acetic+acid+derivatives%3A+novel+classes+of+heparanase+inhibitor&doi=10.1016%2Fj.bmcl.2005.03.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DHay%26aufirst%3DP.%2BA.%26aulast%3DBuck%26aufirst%3DR.%2BT.%26aulast%3DColville%26aufirst%3DC.%2BS.%26aulast%3DPhillips%26aufirst%3DD.%2BJ.%26aulast%3DScopes%26aufirst%3DD.%2BI.%26aulast%3DPollard%26aufirst%3DF.%2BC.%26aulast%3DPage%26aufirst%3DM.%2BJ.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DHircock%26aufirst%3DM.%2BL.%26aulast%3DMcKenzie%26aufirst%3DE.%2BA.%26aulast%3DBhaman%26aufirst%3DM.%26aulast%3DFelix%26aufirst%3DR.%26aulast%3DStubberfield%26aufirst%3DC.%2BR.%26aulast%3DTurner%26aufirst%3DP.%2BR.%26atitle%3DFuranyl-1%252C3-thiazol-2-yl%2520and%2520benzoxazol-5-yl%2520acetic%2520acid%2520derivatives%253A%2520novel%2520classes%2520of%2520heparanase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2295%26epage%3D2299%26doi%3D10.1016%2Fj.bmcl.2005.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madia, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescatori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saccoliti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudino, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scipione, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalvini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roscilli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milazzo, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Santo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, G.</span></span> <span> </span><span class="NLM_article-title">Novel benzazole derivatives endowed with potent anti-heparanase activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6918</span>– <span class="NLM_lpage">6936</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00908</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00908" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6918-6936&author=V.+N.+Madiaauthor=A.+Messoreauthor=L.+Pescatoriauthor=F.+Saccolitiauthor=V.+Tudinoauthor=A.+De+Leoauthor=M.+Bortolamiauthor=L.+Scipioneauthor=R.+Costiauthor=S.+Rivaraauthor=L.+Scalviniauthor=M.+Morauthor=F.+F.+Ferraraauthor=E.+Pavoniauthor=G.+Roscilliauthor=G.+Cassinelliauthor=F.+M.+Milazzoauthor=G.+Battistuzziauthor=R.+Di+Santoauthor=G.+Giannini&title=Novel+benzazole+derivatives+endowed+with+potent+anti-heparanase+activity&doi=10.1021%2Facs.jmedchem.8b00908"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00908%26sid%3Dliteratum%253Aachs%26aulast%3DMadia%26aufirst%3DV.%2BN.%26aulast%3DMessore%26aufirst%3DA.%26aulast%3DPescatori%26aufirst%3DL.%26aulast%3DSaccoliti%26aufirst%3DF.%26aulast%3DTudino%26aufirst%3DV.%26aulast%3DDe%2BLeo%26aufirst%3DA.%26aulast%3DBortolami%26aufirst%3DM.%26aulast%3DScipione%26aufirst%3DL.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DScalvini%26aufirst%3DL.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DF.%2BF.%26aulast%3DPavoni%26aufirst%3DE.%26aulast%3DRoscilli%26aufirst%3DG.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DMilazzo%26aufirst%3DF.%2BM.%26aulast%3DBattistuzzi%26aufirst%3DG.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DGiannini%26aufirst%3DG.%26atitle%3DNovel%2520benzazole%2520derivatives%2520endowed%2520with%2520potent%2520anti-heparanase%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6918%26epage%3D6936%26doi%3D10.1021%2Facs.jmedchem.8b00908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, S. M.</span>; <span class="NLM_string-name">Hay, P. A.</span>; <span class="NLM_string-name">Scopes, D. I.</span></span> <span> </span><span class="NLM_article-title">Benzoxazole, Benzothiazole and Benzimidazole Acid Derivatives and their Use as Heparanase Inhibitors</span>.  <i>PCTInternational Patent Applications</i> <span class="NLM_patent">WO 2004/046122</span>, July 15, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+M.+Courtney&author=P.+A.+Hay&author=D.+I.+Scopes&title=Benzoxazole%2C+Benzothiazole+and+Benzimidazole+Acid+Derivatives+and+their+Use+as+Heparanase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26atitle%3DBenzoxazole%252C%2520Benzothiazole%2520and%2520Benzimidazole%2520Acid%2520Derivatives%2520and%2520their%2520Use%2520as%2520Heparanase%2520Inhibitors%26jtitle%3DPCTInternational%2520Patent%2520Applications%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhalnina, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shishkov, S. V.</span></span> <span> </span><span class="NLM_article-title">A convergent approach to synthesis of bortezomib: the use of TBTU suppresses racemization in the fragment condensation</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">7105</span>– <span class="NLM_lpage">7108</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2009.06.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.tet.2009.06.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVGgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=7105-7108&author=A.+S.+Ivanovauthor=A.+A.+Zhalninaauthor=S.+V.+Shishkov&title=A+convergent+approach+to+synthesis+of+bortezomib%3A+the+use+of+TBTU+suppresses+racemization+in+the+fragment+condensation&doi=10.1016%2Fj.tet.2009.06.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A convergent approach to synthesis of bortezomib: the use of TBTU suppresses racemization in the fragment condensation</span></div><div class="casAuthors">Ivanov, Andrey S.; Zhalnina, Anna A.; Shishkov, Sergey V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7105-7108</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bortezomib (I) is a first-in-class therapeutic antineoplastic agent used for treating patients with multiple myeloma and mantle cell lymphoma.  In this paper we report an improved method for synthesis of the title compd. using a convergent approach.  TBTU was found to efficiently suppress racemization in the fragment condensation.  In comparison with the original synthesis, the presented one is shorter by two steps, higher in yield, and provides better atom economy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoju9EMTW_imrVg90H21EOLACvtfcHk0lgLeuEQB8ycvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVGgtL8%253D&md5=e6bc84fc1b41d91164910fc186697986</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2009.06.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2009.06.042%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aufirst%3DA.%2BS.%26aulast%3DZhalnina%26aufirst%3DA.%2BA.%26aulast%3DShishkov%26aufirst%3DS.%2BV.%26atitle%3DA%2520convergent%2520approach%2520to%2520synthesis%2520of%2520bortezomib%253A%2520the%2520use%2520of%2520TBTU%2520suppresses%2520racemization%2520in%2520the%2520fragment%2520condensation%26jtitle%3DTetrahedron%26date%3D2009%26volume%3D65%26spage%3D7105%26epage%3D7108%26doi%3D10.1016%2Fj.tet.2009.06.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocks, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, D. J. S.</span></span> <span> </span><span class="NLM_article-title">Directed chiral synthesis by way of α-chloro boronic esters</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1536</span>– <span class="NLM_lpage">1543</span>, <span class="refDoi"> DOI: 10.1021/om50005a009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om50005a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1983&pages=1536-1543&author=D.+S.+Mattesonauthor=R.+Rayauthor=R.+R.+Rocksauthor=D.+J.+S.+Tsai&title=Directed+chiral+synthesis+by+way+of+%CE%B1-chloro+boronic+esters&doi=10.1021%2Fom50005a009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fom50005a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom50005a009%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DRay%26aufirst%3DR.%26aulast%3DRocks%26aufirst%3DR.%2BR.%26aulast%3DTsai%26aufirst%3DD.%2BJ.%2BS.%26atitle%3DDirected%2520chiral%2520synthesis%2520by%2520way%2520of%2520%25CE%25B1-chloro%2520boronic%2520esters%26jtitle%3DOrganometallics%26date%3D1983%26volume%3D2%26spage%3D1536%26epage%3D1543%26doi%3D10.1021%2Fom50005a009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutts, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krolikowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, R. J.</span></span> <span> </span><span class="NLM_article-title">Two efficient methods for the cleavage of pinanediol boronate esters yielding the free boronic acids</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">5109</span>– <span class="NLM_lpage">5112</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)77040-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2FS0040-4039%2800%2977040-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADyaK2MXjsFKqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=5109-5112&author=S.+J.+Couttsauthor=J.+Adamsauthor=D.+Krolikowskiauthor=R.+J.+Snow&title=Two+efficient+methods+for+the+cleavage+of+pinanediol+boronate+esters+yielding+the+free+boronic+acids&doi=10.1016%2FS0040-4039%2800%2977040-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Two efficient methods for the cleavage of pinanediol boronate esters yielding the free boronic acids</span></div><div class="casAuthors">Coutts, Simon J.; Adams, Julian; Krolikowski, Dale; Snow, Roger J.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">5109-12</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">Two synthetic methods for the prepn. of boronic acids, e.g., I, from their corresponding pinanediol boronate esters are reported.  The key to success of the procedures relies on removal of the liberated pinanediol from the reaction mixt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovKLzYSZwH67Vg90H21EOLACvtfcHk0lgLHrcS7PZBOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsFKqtg%253D%253D&md5=9f9c563a1a4238b431eaac51124ba31e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2977040-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252977040-7%26sid%3Dliteratum%253Aachs%26aulast%3DCoutts%26aufirst%3DS.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DKrolikowski%26aufirst%3DD.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26atitle%3DTwo%2520efficient%2520methods%2520for%2520the%2520cleavage%2520of%2520pinanediol%2520boronate%2520esters%2520yielding%2520the%2520free%2520boronic%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D5109%26epage%3D5112%26doi%3D10.1016%2FS0040-4039%2800%2977040-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E. H.</span>; <span class="NLM_string-name">Chung, S. G.</span>; <span class="NLM_string-name">Lee, S. H.</span>; <span class="NLM_string-name">Kwon, H. S.</span>; <span class="NLM_string-name">Lee, J. E.</span>; <span class="NLM_string-name">Kang, D. W.</span>; <span class="NLM_string-name">Joo, J. H.</span>; <span class="NLM_string-name">Lee, Y. H.</span></span> <span> </span><span class="NLM_article-title">Piperazine Derivatives and Process for the Preparation Thereof</span>. <span class="NLM_patent">U.S. Patent 6,028,195</span>, February 22, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=E.+H.+Cho&author=S.+G.+Chung&author=S.+H.+Lee&author=H.+S.+Kwon&author=J.+E.+Lee&author=D.+W.+Kang&author=J.+H.+Joo&author=Y.+H.+Lee&title=Piperazine+Derivatives+and+Process+for+the+Preparation+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DE.%2BH.%26atitle%3DPiperazine%2520Derivatives%2520and%2520Process%2520for%2520the%2520Preparation%2520Thereof%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easley, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, W. S.</span></span> <span> </span><span class="NLM_article-title">Tetrahydrothiophene</span>. <i>Org. Synth.</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">90</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1956&pages=89-90&author=K.+J.+Lawsonauthor=W.+K.+Easleyauthor=W.+S.+Wagner&title=Tetrahydrothiophene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DK.%2BJ.%26aulast%3DEasley%26aufirst%3DW.%2BK.%26aulast%3DWagner%26aufirst%3DW.%2BS.%26atitle%3DTetrahydrothiophene%26jtitle%3DOrg.%2520Synth.%26date%3D1956%26volume%3D36%26spage%3D89%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Photis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquette, L. A.</span></span> <span> </span><span class="NLM_article-title">1,2-Dimethylcyclobutenes by reductive ring-contraction of sulfolanes: <i>cis</i>-7,8-dimethylbicyclo[4.2.0]oct-7-ene</span>. <i>Org. Synth.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1977&pages=53-58&author=J.+M.+Photisauthor=L.+A.+Paquette&title=1%2C2-Dimethylcyclobutenes+by+reductive+ring-contraction+of+sulfolanes%3A+cis-7%2C8-dimethylbicyclo%5B4.2.0%5Doct-7-ene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhotis%26aufirst%3DJ.%2BM.%26aulast%3DPaquette%26aufirst%3DL.%2BA.%26atitle%3D1%252C2-Dimethylcyclobutenes%2520by%2520reductive%2520ring-contraction%2520of%2520sulfolanes%253A%2520cis-7%252C8-dimethylbicyclo%255B4.2.0%255Doct-7-ene%26jtitle%3DOrg.%2520Synth.%26date%3D1977%26volume%3D57%26spage%3D53%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potter, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. S.</span></span> <span> </span><span class="NLM_article-title">Predicting the UV–Vis Spectra of tetraarylcyclopentadienones: using DFT molecular orbital energies to model electronic transitions of organic materials</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2995</span>– <span class="NLM_lpage">3004</span>, <span class="refDoi"> DOI: 10.1021/jo701676x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo701676x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=2995-3004&issue=8&author=R.+G.+Potterauthor=T.+S.+Hughes&title=Predicting+the+UV%E2%80%93Vis+Spectra+of+tetraarylcyclopentadienones%3A+using+DFT+molecular+orbital+energies+to+model+electronic+transitions+of+organic+materials&doi=10.1021%2Fjo701676x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo701676x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo701676x%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DR.%2BG.%26aulast%3DHughes%26aufirst%3DT.%2BS.%26atitle%3DPredicting%2520the%2520UV%25E2%2580%2593Vis%2520Spectra%2520of%2520tetraarylcyclopentadienones%253A%2520using%2520DFT%2520molecular%2520orbital%2520energies%2520to%2520model%2520electronic%2520transitions%2520of%2520organic%2520materials%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26issue%3D8%26spage%3D2995%26epage%3D3004%26doi%3D10.1021%2Fjo701676x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imanishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washizuka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takamura, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human β<sub>3</sub>-adrenergic receptor agonists with good oral bioavailability. Part I</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1925</span>– <span class="NLM_lpage">1944</span>, <span class="refDoi"> DOI: 10.1021/jm701324c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701324c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1ekurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1925-1944&author=M.+Imanishiauthor=Y.+Tomishimaauthor=S.+Itouauthor=H.+Hamashimaauthor=Y.+Nakajimaauthor=K.+Washizukaauthor=M.+Sakuraiauthor=S.+Matsuiauthor=E.+Imamuraauthor=K.+Ueshimaauthor=T.+Yamamotoauthor=N.+Yamamotoauthor=H.+Ishikawaauthor=K.+Nakanoauthor=N.+Unamiauthor=K.+Hamadaauthor=Y.+Matsumuraauthor=F.+Takamuraauthor=K.+Hattori&title=Discovery+of+a+novel+series+of+biphenyl+benzoic+acid+derivatives+as+potent+and+selective+human+%CE%B23-adrenergic+receptor+agonists+with+good+oral+bioavailability.+Part+I&doi=10.1021%2Fjm701324c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β3-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I</span></div><div class="casAuthors">Imanishi, Masashi; Tomishima, Yasuyo; Itou, Shinji; Hamashima, Hitoshi; Nakajima, Yutaka; Washizuka, Kenichi; Sakurai, Minoru; Matsui, Shigeo; Imamura, Emiko; Ueshima, Koji; Yamamoto, Takao; Yamamoto, Nobuhiro; Ishikawa, Hirofumi; Nakano, Keiko; Unami, Naoko; Hamada, Kaori; Matsumura, Yasuhiro; Takamura, Fujiko; Hattori, Kouji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1925-1944</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of biphenyl analogs contg. a benzoic acid moiety based on lead compd. I have been identified as potent and selective human β3 adrenergic receptor (β3-AR) agonists with good oral bioavailability and long plasma half-life.  After further substituent effects were investigated at the terminal Ph ring of lead compd. I, it has been discovered that more lipophilic substitution at the R position improved potency and selectivity.  As a result of these studies, II and III were identified as the leading candidates with the best balance of potency, selectivity, and pharmacokinetic profiles.  In addn., compds. II and III were evaluated to be efficacious for a carbachol-induced increase of intravesical pressure, such as an overactive bladder model in anesthetized dogs.  This represents the first demonstrated result dealing with β3-AR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx1QxEQuf51bVg90H21EOLACvtfcHk0lhZY1bTqTk4LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1ekurg%253D&md5=4ec8095eca0542c8566be8aee3bb1619</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm701324c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701324c%26sid%3Dliteratum%253Aachs%26aulast%3DImanishi%26aufirst%3DM.%26aulast%3DTomishima%26aufirst%3DY.%26aulast%3DItou%26aufirst%3DS.%26aulast%3DHamashima%26aufirst%3DH.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DWashizuka%26aufirst%3DK.%26aulast%3DSakurai%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DS.%26aulast%3DImamura%26aufirst%3DE.%26aulast%3DUeshima%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DK.%26aulast%3DUnami%26aufirst%3DN.%26aulast%3DHamada%26aufirst%3DK.%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DTakamura%26aufirst%3DF.%26aulast%3DHattori%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520biphenyl%2520benzoic%2520acid%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%2520with%2520good%2520oral%2520bioavailability.%2520Part%2520I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1925%26epage%3D1944%26doi%3D10.1021%2Fjm701324c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferro, V.</span></span> <span> </span><span class="NLM_article-title">Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>396</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2009.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.ab.2009.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=19748475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGru77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2010&pages=112-116&issue=1&author=E.+Hammondauthor=C.+P.+Liauthor=V.+Ferro&title=Development+of+a+colorimetric+assay+for+heparanase+activity+suitable+for+kinetic+analysis+and+inhibitor+screening&doi=10.1016%2Fj.ab.2009.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening</span></div><div class="casAuthors">Hammond, Edward; Li, Cai Ping; Ferro, Vito</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-116</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role that heparanase plays during metastasis and angiogenesis in tumors makes it an attractive target for cancer therapeutics.  Despite this enzyme's significance, most of the assays developed to measure its activity are complex.  Moreover, they usually rely on labeling variable prepns. of the natural substrate heparan sulfate, making comparisons across studies precarious.  To overcome these problems, we have developed a convenient assay based on the cleavage of the synthetic heparin oligosaccharide fondaparinux.  The assay measures the appearance of the disaccharide product of heparanase-catalyzed fondaparinux cleavage colorimetrically using the tetrazolium salt WST-1.  Because this assay has a homogeneous substrate with a single point of cleavage, the kinetics of the enzyme can be reliably characterized, giving a Km of 46 μM and a kcat of 3.5 s-1 with fondaparinux as substrate.  The inhibition of heparanase by the published inhibitor, PI-88, was also studied, and a Ki of 7.9 nM was detd.  The simplicity and robustness of this method, should, not only greatly assist routine assay of heparanase activity but also could be adapted for high-throughput screening of compd. libraries, with the data generated being directly comparable across studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0F-7b5OIHBbVg90H21EOLACvtfcHk0lhZY1bTqTk4LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGru77P&md5=ac2d77c8c0f99498cb0c061dc3f3e53e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2009.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2009.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DC.%2BP.%26aulast%3DFerro%26aufirst%3DV.%26atitle%3DDevelopment%2520of%2520a%2520colorimetric%2520assay%2520for%2520heparanase%2520activity%2520suitable%2520for%2520kinetic%2520analysis%2520and%2520inhibitor%2520screening%26jtitle%3DAnal.%2520Biochem.%26date%3D2010%26volume%3D396%26issue%3D1%26spage%3D112%26epage%3D116%26doi%3D10.1016%2Fj.ab.2009.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzozowski, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, G. J.</span></span> <span> </span><span class="NLM_article-title">Structural characterization of human heparanase reveals insights into substrate recognition</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1016</span>– <span class="NLM_lpage">1022</span>, <span class="refDoi"> DOI: 10.1038/nsmb.3136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1038%2Fnsmb.3136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=26575439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOgt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1016-1022&author=L.+Wuauthor=C.+M.+Violaauthor=A.+M.+Brzozowskiauthor=G.+J.+Davies&title=Structural+characterization+of+human+heparanase+reveals+insights+into+substrate+recognition&doi=10.1038%2Fnsmb.3136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization of human heparanase reveals insights into substrate recognition</span></div><div class="casAuthors">Wu, Liang; Viola, Cristina M.; Brzozowski, Andrzej M.; Davies, Gideon J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1016-1022</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heparan sulfate (HS) is a glycosaminoglycan that forms a key component of the extracellular matrix (ECM).  Breakdown of HS is carried out by heparanase (HPSE), an endo-β-glucuronidase of the glycoside hydrolase 79 (GH79) family.  Overexpression of HPSE results in breakdown of extracellular HS and release of stored growth factors and hence is strongly linked to cancer metastasis.  Here we present crystal structures of human HPSE at 1.6-Å to 1.9-Å resoln. that reveal how an endo-acting binding cleft is exposed by proteolytic activation of latent proHPSE.  We used oligosaccharide complexes to map the substrate-binding and sulfate-recognition motifs.  These data shed light on the structure and interactions of a key enzyme involved in ECM maintenance and provide a starting point for the design of HPSE inhibitors for use as biochem. tools and anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJvMLF8YGlyrVg90H21EOLACvtfcHk0lhZY1bTqTk4LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOgt7zP&md5=4cfc53cef5da1db59a7be6450f3a0871</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3136%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DL.%26aulast%3DViola%26aufirst%3DC.%2BM.%26aulast%3DBrzozowski%26aufirst%3DA.%2BM.%26aulast%3DDavies%26aufirst%3DG.%2BJ.%26atitle%3DStructural%2520characterization%2520of%2520human%2520heparanase%2520reveals%2520insights%2520into%2520substrate%2520recognition%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D1016%26epage%3D1022%26doi%3D10.1038%2Fnsmb.3136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levy-Adam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud-Jarrous, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beccati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">20457</span>– <span class="NLM_lpage">20466</span>, <span class="refDoi"> DOI: 10.1074/jbc.M414546200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1074%2Fjbc.M414546200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=20457-20466&author=F.+Levy-Adamauthor=G.+Abboud-Jarrousauthor=M.+Guerriniauthor=D.+Beccatiauthor=I.+Vlodavskyauthor=N.+Ilan&title=Identification+and+characterization+of+heparin%2Fheparan+sulfate+binding+domains+of+the+endoglycosidase+heparanase&doi=10.1074%2Fjbc.M414546200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M414546200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M414546200%26sid%3Dliteratum%253Aachs%26aulast%3DLevy-Adam%26aufirst%3DF.%26aulast%3DAbboud-Jarrous%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DM.%26aulast%3DBeccati%26aufirst%3DD.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DIlan%26aufirst%3DN.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520heparin%252Fheparan%2520sulfate%2520binding%2520domains%2520of%2520the%2520endoglycosidase%2520heparanase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D20457%26epage%3D20466%26doi%3D10.1074%2Fjbc.M414546200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nardella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallaoro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vannini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinkühler, C.</span></span> <span> </span><span class="NLM_article-title">Mechanism of activation of human heparanase investigated by protein engineering</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1862</span>– <span class="NLM_lpage">1873</span>, <span class="refDoi"> DOI: 10.1021/bi030203a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi030203a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=1862-1873&author=C.+Nardellaauthor=A.+Lahmauthor=M.+Pallaoroauthor=M.+Brunettiauthor=A.+Vanniniauthor=C.+Steink%C3%BChler&title=Mechanism+of+activation+of+human+heparanase+investigated+by+protein+engineering&doi=10.1021%2Fbi030203a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi030203a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi030203a%26sid%3Dliteratum%253Aachs%26aulast%3DNardella%26aufirst%3DC.%26aulast%3DLahm%26aufirst%3DA.%26aulast%3DPallaoro%26aufirst%3DM.%26aulast%3DBrunetti%26aufirst%3DM.%26aulast%3DVannini%26aufirst%3DA.%26aulast%3DSteink%25C3%25BChler%26aufirst%3DC.%26atitle%3DMechanism%2520of%2520activation%2520of%2520human%2520heparanase%2520investigated%2520by%2520protein%2520engineering%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D1862%26epage%3D1873%26doi%3D10.1021%2Fbi030203a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simizu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodeoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osada, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of a selective heparanase inhibitor as an antimetastatic agent</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1069</span>– <span class="NLM_lpage">1077</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=15367701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFajt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1069-1077&issue=9&author=K.+Ishidaauthor=G.+Hiraiauthor=K.+Murakamiauthor=T.+Teruyaauthor=S.+Simizuauthor=M.+Sodeokaauthor=H.+Osada&title=Structure-based+design+of+a+selective+heparanase+inhibitor+as+an+antimetastatic+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of a selective heparanase inhibitor as an antimetastatic agent</span></div><div class="casAuthors">Ishida, Keisuke; Hirai, Go; Murakami, Koji; Teruya, Takayuki; Simizu, Siro; Sodeoka, Mikiko; Osada, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1069-1077</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Heparanase is an endo-β-D-glucuronidase that degrades heparan sulfate glycosaminoglycans in the extracellular matrix and the basement membrane and is well known to be involved in tumor cell invasion and angiogenesis.  The authors have focused on heparanase as a target for antitumor agents, esp. antimetastatic agents.  (R)-3-hexadecanoyl-5-hydroxymethyltetronic acid (RK-682) was found to display an inhibitory activity against heparanase in the authors screening of natural sources.  Because RK-682 has been reported to show inhibitory activities against several enzymes, the authors have tried to develop selective heparanase inhibitors using the method of rational drug design.  Based on the structure of the heparanase/RK-682 complex, the authors speculated that selective inhibitory activity against heparanase could be acquired by arylalkylation, namely, by benzylation of the 4-position of RK-682.  Among the rationally designed 4-alkyl-RK-682 derivs., 4-benzyl-RK-682 has been found to possess a selective inhibitory activity for heparanase (IC50 for heparanase, 17 μmol/L; IC50 for other enzymes, >100 μmol/L).  4-Benzyl-RK-682 also inhibited the invasion and migration of human fibrosarcoma HT1080 cells (IC50 for invasion, 1.5 μmol/L; IC50 for migration, 3.0 μmol/L).  RK-682 had no inhibitory effect on the invasion and migration of HT1080 cells at doses of ≤100 μmol/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ex0qg365qrVg90H21EOLACvtfcHk0lhiMWgv4GlZDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFajt7g%253D&md5=b3213a11713031464f9ab1a37b37119a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DG.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DTeruya%26aufirst%3DT.%26aulast%3DSimizu%26aufirst%3DS.%26aulast%3DSodeoka%26aufirst%3DM.%26aulast%3DOsada%26aufirst%3DH.%26atitle%3DStructure-based%2520design%2520of%2520a%2520selective%2520heparanase%2520inhibitor%2520as%2520an%2520antimetastatic%2520agent%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26issue%3D9%26spage%3D1069%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zetser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashenko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span> <span> </span><span class="NLM_article-title">Heparanase affects adhesive and tumorigenic potential of human glioma cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">7733</span>– <span class="NLM_lpage">7741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7733-7741&author=A.+Zetserauthor=Y.+Bashenkoauthor=H.+Q.+Miaoauthor=I.+Vlodavskyauthor=N.+Ilan&title=Heparanase+affects+adhesive+and+tumorigenic+potential+of+human+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZetser%26aufirst%3DA.%26aulast%3DBashenko%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DH.%2BQ.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DIlan%26aufirst%3DN.%26atitle%3DHeparanase%2520affects%2520adhesive%2520and%2520tumorigenic%2520potential%2520of%2520human%2520glioma%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7733%26epage%3D7741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortoreto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrangolini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, F.</span></span> <span> </span><span class="NLM_article-title">Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">1424</span>– <span class="NLM_lpage">1432</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2013.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.bcp.2013.02.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=1424-1432&author=G.+Cassinelliauthor=C.+Lanziauthor=M.+Tortoretoauthor=D.+Cominettiauthor=G.+Petrangoliniauthor=E.+Faviniauthor=N.+Zaffaroniauthor=C.+Pisanoauthor=S.+Pencoauthor=I.+Vlodavskyauthor=F.+Zunino&title=Antitumor+efficacy+of+the+heparanase+inhibitor+SST0001+alone+and+in+combination+with+antiangiogenic+agents+in+the+treatment+of+human+pediatric+sarcoma+models&doi=10.1016%2Fj.bcp.2013.02.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DCominetti%26aufirst%3DD.%26aulast%3DPetrangolini%26aufirst%3DG.%26aulast%3DFavini%26aufirst%3DE.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DPisano%26aufirst%3DC.%26aulast%3DPenco%26aufirst%3DS.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DAntitumor%2520efficacy%2520of%2520the%2520heparanase%2520inhibitor%2520SST0001%2520alone%2520and%2520in%2520combination%2520with%2520antiangiogenic%2520agents%2520in%2520the%2520treatment%2520of%2520human%2520pediatric%2520sarcoma%2520models%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D1424%26epage%3D1432%26doi%3D10.1016%2Fj.bcp.2013.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Bo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortoreto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cesare, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanziani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naggi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzi, C.</span></span> <span> </span><span class="NLM_article-title">Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>415</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.canlet.2017.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=29225052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2gurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2018&pages=187-197&author=G.+Cassinelliauthor=L.+Dal+Boauthor=E.+Faviniauthor=D.+Cominettiauthor=S.+Pozziauthor=M.+Tortoretoauthor=M.+De+Cesareauthor=D.+Lecisauthor=E.+Scanzianiauthor=L.+Minoliauthor=A.+Naggiauthor=I.+Vlodavskyauthor=N.+Zaffaroniauthor=C.+Lanzi&title=Supersulfated+low-molecular+weight+heparin+synergizes+with+IGF1R%2FIR+inhibitor+to+suppress+synovial+sarcoma+growth+and+metastases&doi=10.1016%2Fj.canlet.2017.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases</span></div><div class="casAuthors">Cassinelli, Giuliana; Dal Bo, Laura; Favini, Enrica; Cominetti, Denis; Pozzi, Sabina; Tortoreto, Monica; De Cesare, Michelandrea; Lecis, Daniele; Scanziani, Eugenio; Minoli, Lucia; Naggi, Annamaria; Vlodavsky, Israel; Zaffaroni, Nadia; Lanzi, Cinzia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">187-197</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Synovial sarcoma (SS) is an aggressive tumor with propensity for lung metastases which significantly impact patients' prognosis.  New therapeutic approaches are needed to improve treatment outcome.  Targeting the heparanase/heparan sulfate proteoglycan system by heparin derivs. which act as heparanase inhibitors/heparan sulfate mimetics is emerging as a therapeutic approach that can sensitize the tumor response to chemotherapy.  We investigated the therapeutic potential of a supersulfated low mol. wt. heparin (ssLMWH) in preclin. models of SS. ssLMWH showed a potent anti-heparanase activity, dose-dependently inhibited SS colony growth and cell invasion, and downregulated the activation of receptor tyrosine kinases including IGF1R and IR.  The combination of ssLMWH and the IGF1R/IR inhibitor BMS754807 synergistically inhibited proliferation of cells exhibiting IGF1R hyperactivation, also abrogating cell motility and promoting apoptosis in assocn. with PI3K/AKT pathway inhibition.  The drug combination strongly enhanced the antitumor effect against the CME-1 model, as compared to single agent treatment, abrogating orthotopic tumor growth and significantly repressing spontaneous lung metastatic dissemination in treated mice.  These findings provide a strong preclin. rationale for developing drug regimens combining heparanase inhibitors/HS mimetics with IGF1R antagonists for treatment of metastatic SS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJNBQkAdTk1LVg90H21EOLACvtfcHk0lhYDXTH4YyUpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2gurnO&md5=727352c4ff78b61c5315a94a55aac2e0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DDal%2BBo%26aufirst%3DL.%26aulast%3DFavini%26aufirst%3DE.%26aulast%3DCominetti%26aufirst%3DD.%26aulast%3DPozzi%26aufirst%3DS.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DDe%2BCesare%26aufirst%3DM.%26aulast%3DLecis%26aufirst%3DD.%26aulast%3DScanziani%26aufirst%3DE.%26aulast%3DMinoli%26aufirst%3DL.%26aulast%3DNaggi%26aufirst%3DA.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DLanzi%26aufirst%3DC.%26atitle%3DSupersulfated%2520low-molecular%2520weight%2520heparin%2520synergizes%2520with%2520IGF1R%252FIR%2520inhibitor%2520to%2520suppress%2520synovial%2520sarcoma%2520growth%2520and%2520metastases%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D415%26spage%3D187%26epage%3D197%26doi%3D10.1016%2Fj.canlet.2017.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Bo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortoreto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maglie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagrada, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzi, C.</span></span> <span> </span><span class="NLM_article-title">Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">47848</span>– <span class="NLM_lpage">47863</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.18632%2Foncotarget.10292" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=47848-47863&author=G.+Cassinelliauthor=E.+Faviniauthor=L.+Dal+Boauthor=M.+Tortoretoauthor=M.+De+Maglieauthor=G.+Dagradaauthor=S.+Pilottiauthor=F.+Zuninoauthor=N.+Zaffaroniauthor=C.+Lanzi&title=Antitumor+efficacy+of+the+heparan+sulfate+mimic+roneparstat+%28SST0001%29+against+sarcoma+models+involves+multi-target+inhibition+of+receptor+tyrosine+kinases&doi=10.18632%2Foncotarget.10292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10292%26sid%3Dliteratum%253Aachs%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DFavini%26aufirst%3DE.%26aulast%3DDal%2BBo%26aufirst%3DL.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DDe%2BMaglie%26aufirst%3DM.%26aulast%3DDagrada%26aufirst%3DG.%26aulast%3DPilotti%26aufirst%3DS.%26aulast%3DZunino%26aufirst%3DF.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DLanzi%26aufirst%3DC.%26atitle%3DAntitumor%2520efficacy%2520of%2520the%2520heparan%2520sulfate%2520mimic%2520roneparstat%2520%2528SST0001%2529%2520against%2520sarcoma%2520models%2520involves%2520multi-target%2520inhibition%2520of%2520receptor%2520tyrosine%2520kinases%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D47848%26epage%3D47863%26doi%3D10.18632%2Foncotarget.10292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shushy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Izhak, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldshmidt, O.</span></span> <span> </span><span class="NLM_article-title">Human heparanase nuclear localization and enzymatic activity</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1038/labinvest.3700084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1038%2Flabinvest.3700084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=535-544&author=S.+Y.+Schubertauthor=N.+Ilanauthor=M.+Shushyauthor=O.+Ben-Izhakauthor=I.+Vlodavskyauthor=O.+Goldshmidt&title=Human+heparanase+nuclear+localization+and+enzymatic+activity&doi=10.1038%2Flabinvest.3700084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.3700084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.3700084%26sid%3Dliteratum%253Aachs%26aulast%3DSchubert%26aufirst%3DS.%2BY.%26aulast%3DIlan%26aufirst%3DN.%26aulast%3DShushy%26aufirst%3DM.%26aulast%3DBen-Izhak%26aufirst%3DO.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DGoldshmidt%26aufirst%3DO.%26atitle%3DHuman%2520heparanase%2520nuclear%2520localization%2520and%2520enzymatic%2520activity%26jtitle%3DLab.%2520Invest.%26date%3D2004%26volume%3D84%26spage%3D535%26epage%3D544%26doi%3D10.1038%2Flabinvest.3700084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, R. D.</span></span> <span> </span><span class="NLM_article-title">Heparanase regulates levels of syndecan-1 in the nucleus</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e4947</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0004947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1371%2Fjournal.pone.0004947" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=L.+Chenauthor=R.+D.+Sanderson&title=Heparanase+regulates+levels+of+syndecan-1+in+the+nucleus&doi=10.1371%2Fjournal.pone.0004947"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004947%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSanderson%26aufirst%3DR.%2BD.%26atitle%3DHeparanase%2520regulates%2520levels%2520of%2520syndecan-1%2520in%2520the%2520nucleus%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0004947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span> </span><span class="NLM_article-title">Schrödinger
Release 2015–4</span>.  <i>Maestro</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger%0ARelease+2015%E2%80%934.+Maestro%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DSchr%25C3%25B6dinger%250ARelease%25202015%25E2%2580%25934%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span> </span><span class="NLM_article-title">Schrödinger
Release 2015–4</span>.  <i>LigPrep</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger%0ARelease+2015%E2%80%934.+LigPrep%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DSchr%25C3%25B6dinger%250ARelease%25202015%25E2%2580%25934%26btitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span> </span><span class="NLM_article-title">Schrödinger
Release 2015–4</span>.  <i>Glide</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger%0ARelease+2015%E2%80%934.+Glide%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DSchr%25C3%25B6dinger%250ARelease%25202015%25E2%2580%25934%26btitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.%0AA.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=D.+E.+Shawauthor=M.+Shelleyauthor=J.+K.+Perryauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0ljudxp-8QeXHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1750</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1021/jm030644s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.%0AA.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+2.+Enrichment+factors+in+database+screening&doi=10.1021%2Fjm030644s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0ljudxp-8QeXHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25202.%2520Enrichment%2520factors%2520in%2520database%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759%26doi%3D10.1021%2Fjm030644s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaminski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">6474</span>– <span class="NLM_lpage">6487</span>, <span class="refDoi"> DOI: 10.1021/jp003919d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp003919d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2001&pages=6474-6487&author=G.+A.+Kaminskiauthor=R.+A.+Friesnerauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Evaluation+and+reparametrization+of+the+OPLS-AA+force+field+for+proteins+via+comparison+with+accurate+quantum+chemical+calculations+on+peptides&doi=10.1021%2Fjp003919d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides</span></div><div class="casAuthors">Kaminski, George A.; Friesner, Richard A.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6474-6487</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1089-5647</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present results of improving the OPLS-AA force field for peptides by means of refitting the key Fourier torsional coeffs.  The fitting technique combines using accurate ab initio data as the target, choosing an efficient fitting subspace of the whole potential-energy surface, and detg. wts. for each of the fitting points based on magnitudes of the potential-energy gradient.  The av. energy RMS deviation from the LMP2/cc-pVTZ(-f)//HF/6-31G** data is reduced by ∼40% from 0.81 to 0.47 kcal/mol as a result of the fitting for the electrostatically uncharged dipeptides.  Transferability of the parameters is demonstrated by using the same alanine dipeptide-fitted backbone torsional parameters for all of the other dipeptides (with the appropriate side-chain refitting) and the alanine tetrapeptide.  Parameters of nonbonded interactions have also been refitted for the sulfur-contg. dipeptides (cysteine and methionine), and the validity of the new Coulombic charges and the van der Waals σ's and ε's is proved through reproducing gas-phase energies of complex formation heats of vaporization and densities of pure model liqs.  Moreover, a novel approach to fitting torsional parameters for electrostatically charged mol. systems has been presented and successfully tested on five dipeptides with charged side chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSHwmffIQePbVg90H21EOLACvtfcHk0ljudxp-8QeXHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D&md5=3ff059626977ee7f6342466f5820f5b7</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjp003919d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp003919d%26sid%3Dliteratum%253Aachs%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DEvaluation%2520and%2520reparametrization%2520of%2520the%2520OPLS-AA%2520force%2520field%2520for%2520proteins%2520via%2520comparison%2520with%2520accurate%2520quantum%2520chemical%2520calculations%2520on%2520peptides%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2001%26volume%3D105%26spage%3D6474%26epage%3D6487%26doi%3D10.1021%2Fjp003919d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span> </span><span class="NLM_article-title">Schrödinger Release 2016–4</span>.  <i>Desmond Molecular Dynamics System</i>; <span class="NLM_publisher-name">D. E.
Shaw Research</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Release+2016%E2%80%934.+Desmond+Molecular+Dynamics+System%3B+D.+E.%0AShaw+Research%3A+New+York%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DSchr%25C3%25B6dinger%2520Release%25202016%25E2%2580%25934%26btitle%3DDesmond%2520Molecular%2520Dynamics%2520System%26pub%3DD.%2520E.%250AShaw%2520Research%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span> <i>Maestro-Desmond Interoperability
Tools</i>; <span class="NLM_publisher-name">Schrödinger</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Maestro-Desmond+Interoperability%0ATools%3B+Schr%C3%B6dinger%3A+New+York%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro-Desmond%2520Interoperability%250ATools%26pub%3DSchr%25C3%25B6dinger%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span>; <span class="NLM_string-name">Babin, V.</span>; <span class="NLM_string-name">Berryman, J. T.</span>; <span class="NLM_string-name">Betz, R. M.</span>; <span class="NLM_string-name">Cai, Q.</span>; <span class="NLM_string-name">Cerutti, D. S.</span>; <span class="NLM_string-name">Cheatham,  III, T. E.</span>; <span class="NLM_string-name">Darden, T. A.</span>; <span class="NLM_string-name">Duke, R. E.</span>; <span class="NLM_string-name">Gohlke, H.</span>; <span class="NLM_string-name">Goetz, A. W.</span>; <span class="NLM_string-name">Gusarov, S.</span>; <span class="NLM_string-name">Homeyer, N.</span>; <span class="NLM_string-name">Janowski, P.</span>; <span class="NLM_string-name">Kaus, J.</span>; <span class="NLM_string-name">Kolossváry, I.</span>; <span class="NLM_string-name">Kovalenko, A.</span>; <span class="NLM_string-name">Lee, T. S.</span>; <span class="NLM_string-name">LeGrand, S.</span>; <span class="NLM_string-name">Luchko, T.</span>; <span class="NLM_string-name">Luo, R.</span>; <span class="NLM_string-name">Madej, B.</span>; <span class="NLM_string-name">Merz, K. M.</span>; <span class="NLM_string-name">Paesani, F.</span>; <span class="NLM_string-name">Roe, D. R.</span>; <span class="NLM_string-name">Roitberg, A.</span>; <span class="NLM_string-name">Sagui, C.</span>; <span class="NLM_string-name">Salomon-Ferrer, R.</span>; <span class="NLM_string-name">Seabra, G.</span>; <span class="NLM_string-name">Simmerling, C. L.</span>; <span class="NLM_string-name">Smith, W.</span>; <span class="NLM_string-name">Swails, J.</span>; <span class="NLM_string-name">Walker, R. C.</span>; <span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Wolf, R. M.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Kollman, P. A.</span></span> <i>AMBER 14</i>; <span class="NLM_publisher-name">University of California</span>, <span class="NLM_publisher-loc">San Francisco</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+A.+Case&author=V.+Babin&author=J.+T.+Berryman&author=R.+M.+Betz&author=Q.+Cai&author=D.+S.+Cerutti&author=T.+E.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=H.+Gohlke&author=A.+W.+Goetz&author=S.+Gusarov&author=N.+Homeyer&author=P.+Janowski&author=J.+Kaus&author=I.+Kolossv%C3%A1ry&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=T.+Luchko&author=R.+Luo&author=B.+Madej&author=K.+M.+Merz&author=F.+Paesani&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=R.+Salomon-Ferrer&author=G.+Seabra&author=C.+L.+Simmerling&author=W.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.+M.+Wolf&author=X.+Wu&author=P.+A.+Kollman&title=AMBER+14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26btitle%3DAMBER%252014%26pub%3DUniversity%2520of%2520California%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Development and testing of a general amber force field</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.1002/jcc.20035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1002%2Fjcc.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=15116359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1157-1174&author=J.+Wangauthor=R.+M.+Wolfauthor=J.+W.+Caldwellauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Development+and+testing+of+a+general+amber+force+field&doi=10.1002%2Fjcc.20035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Development and testing of a general Amber force field</span></div><div class="casAuthors">Wang, Junmei; Wolf, Romain M.; Caldwell, James W.; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1174</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe here a general Amber force field (GAFF) for org. mols.  GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most org. and pharmaceutical mols. that are composed of H, C, N, O, S, P, and halogens.  It uses a simple functional form and a limited no. of atom types, but incorporates both empirical and heuristic models to est. force consts. and partial at. charges.  The performance of GAFF in test cases is encouraging.  In test I, 74 crystallog. structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 Å, which is comparable to that of the Tripos 5.2 force field (0.25 Å) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 Å, resp.).  In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermol. energies were compared to MP2/6-31G* results.  The RMS of displacements and relative energies were 0.25 Å and 1.2 kcal/mol, resp.  These data are comparable to results from Parm99/RESP (0.16 Å and 1.18 kcal/mol, resp.), which were parameterized to these base pairs.  Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field.  The RMS error in relative energies (compared to expt.) is about 0.5 kcal/mol.  GAFF can be applied to wide range of mols. in an automatic fashion, making it suitable for rational drug design and database searching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW8Gsf8IiW7Vg90H21EOLACvtfcHk0lhdKy_JIkwBNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D&md5=2992017a8cf51f89290ae2562403b115</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520a%2520general%2520amber%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1157%26epage%3D1174%26doi%3D10.1002%2Fjcc.20035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Automatic atom type and bond type perception in molecular mechanical calculations</span>. <i>J. Mol. Graphics Modell.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1016/j.jmgm.2005.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.jmgm.2005.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=16458552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=247-260&author=J.+Wangauthor=W.+Wangauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Automatic+atom+type+and+bond+type+perception+in+molecular+mechanical+calculations&doi=10.1016%2Fj.jmgm.2005.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Automatic atom type and bond type perception in molecular mechanical calculations</span></div><div class="casAuthors">Wang, Junmei; Wang, Wei; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-260</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In mol. mechanics (MM) studies, atom types and/or bond types of mols. are needed to det. prior to energy calcns.  The authors present here an automatic algorithm of perceiving atom types that are defined in a description table, and an automatic algorithm of assigning bond types just based on at. connectivity.  The algorithms have been implemented in a new module of the AMBER packages.  This auxiliary module, antechamber (roughly meaning "before AMBER"), can be applied to generate necessary inputs of leap-the AMBER program to generate topologies for minimization, mol. dynamics, etc., for most org. mols.  The algorithms behind the manipulations may be useful for other mol. mech. packages as well as applications that need to designate atom types and bond types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqizj6F18nBYbVg90H21EOLACvtfcHk0lhdKy_JIkwBNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D&md5=8031a21d2784d5dea12e70868522aa61</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2005.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2005.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DAutomatic%2520atom%2520type%2520and%2520bond%2520type%2520perception%2520in%2520molecular%2520mechanical%2520calculations%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2006%26volume%3D25%26spage%3D247%26epage%3D260%26doi%3D10.1016%2Fj.jmgm.2005.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feller, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, B. R.</span></span> <span> </span><span class="NLM_article-title">Constant pressure molecular dynamics simulation: the Langevin piston method</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">4613</span>– <span class="NLM_lpage">4621</span>, <span class="refDoi"> DOI: 10.1063/1.470648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1063%2F1.470648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADyaK2MXotVentLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=4613-4621&author=S.+E.+Fellerauthor=Y.+Zhangauthor=R.+W.+Pastorauthor=B.+R.+Brooks&title=Constant+pressure+molecular+dynamics+simulation%3A+the+Langevin+piston+method&doi=10.1063%2F1.470648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Constant pressure molecular dynamics simulation: the Langevin piston method</span></div><div class="casAuthors">Feller, Scott E.; Zhang, Yuhong; Pastor, Richard W.; Brooks, Bernard R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4613-21</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">A new method for performing mol. dynamics simulations under const. pressure is presented.  In the method, which is based on the extended system formalism introduced by Andersen, the deterministic equations of motion for the piston degree of freedom are replaced by a Langevin equation; a suitable choice of collision frequency then eliminates the unphys. "ringing" of the vol. assocd. with the piston mass.  In this way it is similar to the "weak coupling algorithm" developed by Berendsen and co-workers to perform mol. dynamics simulation without piston mass effects.  It is shown, however, that the weak coupling algorithm induces artifacts into the simulation which can be quite severe for inhomogeneous systems such as aq. biopolymers or liq./liq. interfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZp5NIYiFpuLVg90H21EOLACvtfcHk0lhdKy_JIkwBNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotVentLo%253D&md5=219a4e0a48397a35fa2c62cf99bf225a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1063%2F1.470648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470648%26sid%3Dliteratum%253Aachs%26aulast%3DFeller%26aufirst%3DS.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPastor%26aufirst%3DR.%2BW.%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26atitle%3DConstant%2520pressure%2520molecular%2520dynamics%2520simulation%253A%2520the%2520Langevin%2520piston%2520method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D4613%26epage%3D4621%26doi%3D10.1063%2F1.470648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lippert, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregersen, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepeis, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolossvary, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">A common, avoidable source of error in molecular dynamics integrators</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">046101</span>, <span class="refDoi"> DOI: 10.1063/1.2431176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1063%2F1.2431176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=17286520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFykt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2007&pages=046101&author=R.+A.+Lippertauthor=K.+J.+Bowersauthor=R.+O.+Drorauthor=M.+P.+Eastwoodauthor=B.+A.+Gregersenauthor=J.+L.+Klepeisauthor=I.+Kolossvaryauthor=D.+E.+Shaw&title=A+common%2C+avoidable+source+of+error+in+molecular+dynamics+integrators&doi=10.1063%2F1.2431176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A common, avoidable source of error in molecular dynamics integrators</span></div><div class="casAuthors">Lippert, Ross A.; Bowers, Kevin J.; Dror, Ron O.; Eastwood, Michael P.; Gregersen, Brent A.; Klepeis, John L.; Kolossvary, Istvan; Shaw, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">046101/1-046101/2</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">In constrained mol. dynamics simulations using some of the most popular mol. dynamics codes, calcn. of the velocities of constrained particles is based solely on the differences in particle positions during two successive time steps.  This creates a numerical instability that the authors' show to be significant in a typical single-precision floating-point simulation.  They describe a simple modification that eliminates this source of instability and demonstrate that this change substantially reduces the energy drift of a sample single-precision NVE simulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-74DiWbDnm7Vg90H21EOLACvtfcHk0lgFWi8d_HRVPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFykt74%253D&md5=ed90e46350484b6d63fabd1b85146254</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1063%2F1.2431176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.2431176%26sid%3Dliteratum%253Aachs%26aulast%3DLippert%26aufirst%3DR.%2BA.%26aulast%3DBowers%26aufirst%3DK.%2BJ.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DEastwood%26aufirst%3DM.%2BP.%26aulast%3DGregersen%26aufirst%3DB.%2BA.%26aulast%3DKlepeis%26aufirst%3DJ.%2BL.%26aulast%3DKolossvary%26aufirst%3DI.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26atitle%3DA%2520common%252C%2520avoidable%2520source%2520of%2520error%2520in%2520molecular%2520dynamics%2520integrators%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D2007%26volume%3D126%26spage%3D046101%26doi%3D10.1063%2F1.2431176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Essmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkowitz, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, L. G.</span></span> <span> </span><span class="NLM_article-title">A smooth particle mesh Ewald method</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8577</span>– <span class="NLM_lpage">8593</span>, <span class="refDoi"> DOI: 10.1063/1.470117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1063%2F1.470117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=8577-8593&author=U.+Essmannauthor=L.+Pereraauthor=M.+L.+Berkowitzauthor=T.+Dardenauthor=H.+Leeauthor=L.+G.+Pedersen&title=A+smooth+particle+mesh+Ewald+method&doi=10.1063%2F1.470117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A smooth particle mesh Ewald method</span></div><div class="casAuthors">Essmann, Ulrich; Perera, Lalith; Berkowitz, Max L.; Darden, Tom; Lee, Hsing; Pedersen, Lee G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8577-93</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The previously developed particle mesh Ewald method is reformulated in terms of efficient B-spline interpolation of the structure factors.  This reformulation allows a natural extension of the method to potentials of the form 1/rp with p ≥ 1.  Furthermore, efficient calcn. of the virial tensor follows.  Use of B-splines in the place of Lagrange interpolation leads to analytic gradients as well as a significant improvement in the accuracy.  The authors demonstrate that arbitrary accuracy can be achieved, independent of system size N, at a cost that scales as N log(N).  For biomol. systems with many thousands of atoms and this method permits the use of Ewald summation at a computational cost comparable to that of a simple truncation method of 10 Å or less.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Bp1XlSY32LVg90H21EOLACvtfcHk0lgFWi8d_HRVPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D&md5=092a679dd3bee08da28df41e302383a7</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1063%2F1.470117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470117%26sid%3Dliteratum%253Aachs%26aulast%3DEssmann%26aufirst%3DU.%26aulast%3DPerera%26aufirst%3DL.%26aulast%3DBerkowitz%26aufirst%3DM.%2BL.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPedersen%26aufirst%3DL.%2BG.%26atitle%3DA%2520smooth%2520particle%2520mesh%2520Ewald%2520method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D8577%26epage%3D8593%26doi%3D10.1063%2F1.470117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuckerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martyna, J.</span></span> <span> </span><span class="NLM_article-title">Reversible multiple time scale molecular dynamics</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1990</span>– <span class="NLM_lpage">2001</span>, <span class="refDoi"> DOI: 10.1063/1.463137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1063%2F1.463137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADyaK38XltFyksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1992&pages=1990-2001&author=M.+Tuckermanauthor=B.+J.+Berneauthor=J.+Martyna&title=Reversible+multiple+time+scale+molecular+dynamics&doi=10.1063%2F1.463137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible multiple time scale molecular dynamics</span></div><div class="casAuthors">Tuckerman, M.; Berne, B. J.; Martyna, G. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1990-2001</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">The Trotter factorization of the Liouville propagator is used to generate new reversible mol. dynamics integrators.  This strategy is applied to derive reversible ref. system propagator algorithms (RESPA) that greatly accelerate simulations of systems with a sepn. of time scales or with long range forces.  The new algorithms have all of the advantages of previous RESPA integrators but are reversible, and more stable than those methods.  These methods are applied to a set of paradigmatic systems and are shown to be superior to earlier methods.  It is shown how the new RESPA methods are related to predictor-corrector integrators.  These methods can be used to accelerate the integration of the equations of motion of systems with Nose thermostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuVNub2HCMQrVg90H21EOLACvtfcHk0lgFWi8d_HRVPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltFyksrg%253D&md5=4bcd9b330f004af953afc474c2fb72f9</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1063%2F1.463137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.463137%26sid%3Dliteratum%253Aachs%26aulast%3DTuckerman%26aufirst%3DM.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DMartyna%26aufirst%3DJ.%26atitle%3DReversible%2520multiple%2520time%2520scale%2520molecular%2520dynamics%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1992%26volume%3D97%26spage%3D1990%26epage%3D2001%26doi%3D10.1063%2F1.463137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamborini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agus, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezzelani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sozzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzarelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierotti, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotti, S.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1094</span>, <span class="refDoi"> DOI: 10.1054/bjoc.2000.1710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1054%2Fbjoc.2000.1710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=11308259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFymurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2001&pages=1087-1094&author=E.+Tamboriniauthor=V.+Agusauthor=A.+Mezzelaniauthor=C.+Rivaauthor=G.+Sozziauthor=A.+Azzarelliauthor=M.+A.+Pierottiauthor=S.+Pilotti&title=Identification+of+a+novel+spliced+variant+of+the+SYT+gene+expressed+in+normal+tissues+and+in+synovial+sarcoma&doi=10.1054%2Fbjoc.2000.1710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma</span></div><div class="casAuthors">Tamborini, E.; Agus, V.; Mezzelani, A.; Riva, C.; Sozzi, G.; Azzarelli, A.; Pierotti, M. A.; Pilotti, S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1087-1094</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Harcourt Publishers Ltd.</span>)
        </div><div class="casAbstract">Synovial sarcoma (SS) is cytogenetically characterized by the translocation t(X;18)(p11.2-q11.2) generating a fusion between the SYT gene on chromosome 18 and one member of the SSX family gene (SSX1; SSX2; SSX4) on chromosome X.  Here, we report for the first time that 2 forms of SYT mRNA are present in both normal tissues and SSs.  By amplifying the full-length SYT cDNA of two SSs, we detected 2 bands, here designated N-SYT and I-SYT.  The latter, previously undescribed, contains an in-frame insertion of 93 bp.  Its sequencing revealed a 100% homol. with the mouse SYT gene.  These two SYT forms were present, although in different amts., in all human normal tissues examd., including kidney, stomach, lung, colon, liver and synovia.  Coexistence of N-SYT and I-SYT (both fused with SSX) was detected in a series of 59 SSs (35 monophasic and 24 biphasic) and in a SS cell line.  A preliminary anal. of the differential expression levels of N-SYT and I-SYT in SSs revealed that the latter was consistently overexpressed, suggesting a role in SS pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobdJqlLXV8z7Vg90H21EOLACvtfcHk0liGWyTX1CUc7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFymurg%253D&md5=5ad1e86142d0f9b649699cf4361c1b91</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1054%2Fbjoc.2000.1710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fbjoc.2000.1710%26sid%3Dliteratum%253Aachs%26aulast%3DTamborini%26aufirst%3DE.%26aulast%3DAgus%26aufirst%3DV.%26aulast%3DMezzelani%26aufirst%3DA.%26aulast%3DRiva%26aufirst%3DC.%26aulast%3DSozzi%26aufirst%3DG.%26aulast%3DAzzarelli%26aufirst%3DA.%26aulast%3DPierotti%26aufirst%3DM.%2BA.%26aulast%3DPilotti%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520novel%2520spliced%2520variant%2520of%2520the%2520SYT%2520gene%2520expressed%2520in%2520normal%2520tissues%2520and%2520in%2520synovial%2520sarcoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2001%26volume%3D84%26spage%3D1087%26epage%3D1094%26doi%3D10.1054%2Fbjoc.2000.1710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonella  Capozzi</span>, <span class="hlFld-ContribAuthor ">Gloria  Riitano</span>, <span class="hlFld-ContribAuthor ">Serena  Recalchi</span>, <span class="hlFld-ContribAuthor ">Valeria  Manganelli</span>, <span class="hlFld-ContribAuthor ">Roberta  Costi</span>, <span class="hlFld-ContribAuthor ">Francesco  Saccoliti</span>, <span class="hlFld-ContribAuthor ">Fabio  Pulcinelli</span>, <span class="hlFld-ContribAuthor ">Tina  Garofalo</span>, <span class="hlFld-ContribAuthor ">Roberta  Misasi</span>, <span class="hlFld-ContribAuthor ">Agostina  Longo</span>, <span class="hlFld-ContribAuthor ">Roberto  Di Santo</span>, <span class="hlFld-ContribAuthor ">Maurizio  Sorice</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti‐β2‐GPI antibodies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Thrombosis and Haemostasis</span><span> <strong>2021,</strong> <em>151 </em><a href="https://doi.org/10.1111/jth.15417" title="DOI URL">https://doi.org/10.1111/jth.15417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jth.15417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjth.15417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thrombosis%2520and%2520Haemostasis%26atitle%3DEffect%252Bof%252Bheparanase%252Binhibitor%252Bon%252Btissue%252Bfactor%252Boverexpression%252Bin%252Bplatelets%252Band%252Bendothelial%252Bcells%252Binduced%252Bby%252Banti%2525E2%252580%252590%2525CE%2525B22%2525E2%252580%252590GPI%252Bantibodies%26aulast%3DCapozzi%26aufirst%3DAntonella%26date%3D2021%26date%3D2021%26volume%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uri  Barash</span>, <span class="hlFld-ContribAuthor ">Shobith  Rangappa</span>, <span class="hlFld-ContribAuthor ">Chakrabhavi Dhananjaya  Mohan</span>, <span class="hlFld-ContribAuthor ">Divakar  Vishwanath</span>, <span class="hlFld-ContribAuthor ">Ilanit  Boyango</span>, <span class="hlFld-ContribAuthor ">Basappa  Basappa</span>, <span class="hlFld-ContribAuthor ">Israel  Vlodavsky</span>, <span class="hlFld-ContribAuthor ">Kanchugarakoppal S.  Rangappa</span>. </span><span class="cited-content_cbyCitation_article-title">New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (12)
                                     , 2959. <a href="https://doi.org/10.3390/cancers13122959" title="DOI URL">https://doi.org/10.3390/cancers13122959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13122959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13122959%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNew%252BHeparanase-Inhibiting%252BTriazolo-Thiadiazoles%252BAttenuate%252BPrimary%252BTumor%252BGrowth%252Band%252BMetastasis%26aulast%3DBarash%26aufirst%3DUri%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D12%26spage%3D2959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice  Nicolai</span>, <span class="hlFld-ContribAuthor ">Valentina Noemi  Madia</span>, <span class="hlFld-ContribAuthor ">Antonella  Messore</span>, <span class="hlFld-ContribAuthor ">Daniela  De Vita</span>, <span class="hlFld-ContribAuthor ">Alessandro  De Leo</span>, <span class="hlFld-ContribAuthor ">Davide  Ialongo</span>, <span class="hlFld-ContribAuthor ">Valeria  Tudino</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Tortorella</span>, <span class="hlFld-ContribAuthor ">Luigi  Scipione</span>, <span class="hlFld-ContribAuthor ">Samanta  Taurone</span>, <span class="hlFld-ContribAuthor ">Tiziano  Pergolizzi</span>, <span class="hlFld-ContribAuthor ">Marco  Artico</span>, <span class="hlFld-ContribAuthor ">Roberto  Di Santo</span>, <span class="hlFld-ContribAuthor ">Roberta  Costi</span>, <span class="hlFld-ContribAuthor ">Susanna  Scarpa</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Tumoral Effects of a (1H-Pyrrol-1-yl)Methyl-1H-Benzoimidazole Carbamate Ester Derivative on Head and Neck Squamous Carcinoma Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (6)
                                     , 564. <a href="https://doi.org/10.3390/ph14060564" title="DOI URL">https://doi.org/10.3390/ph14060564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14060564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14060564%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DAnti-Tumoral%252BEffects%252Bof%252Ba%252B%2525281H-Pyrrol-1-yl%252529Methyl-1H-Benzoimidazole%252BCarbamate%252BEster%252BDerivative%252Bon%252BHead%252Band%252BNeck%252BSquamous%252BCarcinoma%252BCell%252BLines%26aulast%3DNicolai%26aufirst%3DAlice%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D6%26spage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shraddha  Parate</span>, <span class="hlFld-ContribAuthor ">Vikas  Kumar</span>, <span class="hlFld-ContribAuthor ">Danishuddin</span>, <span class="hlFld-ContribAuthor ">Jong  Hong</span>, <span class="hlFld-ContribAuthor ">Keun  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (10)
                                     , 5311. <a href="https://doi.org/10.3390/ijms22105311" title="DOI URL">https://doi.org/10.3390/ijms22105311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22105311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22105311%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DComputational%252BInvestigation%252BIdentified%252BPotential%252BChemical%252BScaffolds%252Bfor%252BHeparanase%252Bas%252BAnticancer%252BTherapeutics%26aulast%3DParate%26aufirst%3DShraddha%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D10%26spage%3D5311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Kelton A.  Schleyer</span>, <span class="hlFld-ContribAuthor ">Tyrel L.  Bryan</span>, <span class="hlFld-ContribAuthor ">Changjian  Xie</span>, <span class="hlFld-ContribAuthor ">Gustavo  Seabra</span>, <span class="hlFld-ContribAuthor ">Yongmei  Xu</span>, <span class="hlFld-ContribAuthor ">Arjun  Kafle</span>, <span class="hlFld-ContribAuthor ">Chao  Cui</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Kunlun  Yin</span>, <span class="hlFld-ContribAuthor ">Benjamin  Fetrow</span>, <span class="hlFld-ContribAuthor ">Paul K. P.  Henderson</span>, <span class="hlFld-ContribAuthor ">Peter Z.  Fatland</span>, <span class="hlFld-ContribAuthor ">Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Hua  Guo</span>, <span class="hlFld-ContribAuthor ">Lina  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Ultrasensitive small molecule fluorogenic probe for human heparanase. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 239-246. <a href="https://doi.org/10.1039/D0SC04872K" title="DOI URL">https://doi.org/10.1039/D0SC04872K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC04872K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC04872K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DUltrasensitive%252Bsmall%252Bmolecule%252Bfluorogenic%252Bprobe%252Bfor%252Bhuman%252Bheparanase%26aulast%3DLiu%26aufirst%3DJun%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D239%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zehra  Elgundi</span>, <span class="hlFld-ContribAuthor ">Michael  Papanicolaou</span>, <span class="hlFld-ContribAuthor ">Gretel  Major</span>, <span class="hlFld-ContribAuthor ">Thomas R.  Cox</span>, <span class="hlFld-ContribAuthor ">James  Melrose</span>, <span class="hlFld-ContribAuthor ">John M.  Whitelock</span>, <span class="hlFld-ContribAuthor ">Brooke L.  Farrugia</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>9 </em><a href="https://doi.org/10.3389/fonc.2019.01482" title="DOI URL">https://doi.org/10.3389/fonc.2019.01482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2019.01482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2019.01482%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DCancer%252BMetastasis%25253A%252BThe%252BRole%252Bof%252Bthe%252BExtracellular%252BMatrix%252Band%252Bthe%252BHeparan%252BSulfate%252BProteoglycan%252BPerlecan%26aulast%3DElgundi%26aufirst%3DZehra%26date%3D2020%26date%3D2020%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuliana  Cassinelli</span>, <span class="hlFld-ContribAuthor ">Cinzia  Lanzi</span>. </span><span class="cited-content_cbyCitation_article-title">Heparanase: A Potential Therapeutic Target in Sarcomas. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 405-431. <a href="https://doi.org/10.1007/978-3-030-34521-1_15" title="DOI URL">https://doi.org/10.1007/978-3-030-34521-1_15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-34521-1_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-34521-1_15%26sid%3Dliteratum%253Aachs%26atitle%3DHeparanase%25253A%252BA%252BPotential%252BTherapeutic%252BTarget%252Bin%252BSarcomas%26aulast%3DCassinelli%26aufirst%3DGiuliana%26date%3D2020%26date%3D2020%26spage%3D405%26epage%3D431%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeparanase%26aulast%3DVlodavsky%26aufirst%3DIsrael%26date%3D2020%26volume%3D1221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Battistuzzi</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>. </span><span class="cited-content_cbyCitation_article-title">The Control of Heparanase Through the Use of Small Molecules. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 567-603. <a href="https://doi.org/10.1007/978-3-030-34521-1_23" title="DOI URL">https://doi.org/10.1007/978-3-030-34521-1_23</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-34521-1_23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-34521-1_23%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BControl%252Bof%252BHeparanase%252BThrough%252Bthe%252BUse%252Bof%252BSmall%252BMolecules%26aulast%3DGiannini%26aufirst%3DGiuseppe%26date%3D2020%26date%3D2020%26spage%3D567%26epage%3D603%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeparanase%26aulast%3DVlodavsky%26aufirst%3DIsrael%26date%3D2020%26volume%3D1221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaun M.  Gaskin</span>, <span class="hlFld-ContribAuthor ">Tatiana P.  Soares Da Costa</span>, <span class="hlFld-ContribAuthor ">Mark D.  Hulett</span>. </span><span class="cited-content_cbyCitation_article-title">Heparanase: Cloning, Function and Regulation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 189-229. <a href="https://doi.org/10.1007/978-3-030-34521-1_7" title="DOI URL">https://doi.org/10.1007/978-3-030-34521-1_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-34521-1_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-34521-1_7%26sid%3Dliteratum%253Aachs%26atitle%3DHeparanase%25253A%252BCloning%25252C%252BFunction%252Band%252BRegulation%26aulast%3DGaskin%26aufirst%3DShaun%2BM.%26date%3D2020%26date%3D2020%26spage%3D189%26epage%3D229%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeparanase%26aulast%3DVlodavsky%26aufirst%3DIsrael%26date%3D2020%26volume%3D1221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniele  Pala</span>, <span class="hlFld-ContribAuthor ">Laura  Scalvini</span>, <span class="hlFld-ContribAuthor ">Gian Marco  Elisi</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Gilberto  Spadoni</span>, <span class="hlFld-ContribAuthor ">Fabiana F.  Ferrara</span>, <span class="hlFld-ContribAuthor ">Emiliano  Pavoni</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Roscilli</span>, <span class="hlFld-ContribAuthor ">Ferdinando M.  Milazzo</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Battistuzzi</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>. </span><span class="cited-content_cbyCitation_article-title">New classes of potent heparanase inhibitors from ligand-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1685-1696. <a href="https://doi.org/10.1080/14756366.2020.1811701" title="DOI URL">https://doi.org/10.1080/14756366.2020.1811701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1811701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1811701%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bclasses%252Bof%252Bpotent%252Bheparanase%252Binhibitors%252Bfrom%252Bligand-based%252Bvirtual%252Bscreening%26aulast%3DPala%26aufirst%3DDaniele%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1685%26epage%3D1696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deirdre R.  Coombe</span>, <span class="hlFld-ContribAuthor ">Neha S.  Gandhi</span>. </span><span class="cited-content_cbyCitation_article-title">Heparanase: A Challenging Cancer Drug Target. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2019,</strong> <em>9 </em><a href="https://doi.org/10.3389/fonc.2019.01316" title="DOI URL">https://doi.org/10.3389/fonc.2019.01316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2019.01316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2019.01316%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DHeparanase%25253A%252BA%252BChallenging%252BCancer%252BDrug%252BTarget%26aulast%3DCoombe%26aufirst%3DDeirdre%2BR.%26date%3D2019%26date%3D2019%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of benzazole-Hpse inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0001.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of the Newly Designed Benzazole Derivatives <b>5a–f</b>, <b>6a,b</b>, <b>7a–g</b>, <b>8a–c</b>, <b>9a,b</b>, <b>10a,b</b> and <b>11a–i</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to <b>5a-e</b>, <b>6a,b</b>, <b>7a-c,g</b>, and <b>8a,b</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry or THF dry, N<sub>2</sub>, 0 °C to room temp, 24–44 h, 40–100% yield; (ii) thio-CDI, CH<sub>2</sub>Cl<sub>2</sub>, 40 °C, 12 h, 60% yield; (iii) thiophosgene, chlorobenzene, DMF cat., reflux, 2–4 h, 100% yield; (iv) <b>12c</b> or <b>13</b>, DMSO dry, 200 W, N<sub>2</sub>, 80 °C, 3 min, 30–70% yield; (v) LiOH, 5:1 THF/H<sub>2</sub>O, room temp, 3.5–48 h, 49–99% yield; (vi) NaOH, 5:1 THF/H<sub>2</sub>O, room temp, overnight, 44–100% yield; (vii) appropriate amino ester detailed in the <a class="ref internalNav" href="#sec6" aria-label="Experimental section">Experimental section</a>, EDCI, DMAP, DIPEA, THF dry, or DMF dry, N<sub>2</sub>, room temp, overnight, 64–85% yield.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to the <b>5f</b> Derivative<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) hexamethyldisilazane, EDCI, MeCN, 0 °C to room temp, 5 days, 70% yield; (ii) LiOH, 5:1 DMSO/H<sub>2</sub>O, room temp, 3 days, 70% yield.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route to <b>7d</b>–<b>f</b> and <b>8c</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (<i>R</i>)-boroLeu-(+)-pinanediol HCl, EDCI, DMAP, DIPEA, THF dry, N<sub>2</sub>, room temp, overnight, 87% yield; (ii) (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methanaminium chloride, TBTU, DIPEA, DMF dry, N<sub>2</sub>, −80 °C to room temp, 5 h, 30–35 yield; (iii) (<i>R</i>)-boroLeu-(+)-pinanediol HCl, TBTU, DIPEA, DMF dry, N<sub>2</sub>, −80 °C to room temp, 5 h, 96.2% yield; (iv) NH<sub>4</sub>OAc<sub>aq</sub> 0.1 N, NaIO<sub>4</sub>, THF, room temp, 47 h, 60% yield.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to <b>9a,b</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) proper acyl chloride, Et<sub>3</sub>N, THF dry, N<sub>2</sub>, 0 °C to room temp, 3 h, 100% yield; (ii) PTSA, toluene, reflux, overnight, 40–68% yield; (iii) H<sub>2</sub>, Pd/C, AcOEt, 40 psi, room temp, 3–6 h, 75–95% yield; (iv) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry, N<sub>2</sub>, 0 °C to room temp, overnight, 32% yield.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to <b>10a,b</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 1) potassium ethyl xanthogenate, pyridine, N<sub>2</sub>, reflux, 2 h, 2) 4-(<i>N</i>-Boc-amino)piperidine, <i>m</i>-xylene, N<sub>2</sub>, 150 °C, 1.5 h, 62–67% yield; (ii) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub> dry, room temp, 45 min, 100% yield; (iii) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry, 0 °C to room temp, overnight, 11–68% yield; (iv) LiOH, 5:1 THF/H<sub>2</sub>O, room temp, overnight, 100% yield.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route to <b>11b,d–g</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry, N<sub>2</sub>, 0 °C to room temp, overnight, 23% yield; (ii) thiophosgene, chlorobenzene, DMF cat., room temp to reflux, 1 h, 61% yield; (iii) methyl 4-amino-3-fluorobenzoate, DMSO dry, 200 W, N<sub>2</sub>, 80 °C, 1 min, 30% yield; (iv) (1) TosMIC, NaOH 40%, TBAI, CH<sub>2</sub>Cl<sub>2</sub>, N<sub>2</sub>, room temp, 3 h; (2) HCl 37%, 64% yield; (v) ethylene glycol, PTSA monohydrate, toluene, reflux, overnight, 80% yield; (vi) NaBH<sub>4</sub>, 1:1 MeOH/THF, 0 °C to room temp, overnight, 70% yield; (vii) LiOH, 5:1 THF/H<sub>2</sub>O, room temp, 24–96 h, 45–82% yield; (viii) NaOH 20%, 5:1 THF/H<sub>2</sub>O, reflux or room temp, 24–72 h, 63–71% yield; (ix) methyl 2-(3-aminophenyl)acetate or ethyl 3-aminobenzoate, EDCI, HOBt, NMM, DMF dry, N<sub>2</sub>, room temp, 4–48 h, 51–85% yield; (x) (1) oxalyl chloride, THF dry, DMF dry cat., N<sub>2</sub>, room temp, 4–24 h; (2) methyl 2-(3-aminophenyl)acetate or methyl 2-(3-amino-4-hydroxyphenyl)acetate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry or THF dry, N<sub>2</sub>, 0 °C to room temp, 0.5–24 h, 20–100% yield; (xi) LiOH, 10:1 DMSO/H<sub>2</sub>O, room temp, 0.5–72 h, 70–90% yield; (xii) CF<sub>3</sub>COOH, N<sub>2</sub>, room temp, overnight, 80% yield.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthetic Route to <b>11a,c</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>p</i>-nitrobenzoyl chloride, Et<sub>3</sub>N, THF dry, N<sub>2</sub>, 0 °C to room temp, 3 h 100% yield; (ii) <i>p</i>-nitrobenzenesulfonyl chloride, pyridine, dichloroethane dry, N<sub>2</sub>, 0 °C to room temp, overnight, 88.5% yield; (iii) acetic anhydride, Et<sub>3</sub>N, room temp, 48 h, 52% yield; (iv) H<sub>2</sub>, Pd/C, AcOEt, 40 psi, room temp, 1 h, 100% yield; (v) ammonium formate, Et<sub>3</sub>N, Pd/C, dioxane, N<sub>2</sub>, 30 °C, 2 h, 67% yield; (vi) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry or 1:1 CH<sub>2</sub>Cl<sub>2</sub>/THF dry, N<sub>2</sub>, 0 °C to room temp, 24–48 h, 20–22% yield; (vii) LiOH, 5:1 THF/H<sub>2</sub>O, room temp, overnight, 13–49% yield.</p></p></figure><figure data-id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthetic Route to <b>11i</b> Derivative<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>p</i>-nitrobenzoyl chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> dry, N<sub>2</sub>, 0 °C to room temp, 3 h, 92% yield; (ii) KOAc, pinacol diborane, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, dioxane dry, N<sub>2</sub>, 100 °C, 2 h, 75% yield; (iii) H<sub>2</sub>, Pd/C, AcOEt, 40 psi, room temp, 1.5 h, 95% yield; (iv) triphosgene, Et<sub>3</sub>N, THF dry, N<sub>2</sub>, 0 °C to room temp, overnight, 43% yield; (v) 0.1 N NH<sub>4</sub>OAc<sub>aq</sub>, NaIO<sub>4</sub>, acetone, room temp, 27 h, 95% yield.</p></p></figure><figure data-id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding poses obtained for compounds <b>1</b> (green carbons, panel A), <b>5c</b> (orange carbons, panel B), and <b>7g</b> (violet carbons, panel C). In panel A, the co-crystallized tetrasaccharide inhibitor dp4 is represented with purple carbons (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E9C">5E9C</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>5c</b> and inhibition of the proliferation of human CME-1 synovial sarcoma cells. Cells were treated with drug concentrations in the range of 10–0.7 μM. After 72 h, cells were counted and the results expressed as proliferation percent with respect to control cells. Curve is from one representative experiment out of two, performed in duplicate. Data represent mean percentage values ± SD; IC<sub>50</sub> is from two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>5c</b> inhibition of the invasive ability of human CME-1 synovial sarcoma cells. Cells pretreated with compound <b>5c</b> at the indicated concentrations were transferred to Matrigel-coated Transwell chambers and incubated for an additional 24 h. Results are expressed as invasion percent (mean plus or minus the SE of two experiments performed in duplicate) with respect to the control cells. Representative images of filters are shown. Original magnification: 100×. Asterisks indicate <i>P</i> < 0.05</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/medium/jm-2018-01497h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compounds <b>5c</b>, <b>7a</b>, and <b>7g</b> as compared to the internal reference <b>3</b> with regard to the expression of selected angiogenesis-related genes. The expression levels of FGF-1, FGF-2, VEGF, MMP-9, and HSPE-1 mRNA in HT1080 cells, upon 24 h of treatment, were measured through real-time quantitative polymerase chain reaction analysis. Results are expressed as percent with respect to untreated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01497/20190108/images/large/jm-2018-01497h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01497&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i144">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 62 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parish, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulett, M. D.</span></span> <span> </span><span class="NLM_article-title">Heparanase: a key enzyme involved in cell invasion</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1471</i></span>,  <span class="NLM_fpage">M99</span>– <span class="NLM_lpage">M108</span>, <span class="refDoi"> DOI: 10.1016/S0304-419X(01)00017-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2FS0304-419X%2801%2900017-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=11250066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsl2jsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1471&publication_year=2001&pages=M99-M108&author=C.+R.+Parishauthor=C.+Freemanauthor=M.+D.+Hulett&title=Heparanase%3A+a+key+enzyme+involved+in+cell+invasion&doi=10.1016%2FS0304-419X%2801%2900017-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Heparanase: a key enzyme involved in cell invasion</span></div><div class="casAuthors">Parish, C. R.; Freeman, C.; Hulett, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1471</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">M99-M108</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 50 refs.  The role of the heparanase in cell invasion, the current status of its inhibitors, and key aspects of the enzyme that need to be investigated in the future is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-yuTg1bfgILVg90H21EOLACvtfcHk0ljoKNm5Y_JIaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsl2jsr8%253D&md5=52fb4b90d755e5ecfc6cfec692e52a16</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0304-419X%2801%2900017-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-419X%252801%252900017-8%26sid%3Dliteratum%253Aachs%26aulast%3DParish%26aufirst%3DC.%2BR.%26aulast%3DFreeman%26aufirst%3DC.%26aulast%3DHulett%26aufirst%3DM.%2BD.%26atitle%3DHeparanase%253A%2520a%2520key%2520enzyme%2520involved%2520in%2520cell%2520invasion%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1471%26spage%3DM99%26epage%3DM108%26doi%3D10.1016%2FS0304-419X%2801%2900017-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fairbanks, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mildner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavey, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drong, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slightom, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienkowski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannow, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrikson, R. L.</span></span> <span> </span><span class="NLM_article-title">Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">29587</span>– <span class="NLM_lpage">29590</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.42.29587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1074%2Fjbc.274.42.29587" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=29587-29590&author=M.+B.+Fairbanksauthor=A.+M.+Mildnerauthor=J.+W.+Leoneauthor=G.+S.+Caveyauthor=W.+R.+Mathewsauthor=R.+F.+Drongauthor=J.+L.+Slightomauthor=M.+J.+Bienkowskiauthor=C.+W.+Smithauthor=C.+A.+Bannowauthor=R.+L.+Heinrikson&title=Processing+of+the+human+heparanase+precursor+and+evidence+that+the+active+enzyme+is+a+heterodimer&doi=10.1074%2Fjbc.274.42.29587"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.42.29587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.42.29587%26sid%3Dliteratum%253Aachs%26aulast%3DFairbanks%26aufirst%3DM.%2BB.%26aulast%3DMildner%26aufirst%3DA.%2BM.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DCavey%26aufirst%3DG.%2BS.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DDrong%26aufirst%3DR.%2BF.%26aulast%3DSlightom%26aufirst%3DJ.%2BL.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BW.%26aulast%3DBannow%26aufirst%3DC.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26atitle%3DProcessing%2520of%2520the%2520human%2520heparanase%2520precursor%2520and%2520evidence%2520that%2520the%2520active%2520enzyme%2520is%2520a%2520heterodimer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D29587%26epage%3D29590%26doi%3D10.1074%2Fjbc.274.42.29587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson-Lindahl, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haage, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taube, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egeciouglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Admyre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, S. L.</span></span> <span> </span><span class="NLM_article-title">Correction: heparanase affects food intake and regulates energy balance in mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">10</span>), <span class="NLM_elocation-id">e34313</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0034313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1371%2Fjournal.pone.0034313" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=10&author=L.+Karlsson-Lindahlauthor=L.+Schmidtauthor=D.+Haageauthor=C.+Hanssonauthor=M.+Taubeauthor=E.+Egeciougluauthor=Y.+Tanauthor=T.+Admyreauthor=J.+O.+Janssonauthor=I.+Vlodavskyauthor=J.+P.+Liauthor=U.+Lindahlauthor=S.+L.+Dickson&title=Correction%3A+heparanase+affects+food+intake+and+regulates+energy+balance+in+mice&doi=10.1371%2Fjournal.pone.0034313"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0034313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0034313%26sid%3Dliteratum%253Aachs%26aulast%3DKarlsson-Lindahl%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DL.%26aulast%3DHaage%26aufirst%3DD.%26aulast%3DHansson%26aufirst%3DC.%26aulast%3DTaube%26aufirst%3DM.%26aulast%3DEgeciouglu%26aufirst%3DE.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DAdmyre%26aufirst%3DT.%26aulast%3DJansson%26aufirst%3DJ.%2BO.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DLindahl%26aufirst%3DU.%26aulast%3DDickson%26aufirst%3DS.%2BL.%26atitle%3DCorrection%253A%2520heparanase%2520affects%2520food%2520intake%2520and%2520regulates%2520energy%2520balance%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D10%26doi%3D10.1371%2Fjournal.pone.0034313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nybakken, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrimon, N.</span></span> <span> </span><span class="NLM_article-title">Heparan sulphate proteoglycans: the sweet side of development</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nrm1681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1038%2Fnrm1681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=16072037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A280%3ADC%252BD2MvgtFKjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=530-541&author=U.+Hackerauthor=K.+Nybakkenauthor=N.+Perrimon&title=Heparan+sulphate+proteoglycans%3A+the+sweet+side+of+development&doi=10.1038%2Fnrm1681"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Heparan sulphate proteoglycans: the sweet side of development</span></div><div class="casAuthors">Hacker Udo; Nybakken Kent; Perrimon Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Molecular cell biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">530-41</span>
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    </div><div class="casAbstract">Pattern formation during development is controlled to a great extent by a small number of conserved signal transduction pathways that are activated by extracellular ligands such as Hedgehog, Wingless or Decapentaplegic.  Genetic experiments have identified heparan sulphate proteoglycans (HSPGs) as important regulators of the tissue distribution of these extracellular signalling molecules.  Several recent reports provide important new insights into the mechanisms by which HSPGs function during development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBI4VWCsjP4z0O18WR3iAofW6udTcc2eaNZFJ8lWOgNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MvgtFKjsg%253D%253D&md5=9398fa60cabf65f4692b7b3fc7f2278d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm1681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1681%26sid%3Dliteratum%253Aachs%26aulast%3DHacker%26aufirst%3DU.%26aulast%3DNybakken%26aufirst%3DK.%26aulast%3DPerrimon%26aufirst%3DN.%26atitle%3DHeparan%2520sulphate%2520proteoglycans%253A%2520the%2520sweet%2520side%2520of%2520development%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2005%26volume%3D6%26spage%3D530%26epage%3D541%26doi%3D10.1038%2Fnrm1681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aalkjaer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boedtkjer, D. B.</span></span> <span> </span><span class="NLM_article-title">Getting neointimal: the emergence of heparanase into the vascular matrix</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">279</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.108.192625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1161%2FCIRCRESAHA.108.192625" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=277-279&author=C.+Aalkjaerauthor=D.+B.+Boedtkjer&title=Getting+neointimal%3A+the+emergence+of+heparanase+into+the+vascular+matrix&doi=10.1161%2FCIRCRESAHA.108.192625"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.108.192625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.108.192625%26sid%3Dliteratum%253Aachs%26aulast%3DAalkjaer%26aufirst%3DC.%26aulast%3DBoedtkjer%26aufirst%3DD.%2BB.%26atitle%3DGetting%2520neointimal%253A%2520the%2520emergence%2520of%2520heparanase%2520into%2520the%2520vascular%2520matrix%26jtitle%3DCirc.%2520Res.%26date%3D2009%26volume%3D104%26spage%3D277%26epage%3D279%26doi%3D10.1161%2FCIRCRESAHA.108.192625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Billings, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacifici, M.</span></span> <span> </span><span class="NLM_article-title">Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries</span>. <i>Connect. Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.3109/03008207.2015.1045066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.3109%2F03008207.2015.1045066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=26076122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1SgsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=272-280&issue=4&author=P.+C.+Billingsauthor=M.+Pacifici&title=Interactions+of+signaling+proteins%2C+growth+factors+and+other+proteins+with+heparan+sulfate%3A+mechanisms+and+mysteries&doi=10.3109%2F03008207.2015.1045066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries</span></div><div class="casAuthors">Billings, Paul C.; Pacifici, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Connective Tissue Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">272-280</span>CODEN:
                <span class="NLM_cas:coden">CVTRBC</span>;
        ISSN:<span class="NLM_cas:issn">0300-8207</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Heparan sulfate (HS) is a component of cell surface and matrix-assocd. proteoglycans (HSPGs) that, collectively, play crucial roles in many physiol. processes including cell differentiation, organ morphogenesis and cancer.  A key function of HS is to bind and interact with signaling proteins, growth factors, plasma proteins, immune-modulators and other factors.  In doing so, the HS chains and HSPGs are able to regulate protein distribution, bio-availability and action on target cells and can also serve as cell surface co-receptors, facilitating ligand-receptor interactions.  These proteins contain an HS/heparin-binding domain (HBD) that mediates their assocn. and contacts with HS.  HBDs are highly diverse in sequence and predicted structure, contain clusters of basic amino acids (Lys and Arg) and possess an overall net pos. charge, most often within a consensus Cardin-Weintraub (CW) motif.  Interestingly, other domains and residues are now known to influence protein-HS interactions, as well as interactions with other glycosaminoglycans, such as chondroitin sulfate.  In this review, we provide a description and anal. of HBDs in proteins including amphiregulin, fibroblast growth factor family members, heparanase, sclerostin and hedgehog protein family members.  We discuss HBD structural and functional features and important roles carried out by other protein domains, and also provide novel conformational insights into the diversity of CW motifs present in Sonic, Indian and Desert hedgehogs.  Finally, we review progress in understanding the pathogenesis of a rare pediatric skeletal disorder, Hereditary Multiple Exostoses (HME), characterized by HS deficiency and cartilage tumor formation.  Advances in understanding protein-HS interactions will have broad implications for basic biol. and translational medicine as well as for the development of HS-based therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcJq2JP2IKDLVg90H21EOLACvtfcHk0lgUUgPcj2uWzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1SgsbrJ&md5=2dddb8993d1699e267be5ed33d9ba407</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3109%2F03008207.2015.1045066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03008207.2015.1045066%26sid%3Dliteratum%253Aachs%26aulast%3DBillings%26aufirst%3DP.%2BC.%26aulast%3DPacifici%26aufirst%3DM.%26atitle%3DInteractions%2520of%2520signaling%2520proteins%252C%2520growth%2520factors%2520and%2520other%2520proteins%2520with%2520heparan%2520sulfate%253A%2520mechanisms%2520and%2520mysteries%26jtitle%3DConnect.%2520Tissue%2520Res.%26date%3D2015%26volume%3D56%26issue%3D4%26spage%3D272%26epage%3D280%26doi%3D10.3109%2F03008207.2015.1045066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedmann, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aingorn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atzmon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishai-Michaeli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peretz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecker, I.</span></span> <span> </span><span class="NLM_article-title">Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">802</span>, <span class="refDoi"> DOI: 10.1038/10518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1038%2F10518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10395325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=793-802&author=I.+Vlodavskyauthor=Y.+Friedmannauthor=M.+Elkinauthor=H.+Aingornauthor=R.+Atzmonauthor=R.+Ishai-Michaeliauthor=M.+Bitanauthor=O.+Pappoauthor=T.+Peretzauthor=I.+Michalauthor=L.+Spectorauthor=I.+Pecker&title=Mammalian+heparanase%3A+gene+cloning%2C+expression+and+function+in+tumor+progression+and+metastasis&doi=10.1038%2F10518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis</span></div><div class="casAuthors">Vlodavsky, Israel; Friedmann, Yael; Elkin, Michael; Aingorn, Helena; Atzmon, Ruth; Ishai-Michaeli, Rivka; Bitan, Menachem; Pappo, Orit; Peretz, Tuvia; Michal, Israel; Spector, Larissa; Pecker, Iris</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">793-802</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Heparan sulfate proteoglycans interact with many extracellular matrix constituents, growth factors and enzymes.  Degrdn. of heparan sulfate by endoglycosidic heparanase cleavage affects a variety of biol. processes.  The authors have purified a 50-kDa heparanase from human hepatoma and placenta, and now report cloning of the cDNA and gene encoding this enzyme.  Expression of the cloned cDNA in insect and mammalian cells yielded 65-kDa and 50-kDa recombinant heparanase proteins.  The 50-kDa enzyme represents an N-terminally processed enzyme, at least 100-fold more active than the 65-kDa form.  The heparanase mRNA and protein are preferentially expressed in metastatic cell lines and specimens of human breast, colon and liver carcinomas.  Low metastatic murine T-lymphoma and melanoma cells transfected with the heparanase cDNA acquired a highly metastatic phenotype in vivo, reflected by a massive liver and lung colonization.  This represents the first cloned mammalian heparanase, to the knowledge, and provides direct evidence for its role in tumor metastasis.  Cloning of the heparanase gene enables the development of specific mol. probes for early detection and treatment of cancer metastasis and autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmCf4QKJxqWLVg90H21EOLACvtfcHk0lgUUgPcj2uWzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCrs7s%253D&md5=4af36ad4e654e6538f474d8361236ed6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F10518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F10518%26sid%3Dliteratum%253Aachs%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DFriedmann%26aufirst%3DY.%26aulast%3DElkin%26aufirst%3DM.%26aulast%3DAingorn%26aufirst%3DH.%26aulast%3DAtzmon%26aufirst%3DR.%26aulast%3DIshai-Michaeli%26aufirst%3DR.%26aulast%3DBitan%26aufirst%3DM.%26aulast%3DPappo%26aufirst%3DO.%26aulast%3DPeretz%26aufirst%3DT.%26aulast%3DMichal%26aufirst%3DI.%26aulast%3DSpector%26aufirst%3DL.%26aulast%3DPecker%26aufirst%3DI.%26atitle%3DMammalian%2520heparanase%253A%2520gene%2520cloning%252C%2520expression%2520and%2520function%2520in%2520tumor%2520progression%2520and%2520metastasis%26jtitle%3DNat.%2520Med.%26date%3D1999%26volume%3D5%26spage%3D793%26epage%3D802%26doi%3D10.1038%2F10518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milazzo, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, G.</span></span> <span> </span><span class="NLM_article-title">Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.4155%2Ffmc-2016-0012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=27057774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFSqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=647-680&author=S.+Rivaraauthor=F.+M.+Milazzoauthor=G.+Giannini&title=Heparanase%3A+a+rainbow+pharmacological+target+associated+to+multiple+pathologies+including+rare+diseases&doi=10.4155%2Ffmc-2016-0012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases</span></div><div class="casAuthors">Rivara, Silvia; Milazzo, Ferdinando M.; Giannini, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-680</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, heparanase has attracted considerable attention as a promising target for innovative pharmacol. applications.  Heparanase is a multifaceted protein endowed with enzymic activity, as an endo-β-D-glucuronidase, and nonenzymic functions.  It is responsible for the cleavage of heparan sulfate side chains of proteoglycans, resulting in structural alterations of the extracellular matrix.  Heparanase appears to be involved in major human diseases, from the most studied tumors to chronic inflammation, diabetic nephropathy, bone osteolysis, thrombosis and atherosclerosis, in addn. to more recent investigation in various rare diseases.  The present review provides an overview on heparanase, its biol. role, inhibitors and possible clin. applications, covering the latest findings in these areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNHQlhGkAAgLVg90H21EOLACvtfcHk0liYnlQZP3X9nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFSqsL4%253D&md5=9227956bc0ce1c4a2eaca7342b60a36a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0012%26sid%3Dliteratum%253Aachs%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMilazzo%26aufirst%3DF.%2BM.%26aulast%3DGiannini%26aufirst%3DG.%26atitle%3DHeparanase%253A%2520a%2520rainbow%2520pharmacological%2520target%2520associated%2520to%2520multiple%2520pathologies%2520including%2520rare%2520diseases%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D647%26epage%3D680%26doi%3D10.4155%2Ffmc-2016-0012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbieri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noseda, A.</span></span> <span> </span><span class="NLM_article-title">Roneparstat and heparanase inhibition: a new tool for cancer treatment</span>. <i>J. Pharmacol. Clin. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1074</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=1071-1074&issue=2&author=P.+Barbieriauthor=D.+Paolettiauthor=G.+Gianniniauthor=R.+D.+Sandersonauthor=A.+Noseda&title=Roneparstat+and+heparanase+inhibition%3A+a+new+tool+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarbieri%26aufirst%3DP.%26aulast%3DPaoletti%26aufirst%3DD.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DSanderson%26aufirst%3DR.%2BD.%26aulast%3DNoseda%26aufirst%3DA.%26atitle%3DRoneparstat%2520and%2520heparanase%2520inhibition%253A%2520a%2520new%2520tool%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Pharmacol.%2520Clin.%2520Toxicol.%26date%3D2017%26volume%3D5%26issue%3D2%26spage%3D1071%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckhove, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meirovitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkin, M.</span></span> <span> </span><span class="NLM_article-title">Significance of heparanase in cancer and inflammation</span>. <i>Cancer Microenviron.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1007/s12307-011-0082-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1007%2Fs12307-011-0082-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=21811836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=115-132&author=I.+Vlodavskyauthor=P.+Beckhoveauthor=I.+Lernerauthor=C.+Pisanoauthor=A.+Meirovitzauthor=N.+Ilanauthor=M.+Elkin&title=Significance+of+heparanase+in+cancer+and+inflammation&doi=10.1007%2Fs12307-011-0082-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of Heparanase in Cancer and Inflammation</span></div><div class="casAuthors">Vlodavsky, Israel; Beckhove, Phillip; Lerner, Immanuel; Pisano, Claudio; Meirovitz, Amichai; Ilan, Neta; Elkin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Microenvironment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-132</span>CODEN:
                <span class="NLM_cas:coden">CMAICW</span>;
        ISSN:<span class="NLM_cas:issn">1875-2284</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Heparan sulfate proteoglycans (HSPGs) are primary components at the interface between virtually every eukaryotic cell and its extracellular matrix.  HSPGs not only provide a storage depot for heparin-binding mols. in the cell microenvironment, but also decisively regulate their accessibility, function and mode of action.  As such, they are intimately involved in modulating cell invasion and signaling loops that are crit. for tumor growth, inflammation and kidney function.  In a series of studies performed since the cloning of the human heparanase gene, we and others have demonstrated that heparanase, the sole heparan sulfate degrading endoglycosidase, is causally involved in cancer progression, inflammation and diabetic nephropathy and hence is a valid target for drug development.  Heparanase is causally involved in inflammation and accelerates colon tumorigenesis assocd. with inflammatory bowel disease.  Notably, heparanase stimulates macrophage activation, while macrophages induce prodn. and activation of latent heparanase contributed by the colon epithelium, together generating a vicious cycle that powers colitis and the assocd. tumorigenesis.  Heparanase also plays a decisive role in the pathogenesis of diabetic nephropathy, degrading heparan sulfate in the glomerular basement membrane and ultimately leading to proteinuria and kidney dysfunction.  Notably, clin. relevant doses of ionizing radiation (IR) upregulate heparanase expression and thereby augment the metastatic potential of pancreatic carcinoma.  Thus, combining radiotherapy with heparanase inhibition is an effective strategy to prevent tumor resistance and dissemination in IR-treated pancreatic cancer patients.  Also, accumulating evidence indicate that peptides derived from human heparanase elicit a potent anti-tumor immune response, suggesting that heparanase represents a promising target antigen for immunotherapeutic approaches against a broad variety of tumors.  Oligosaccharide-based compds. that inhibit heparanase enzymic activity were developed, aiming primarily at halting tumor growth, metastasis and angiogenesis.  Some of these compds. are being evaluated in clin. trials, targeting both the tumor and tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofpxC8zEsqc7Vg90H21EOLACvtfcHk0liYnlQZP3X9nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7nO&md5=8a09c46170effe91706bedc387dabe4d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs12307-011-0082-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12307-011-0082-7%26sid%3Dliteratum%253Aachs%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DBeckhove%26aufirst%3DP.%26aulast%3DLerner%26aufirst%3DI.%26aulast%3DPisano%26aufirst%3DC.%26aulast%3DMeirovitz%26aufirst%3DA.%26aulast%3DIlan%26aufirst%3DN.%26aulast%3DElkin%26aufirst%3DM.%26atitle%3DSignificance%2520of%2520heparanase%2520in%2520cancer%2520and%2520inflammation%26jtitle%3DCancer%2520Microenviron.%26date%3D2012%26volume%3D5%26spage%3D115%26epage%3D132%26doi%3D10.1007%2Fs12307-011-0082-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span> <span> </span><span class="NLM_article-title">Heparin, heparan sulfate and heparanase in inflammatory reactions</span>. <i>Thromb. Haemostasis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">828</span>, <span class="refDoi"> DOI: 10.1160/TH09-02-0091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1160%2FTH09-02-0091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=19888515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFajtr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2009&pages=823-828&author=J.+P.+Liauthor=I.+Vlodavsky&title=Heparin%2C+heparan+sulfate+and+heparanase+in+inflammatory+reactions&doi=10.1160%2FTH09-02-0091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin, heparan sulfate and heparanase in inflammatory reactions</span></div><div class="casAuthors">Li, Jin-ping; Vlodavsky, Israel</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-828</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">A review.  Heparan sulfate (HS) proteoglycans at the cell surface and in the extracellular matrix of most animal tissues are essential in development and homeostasis, and are implicated in disease processes.  Emerging evidence demonstrates the important roles of HS in inflammatory reactions, particularly in the regulation of leukocyte extravasation.  Heparin, a classical anticoagulant, exhibits anti-inflammatory effects in animal models and in the clinic, presumably through interference with the functions of HS, as both polysaccharides share a high similarity in mol. structure.  Apart of regulation during biosynthesis, the structures of HS and heparin are significantly modulated by heparanase, an endoglycosidase that is upregulated in a no. of inflammatory conditions.  Exploring the physiol. roles of HS and heparin and the mode of heparanase action in modulating their functions during inflammation responses is of importance for future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZKBPySlsXrbVg90H21EOLACvtfcHk0liN1QsEMhzJog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFajtr%252FI&md5=ae8b73a83472035e8527de458338bf7c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1160%2FTH09-02-0091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH09-02-0091%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DVlodavsky%26aufirst%3DI.%26atitle%3DHeparin%252C%2520heparan%2520sulfate%2520and%2520heparanase%2520in%2520inflammatory%2520reactions%26jtitle%3DThromb.%2520Haemostasis%26date%3D2009%26volume%3D102%26spage%3D823%26epage%3D828%26doi%3D10.1160%2FTH09-02-0091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pisano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, F.</span></span> <span> </span><span class="NLM_article-title">The potential of heparanase as a therapeutic target in cancer</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2014.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.bcp.2014.02.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2014&pages=12-19&author=C.+Pisanoauthor=I.+Vlodavskyauthor=N.+Ilanauthor=F.+Zunino&title=The+potential+of+heparanase+as+a+therapeutic+target+in+cancer&doi=10.1016%2Fj.bcp.2014.02.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2014.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2014.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DPisano%26aufirst%3DC.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DIlan%26aufirst%3DN.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DThe%2520potential%2520of%2520heparanase%2520as%2520a%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2014%26volume%3D89%26spage%3D12%26epage%3D19%26doi%3D10.1016%2Fj.bcp.2014.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shteingauz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyango, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naroditsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doweck, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span> <span> </span><span class="NLM_article-title">Heparanase enhances tumor growth and chemoresistance by promoting autophagy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">3946</span>– <span class="NLM_lpage">3957</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-0037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1158%2F0008-5472.CAN-15-0037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=3946-3957&author=A.+Shteingauzauthor=I.+Boyangoauthor=I.+Naroditskyauthor=E.+Hammondauthor=M.+Gruberauthor=I.+Doweckauthor=N.+Ilanauthor=I.+Vlodavsky&title=Heparanase+enhances+tumor+growth+and+chemoresistance+by+promoting+autophagy&doi=10.1158%2F0008-5472.CAN-15-0037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-0037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-0037%26sid%3Dliteratum%253Aachs%26aulast%3DShteingauz%26aufirst%3DA.%26aulast%3DBoyango%26aufirst%3DI.%26aulast%3DNaroditsky%26aufirst%3DI.%26aulast%3DHammond%26aufirst%3DE.%26aulast%3DGruber%26aufirst%3DM.%26aulast%3DDoweck%26aufirst%3DI.%26aulast%3DIlan%26aufirst%3DN.%26aulast%3DVlodavsky%26aufirst%3DI.%26atitle%3DHeparanase%2520enhances%2520tumor%2520growth%2520and%2520chemoresistance%2520by%2520promoting%2520autophagy%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D3946%26epage%3D3957%26doi%3D10.1158%2F0008-5472.CAN-15-0037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramani, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbieri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noseda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, R. D.</span></span> <span> </span><span class="NLM_article-title">Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype</span>. <i>Matrix Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.matbio.2016.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.matbio.2016.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=27016342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVWksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=22-34&author=V.+C.+Ramaniauthor=I.+Vlodavskyauthor=M.+Ngauthor=Y.+Zhangauthor=P.+Barbieriauthor=A.+Nosedaauthor=R.+D.+Sanderson&title=Chemotherapy+induces+expression+and+release+of+heparanase+leading+to+changes+associated+with+an+aggressive+tumor+phenotype&doi=10.1016%2Fj.matbio.2016.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype</span></div><div class="casAuthors">Ramani, Vishnu C.; Vlodavsky, Israel; Ng, Mary; Zhang, Yi; Barbieri, Paola; Noseda, Alessandro; Sanderson, Ralph D.</div><div class="citationInfo"><span class="NLM_cas:title">Matrix Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-34</span>CODEN:
                <span class="NLM_cas:coden">MTBOEC</span>;
        ISSN:<span class="NLM_cas:issn">0945-053X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High heparanase expression is assocd. with enhanced tumor growth, angiogenesis, and metastasis in many types of cancer.  However, the mechanisms driving high heparanase expression are not fully understood.  In the present study, we discovered that drugs used in the treatment of myeloma upregulate heparanase expression.  Frontline anti-myeloma drugs, bortezomib and carfilzomib activate the nuclear factor-kappa B (NF-κB) pathway to trigger heparanase expression in tumor cells.  Blocking the NF-κB pathway diminished this chemotherapy-induced upregulation of heparanase expression.  Activated NF-κB signaling was also found to drive high heparanase expression in drug resistant myeloma cell lines.  In addn. to enhancing heparanase expression, chemotherapy also caused release of heparanase by tumor cells into the conditioned medium.  This sol. heparanase was taken up by macrophages and triggered an increase in TNF-α prodn.  Heparanase is also taken up by tumor cells where it induced expression of HGF, VEGF and MMP-9 and activated ERK and Akt signaling pathways.  These changes induced by heparanase are known to be assocd. with the promotion of an aggressive tumor phenotype.  Importantly, the heparanase inhibitor Roneparstat diminished the uptake and the downstream effects of sol. heparanase.  Together, these discoveries reveal a novel mechanism whereby chemotherapy upregulates heparanase, a known promoter of myeloma growth, and suggest that therapeutic targeting of heparanase during anti-cancer therapy may improve patient outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHVXAsywkd3rVg90H21EOLACvtfcHk0liN1QsEMhzJog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVWksrw%253D&md5=2903884c8750865574d1e4609432a9dc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.matbio.2016.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.matbio.2016.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DRamani%26aufirst%3DV.%2BC.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DNg%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBarbieri%26aufirst%3DP.%26aulast%3DNoseda%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DR.%2BD.%26atitle%3DChemotherapy%2520induces%2520expression%2520and%2520release%2520of%2520heparanase%2520leading%2520to%2520changes%2520associated%2520with%2520an%2520aggressive%2520tumor%2520phenotype%26jtitle%3DMatrix%2520Biol.%26date%3D2016%26volume%3D55%26spage%3D22%26epage%3D34%26doi%3D10.1016%2Fj.matbio.2016.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the discovery of heparanase inhibitors as anti-cancer agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.ejmech.2016.05.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=209-220&author=L.+Jiaauthor=S.+Ma&title=Recent+advances+in+the+discovery+of+heparanase+inhibitors+as+anti-cancer+agents&doi=10.1016%2Fj.ejmech.2016.05.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.052%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520heparanase%2520inhibitors%2520as%2520anti-cancer%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D209%26epage%3D220%26doi%3D10.1016%2Fj.ejmech.2016.05.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassinelli, G.</span></span> <span> </span><span class="NLM_article-title">Targeting heparan sulfate proteoglycans and their modifying enzymes to enhance anticancer chemotherapy efficacy and overcome drug resistance</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2860</span>– <span class="NLM_lpage">2886</span>, <span class="refDoi"> DOI: 10.2174/0929867324666170216114248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.2174%2F0929867324666170216114248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=28215163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sru7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=2860-2886&author=C.+Lanziauthor=N.+Zaffaroniauthor=G.+Cassinelli&title=Targeting+heparan+sulfate+proteoglycans+and+their+modifying+enzymes+to+enhance+anticancer+chemotherapy+efficacy+and+overcome+drug+resistance&doi=10.2174%2F0929867324666170216114248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance</span></div><div class="casAuthors">Lanzi, Cinzia; Zaffaroni, Nadia; Cassinelli, Giuliana</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2860-2886</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Targeting heparan sulfate proteoglycans (HSPGs) and enzymes involved in heparan sulfate (HS) chain editing is emerging as a new anticancer strategy.  The involvement of HSPGs in tumor cell signaling, inflammation, angiogenesis and metastasis indicates that agents able to inhibit aberrant HSPG functions can potentially act as multitarget drugs affecting both tumor cell growth and the supportive boost provided by the microenvironment.  Moreover, accumulating evidence supports that an altered expression or function of HSPGs, or of the complex enzyme system regulating their activities, can also depress the tumor response to anticancer treatments in several tumor types.  Thereby, targeting HSPGs or HSPG modifying enzymes appears an appealing approach to enhance chemotherapy efficacy.  A great deal of effort from academia and industry has led to the development of agents mimicking HS, and/or inhibiting HSPG modifying enzymes.  Inhibitors of Sulf-2, an endosulfatase that edits the HS sulfation pattern, and inhibitors of heparanase, the endoglycosidase that produces functional HS fragments, appear particularly promising.  In fact, a Sulf-2 inhibitor (OKN-007), and two heparanase inhibitors/HS mimics (roneparstat, PG545) are currently under early clin. investigation.  In this review, we summarized preclin. studies in exptl. tumor models of the main chem. classes of Sulf-2 and heparanase inhibitors.  We described examples of different mechanisms through which heparanase and HSPGs, often in cooperation, may impact tumor sensitivity to various antitumor agents.  Finally, we reported a few preclin. studies showing increased antitumor efficacy obtained with the use of candidate clin. HS mimics in combination regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvdqVvYpaCJbVg90H21EOLACvtfcHk0li0WTkYhjakHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sru7rF&md5=395b84e9f52c311599d928949376f59c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F0929867324666170216114248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867324666170216114248%26sid%3Dliteratum%253Aachs%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DCassinelli%26aufirst%3DG.%26atitle%3DTargeting%2520heparan%2520sulfate%2520proteoglycans%2520and%2520their%2520modifying%2520enzymes%2520to%2520enhance%2520anticancer%2520chemotherapy%2520efficacy%2520and%2520overcome%2520drug%2520resistance%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2017%26volume%3D24%26spage%3D2860%26epage%3D2886%26doi%3D10.2174%2F0929867324666170216114248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, G.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, L.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, K.-L.</span></span> <span> </span><span class="NLM_article-title">624PD - A phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">v209</span>– <span class="NLM_lpage">v268</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdx369.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1093%2Fannonc%2Fmdx369.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=v209-v268&issue=5&author=P.-J.+Chenauthor=P.-H.+Leeauthor=K.-H.+Hanauthor=J.+Fanauthor=T.+T.+Cheungauthor=R.-H.+Huauthor=S.+W.+Paikauthor=W.-C.+Leeauthor=G.-Y.+Chauauthor=L.-B.+Jengauthor=H.+J.+Wangauthor=J.+Y.+Choiauthor=C.-L.+Chenauthor=M.+Choauthor=M.-C.+Hoauthor=C.-C.+Wuauthor=K.+S.+Leeauthor=Y.+Maoauthor=F.-C.+Huauthor=K.-L.+Lai&title=624PD+-+A+phase+III+trial+of+muparfostat+%28PI-88%29+as+adjuvant+therapy+in+patients+with+hepatitis+virus+related+hepatocellular+carcinoma+%28HV-HCC%29+after+resection&doi=10.1093%2Fannonc%2Fmdx369.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdx369.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdx369.008%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.-J.%26aulast%3DLee%26aufirst%3DP.-H.%26aulast%3DHan%26aufirst%3DK.-H.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DT.%2BT.%26aulast%3DHu%26aufirst%3DR.-H.%26aulast%3DPaik%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DW.-C.%26aulast%3DChau%26aufirst%3DG.-Y.%26aulast%3DJeng%26aufirst%3DL.-B.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DChen%26aufirst%3DC.-L.%26aulast%3DCho%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DM.-C.%26aulast%3DWu%26aufirst%3DC.-C.%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DF.-C.%26aulast%3DLai%26aufirst%3DK.-L.%26atitle%3D624PD%2520-%2520A%2520phase%2520III%2520trial%2520of%2520muparfostat%2520%2528PI-88%2529%2520as%2520adjuvant%2520therapy%2520in%2520patients%2520with%2520hepatitis%2520virus%2520related%2520hepatocellular%2520carcinoma%2520%2528HV-HCC%2529%2520after%2520resection%26jtitle%3DAnn.%2520Oncol.%26date%3D2017%26volume%3D28%26issue%3D5%26spage%3Dv209%26epage%3Dv268%26doi%3D10.1093%2Fannonc%2Fmdx369.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nix, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. P.</span></span> <span> </span><span class="NLM_article-title">Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: phase I results</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1429</span>– <span class="NLM_lpage">1439</span>, <span class="refDoi"> DOI: 10.1634/theoncologist.2017-0472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1634%2Ftheoncologist.2017-0472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=29158367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovFCnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1429-1439&issue=12&author=E.+M.+O%E2%80%99Reillyauthor=J.+Roachauthor=P.+Millerauthor=K.+H.+Yuauthor=C.+Tjanauthor=M.+Rosanoauthor=S.+Krauseauthor=W.+Averyauthor=J.+Wolfauthor=K.+Flahertyauthor=D.+Nixauthor=D.+P.+Ryan&title=Safety%2C+pharmacokinetics%2C+pharmacodynamics%2C+and+antitumor+activity+of+necuparanib+combined+with+nab-paclitaxel+and+gemcitabine+in+patients+with+metastatic+pancreatic+cancer%3A+phase+I+results&doi=10.1634%2Ftheoncologist.2017-0472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results</span></div><div class="casAuthors">O'Reilly, Eileen M.; Roach, James; Miller, Paul; Yu, Kenneth H.; Tjan, Catherine; Rosano, Molly; Krause, Silva; Avery, William; Wolf, Julie; Flaherty, Keith; Nix, Darrell; Ryan, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1429-e139</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1549-490X</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">Lessons Learned : Despite the compelling preclin. rationale of evaluating the genetically engineered heparin deriv., necuparanib, combined with std. therapy in metastatic pancreas adenocarcinoma, the results were ultimately disappointing.  Safety was documented, although dose escalation was limited by the no. of s.c. injections, the potential for skin toxicity (cellulitis), and low-level anticoagulant effect.  Nonetheless, the hypothesis of targeting prothrombotic pathways in pancreas adenocarcinoma remains compelling.  Background : Necuparanib is derived from unfractionated heparin and engineered for reduced anticoagulant activity while preserving known heparin-assocd. antitumor properties.  This trial assessed the safety, pharmacokinetics (PK), pharmacodynamics, and initial efficacy of necuparanib combined with gemcitabine ± nab-paclitaxel in patients with metastatic pancreatic cancer.  Methods : Patients received escalating daily s.c. doses of necuparanib plus 1,000 mg/m2 gemcitabine (days 1, 8, 15, and every 28 days).  The protocol was amended to include 125 mg/m2 nab-paclitaxel after two cohorts (following release of the phase III MPACT data).  The necuparanib starting dose was 0.5 mg/kg, with escalation via a modified 3 + 3 design until the max. tolerated dose (MTD) was detd.  Results : Thirty-nine patients were enrolled into seven cohorts (necuparanib 0.5, 1 mg/kg + gemcitabine; necuparanib 1, 2, 4, 6, and 5 mg/kg + nab-paclitaxel + gemcitabine).  The most common adverse events were anemia (56%), fatigue (51%), neutropenia (51%), leukopenia (41%), and thrombocytopenia (41%).  No deaths and two serious adverse events were potentially related to necuparanib.  Measurable levels of necuparanib were seen starting at the 2 mg/kg dose.  Of 24 patients who received at least one dose of necuparanib + nab-paclitaxel + gemcitabine, 9 (38%) achieved a partial response and 6 (25%) achieved stable disease (63% disease control rate).  Given a cellulitis event and mild activated partial thromboplastin time increases at 6 mg/kg, the 5 mg/kg dose was considered the MTD and selected for further assessment in phase II.  Conclusion : Acceptable safety and encouraging signals of activity in patients with metastatic pancreatic cancer receiving necuparanib, nab-paclitaxel, and gemcitabine were demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkOVw6q0wV0rVg90H21EOLACvtfcHk0li0WTkYhjakHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovFCnt70%253D&md5=e731677d7506bc7f1fdb368acaa77e52</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2017-0472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2017-0472%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DE.%2BM.%26aulast%3DRoach%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DK.%2BH.%26aulast%3DTjan%26aufirst%3DC.%26aulast%3DRosano%26aufirst%3DM.%26aulast%3DKrause%26aufirst%3DS.%26aulast%3DAvery%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DJ.%26aulast%3DFlaherty%26aufirst%3DK.%26aulast%3DNix%26aufirst%3DD.%26aulast%3DRyan%26aufirst%3DD.%2BP.%26atitle%3DSafety%252C%2520pharmacokinetics%252C%2520pharmacodynamics%252C%2520and%2520antitumor%2520activity%2520of%2520necuparanib%2520combined%2520with%2520nab-paclitaxel%2520and%2520gemcitabine%2520in%2520patients%2520with%2520metastatic%2520pancreatic%2520cancer%253A%2520phase%2520I%2520results%26jtitle%3DOncologist%26date%3D2017%26volume%3D22%26issue%3D12%26spage%3D1429%26epage%3D1439%26doi%3D10.1634%2Ftheoncologist.2017-0472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parish, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowden, W. B.</span></span> <span> </span><span class="NLM_article-title">Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3433</span>– <span class="NLM_lpage">3441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=3433-3441&issue=14&author=C.+R.+Parishauthor=C.+Freemanauthor=K.+J.+Brownauthor=D.+J.+Francisauthor=W.+B.+Cowden&title=Identification+of+sulfated+oligosaccharide-based+inhibitors+of+tumor+growth+and+metastasis+using+novel+in+vitro+assays+for+angiogenesis+and+heparanase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParish%26aufirst%3DC.%2BR.%26aulast%3DFreeman%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DK.%2BJ.%26aulast%3DFrancis%26aufirst%3DD.%2BJ.%26aulast%3DCowden%26aufirst%3DW.%2BB.%26atitle%3DIdentification%2520of%2520sulfated%2520oligosaccharide-based%2520inhibitors%2520of%2520tumor%2520growth%2520and%2520metastasis%2520using%2520novel%2520in%2520vitro%2520assays%2520for%2520angiogenesis%2520and%2520heparanase%2520activity%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D14%26spage%3D3433%26epage%3D3441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dredge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bytheway, I.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues</span>. <i>FEBS Open Bio</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1016/j.fob.2013.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.fob.2013.07.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=346-351&author=E.+Hammondauthor=P.+Handleyauthor=K.+Dredgeauthor=I.+Bytheway&title=Mechanisms+of+heparanase+inhibition+by+the+heparan+sulfate+mimetic+PG545+and+three+structural+analogues&doi=10.1016%2Fj.fob.2013.07.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.fob.2013.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fob.2013.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DE.%26aulast%3DHandley%26aufirst%3DP.%26aulast%3DDredge%26aufirst%3DK.%26aulast%3DBytheway%26aufirst%3DI.%26atitle%3DMechanisms%2520of%2520heparanase%2520inhibition%2520by%2520the%2520heparan%2520sulfate%2520mimetic%2520PG545%2520and%2520three%2520structural%2520analogues%26jtitle%3DFEBS%2520Open%2520Bio%26date%3D2013%26volume%3D3%26spage%3D346%26epage%3D351%26doi%3D10.1016%2Fj.fob.2013.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dredge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lickliter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bampton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lankesheer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrish, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millward, M.</span></span> <span> </span><span class="NLM_article-title">A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1041</span>, <span class="refDoi"> DOI: 10.1038/s41416-018-0006-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1038%2Fs41416-018-0006-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=29531325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos12qtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2018&pages=1035-1041&issue=8&author=K.+Dredgeauthor=T.+V.+Brennanauthor=E.+Hammondauthor=J.+D.+Lickliterauthor=L.+Linauthor=D.+Bamptonauthor=P.+Handleyauthor=F.+Lankesheerauthor=G.+Morrishauthor=Y.+Yangauthor=M.+P.+Brownauthor=M.+Millward&title=A+Phase+I+study+of+the+novel+immunomodulatory+agent+PG545+%28pixatimod%29+in+subjects+with+advanced+solid+tumours&doi=10.1038%2Fs41416-018-0006-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours</span></div><div class="casAuthors">Dredge, Keith; Brennan, Todd V.; Hammond, Edward; Lickliter, Jason D.; Lin, Liwen; Bampton, Darryn; Handley, Paul; Lankesheer, Fleur; Morrish, Glynn; Yang, Yiping; Brown, Michael P.; Millward, Michael</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1035-1041</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: PG545 (pixatimod) is a novel immunomodulatory agent, which has been demonstrated to stimulate innate immune responses against tumors in preclin. cancer models.  Methods: This Phase I study investigated the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of PG545 monotherapy.  Escalating doses of PG545 were administered to patients with advanced solid malignancies as a weekly 1-h i.v. infusion.  Results: Twenty-three subjects were enroled across four cohorts (25, 50, 100 and 150 mg).  Three dose-limiting toxicities (DLTs)-hypertension (2), epistaxis (1)-occurred in the 150 mg cohort.  No DLTs were noted in the 100 mg cohort, which was identified as the max.-tolerated dose.  No objective responses were reported.  Best response was stable disease up to 24 wk, with the disease control rate in evaluable subjects of 38%.  Exposure was proportional up to 100 mg and mean half-life was 141 h.  The pharmacodynamic data revealed increases in innate immune cell activation, plasma IFNγ, TNFα, IP-10 and MCP-1.  Conclusion: PG545 demonstrated a tolerable safety profile, proportional PK, evidence of immune cell stimulation and disease control in some subjects.  Taken together, these data support the proposed mechanism of action, which represents a promising approach for use in combination with existing therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJrZFH2H5d6rVg90H21EOLACvtfcHk0lh1CSdbkYX7zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos12qtb4%253D&md5=77372f48c3126f68968aad2ff1d255df</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fs41416-018-0006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41416-018-0006-0%26sid%3Dliteratum%253Aachs%26aulast%3DDredge%26aufirst%3DK.%26aulast%3DBrennan%26aufirst%3DT.%2BV.%26aulast%3DHammond%26aufirst%3DE.%26aulast%3DLickliter%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DBampton%26aufirst%3DD.%26aulast%3DHandley%26aufirst%3DP.%26aulast%3DLankesheer%26aufirst%3DF.%26aulast%3DMorrish%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BP.%26aulast%3DMillward%26aufirst%3DM.%26atitle%3DA%2520Phase%2520I%2520study%2520of%2520the%2520novel%2520immunomodulatory%2520agent%2520PG545%2520%2528pixatimod%2529%2520in%2520subjects%2520with%2520advanced%2520solid%2520tumours%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2018%26volume%3D118%26issue%3D8%26spage%3D1035%26epage%3D1041%26doi%3D10.1038%2Fs41416-018-0006-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specchia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einsele, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celeghini, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbieri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambaldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagler, A.</span></span> <span> </span><span class="NLM_article-title">Phase I study of the heparanase inhibitor roneparstat: an innovative approach for multiple myeloma therapy</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">e469</span>, <span class="refDoi"> DOI: 10.3324/haematol.2017.182865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.3324%2Fhaematol.2017.182865" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2018&pages=e469&author=M.+Galliauthor=M.+Chatterjeeauthor=M.+Grassoauthor=G.+Specchiaauthor=H.+Magenauthor=H.+Einseleauthor=I.+Celeghiniauthor=P.+Barbieriauthor=D.+Paolettiauthor=S.+Paceauthor=R.+D.+Sandersonauthor=A.+Rambaldiauthor=A.+Nagler&title=Phase+I+study+of+the+heparanase+inhibitor+roneparstat%3A+an+innovative+approach+for+multiple+myeloma+therapy&doi=10.3324%2Fhaematol.2017.182865"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2017.182865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2017.182865%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DM.%26aulast%3DChatterjee%26aufirst%3DM.%26aulast%3DGrasso%26aufirst%3DM.%26aulast%3DSpecchia%26aufirst%3DG.%26aulast%3DMagen%26aufirst%3DH.%26aulast%3DEinsele%26aufirst%3DH.%26aulast%3DCeleghini%26aufirst%3DI.%26aulast%3DBarbieri%26aufirst%3DP.%26aulast%3DPaoletti%26aufirst%3DD.%26aulast%3DPace%26aufirst%3DS.%26aulast%3DSanderson%26aufirst%3DR.%2BD.%26aulast%3DRambaldi%26aufirst%3DA.%26aulast%3DNagler%26aufirst%3DA.%26atitle%3DPhase%2520I%2520study%2520of%2520the%2520heparanase%2520inhibitor%2520roneparstat%253A%2520an%2520innovative%2520approach%2520for%2520multiple%2520myeloma%2520therapy%26jtitle%3DHaematologica%26date%3D2018%26volume%3D103%26spage%3De469%26doi%3D10.3324%2Fhaematol.2017.182865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonra, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahiji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kussie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselyov, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">1-[4-(1<i>H</i>-benzoimidazol-2-yl)-phenyl]-3-[4-(1<i>H</i>-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.09.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.bmcl.2005.09.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=409-412&issue=2&author=W.+Panauthor=H.+Q.+Miaoauthor=Y.+J.+Xuauthor=E.+C.+Navarroauthor=J.+R.+Tonraauthor=E.+Corcoranauthor=A.+Lahijiauthor=P.+Kussieauthor=A.+S.+Kiselyovauthor=W.+C.+Wongauthor=H.+Liu&title=1-%5B4-%281H-benzoimidazol-2-yl%29-phenyl%5D-3-%5B4-%281H-benzoimidazol-2-yl%29-phenyl%5D-urea+derivatives+as+small+molecule+heparanase+inhibitors&doi=10.1016%2Fj.bmcl.2005.09.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.09.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.09.069%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DW.%26aulast%3DMiao%26aufirst%3DH.%2BQ.%26aulast%3DXu%26aufirst%3DY.%2BJ.%26aulast%3DNavarro%26aufirst%3DE.%2BC.%26aulast%3DTonra%26aufirst%3DJ.%2BR.%26aulast%3DCorcoran%26aufirst%3DE.%26aulast%3DLahiji%26aufirst%3DA.%26aulast%3DKussie%26aufirst%3DP.%26aulast%3DKiselyov%26aufirst%3DA.%2BS.%26aulast%3DWong%26aufirst%3DW.%2BC.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3D1-%255B4-%25281H-benzoimidazol-2-yl%2529-phenyl%255D-3-%255B4-%25281H-benzoimidazol-2-yl%2529-phenyl%255D-urea%2520derivatives%2520as%2520small%2520molecule%2520heparanase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D2%26spage%3D409%26epage%3D412%26doi%3D10.1016%2Fj.bmcl.2005.09.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bathini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manga, V.</span></span> <span> </span><span class="NLM_article-title">3D QSAR based design of novel substituted urea molecules as heparanase inhibitors</span>. <i>J. Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">754</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1016/j.jopr.2013.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.jopr.2013.08.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyls7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=754-761&issue=8&author=R.+Bathiniauthor=S.+Fatimaauthor=S.+K.+Sivanauthor=V.+Manga&title=3D+QSAR+based+design+of+novel+substituted+urea+molecules+as+heparanase+inhibitors&doi=10.1016%2Fj.jopr.2013.08.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">3D QSAR based design of novel substituted urea molecules as heparanase inhibitors</span></div><div class="casAuthors">Bathini, Raju; Fatima, Sabiha; Sivan, Sree Kanth; Manga, Vijjulatha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy Research (Gurgaon, India)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">754-761</span>CODEN:
                <span class="NLM_cas:coden">JPROFW</span>;
        ISSN:<span class="NLM_cas:issn">0974-6943</span>.
    
            (<span class="NLM_cas:orgname">Reed Elsevier India Pvt. Ltd.</span>)
        </div><div class="casAbstract">To study the key pharmacophore requirements for heparanase inhibition and design of new mols.Three dimensional quant. structure activity relationship (3D QSAR) methodologies namely Comparative Mol. Field Anal. (CoMFA) and Comparative Mol. Similarity Indexes Anal. (CoMSIA) were applied, PLS anal. was performed and QSAR models were generated for a set of 43 bezoxazol-5-yl acetic acid derivs. and 1,3-bis 4-(1H-bezimidazol-2-yl)-Ph urea reported as potent inhibitors of heparanase.QSAR model showed good internal and external statistical reliability that is evident from the q2loo, r2ncv and r2pred.  CoMFA model provides a correlation of steric and electrostatic field with biol. activities.  CoMSIA model provides a correlation of steric, electrostatic, acceptor, donor and hydrophobic fields with biol. activities.The identified key features enabled us to design novel sym. 1,3-bis 4-(1H-bezimidazol-2-yl)-Ph urea derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0HTM_dyPhbVg90H21EOLACvtfcHk0ljvSxLXFA4fZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyls7rJ&md5=f60b361092754dbbbcbcb9c67674ce10</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jopr.2013.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jopr.2013.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DBathini%26aufirst%3DR.%26aulast%3DFatima%26aufirst%3DS.%26aulast%3DSivan%26aufirst%3DS.%2BK.%26aulast%3DManga%26aufirst%3DV.%26atitle%3D3D%2520QSAR%2520based%2520design%2520of%2520novel%2520substituted%2520urea%2520molecules%2520as%2520heparanase%2520inhibitors%26jtitle%3DJ.%2520Pharm.%2520Res.%26date%3D2013%26volume%3D7%26issue%3D8%26spage%3D754%26epage%3D761%26doi%3D10.1016%2Fj.jopr.2013.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colville, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scopes, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hircock, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhaman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felix, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubberfield, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, P. R.</span></span> <span> </span><span class="NLM_article-title">Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2295</span>– <span class="NLM_lpage">2299</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.bmcl.2005.03.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2295-2299&author=S.+M.+Courtneyauthor=P.+A.+Hayauthor=R.+T.+Buckauthor=C.+S.+Colvilleauthor=D.+J.+Phillipsauthor=D.+I.+Scopesauthor=F.+C.+Pollardauthor=M.+J.+Pageauthor=J.+M.+Bennettauthor=M.+L.+Hircockauthor=E.+A.+McKenzieauthor=M.+Bhamanauthor=R.+Felixauthor=C.+R.+Stubberfieldauthor=P.+R.+Turner&title=Furanyl-1%2C3-thiazol-2-yl+and+benzoxazol-5-yl+acetic+acid+derivatives%3A+novel+classes+of+heparanase+inhibitor&doi=10.1016%2Fj.bmcl.2005.03.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DHay%26aufirst%3DP.%2BA.%26aulast%3DBuck%26aufirst%3DR.%2BT.%26aulast%3DColville%26aufirst%3DC.%2BS.%26aulast%3DPhillips%26aufirst%3DD.%2BJ.%26aulast%3DScopes%26aufirst%3DD.%2BI.%26aulast%3DPollard%26aufirst%3DF.%2BC.%26aulast%3DPage%26aufirst%3DM.%2BJ.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DHircock%26aufirst%3DM.%2BL.%26aulast%3DMcKenzie%26aufirst%3DE.%2BA.%26aulast%3DBhaman%26aufirst%3DM.%26aulast%3DFelix%26aufirst%3DR.%26aulast%3DStubberfield%26aufirst%3DC.%2BR.%26aulast%3DTurner%26aufirst%3DP.%2BR.%26atitle%3DFuranyl-1%252C3-thiazol-2-yl%2520and%2520benzoxazol-5-yl%2520acetic%2520acid%2520derivatives%253A%2520novel%2520classes%2520of%2520heparanase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2295%26epage%3D2299%26doi%3D10.1016%2Fj.bmcl.2005.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madia, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescatori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saccoliti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudino, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scipione, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalvini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roscilli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milazzo, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Santo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, G.</span></span> <span> </span><span class="NLM_article-title">Novel benzazole derivatives endowed with potent anti-heparanase activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6918</span>– <span class="NLM_lpage">6936</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00908</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00908" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6918-6936&author=V.+N.+Madiaauthor=A.+Messoreauthor=L.+Pescatoriauthor=F.+Saccolitiauthor=V.+Tudinoauthor=A.+De+Leoauthor=M.+Bortolamiauthor=L.+Scipioneauthor=R.+Costiauthor=S.+Rivaraauthor=L.+Scalviniauthor=M.+Morauthor=F.+F.+Ferraraauthor=E.+Pavoniauthor=G.+Roscilliauthor=G.+Cassinelliauthor=F.+M.+Milazzoauthor=G.+Battistuzziauthor=R.+Di+Santoauthor=G.+Giannini&title=Novel+benzazole+derivatives+endowed+with+potent+anti-heparanase+activity&doi=10.1021%2Facs.jmedchem.8b00908"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00908%26sid%3Dliteratum%253Aachs%26aulast%3DMadia%26aufirst%3DV.%2BN.%26aulast%3DMessore%26aufirst%3DA.%26aulast%3DPescatori%26aufirst%3DL.%26aulast%3DSaccoliti%26aufirst%3DF.%26aulast%3DTudino%26aufirst%3DV.%26aulast%3DDe%2BLeo%26aufirst%3DA.%26aulast%3DBortolami%26aufirst%3DM.%26aulast%3DScipione%26aufirst%3DL.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DScalvini%26aufirst%3DL.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DF.%2BF.%26aulast%3DPavoni%26aufirst%3DE.%26aulast%3DRoscilli%26aufirst%3DG.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DMilazzo%26aufirst%3DF.%2BM.%26aulast%3DBattistuzzi%26aufirst%3DG.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DGiannini%26aufirst%3DG.%26atitle%3DNovel%2520benzazole%2520derivatives%2520endowed%2520with%2520potent%2520anti-heparanase%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6918%26epage%3D6936%26doi%3D10.1021%2Facs.jmedchem.8b00908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, S. M.</span>; <span class="NLM_string-name">Hay, P. A.</span>; <span class="NLM_string-name">Scopes, D. I.</span></span> <span> </span><span class="NLM_article-title">Benzoxazole, Benzothiazole and Benzimidazole Acid Derivatives and their Use as Heparanase Inhibitors</span>.  <i>PCTInternational Patent Applications</i> <span class="NLM_patent">WO 2004/046122</span>, July 15, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+M.+Courtney&author=P.+A.+Hay&author=D.+I.+Scopes&title=Benzoxazole%2C+Benzothiazole+and+Benzimidazole+Acid+Derivatives+and+their+Use+as+Heparanase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26atitle%3DBenzoxazole%252C%2520Benzothiazole%2520and%2520Benzimidazole%2520Acid%2520Derivatives%2520and%2520their%2520Use%2520as%2520Heparanase%2520Inhibitors%26jtitle%3DPCTInternational%2520Patent%2520Applications%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhalnina, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shishkov, S. V.</span></span> <span> </span><span class="NLM_article-title">A convergent approach to synthesis of bortezomib: the use of TBTU suppresses racemization in the fragment condensation</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">7105</span>– <span class="NLM_lpage">7108</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2009.06.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.tet.2009.06.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVGgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=7105-7108&author=A.+S.+Ivanovauthor=A.+A.+Zhalninaauthor=S.+V.+Shishkov&title=A+convergent+approach+to+synthesis+of+bortezomib%3A+the+use+of+TBTU+suppresses+racemization+in+the+fragment+condensation&doi=10.1016%2Fj.tet.2009.06.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A convergent approach to synthesis of bortezomib: the use of TBTU suppresses racemization in the fragment condensation</span></div><div class="casAuthors">Ivanov, Andrey S.; Zhalnina, Anna A.; Shishkov, Sergey V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7105-7108</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bortezomib (I) is a first-in-class therapeutic antineoplastic agent used for treating patients with multiple myeloma and mantle cell lymphoma.  In this paper we report an improved method for synthesis of the title compd. using a convergent approach.  TBTU was found to efficiently suppress racemization in the fragment condensation.  In comparison with the original synthesis, the presented one is shorter by two steps, higher in yield, and provides better atom economy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoju9EMTW_imrVg90H21EOLACvtfcHk0lhWcVwS_3c6sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVGgtL8%253D&md5=e6bc84fc1b41d91164910fc186697986</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2009.06.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2009.06.042%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aufirst%3DA.%2BS.%26aulast%3DZhalnina%26aufirst%3DA.%2BA.%26aulast%3DShishkov%26aufirst%3DS.%2BV.%26atitle%3DA%2520convergent%2520approach%2520to%2520synthesis%2520of%2520bortezomib%253A%2520the%2520use%2520of%2520TBTU%2520suppresses%2520racemization%2520in%2520the%2520fragment%2520condensation%26jtitle%3DTetrahedron%26date%3D2009%26volume%3D65%26spage%3D7105%26epage%3D7108%26doi%3D10.1016%2Fj.tet.2009.06.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocks, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, D. J. S.</span></span> <span> </span><span class="NLM_article-title">Directed chiral synthesis by way of α-chloro boronic esters</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1536</span>– <span class="NLM_lpage">1543</span>, <span class="refDoi"> DOI: 10.1021/om50005a009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om50005a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1983&pages=1536-1543&author=D.+S.+Mattesonauthor=R.+Rayauthor=R.+R.+Rocksauthor=D.+J.+S.+Tsai&title=Directed+chiral+synthesis+by+way+of+%CE%B1-chloro+boronic+esters&doi=10.1021%2Fom50005a009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fom50005a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom50005a009%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DRay%26aufirst%3DR.%26aulast%3DRocks%26aufirst%3DR.%2BR.%26aulast%3DTsai%26aufirst%3DD.%2BJ.%2BS.%26atitle%3DDirected%2520chiral%2520synthesis%2520by%2520way%2520of%2520%25CE%25B1-chloro%2520boronic%2520esters%26jtitle%3DOrganometallics%26date%3D1983%26volume%3D2%26spage%3D1536%26epage%3D1543%26doi%3D10.1021%2Fom50005a009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutts, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krolikowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, R. J.</span></span> <span> </span><span class="NLM_article-title">Two efficient methods for the cleavage of pinanediol boronate esters yielding the free boronic acids</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">5109</span>– <span class="NLM_lpage">5112</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)77040-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2FS0040-4039%2800%2977040-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADyaK2MXjsFKqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=5109-5112&author=S.+J.+Couttsauthor=J.+Adamsauthor=D.+Krolikowskiauthor=R.+J.+Snow&title=Two+efficient+methods+for+the+cleavage+of+pinanediol+boronate+esters+yielding+the+free+boronic+acids&doi=10.1016%2FS0040-4039%2800%2977040-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Two efficient methods for the cleavage of pinanediol boronate esters yielding the free boronic acids</span></div><div class="casAuthors">Coutts, Simon J.; Adams, Julian; Krolikowski, Dale; Snow, Roger J.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">5109-12</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">Two synthetic methods for the prepn. of boronic acids, e.g., I, from their corresponding pinanediol boronate esters are reported.  The key to success of the procedures relies on removal of the liberated pinanediol from the reaction mixt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovKLzYSZwH67Vg90H21EOLACvtfcHk0lhWcVwS_3c6sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsFKqtg%253D%253D&md5=9f9c563a1a4238b431eaac51124ba31e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2977040-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252977040-7%26sid%3Dliteratum%253Aachs%26aulast%3DCoutts%26aufirst%3DS.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DKrolikowski%26aufirst%3DD.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26atitle%3DTwo%2520efficient%2520methods%2520for%2520the%2520cleavage%2520of%2520pinanediol%2520boronate%2520esters%2520yielding%2520the%2520free%2520boronic%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D5109%26epage%3D5112%26doi%3D10.1016%2FS0040-4039%2800%2977040-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E. H.</span>; <span class="NLM_string-name">Chung, S. G.</span>; <span class="NLM_string-name">Lee, S. H.</span>; <span class="NLM_string-name">Kwon, H. S.</span>; <span class="NLM_string-name">Lee, J. E.</span>; <span class="NLM_string-name">Kang, D. W.</span>; <span class="NLM_string-name">Joo, J. H.</span>; <span class="NLM_string-name">Lee, Y. H.</span></span> <span> </span><span class="NLM_article-title">Piperazine Derivatives and Process for the Preparation Thereof</span>. <span class="NLM_patent">U.S. Patent 6,028,195</span>, February 22, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=E.+H.+Cho&author=S.+G.+Chung&author=S.+H.+Lee&author=H.+S.+Kwon&author=J.+E.+Lee&author=D.+W.+Kang&author=J.+H.+Joo&author=Y.+H.+Lee&title=Piperazine+Derivatives+and+Process+for+the+Preparation+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DE.%2BH.%26atitle%3DPiperazine%2520Derivatives%2520and%2520Process%2520for%2520the%2520Preparation%2520Thereof%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easley, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, W. S.</span></span> <span> </span><span class="NLM_article-title">Tetrahydrothiophene</span>. <i>Org. Synth.</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">90</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1956&pages=89-90&author=K.+J.+Lawsonauthor=W.+K.+Easleyauthor=W.+S.+Wagner&title=Tetrahydrothiophene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DK.%2BJ.%26aulast%3DEasley%26aufirst%3DW.%2BK.%26aulast%3DWagner%26aufirst%3DW.%2BS.%26atitle%3DTetrahydrothiophene%26jtitle%3DOrg.%2520Synth.%26date%3D1956%26volume%3D36%26spage%3D89%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Photis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquette, L. A.</span></span> <span> </span><span class="NLM_article-title">1,2-Dimethylcyclobutenes by reductive ring-contraction of sulfolanes: <i>cis</i>-7,8-dimethylbicyclo[4.2.0]oct-7-ene</span>. <i>Org. Synth.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1977&pages=53-58&author=J.+M.+Photisauthor=L.+A.+Paquette&title=1%2C2-Dimethylcyclobutenes+by+reductive+ring-contraction+of+sulfolanes%3A+cis-7%2C8-dimethylbicyclo%5B4.2.0%5Doct-7-ene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhotis%26aufirst%3DJ.%2BM.%26aulast%3DPaquette%26aufirst%3DL.%2BA.%26atitle%3D1%252C2-Dimethylcyclobutenes%2520by%2520reductive%2520ring-contraction%2520of%2520sulfolanes%253A%2520cis-7%252C8-dimethylbicyclo%255B4.2.0%255Doct-7-ene%26jtitle%3DOrg.%2520Synth.%26date%3D1977%26volume%3D57%26spage%3D53%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potter, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. S.</span></span> <span> </span><span class="NLM_article-title">Predicting the UV–Vis Spectra of tetraarylcyclopentadienones: using DFT molecular orbital energies to model electronic transitions of organic materials</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2995</span>– <span class="NLM_lpage">3004</span>, <span class="refDoi"> DOI: 10.1021/jo701676x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo701676x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=2995-3004&issue=8&author=R.+G.+Potterauthor=T.+S.+Hughes&title=Predicting+the+UV%E2%80%93Vis+Spectra+of+tetraarylcyclopentadienones%3A+using+DFT+molecular+orbital+energies+to+model+electronic+transitions+of+organic+materials&doi=10.1021%2Fjo701676x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo701676x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo701676x%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DR.%2BG.%26aulast%3DHughes%26aufirst%3DT.%2BS.%26atitle%3DPredicting%2520the%2520UV%25E2%2580%2593Vis%2520Spectra%2520of%2520tetraarylcyclopentadienones%253A%2520using%2520DFT%2520molecular%2520orbital%2520energies%2520to%2520model%2520electronic%2520transitions%2520of%2520organic%2520materials%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26issue%3D8%26spage%3D2995%26epage%3D3004%26doi%3D10.1021%2Fjo701676x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imanishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washizuka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takamura, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human β<sub>3</sub>-adrenergic receptor agonists with good oral bioavailability. Part I</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1925</span>– <span class="NLM_lpage">1944</span>, <span class="refDoi"> DOI: 10.1021/jm701324c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701324c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1ekurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1925-1944&author=M.+Imanishiauthor=Y.+Tomishimaauthor=S.+Itouauthor=H.+Hamashimaauthor=Y.+Nakajimaauthor=K.+Washizukaauthor=M.+Sakuraiauthor=S.+Matsuiauthor=E.+Imamuraauthor=K.+Ueshimaauthor=T.+Yamamotoauthor=N.+Yamamotoauthor=H.+Ishikawaauthor=K.+Nakanoauthor=N.+Unamiauthor=K.+Hamadaauthor=Y.+Matsumuraauthor=F.+Takamuraauthor=K.+Hattori&title=Discovery+of+a+novel+series+of+biphenyl+benzoic+acid+derivatives+as+potent+and+selective+human+%CE%B23-adrenergic+receptor+agonists+with+good+oral+bioavailability.+Part+I&doi=10.1021%2Fjm701324c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β3-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I</span></div><div class="casAuthors">Imanishi, Masashi; Tomishima, Yasuyo; Itou, Shinji; Hamashima, Hitoshi; Nakajima, Yutaka; Washizuka, Kenichi; Sakurai, Minoru; Matsui, Shigeo; Imamura, Emiko; Ueshima, Koji; Yamamoto, Takao; Yamamoto, Nobuhiro; Ishikawa, Hirofumi; Nakano, Keiko; Unami, Naoko; Hamada, Kaori; Matsumura, Yasuhiro; Takamura, Fujiko; Hattori, Kouji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1925-1944</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of biphenyl analogs contg. a benzoic acid moiety based on lead compd. I have been identified as potent and selective human β3 adrenergic receptor (β3-AR) agonists with good oral bioavailability and long plasma half-life.  After further substituent effects were investigated at the terminal Ph ring of lead compd. I, it has been discovered that more lipophilic substitution at the R position improved potency and selectivity.  As a result of these studies, II and III were identified as the leading candidates with the best balance of potency, selectivity, and pharmacokinetic profiles.  In addn., compds. II and III were evaluated to be efficacious for a carbachol-induced increase of intravesical pressure, such as an overactive bladder model in anesthetized dogs.  This represents the first demonstrated result dealing with β3-AR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx1QxEQuf51bVg90H21EOLACvtfcHk0lguT50uGZOSUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1ekurg%253D&md5=4ec8095eca0542c8566be8aee3bb1619</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm701324c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701324c%26sid%3Dliteratum%253Aachs%26aulast%3DImanishi%26aufirst%3DM.%26aulast%3DTomishima%26aufirst%3DY.%26aulast%3DItou%26aufirst%3DS.%26aulast%3DHamashima%26aufirst%3DH.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DWashizuka%26aufirst%3DK.%26aulast%3DSakurai%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DS.%26aulast%3DImamura%26aufirst%3DE.%26aulast%3DUeshima%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DK.%26aulast%3DUnami%26aufirst%3DN.%26aulast%3DHamada%26aufirst%3DK.%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DTakamura%26aufirst%3DF.%26aulast%3DHattori%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520biphenyl%2520benzoic%2520acid%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B23-adrenergic%2520receptor%2520agonists%2520with%2520good%2520oral%2520bioavailability.%2520Part%2520I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1925%26epage%3D1944%26doi%3D10.1021%2Fjm701324c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferro, V.</span></span> <span> </span><span class="NLM_article-title">Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>396</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2009.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.ab.2009.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=19748475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGru77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2010&pages=112-116&issue=1&author=E.+Hammondauthor=C.+P.+Liauthor=V.+Ferro&title=Development+of+a+colorimetric+assay+for+heparanase+activity+suitable+for+kinetic+analysis+and+inhibitor+screening&doi=10.1016%2Fj.ab.2009.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening</span></div><div class="casAuthors">Hammond, Edward; Li, Cai Ping; Ferro, Vito</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-116</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role that heparanase plays during metastasis and angiogenesis in tumors makes it an attractive target for cancer therapeutics.  Despite this enzyme's significance, most of the assays developed to measure its activity are complex.  Moreover, they usually rely on labeling variable prepns. of the natural substrate heparan sulfate, making comparisons across studies precarious.  To overcome these problems, we have developed a convenient assay based on the cleavage of the synthetic heparin oligosaccharide fondaparinux.  The assay measures the appearance of the disaccharide product of heparanase-catalyzed fondaparinux cleavage colorimetrically using the tetrazolium salt WST-1.  Because this assay has a homogeneous substrate with a single point of cleavage, the kinetics of the enzyme can be reliably characterized, giving a Km of 46 μM and a kcat of 3.5 s-1 with fondaparinux as substrate.  The inhibition of heparanase by the published inhibitor, PI-88, was also studied, and a Ki of 7.9 nM was detd.  The simplicity and robustness of this method, should, not only greatly assist routine assay of heparanase activity but also could be adapted for high-throughput screening of compd. libraries, with the data generated being directly comparable across studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0F-7b5OIHBbVg90H21EOLACvtfcHk0liKbUI2NC4t0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGru77P&md5=ac2d77c8c0f99498cb0c061dc3f3e53e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2009.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2009.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DC.%2BP.%26aulast%3DFerro%26aufirst%3DV.%26atitle%3DDevelopment%2520of%2520a%2520colorimetric%2520assay%2520for%2520heparanase%2520activity%2520suitable%2520for%2520kinetic%2520analysis%2520and%2520inhibitor%2520screening%26jtitle%3DAnal.%2520Biochem.%26date%3D2010%26volume%3D396%26issue%3D1%26spage%3D112%26epage%3D116%26doi%3D10.1016%2Fj.ab.2009.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzozowski, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, G. J.</span></span> <span> </span><span class="NLM_article-title">Structural characterization of human heparanase reveals insights into substrate recognition</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1016</span>– <span class="NLM_lpage">1022</span>, <span class="refDoi"> DOI: 10.1038/nsmb.3136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1038%2Fnsmb.3136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=26575439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOgt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1016-1022&author=L.+Wuauthor=C.+M.+Violaauthor=A.+M.+Brzozowskiauthor=G.+J.+Davies&title=Structural+characterization+of+human+heparanase+reveals+insights+into+substrate+recognition&doi=10.1038%2Fnsmb.3136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization of human heparanase reveals insights into substrate recognition</span></div><div class="casAuthors">Wu, Liang; Viola, Cristina M.; Brzozowski, Andrzej M.; Davies, Gideon J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1016-1022</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heparan sulfate (HS) is a glycosaminoglycan that forms a key component of the extracellular matrix (ECM).  Breakdown of HS is carried out by heparanase (HPSE), an endo-β-glucuronidase of the glycoside hydrolase 79 (GH79) family.  Overexpression of HPSE results in breakdown of extracellular HS and release of stored growth factors and hence is strongly linked to cancer metastasis.  Here we present crystal structures of human HPSE at 1.6-Å to 1.9-Å resoln. that reveal how an endo-acting binding cleft is exposed by proteolytic activation of latent proHPSE.  We used oligosaccharide complexes to map the substrate-binding and sulfate-recognition motifs.  These data shed light on the structure and interactions of a key enzyme involved in ECM maintenance and provide a starting point for the design of HPSE inhibitors for use as biochem. tools and anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJvMLF8YGlyrVg90H21EOLACvtfcHk0liKbUI2NC4t0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOgt7zP&md5=4cfc53cef5da1db59a7be6450f3a0871</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3136%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DL.%26aulast%3DViola%26aufirst%3DC.%2BM.%26aulast%3DBrzozowski%26aufirst%3DA.%2BM.%26aulast%3DDavies%26aufirst%3DG.%2BJ.%26atitle%3DStructural%2520characterization%2520of%2520human%2520heparanase%2520reveals%2520insights%2520into%2520substrate%2520recognition%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D1016%26epage%3D1022%26doi%3D10.1038%2Fnsmb.3136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levy-Adam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud-Jarrous, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beccati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">20457</span>– <span class="NLM_lpage">20466</span>, <span class="refDoi"> DOI: 10.1074/jbc.M414546200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1074%2Fjbc.M414546200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=20457-20466&author=F.+Levy-Adamauthor=G.+Abboud-Jarrousauthor=M.+Guerriniauthor=D.+Beccatiauthor=I.+Vlodavskyauthor=N.+Ilan&title=Identification+and+characterization+of+heparin%2Fheparan+sulfate+binding+domains+of+the+endoglycosidase+heparanase&doi=10.1074%2Fjbc.M414546200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M414546200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M414546200%26sid%3Dliteratum%253Aachs%26aulast%3DLevy-Adam%26aufirst%3DF.%26aulast%3DAbboud-Jarrous%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DM.%26aulast%3DBeccati%26aufirst%3DD.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DIlan%26aufirst%3DN.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520heparin%252Fheparan%2520sulfate%2520binding%2520domains%2520of%2520the%2520endoglycosidase%2520heparanase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D20457%26epage%3D20466%26doi%3D10.1074%2Fjbc.M414546200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nardella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallaoro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vannini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinkühler, C.</span></span> <span> </span><span class="NLM_article-title">Mechanism of activation of human heparanase investigated by protein engineering</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1862</span>– <span class="NLM_lpage">1873</span>, <span class="refDoi"> DOI: 10.1021/bi030203a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi030203a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=1862-1873&author=C.+Nardellaauthor=A.+Lahmauthor=M.+Pallaoroauthor=M.+Brunettiauthor=A.+Vanniniauthor=C.+Steink%C3%BChler&title=Mechanism+of+activation+of+human+heparanase+investigated+by+protein+engineering&doi=10.1021%2Fbi030203a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi030203a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi030203a%26sid%3Dliteratum%253Aachs%26aulast%3DNardella%26aufirst%3DC.%26aulast%3DLahm%26aufirst%3DA.%26aulast%3DPallaoro%26aufirst%3DM.%26aulast%3DBrunetti%26aufirst%3DM.%26aulast%3DVannini%26aufirst%3DA.%26aulast%3DSteink%25C3%25BChler%26aufirst%3DC.%26atitle%3DMechanism%2520of%2520activation%2520of%2520human%2520heparanase%2520investigated%2520by%2520protein%2520engineering%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D1862%26epage%3D1873%26doi%3D10.1021%2Fbi030203a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simizu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodeoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osada, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of a selective heparanase inhibitor as an antimetastatic agent</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1069</span>– <span class="NLM_lpage">1077</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=15367701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFajt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1069-1077&issue=9&author=K.+Ishidaauthor=G.+Hiraiauthor=K.+Murakamiauthor=T.+Teruyaauthor=S.+Simizuauthor=M.+Sodeokaauthor=H.+Osada&title=Structure-based+design+of+a+selective+heparanase+inhibitor+as+an+antimetastatic+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of a selective heparanase inhibitor as an antimetastatic agent</span></div><div class="casAuthors">Ishida, Keisuke; Hirai, Go; Murakami, Koji; Teruya, Takayuki; Simizu, Siro; Sodeoka, Mikiko; Osada, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1069-1077</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Heparanase is an endo-β-D-glucuronidase that degrades heparan sulfate glycosaminoglycans in the extracellular matrix and the basement membrane and is well known to be involved in tumor cell invasion and angiogenesis.  The authors have focused on heparanase as a target for antitumor agents, esp. antimetastatic agents.  (R)-3-hexadecanoyl-5-hydroxymethyltetronic acid (RK-682) was found to display an inhibitory activity against heparanase in the authors screening of natural sources.  Because RK-682 has been reported to show inhibitory activities against several enzymes, the authors have tried to develop selective heparanase inhibitors using the method of rational drug design.  Based on the structure of the heparanase/RK-682 complex, the authors speculated that selective inhibitory activity against heparanase could be acquired by arylalkylation, namely, by benzylation of the 4-position of RK-682.  Among the rationally designed 4-alkyl-RK-682 derivs., 4-benzyl-RK-682 has been found to possess a selective inhibitory activity for heparanase (IC50 for heparanase, 17 μmol/L; IC50 for other enzymes, >100 μmol/L).  4-Benzyl-RK-682 also inhibited the invasion and migration of human fibrosarcoma HT1080 cells (IC50 for invasion, 1.5 μmol/L; IC50 for migration, 3.0 μmol/L).  RK-682 had no inhibitory effect on the invasion and migration of HT1080 cells at doses of ≤100 μmol/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ex0qg365qrVg90H21EOLACvtfcHk0lhgjx6kCC0p5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFajt7g%253D&md5=b3213a11713031464f9ab1a37b37119a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DG.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DTeruya%26aufirst%3DT.%26aulast%3DSimizu%26aufirst%3DS.%26aulast%3DSodeoka%26aufirst%3DM.%26aulast%3DOsada%26aufirst%3DH.%26atitle%3DStructure-based%2520design%2520of%2520a%2520selective%2520heparanase%2520inhibitor%2520as%2520an%2520antimetastatic%2520agent%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26issue%3D9%26spage%3D1069%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zetser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashenko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span> <span> </span><span class="NLM_article-title">Heparanase affects adhesive and tumorigenic potential of human glioma cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">7733</span>– <span class="NLM_lpage">7741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7733-7741&author=A.+Zetserauthor=Y.+Bashenkoauthor=H.+Q.+Miaoauthor=I.+Vlodavskyauthor=N.+Ilan&title=Heparanase+affects+adhesive+and+tumorigenic+potential+of+human+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZetser%26aufirst%3DA.%26aulast%3DBashenko%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DH.%2BQ.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DIlan%26aufirst%3DN.%26atitle%3DHeparanase%2520affects%2520adhesive%2520and%2520tumorigenic%2520potential%2520of%2520human%2520glioma%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7733%26epage%3D7741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortoreto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrangolini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, F.</span></span> <span> </span><span class="NLM_article-title">Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">1424</span>– <span class="NLM_lpage">1432</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2013.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.bcp.2013.02.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=1424-1432&author=G.+Cassinelliauthor=C.+Lanziauthor=M.+Tortoretoauthor=D.+Cominettiauthor=G.+Petrangoliniauthor=E.+Faviniauthor=N.+Zaffaroniauthor=C.+Pisanoauthor=S.+Pencoauthor=I.+Vlodavskyauthor=F.+Zunino&title=Antitumor+efficacy+of+the+heparanase+inhibitor+SST0001+alone+and+in+combination+with+antiangiogenic+agents+in+the+treatment+of+human+pediatric+sarcoma+models&doi=10.1016%2Fj.bcp.2013.02.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DCominetti%26aufirst%3DD.%26aulast%3DPetrangolini%26aufirst%3DG.%26aulast%3DFavini%26aufirst%3DE.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DPisano%26aufirst%3DC.%26aulast%3DPenco%26aufirst%3DS.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DAntitumor%2520efficacy%2520of%2520the%2520heparanase%2520inhibitor%2520SST0001%2520alone%2520and%2520in%2520combination%2520with%2520antiangiogenic%2520agents%2520in%2520the%2520treatment%2520of%2520human%2520pediatric%2520sarcoma%2520models%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D1424%26epage%3D1432%26doi%3D10.1016%2Fj.bcp.2013.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Bo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortoreto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cesare, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanziani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naggi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzi, C.</span></span> <span> </span><span class="NLM_article-title">Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>415</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.canlet.2017.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=29225052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2gurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2018&pages=187-197&author=G.+Cassinelliauthor=L.+Dal+Boauthor=E.+Faviniauthor=D.+Cominettiauthor=S.+Pozziauthor=M.+Tortoretoauthor=M.+De+Cesareauthor=D.+Lecisauthor=E.+Scanzianiauthor=L.+Minoliauthor=A.+Naggiauthor=I.+Vlodavskyauthor=N.+Zaffaroniauthor=C.+Lanzi&title=Supersulfated+low-molecular+weight+heparin+synergizes+with+IGF1R%2FIR+inhibitor+to+suppress+synovial+sarcoma+growth+and+metastases&doi=10.1016%2Fj.canlet.2017.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases</span></div><div class="casAuthors">Cassinelli, Giuliana; Dal Bo, Laura; Favini, Enrica; Cominetti, Denis; Pozzi, Sabina; Tortoreto, Monica; De Cesare, Michelandrea; Lecis, Daniele; Scanziani, Eugenio; Minoli, Lucia; Naggi, Annamaria; Vlodavsky, Israel; Zaffaroni, Nadia; Lanzi, Cinzia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">187-197</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Synovial sarcoma (SS) is an aggressive tumor with propensity for lung metastases which significantly impact patients' prognosis.  New therapeutic approaches are needed to improve treatment outcome.  Targeting the heparanase/heparan sulfate proteoglycan system by heparin derivs. which act as heparanase inhibitors/heparan sulfate mimetics is emerging as a therapeutic approach that can sensitize the tumor response to chemotherapy.  We investigated the therapeutic potential of a supersulfated low mol. wt. heparin (ssLMWH) in preclin. models of SS. ssLMWH showed a potent anti-heparanase activity, dose-dependently inhibited SS colony growth and cell invasion, and downregulated the activation of receptor tyrosine kinases including IGF1R and IR.  The combination of ssLMWH and the IGF1R/IR inhibitor BMS754807 synergistically inhibited proliferation of cells exhibiting IGF1R hyperactivation, also abrogating cell motility and promoting apoptosis in assocn. with PI3K/AKT pathway inhibition.  The drug combination strongly enhanced the antitumor effect against the CME-1 model, as compared to single agent treatment, abrogating orthotopic tumor growth and significantly repressing spontaneous lung metastatic dissemination in treated mice.  These findings provide a strong preclin. rationale for developing drug regimens combining heparanase inhibitors/HS mimetics with IGF1R antagonists for treatment of metastatic SS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJNBQkAdTk1LVg90H21EOLACvtfcHk0lhgjx6kCC0p5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2gurnO&md5=727352c4ff78b61c5315a94a55aac2e0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DDal%2BBo%26aufirst%3DL.%26aulast%3DFavini%26aufirst%3DE.%26aulast%3DCominetti%26aufirst%3DD.%26aulast%3DPozzi%26aufirst%3DS.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DDe%2BCesare%26aufirst%3DM.%26aulast%3DLecis%26aufirst%3DD.%26aulast%3DScanziani%26aufirst%3DE.%26aulast%3DMinoli%26aufirst%3DL.%26aulast%3DNaggi%26aufirst%3DA.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DLanzi%26aufirst%3DC.%26atitle%3DSupersulfated%2520low-molecular%2520weight%2520heparin%2520synergizes%2520with%2520IGF1R%252FIR%2520inhibitor%2520to%2520suppress%2520synovial%2520sarcoma%2520growth%2520and%2520metastases%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D415%26spage%3D187%26epage%3D197%26doi%3D10.1016%2Fj.canlet.2017.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Bo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortoreto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maglie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagrada, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffaroni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzi, C.</span></span> <span> </span><span class="NLM_article-title">Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">47848</span>– <span class="NLM_lpage">47863</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.18632%2Foncotarget.10292" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=47848-47863&author=G.+Cassinelliauthor=E.+Faviniauthor=L.+Dal+Boauthor=M.+Tortoretoauthor=M.+De+Maglieauthor=G.+Dagradaauthor=S.+Pilottiauthor=F.+Zuninoauthor=N.+Zaffaroniauthor=C.+Lanzi&title=Antitumor+efficacy+of+the+heparan+sulfate+mimic+roneparstat+%28SST0001%29+against+sarcoma+models+involves+multi-target+inhibition+of+receptor+tyrosine+kinases&doi=10.18632%2Foncotarget.10292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10292%26sid%3Dliteratum%253Aachs%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DFavini%26aufirst%3DE.%26aulast%3DDal%2BBo%26aufirst%3DL.%26aulast%3DTortoreto%26aufirst%3DM.%26aulast%3DDe%2BMaglie%26aufirst%3DM.%26aulast%3DDagrada%26aufirst%3DG.%26aulast%3DPilotti%26aufirst%3DS.%26aulast%3DZunino%26aufirst%3DF.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DLanzi%26aufirst%3DC.%26atitle%3DAntitumor%2520efficacy%2520of%2520the%2520heparan%2520sulfate%2520mimic%2520roneparstat%2520%2528SST0001%2529%2520against%2520sarcoma%2520models%2520involves%2520multi-target%2520inhibition%2520of%2520receptor%2520tyrosine%2520kinases%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D47848%26epage%3D47863%26doi%3D10.18632%2Foncotarget.10292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shushy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Izhak, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlodavsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldshmidt, O.</span></span> <span> </span><span class="NLM_article-title">Human heparanase nuclear localization and enzymatic activity</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1038/labinvest.3700084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1038%2Flabinvest.3700084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=535-544&author=S.+Y.+Schubertauthor=N.+Ilanauthor=M.+Shushyauthor=O.+Ben-Izhakauthor=I.+Vlodavskyauthor=O.+Goldshmidt&title=Human+heparanase+nuclear+localization+and+enzymatic+activity&doi=10.1038%2Flabinvest.3700084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.3700084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.3700084%26sid%3Dliteratum%253Aachs%26aulast%3DSchubert%26aufirst%3DS.%2BY.%26aulast%3DIlan%26aufirst%3DN.%26aulast%3DShushy%26aufirst%3DM.%26aulast%3DBen-Izhak%26aufirst%3DO.%26aulast%3DVlodavsky%26aufirst%3DI.%26aulast%3DGoldshmidt%26aufirst%3DO.%26atitle%3DHuman%2520heparanase%2520nuclear%2520localization%2520and%2520enzymatic%2520activity%26jtitle%3DLab.%2520Invest.%26date%3D2004%26volume%3D84%26spage%3D535%26epage%3D544%26doi%3D10.1038%2Flabinvest.3700084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, R. D.</span></span> <span> </span><span class="NLM_article-title">Heparanase regulates levels of syndecan-1 in the nucleus</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e4947</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0004947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1371%2Fjournal.pone.0004947" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=L.+Chenauthor=R.+D.+Sanderson&title=Heparanase+regulates+levels+of+syndecan-1+in+the+nucleus&doi=10.1371%2Fjournal.pone.0004947"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004947%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSanderson%26aufirst%3DR.%2BD.%26atitle%3DHeparanase%2520regulates%2520levels%2520of%2520syndecan-1%2520in%2520the%2520nucleus%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0004947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span> </span><span class="NLM_article-title">Schrödinger
Release 2015–4</span>.  <i>Maestro</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger%0ARelease+2015%E2%80%934.+Maestro%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DSchr%25C3%25B6dinger%250ARelease%25202015%25E2%2580%25934%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span> </span><span class="NLM_article-title">Schrödinger
Release 2015–4</span>.  <i>LigPrep</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger%0ARelease+2015%E2%80%934.+LigPrep%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DSchr%25C3%25B6dinger%250ARelease%25202015%25E2%2580%25934%26btitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span> </span><span class="NLM_article-title">Schrödinger
Release 2015–4</span>.  <i>Glide</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger%0ARelease+2015%E2%80%934.+Glide%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DSchr%25C3%25B6dinger%250ARelease%25202015%25E2%2580%25934%26btitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.%0AA.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=D.+E.+Shawauthor=M.+Shelleyauthor=J.+K.+Perryauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lgxbMJW4ek8Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1750</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1021/jm030644s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.%0AA.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+2.+Enrichment+factors+in+database+screening&doi=10.1021%2Fjm030644s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0lgxbMJW4ek8Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25202.%2520Enrichment%2520factors%2520in%2520database%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759%26doi%3D10.1021%2Fjm030644s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaminski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">6474</span>– <span class="NLM_lpage">6487</span>, <span class="refDoi"> DOI: 10.1021/jp003919d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp003919d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2001&pages=6474-6487&author=G.+A.+Kaminskiauthor=R.+A.+Friesnerauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Evaluation+and+reparametrization+of+the+OPLS-AA+force+field+for+proteins+via+comparison+with+accurate+quantum+chemical+calculations+on+peptides&doi=10.1021%2Fjp003919d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides</span></div><div class="casAuthors">Kaminski, George A.; Friesner, Richard A.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6474-6487</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1089-5647</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present results of improving the OPLS-AA force field for peptides by means of refitting the key Fourier torsional coeffs.  The fitting technique combines using accurate ab initio data as the target, choosing an efficient fitting subspace of the whole potential-energy surface, and detg. wts. for each of the fitting points based on magnitudes of the potential-energy gradient.  The av. energy RMS deviation from the LMP2/cc-pVTZ(-f)//HF/6-31G** data is reduced by ∼40% from 0.81 to 0.47 kcal/mol as a result of the fitting for the electrostatically uncharged dipeptides.  Transferability of the parameters is demonstrated by using the same alanine dipeptide-fitted backbone torsional parameters for all of the other dipeptides (with the appropriate side-chain refitting) and the alanine tetrapeptide.  Parameters of nonbonded interactions have also been refitted for the sulfur-contg. dipeptides (cysteine and methionine), and the validity of the new Coulombic charges and the van der Waals σ's and ε's is proved through reproducing gas-phase energies of complex formation heats of vaporization and densities of pure model liqs.  Moreover, a novel approach to fitting torsional parameters for electrostatically charged mol. systems has been presented and successfully tested on five dipeptides with charged side chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSHwmffIQePbVg90H21EOLACvtfcHk0lh7c60cgORsrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislKhsLk%253D&md5=3ff059626977ee7f6342466f5820f5b7</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjp003919d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp003919d%26sid%3Dliteratum%253Aachs%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DEvaluation%2520and%2520reparametrization%2520of%2520the%2520OPLS-AA%2520force%2520field%2520for%2520proteins%2520via%2520comparison%2520with%2520accurate%2520quantum%2520chemical%2520calculations%2520on%2520peptides%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2001%26volume%3D105%26spage%3D6474%26epage%3D6487%26doi%3D10.1021%2Fjp003919d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span> </span><span class="NLM_article-title">Schrödinger Release 2016–4</span>.  <i>Desmond Molecular Dynamics System</i>; <span class="NLM_publisher-name">D. E.
Shaw Research</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Release+2016%E2%80%934.+Desmond+Molecular+Dynamics+System%3B+D.+E.%0AShaw+Research%3A+New+York%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DSchr%25C3%25B6dinger%2520Release%25202016%25E2%2580%25934%26btitle%3DDesmond%2520Molecular%2520Dynamics%2520System%26pub%3DD.%2520E.%250AShaw%2520Research%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span> <i>Maestro-Desmond Interoperability
Tools</i>; <span class="NLM_publisher-name">Schrödinger</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Maestro-Desmond+Interoperability%0ATools%3B+Schr%C3%B6dinger%3A+New+York%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro-Desmond%2520Interoperability%250ATools%26pub%3DSchr%25C3%25B6dinger%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span>; <span class="NLM_string-name">Babin, V.</span>; <span class="NLM_string-name">Berryman, J. T.</span>; <span class="NLM_string-name">Betz, R. M.</span>; <span class="NLM_string-name">Cai, Q.</span>; <span class="NLM_string-name">Cerutti, D. S.</span>; <span class="NLM_string-name">Cheatham,  III, T. E.</span>; <span class="NLM_string-name">Darden, T. A.</span>; <span class="NLM_string-name">Duke, R. E.</span>; <span class="NLM_string-name">Gohlke, H.</span>; <span class="NLM_string-name">Goetz, A. W.</span>; <span class="NLM_string-name">Gusarov, S.</span>; <span class="NLM_string-name">Homeyer, N.</span>; <span class="NLM_string-name">Janowski, P.</span>; <span class="NLM_string-name">Kaus, J.</span>; <span class="NLM_string-name">Kolossváry, I.</span>; <span class="NLM_string-name">Kovalenko, A.</span>; <span class="NLM_string-name">Lee, T. S.</span>; <span class="NLM_string-name">LeGrand, S.</span>; <span class="NLM_string-name">Luchko, T.</span>; <span class="NLM_string-name">Luo, R.</span>; <span class="NLM_string-name">Madej, B.</span>; <span class="NLM_string-name">Merz, K. M.</span>; <span class="NLM_string-name">Paesani, F.</span>; <span class="NLM_string-name">Roe, D. R.</span>; <span class="NLM_string-name">Roitberg, A.</span>; <span class="NLM_string-name">Sagui, C.</span>; <span class="NLM_string-name">Salomon-Ferrer, R.</span>; <span class="NLM_string-name">Seabra, G.</span>; <span class="NLM_string-name">Simmerling, C. L.</span>; <span class="NLM_string-name">Smith, W.</span>; <span class="NLM_string-name">Swails, J.</span>; <span class="NLM_string-name">Walker, R. C.</span>; <span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Wolf, R. M.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Kollman, P. A.</span></span> <i>AMBER 14</i>; <span class="NLM_publisher-name">University of California</span>, <span class="NLM_publisher-loc">San Francisco</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+A.+Case&author=V.+Babin&author=J.+T.+Berryman&author=R.+M.+Betz&author=Q.+Cai&author=D.+S.+Cerutti&author=T.+E.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=H.+Gohlke&author=A.+W.+Goetz&author=S.+Gusarov&author=N.+Homeyer&author=P.+Janowski&author=J.+Kaus&author=I.+Kolossv%C3%A1ry&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=T.+Luchko&author=R.+Luo&author=B.+Madej&author=K.+M.+Merz&author=F.+Paesani&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=R.+Salomon-Ferrer&author=G.+Seabra&author=C.+L.+Simmerling&author=W.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.+M.+Wolf&author=X.+Wu&author=P.+A.+Kollman&title=AMBER+14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26btitle%3DAMBER%252014%26pub%3DUniversity%2520of%2520California%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Development and testing of a general amber force field</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.1002/jcc.20035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1002%2Fjcc.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=15116359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1157-1174&author=J.+Wangauthor=R.+M.+Wolfauthor=J.+W.+Caldwellauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Development+and+testing+of+a+general+amber+force+field&doi=10.1002%2Fjcc.20035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Development and testing of a general Amber force field</span></div><div class="casAuthors">Wang, Junmei; Wolf, Romain M.; Caldwell, James W.; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1174</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe here a general Amber force field (GAFF) for org. mols.  GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most org. and pharmaceutical mols. that are composed of H, C, N, O, S, P, and halogens.  It uses a simple functional form and a limited no. of atom types, but incorporates both empirical and heuristic models to est. force consts. and partial at. charges.  The performance of GAFF in test cases is encouraging.  In test I, 74 crystallog. structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 Å, which is comparable to that of the Tripos 5.2 force field (0.25 Å) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 Å, resp.).  In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermol. energies were compared to MP2/6-31G* results.  The RMS of displacements and relative energies were 0.25 Å and 1.2 kcal/mol, resp.  These data are comparable to results from Parm99/RESP (0.16 Å and 1.18 kcal/mol, resp.), which were parameterized to these base pairs.  Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field.  The RMS error in relative energies (compared to expt.) is about 0.5 kcal/mol.  GAFF can be applied to wide range of mols. in an automatic fashion, making it suitable for rational drug design and database searching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW8Gsf8IiW7Vg90H21EOLACvtfcHk0lh7c60cgORsrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D&md5=2992017a8cf51f89290ae2562403b115</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520a%2520general%2520amber%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1157%26epage%3D1174%26doi%3D10.1002%2Fjcc.20035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Automatic atom type and bond type perception in molecular mechanical calculations</span>. <i>J. Mol. Graphics Modell.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1016/j.jmgm.2005.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1016%2Fj.jmgm.2005.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=16458552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=247-260&author=J.+Wangauthor=W.+Wangauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Automatic+atom+type+and+bond+type+perception+in+molecular+mechanical+calculations&doi=10.1016%2Fj.jmgm.2005.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Automatic atom type and bond type perception in molecular mechanical calculations</span></div><div class="casAuthors">Wang, Junmei; Wang, Wei; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-260</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In mol. mechanics (MM) studies, atom types and/or bond types of mols. are needed to det. prior to energy calcns.  The authors present here an automatic algorithm of perceiving atom types that are defined in a description table, and an automatic algorithm of assigning bond types just based on at. connectivity.  The algorithms have been implemented in a new module of the AMBER packages.  This auxiliary module, antechamber (roughly meaning "before AMBER"), can be applied to generate necessary inputs of leap-the AMBER program to generate topologies for minimization, mol. dynamics, etc., for most org. mols.  The algorithms behind the manipulations may be useful for other mol. mech. packages as well as applications that need to designate atom types and bond types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqizj6F18nBYbVg90H21EOLACvtfcHk0lgBRWYK01p9tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D&md5=8031a21d2784d5dea12e70868522aa61</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2005.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2005.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DAutomatic%2520atom%2520type%2520and%2520bond%2520type%2520perception%2520in%2520molecular%2520mechanical%2520calculations%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2006%26volume%3D25%26spage%3D247%26epage%3D260%26doi%3D10.1016%2Fj.jmgm.2005.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feller, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, B. R.</span></span> <span> </span><span class="NLM_article-title">Constant pressure molecular dynamics simulation: the Langevin piston method</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">4613</span>– <span class="NLM_lpage">4621</span>, <span class="refDoi"> DOI: 10.1063/1.470648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1063%2F1.470648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADyaK2MXotVentLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=4613-4621&author=S.+E.+Fellerauthor=Y.+Zhangauthor=R.+W.+Pastorauthor=B.+R.+Brooks&title=Constant+pressure+molecular+dynamics+simulation%3A+the+Langevin+piston+method&doi=10.1063%2F1.470648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Constant pressure molecular dynamics simulation: the Langevin piston method</span></div><div class="casAuthors">Feller, Scott E.; Zhang, Yuhong; Pastor, Richard W.; Brooks, Bernard R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4613-21</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">A new method for performing mol. dynamics simulations under const. pressure is presented.  In the method, which is based on the extended system formalism introduced by Andersen, the deterministic equations of motion for the piston degree of freedom are replaced by a Langevin equation; a suitable choice of collision frequency then eliminates the unphys. "ringing" of the vol. assocd. with the piston mass.  In this way it is similar to the "weak coupling algorithm" developed by Berendsen and co-workers to perform mol. dynamics simulation without piston mass effects.  It is shown, however, that the weak coupling algorithm induces artifacts into the simulation which can be quite severe for inhomogeneous systems such as aq. biopolymers or liq./liq. interfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZp5NIYiFpuLVg90H21EOLACvtfcHk0lgBRWYK01p9tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotVentLo%253D&md5=219a4e0a48397a35fa2c62cf99bf225a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1063%2F1.470648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470648%26sid%3Dliteratum%253Aachs%26aulast%3DFeller%26aufirst%3DS.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPastor%26aufirst%3DR.%2BW.%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26atitle%3DConstant%2520pressure%2520molecular%2520dynamics%2520simulation%253A%2520the%2520Langevin%2520piston%2520method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D4613%26epage%3D4621%26doi%3D10.1063%2F1.470648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lippert, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregersen, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepeis, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolossvary, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">A common, avoidable source of error in molecular dynamics integrators</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">046101</span>, <span class="refDoi"> DOI: 10.1063/1.2431176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1063%2F1.2431176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=17286520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFykt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2007&pages=046101&author=R.+A.+Lippertauthor=K.+J.+Bowersauthor=R.+O.+Drorauthor=M.+P.+Eastwoodauthor=B.+A.+Gregersenauthor=J.+L.+Klepeisauthor=I.+Kolossvaryauthor=D.+E.+Shaw&title=A+common%2C+avoidable+source+of+error+in+molecular+dynamics+integrators&doi=10.1063%2F1.2431176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A common, avoidable source of error in molecular dynamics integrators</span></div><div class="casAuthors">Lippert, Ross A.; Bowers, Kevin J.; Dror, Ron O.; Eastwood, Michael P.; Gregersen, Brent A.; Klepeis, John L.; Kolossvary, Istvan; Shaw, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">046101/1-046101/2</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">In constrained mol. dynamics simulations using some of the most popular mol. dynamics codes, calcn. of the velocities of constrained particles is based solely on the differences in particle positions during two successive time steps.  This creates a numerical instability that the authors' show to be significant in a typical single-precision floating-point simulation.  They describe a simple modification that eliminates this source of instability and demonstrate that this change substantially reduces the energy drift of a sample single-precision NVE simulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-74DiWbDnm7Vg90H21EOLACvtfcHk0lgBRWYK01p9tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFykt74%253D&md5=ed90e46350484b6d63fabd1b85146254</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1063%2F1.2431176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.2431176%26sid%3Dliteratum%253Aachs%26aulast%3DLippert%26aufirst%3DR.%2BA.%26aulast%3DBowers%26aufirst%3DK.%2BJ.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DEastwood%26aufirst%3DM.%2BP.%26aulast%3DGregersen%26aufirst%3DB.%2BA.%26aulast%3DKlepeis%26aufirst%3DJ.%2BL.%26aulast%3DKolossvary%26aufirst%3DI.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26atitle%3DA%2520common%252C%2520avoidable%2520source%2520of%2520error%2520in%2520molecular%2520dynamics%2520integrators%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D2007%26volume%3D126%26spage%3D046101%26doi%3D10.1063%2F1.2431176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Essmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkowitz, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, L. G.</span></span> <span> </span><span class="NLM_article-title">A smooth particle mesh Ewald method</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8577</span>– <span class="NLM_lpage">8593</span>, <span class="refDoi"> DOI: 10.1063/1.470117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1063%2F1.470117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=8577-8593&author=U.+Essmannauthor=L.+Pereraauthor=M.+L.+Berkowitzauthor=T.+Dardenauthor=H.+Leeauthor=L.+G.+Pedersen&title=A+smooth+particle+mesh+Ewald+method&doi=10.1063%2F1.470117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A smooth particle mesh Ewald method</span></div><div class="casAuthors">Essmann, Ulrich; Perera, Lalith; Berkowitz, Max L.; Darden, Tom; Lee, Hsing; Pedersen, Lee G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8577-93</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The previously developed particle mesh Ewald method is reformulated in terms of efficient B-spline interpolation of the structure factors.  This reformulation allows a natural extension of the method to potentials of the form 1/rp with p ≥ 1.  Furthermore, efficient calcn. of the virial tensor follows.  Use of B-splines in the place of Lagrange interpolation leads to analytic gradients as well as a significant improvement in the accuracy.  The authors demonstrate that arbitrary accuracy can be achieved, independent of system size N, at a cost that scales as N log(N).  For biomol. systems with many thousands of atoms and this method permits the use of Ewald summation at a computational cost comparable to that of a simple truncation method of 10 Å or less.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Bp1XlSY32LVg90H21EOLACvtfcHk0lgBRWYK01p9tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D&md5=092a679dd3bee08da28df41e302383a7</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1063%2F1.470117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470117%26sid%3Dliteratum%253Aachs%26aulast%3DEssmann%26aufirst%3DU.%26aulast%3DPerera%26aufirst%3DL.%26aulast%3DBerkowitz%26aufirst%3DM.%2BL.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPedersen%26aufirst%3DL.%2BG.%26atitle%3DA%2520smooth%2520particle%2520mesh%2520Ewald%2520method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D8577%26epage%3D8593%26doi%3D10.1063%2F1.470117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuckerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martyna, J.</span></span> <span> </span><span class="NLM_article-title">Reversible multiple time scale molecular dynamics</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1990</span>– <span class="NLM_lpage">2001</span>, <span class="refDoi"> DOI: 10.1063/1.463137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1063%2F1.463137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADyaK38XltFyksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1992&pages=1990-2001&author=M.+Tuckermanauthor=B.+J.+Berneauthor=J.+Martyna&title=Reversible+multiple+time+scale+molecular+dynamics&doi=10.1063%2F1.463137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible multiple time scale molecular dynamics</span></div><div class="casAuthors">Tuckerman, M.; Berne, B. J.; Martyna, G. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1990-2001</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">The Trotter factorization of the Liouville propagator is used to generate new reversible mol. dynamics integrators.  This strategy is applied to derive reversible ref. system propagator algorithms (RESPA) that greatly accelerate simulations of systems with a sepn. of time scales or with long range forces.  The new algorithms have all of the advantages of previous RESPA integrators but are reversible, and more stable than those methods.  These methods are applied to a set of paradigmatic systems and are shown to be superior to earlier methods.  It is shown how the new RESPA methods are related to predictor-corrector integrators.  These methods can be used to accelerate the integration of the equations of motion of systems with Nose thermostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuVNub2HCMQrVg90H21EOLACvtfcHk0lgaFeHZAO3Y_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltFyksrg%253D&md5=4bcd9b330f004af953afc474c2fb72f9</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1063%2F1.463137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.463137%26sid%3Dliteratum%253Aachs%26aulast%3DTuckerman%26aufirst%3DM.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DMartyna%26aufirst%3DJ.%26atitle%3DReversible%2520multiple%2520time%2520scale%2520molecular%2520dynamics%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1992%26volume%3D97%26spage%3D1990%26epage%3D2001%26doi%3D10.1063%2F1.463137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamborini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agus, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezzelani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sozzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzarelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierotti, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotti, S.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1094</span>, <span class="refDoi"> DOI: 10.1054/bjoc.2000.1710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=10.1054%2Fbjoc.2000.1710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=11308259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFymurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2001&pages=1087-1094&author=E.+Tamboriniauthor=V.+Agusauthor=A.+Mezzelaniauthor=C.+Rivaauthor=G.+Sozziauthor=A.+Azzarelliauthor=M.+A.+Pierottiauthor=S.+Pilotti&title=Identification+of+a+novel+spliced+variant+of+the+SYT+gene+expressed+in+normal+tissues+and+in+synovial+sarcoma&doi=10.1054%2Fbjoc.2000.1710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma</span></div><div class="casAuthors">Tamborini, E.; Agus, V.; Mezzelani, A.; Riva, C.; Sozzi, G.; Azzarelli, A.; Pierotti, M. A.; Pilotti, S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1087-1094</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Harcourt Publishers Ltd.</span>)
        </div><div class="casAbstract">Synovial sarcoma (SS) is cytogenetically characterized by the translocation t(X;18)(p11.2-q11.2) generating a fusion between the SYT gene on chromosome 18 and one member of the SSX family gene (SSX1; SSX2; SSX4) on chromosome X.  Here, we report for the first time that 2 forms of SYT mRNA are present in both normal tissues and SSs.  By amplifying the full-length SYT cDNA of two SSs, we detected 2 bands, here designated N-SYT and I-SYT.  The latter, previously undescribed, contains an in-frame insertion of 93 bp.  Its sequencing revealed a 100% homol. with the mouse SYT gene.  These two SYT forms were present, although in different amts., in all human normal tissues examd., including kidney, stomach, lung, colon, liver and synovia.  Coexistence of N-SYT and I-SYT (both fused with SSX) was detected in a series of 59 SSs (35 monophasic and 24 biphasic) and in a SS cell line.  A preliminary anal. of the differential expression levels of N-SYT and I-SYT in SSs revealed that the latter was consistently overexpressed, suggesting a role in SS pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobdJqlLXV8z7Vg90H21EOLACvtfcHk0lgaFeHZAO3Y_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFymurg%253D&md5=5ad1e86142d0f9b649699cf4361c1b91</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1054%2Fbjoc.2000.1710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fbjoc.2000.1710%26sid%3Dliteratum%253Aachs%26aulast%3DTamborini%26aufirst%3DE.%26aulast%3DAgus%26aufirst%3DV.%26aulast%3DMezzelani%26aufirst%3DA.%26aulast%3DRiva%26aufirst%3DC.%26aulast%3DSozzi%26aufirst%3DG.%26aulast%3DAzzarelli%26aufirst%3DA.%26aulast%3DPierotti%26aufirst%3DM.%2BA.%26aulast%3DPilotti%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520novel%2520spliced%2520variant%2520of%2520the%2520SYT%2520gene%2520expressed%2520in%2520normal%2520tissues%2520and%2520in%2520synovial%2520sarcoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2001%26volume%3D84%26spage%3D1087%26epage%3D1094%26doi%3D10.1054%2Fbjoc.2000.1710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E9C" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E9C','PDB','5E9C'); return false;">PDB: 5E9C</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i140"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01497">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_21356"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01497">10.1021/acs.jmedchem.8b01497</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">RMSD values of derivative <b>5c</b>; values of docking scoring function for compounds <b>5a</b>,<b>c</b>−<b>f</b>, <b>6a</b>,<b>b</b>, and <b>9a</b>,<b>b</b>; cell-invasion assays for <b>7a</b> and <b>7g</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Human GS3 Hpse model in complex with docking poses of compounds <b>1</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_003.pdb">PDB</a>), <b>5c</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_004.pdb">PDB</a>), <b>7g</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_005.pdb">PDB</a>): authors will release the atomic coordinates and experimental data upon article publication</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_001.csv">jm8b01497_si_001.csv (9.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_002.pdf">jm8b01497_si_002.pdf (461.25 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_003.pdb">jm8b01497_si_003.pdb (300.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_004.pdb">jm8b01497_si_004.pdb (300.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01497/suppl_file/jm8b01497_si_005.pdb">jm8b01497_si_005.pdb (302.18 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01497&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-23%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01497" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01497" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679996796ce41975","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
